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Abstract 
Chinese Hamster Ovary (CHO) cells are the primary system for the production of 
recombinant proteins for therapeutic use. Protein productivity is directly proportional to 
viable biomass, viability and culture longevity. Identification of proteins and microRNAs 
(miRNAs) associated with regulation of growth and viability of CHO cells could improve 
recombinant protein productivity. 
Low temperature cultivation of CHO cells can reduce growth and improve viability and 
productivity of culture by extending the viable culture period. CHO-K1 cells grown in 
temperature-shifted culture (initially maintained at 370C to maximize biomass and then 
shifted to 310C to arrest cell growth) and standard culture at 370C were analysed using 2D-
DIGE. From the total of 53 identified differentially expressed proteins, 23 proteins were 
specifically differentially expressed in temperature-shifted culture and were involved in 
regulation of variety of cellular functions such as growth (HNRPC), cap-independent 
translation (EIF4A) and cytoskeleton (PFN2). The inhibition of HNRPC, EIF4A and PFN2 
using siRNAs was found to reduce growth and increase specific productivity (Qp) of SEAP 
in CHO-K1 cells suggesting them as potential target to improve productivity of cells.  
miRNA profiles of CHO cells grown in biphasic culture were established using Ambion 
miRNA-bioarray and miRNA TaqMan® Low Density Arrays (miRNA-TLDA) to identify 
miRNAs associated with regulation of cell growth and viability at low temperature. Two 
known growth regulatory miRNAs, miR-7 (down regulated) and miR-24 (up regulated), 
were observed to be differentially expressed following temperature-shift. Inhibition and 
over-expression studies showed that over-expression of miR-7 and miR-24 arrested growth 
(88% and 56% respectively) and increased Qp (116% and 68% respectively) of SEAP in 
 vii 
CHO-K1 cells in a temperature-independent fashion. These miRNAs represent attractive 
targets for regulating cell growth and improving productivity in CHO cells.  
Secreted proteins and peptides by CHO cells into culture medium can modulate growth and 
viability of culture as well as quality of product. The secretome of CHO-K1 cells was 
profiled using IMAC30 and Q10 chip surfaces with SELDI-ToF MS to investigate 
differential expression of proteins/peptides over time. While not identified yet, some of 
these peaks appear at different phases of cell cycle (i.e. lag, log and stationary) and may 
provide markers for monitoring proteolytic activity and health of the culture to maximize 
recombinant protein therapeutic production.  
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1.1 Chinese Hamster Ovary Cells 
Although various expression systems (prokaryotes, yeast and insects, etc) are capable of 
producing large amounts of protein, the decision to employ mammalian cells has been 
driven by the need for biologically active proteins. The biological activity of proteins can 
depend on a number of complex protein modifications including proper folding and post-
translational modifications such as glycosylation. Lower organisms such as prokaryotes and 
yeast cells, cannot perform these complex post-translational modifications and hence 
restricts their use in the production of pharmaceutical bio-products. 
Mammalian cells, in particular the Chinese Hamster Ovary (CHO) cell line, have emerged 
as the preferred host for the large scale production of recombinant proteins for therapeutic 
use. A large number of recombinant protein products, such as interferons (IF-γ and IF-β), 
tissue plasminogen activator, antibodies, growth factors (VEGF) and viruses (sindbis), are 
being industrially produced using CHO cells. CHO cells are epithelial-like (sometimes also 
described as ‘fibroblast-like’) cells that were established in 1957 by TT Puck and 
colleagues at the Department of Biophysics, University of Colorado Medical School in 
Denver, USA from an ovarian biopsy of an adult Chinese hamster (Puck et al. 1958). The 
CHO cell lines were found to have the following attributes that make it suitable for 
recombinant protein production: 
• Easy to handle and culture (CHO are a very fast growing cell line) 
• Highly adaptable to a variety of growth conditions including serum-free media 
• Exogenous DNA can be readily transfected into CHO cells  
• Genetic manipulation of CHO cells is simplified by virtue of their functionally 
haploid state (Siminovitch 1985).  
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Many commercially available subclones of the parental CHO and/or derivatives of CHO 
cells have been constructed to exhibit certain features that may help to improve the 
efficiency of production processes (Table 1). 
 
Table: 1 Commercially available subclones of the CHO cell line  
Cell line Description 
A2 Overproduces ornithine decarboxylase in response to polyamine 
deprivation 
A2H A recline of “Clone A” established by Puck (the “H” denotes 
MRC Harwell) 
CHO-DHFR or CHO-
DUKX-B11 
Dehydrofolate reductase negative subclone of the original CHO 
cell line  
CHO-K1 A subclone from the parental CHO cell line 
CHO MT+ A subclone of the parental CHO cell line 
Pro-5 The cells are proline auxotrophs and must be grown in a medium 
that contains proline (40 mg/L) 
CHO-SSF A subclone of CHO-DUKX-B11 
CHO-protein free The cells have been adapted to grow in protein-free medium 
SuperCHO A subclone of CHO-K1 expressing insulin, transferrin and IGF-1 
ViggieCHO A subclone of DUKX-B11 adapted to grow in the absence of 
exogenous growth factors 
 
Over the last two decades, significant improvements in recombinant protein productivity in 
CHO cells have taken place. This improvement is mainly due to improved media 
formulation, cell engineering approaches and reactor design (Wurm 2004). Until 1986, 
CHO cells typically reached a maximal density of ~2x106 cells/mL, specific productivity 
~10pg/cell/day and product titre ~50mg/l in a batch process production phase of about 7 
days. By 2004, cells were observed to rapidly grow >10x106 cells/mL with specific 
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productivity ~90pg/cells/day and product titre ~4.7 g/L and can maintain high viability for 
up to 3 weeks. 
 
1.2 CHO Cell Culture 
Although each clone has its own specific media requirement, CHO cells can be generally 
grown as an adherent culture with commercially available media such as DMEM, α-MEM 
or Ham’s F-12, usually in the presence of 10% fetal calf serum in a humidified incubator at 
370C and 5% CO2. However CHO cells can readily be adapted to grow in serum-free or 
protein-free medium. CHO cells usually grow quickly, so sub-culturing at least twice-a-
week is recommended. CHO cells can be frozen for storage in culture medium 
supplemented with 5% DMSO in liquid nitrogen. 
1.2.1 Types of CHO Cell Cultivation 
CHO cells can be cultured as adherent or suspension culture.   
1.2.1.1 Suspension Culture (non-anchorage dependent cells) 
Cells that do not require a surface to attach for growth are generally grown in suspension 
culture. However due to the absence of the cell wall, mammalian systems are prone to 
damage by shear forces and therefore the development of novel techniques to cultivate 
mammalian suspension cultures has focussed on the need to avoid creating high shear 
stresses. Suspension cultures are adaptable, homogenous and scalable systems. Their 
engineering is thoroughly understood and standardized at large scale, and automation and 
cleaning procedures are well established. Suspension systems offer the possibility of quick 
implementation of production protocols due to their ability to be scaled easily once the 
basic culture parameters are understood. The scale of operation of freely suspended 
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mammalian cell culture has been increasing and in order to meet the demand for 
recombinant therapeutic products, this increase is likely to continue (Wurm 2004). One of 
the great advantages of suspension culture is the opportunity it provides to study 
interactions of metabolic and production phenomena in chemostat or turbidostat steady-
state systems. Furthermore, in suspension cultures from which cell number and cell mass 
measurements are very easy to obtain, rigorous and quantitative estimations of the effects 
of growth conditions or perturbations of metabolic homeostasis can be made. Such studies 
speed up the development of optimal processes (Wurm 2004). CHO cells are very 
amenable to suspension culture and are generally grown at 60-100 rpm agitation speed, 20-
80% DO, 5% CO2, 7.2-7.4 pH and 370C (either in the presence or absence of serum).  
 
1.2.1.2 Anchorage dependent cells 
Anchorage-dependent cells require a surface substratum for growth. The routinely used 
surfaces, i.e. petri dishes, carrel flasks, T-flasks and roux bottles that are used for small 
scale cultures, are not amenable to scale-up since they provide only a limited growth 
surface to volume ratio. The first challenge for the production of recombinant protein 
products from anchorage dependent CHO cells was to increase the surface to volume ratio 
for attainment of maximal cell densities in the bioreactor. In the 1950s, many industrial 
vaccine production plants started using roller bottles which provide an inner surface as the 
substratum for growth. The roller bottles were rotated mechanically at optimized speed and 
each rotation ensures that the cells bound to the inner surface are exposed to gases and 
nutrients from the culture medium for growth. The disadvantage of such a process is that it 
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is labour intensive, expensive and the risks of contamination are enhanced because of the 
degree of handling necessary.  
1.2.1.3 Suspension culture of anchorage dependent cells 
The traditional approaches for the production of recombinant protein products from 
adherent cell culture were based on roller bottle cultures. The discovery of microcarriers 
combined the potentials of attached with suspension culture and opened the possibility of 
growing anchorage-dependent cells in suspension. The first microcarrier culture was 
diethylaminoethyl (DEAE) Sephadex A50 which was originally designed for ion exchange 
chromatography (van Wezel 1967). Most conventional microcarriers have a diameter of 
approximately 200- 250µm when suspended in medium and a specific density of 1.02-
1.03g/cm3, slightly higher than that of the medium. This allows minimum agitation to be 
used to keep them in suspension. It also allows a quick settlement after agitation is turned 
off, which is ideal for culture harvest or exchange of medium for supporting higher cell 
growth. The potential for increasing cell growth surface area was further advanced by the 
development of macroporous microcarriers. These are highly porous convoluted spheres 
with spacious internal cavities for cell attachment and growth. The cells in the interior of 
the macroporous microcarriers are also shielded from detrimental shear effect. The ease of 
cell retention in microcarriers in culture also enables the use of perfusion system. 
1.2.2 Modes of cell culture in Bioreactors 
The following modes of cultivation are available for cells grown in bioreactors: 
1.2.2.1 Batch Culture 
Batch culture is a closed system in which cells and medium are added once to the reactor at 
the beginning of culture and harvested after an appropriate time interval. The physical as 
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well as chemical environment in batch culture varies with time. Proper agitation and 
aeration are required for good cell growth and production. Nutrient depletion and waste 
accumulation are the major critical factors determining cell growth in batch culture. Batch 
culture was the method of choice for pharmaceutical production until recently. It is 
economical, flexible for different products or cell types with lower risk of contamination or 
cell mutation because of the relatively short cultivation time. On the other hand, it is time 
and labour consuming, requires a higher cost of inoculum preparation, needs 
instrumentation more frequently (i.e. autoclave and washer, etc) and is less productive.  
1.2.2.2 Fed-batch Culture 
Fed-batch culture is a modified version of batch culture to improve productivity. In fed-
batch culture, small volumes of medium or selected nutrients are fed to the culture during 
the growth cycle to enhance growth and productivity of the culture. The culture is 
subsequently harvested and the product is recovered. In this type of culture method, 
accumulation of waste products is the major limiting factor for cell growth and recombinant 
protein productivity. Fed-batch cultures are more productive and can maintain higher viable 
cell densities for longer time periods compared to the batch mode.  
1.2.2.3 Perfusion Culture 
In perfusion cultures, cells are physically retained in the vessel while the spent medium is 
withdrawn continuously from the culture system and an equal volume of fresh medium is 
added. The perfusion culture production requires reliable cell retention and proper feed rate 
specifications. The rate of medium replacement (perfusion) is controlled by the nutritional 
requirements of the cells. They are highly automated, consistent and productive with 
reduced labour and instrumentation requirements. However, they are less flexibile and 
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difficult to monitor cell, require uniformity of raw material and high cost due to continuous 
replenishment of medium, and have a higher risk of contamination and cell mutation.  
 
1.3 Generation of suitable production clones 
For the production of a recombinant protein, the gene coding for the protein of interest 
needs to be stably transfected into CHO cells. Lipofection, using cationic lipid-based 
transfection reagents e.g. Lipofectamine-2000 (Invitrogen), is the most commonly used 
method for high transfection efficiency (Gamper and Shapiro 2003). However, calcium 
phosphate-mediated method is a cheap and reliable method. 
The gene of interest is expressed using selectable and amplifiable expression systems to 
increase recombinant protein production. There are a number of expression systems 
available to express the protein of interest in CHO cells. These include dihydrofolate 
reductase (DHFR), neomycine phosphotranspherase (NPT)-G418, glutamine synthetase 
(GS) and metallothionein (MT) expression systems. The use of selectable marker (e.g. 
DHFR, NPT, GS or MT) enables survival of only those cells which produce increased 
amounts of the marker gene product (due to exogenous plasmid) in presence of selection 
pressure (methotrexate, G418, reduced glutamine or increased metal) in culture medium. 
This facilitaes easy isolation of recombinant variants.  
All expression systems also have issues with their stability in expression which is an 
important aspect to consider when selecting expression systems. The presence of selective 
pressure at an optimized concentration is a constant requirement for stable production of 
recombinant proteins (Bailey et al. 2002). A drop in recombinant protein production has 
also been observed in the presence of selection pressure over time (Strutzenberger et al. 
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1999). An increase in selection pressure above optimum concentration can increase the 
gene copy number in the genome of rCHO but it may not significantly enhance the 
productivity due to limited transcription in cells (Fann et al. 2000). The removal of 
selection pressure in culture results in reduced gene copy number with time and this results 
in reduced production (Barnes et al. 2003). Also, the co-amplification of marker and 
recombinant genes can result in reduced cell growth due to increased metabolic load on the 
cell (Yallop and Svendsen 2001, Gu et al. 1995). Apart from this, the site of incorporation 
of the recombinant gene within the host cell genome and clonal variation can also affect 
stability and transcription of recombinant genes (Barnes et al. 2003, Kim et al. 2001).  
Therefore, a better understanding of these processes will be helpful to engineer cells for 
improved cell growth and productivity. 
 
1.4 Culture Medium 
Culture medium is an important compartment in designing any culture process since 
productivity is directly proportional to biomass and viability of producer cells. Each culture 
medium contains a large number of components i.e. amino-acids (essential and non-
essential), vitamins, nucleic acids, lipids, inorganic salts, growth promoters (IGF, EGF and 
FGF, etc) and an energy source, and vary from each other in their composition. Based on 
composition, culture medium should be able to satisfy all the nutritional needs of cells 
throughout the culture. At the same time, culture medium should not increase osmolality or 
encourage generation of excess metabolic waste products as these issues affect both 
quantity and quality of product (Castro et al. 1992, Lao and Schalla 1996). Recent 
developments in media formulation can be broadly divided into following categories. 
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1.4.1 Serum supplemented medium 
Serum, a non-cellular portion of blood that remains after removal of blood cells and 
clotting proteins, is one of the most important basic requirements for most mammalian cell 
lines during in vitro culture. It contains an ill-defined mixture of plasma proteins and 
polypeptides, lipids and hormones, nutrients, minerals and a variety of other unknown 
substances that may or may not be advantageous for cell culture (Sato 1983). Serum exerts 
shear-protective and anti-apoptotic effects on cells (Zanghi et al. 1999). However, serum 
can show relatively high batch-to-batch variation and has also been considered as a great 
source of microbial contaminations such as viruses, mycoplasmas or prions.  
1.4.2 Serum-free medium formulation 
Elimination of serum from culture medium is an important factor when a product is for 
therapeutic purposes since serum may be a source of contaminants (e.g. viruses, 
mycoplasma or prions), is hard to standardize (batch to batch variation), and increases the 
cost of down stream processing. A number of serum-free media formulations for CHO cells 
have been developed by various researchers using different approaches. These includes 
GC3 (Gasser et al. 1985), WCM5 (Keen and Rapson 1995), CHO-T1-SF (Schroder et al. 
2004),  ExCell (Wyatt DE 1994) or UC203 (Ii et al. 1995). A number of animal 
component-free and chemically-defined serum-free media are also commercially available 
for CHO cell growth i.e., ExCell CD (Sigma).  
1.4.3 Protein-free medium formulation  
The elimination of proteins from medium would be a major achievement in pharmaceutical 
protein production as it allows a further reduction in downstream processing costs. A 
number of protein-free media formulations are available to date, including MCDB301 
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(Hamilton and Ham 1977) and  CHO-T1-PF (Schroder et al. 2004). A few animal 
component-free and chemically-defined protein-free media are also available for CHO cell 
growth, such as CHO-PF-AF (Sigma). 
 
1.5 Translation 
Decoding of messenger RNA (mRNA) to produce a specific protein (or polypeptide) 
according to the rules specified by the genetic code is called translation. Translation is the 
first stage of protein biosynthesis and occurs in the cytoplasm at ribosomes. Ribosomes are 
made of a small and large subunit. During translation, mRNA sequence provides a template 
to guide the synthesis of a chain of amino acids that form a protein. Eukaryotic translation 
proceeds in three phases: activation, initiation, elongation and termination. 
1.5.1 Eukaryotic translation initiation  
The amino acid is joined by its carboxyl group to the 3' OH of the transfer RNA (tRNA) by 
an ester bond and therefore decoding of mRNA during translation proceeds in the 5’→ 3’ 
direction. The small ribosomal subunit has to be recruited to the mRNA at the 5’end for 
translation initiation. The eukaryotic translation initiation is one of the major control points 
in translation. Two principle pathways, cap-dependent and cap-independent, are available 
for attachment of the ribosome in eukaryotes for translation initiation. Cap-dependent 
translation pathway is preferable translational mechanism, however cells may also use the 
cap-indepndent translation mechanism under various stress conditions such as hypoxia or 
hypothermia (Al-Fageeh et al. 2006, Al-Fageeh and Smales 2006).  
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1.5.1.1 Cap-dependent translation initiation 
The cap-structure is added to the 5’ end of the pre-mRNA during transcription. Cap-
structure consists 7-methylguanosine linked to the first nucleoside via a 5’-5’ triphosphate 
bridge added during the synthesis of the primary transcript. It facilitates slicing, 
polyadenylation, nuclear export, stability and recognition of mRNA for translation.  
Cap-dependent translation initiation involves large numbers of eukaryotic translation 
initiation factors (eIFs) and other proteins that participate in the stepwise assembly of the 
80S ribosome initiation complex (translation initiation complex) (Holcik et al. 2000) and 
can be explained in following 5 specific steps (Figure 1.5.1): 
1. The ribosome must dissociate into 40S and 60S subunits; 
2. The pre-initiation complex is formed when eIF2 binds Met-tRNA with GTP 
(eIF2.Met-tRNA.GTP), which then binds 40S subunit to form 43S ribosomal 
subunit. tRNAs carry the amino acids to the actively translating ribosome during 
protein synthesis; 
3. The 7’-Methyl-Gppp cap-structure at 5’-UTR of mRNA is recognised by eIF4E 
which is part of the cap-binding protein complex eIF4F (composed of the RNA 
helicase eIF-4A, the scaffold protein eIF4G, and the cap-binding protein eIF4E). 
eIF-4B and eIF-4H also joins this complex. This complex melts the secondary 
structure of near the 5’ end of mRNA;  
4. eIF-3 of 43S pre-initiation complex binds to eIF-4G at cap-structure and searches 
for the translation initiation signal. The eukaryotic signal to begin translation is an 
AUG codon in a particular context and as such, all proteins begin with a Methionine 
(encoded by AUG and recognised by t-Met) that is later cleaved. Binding of pre-
 13 
initiation complex to AUG releases the associated translation initiation factors 
which are used in further translation initiation cycles; 
5. The 60S subunit then associates with the pre-initiation subunit to form the 80S 
initiation complex. 
 
Figure 1.5.1: Schematic diagram of cap-depndent translation initiation. 
 
 
1.5.1.2 Cap-independent translation initiation 
The cap-independent translation initiation involves recruiting and binding of the small 
ribosomal subunit (40S) to a complex secondary structure element within the mRNA, 
known as the internal ribosomal entry site (IRES) (Pelletier and Sonenberg 1988). IRES 
elements are often found in characteristically long structured regions on the 5'-UTR of an 
mRNA that may or may not have regulatory upstream open reading frames (uORFs). Both 
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of these features on the 5'-end of the mRNA hinder ribosomal scanning, and thus promote a 
cap-independent translation initiation mechanism. The molecular mechanism of cap-
indepdent translation is not known. A number of proteins (represented by Factor X), such 
as FUBP2 (Lin et al. 2009), HNRPL (Hwang et al. 2009), and HNRPD (Paek et al. 2008), 
have been observed to bind with IRES elements which could be involved in cap-
independent translation initiation (Figure 1.5.2). The variant of eIF-4G (or other members 
of eIF-4G familiy such as p97) could also be expected to facilitate the IRES-mediated 
interaction between mRNA and 40S ribosomal unit as the truncated form of eIF-4G has 
been observed to stimulate translation of some of the viral mRNAs containing an IRES 
(Borman et al. 1997). In cap-dependent translation initiation, eIF-4G is responsible to bring 
together the capped end of the mRNA (via cap-binding protein eIF-4E) with the 40S 
ribosomal subunit (via eIF-3). eIF-4G is a subunit of the trimolecular eIF-4F complex, 
together with eIF-4E and eIF-4A. Once 40S subunit finds initiation codons, the 60S subunit 
joins this IRES-mediated pre-initiation complex and facilitates translation.    
  
 
Figure 1.5.2 IRES-mediated cap-independent translation initiation. 
 
 
 
1.5.2 Translation elongation 
 
Each translation elongation cycle adds one amino acid at a time to a growing polypeptide 
according to the sequence of codons found in the mRNA. The translation initiation codon 
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(AUG) facilitates binding of t-RNA containing methionine amino acid at the P-site. The 
extension of the polypeptide chain occurs when a specific aminoacyl-tRNA, as determined 
by the template mRNA, binds to ribosome at the A-site. The peptidyl transferase catalyses 
the formation of a peptide bond between the incoming amino acid at the A-site and peptide 
at P-site resulting the transfer of naïve peptide to t-RNA at the A-site. Thereafter peptidyl-
tRNA at their A-site physically translocates to the P-site and another cycle of elongation 
starts to add further amino acids into the growing peptide. 
1.5.3 Translation termination 
Termination of the polypeptide happens when the ribosome encounters a stop codon (UAA, 
UAG, or UGA). No tRNA can recognize stop codons. Releasing factors recognize these 
nonsense codons (stop codons) and cause release of the polypeptide chain.  
 
1.6 Regulation of cell proliferation and productivity 
An increase in the number of cells as a result of cell growth and cell division is called cell 
proliferation. Recombinant protein yields from CHO cell fermentations are directly 
correlated with cell number and culture longevity. Cell growth in standard production 
culture systems can be divided into four phases, i.e. lag, log, stationary and decline phase. 
Long lag phases (slow growth rate) are undesirable. High growth rates are necessary 
essential at the beginning of a process to achieve sufficient cells for maximal production. 
Uncontrolled proliferation beyond a certain desired cell density is also undesirable due to 
nutrient and oxygen depletion, toxic metabolite accumulation, cell death and degradation of 
the products (al-Rubeai and Singh 1998, Zeng et al. 1998, Zeng and Deckwer 1999). 
Regulation of cell proliferation in production cultures has been a topic of interest for 
researchers. Proliferation control strategies are typically implemented in the mid- or late-
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phases of exponential growth and have been shown to improve both the productivity and 
duration of production processes. Regulation of cell proliferation can generally be achieved 
through cell cycle arrest or through regulation of nutrients availability.  
1.6.1 Cell cycle arrest based approaches 
Protein production is dependent on the phase of the cell-cycle and several genes such as 
those involved in ribosome biogenesis and protein translation are expressed highly in the 
G1 phase (Al-Fageeh et al. 2006, Al-Fageeh and Smales 2006, Sonna et al. 2002). Cells 
arrested at the end of G1-phase of cell cycle are metabolically more active and bigger in 
size than non-arrested cells (Bi et al. 2004, Carvalhal et al. 2003). For these reasons, the 
G1-phase of the cell cycle is considered the ideal time for increased production of 
recombinant proteins and G1 arrest has been used to increase the productivity in a number 
of commercially relevant cell lines such as hybridomas and CHO cells (Al-Fageeh et al. 
2006, Al-Fageeh and Smales 2006, Sonna et al. 2002). Some studies have reported the S 
phase as the optimal production phase (Lloyd et al. 2000, Fox et al. 2005), an example 
being the increased production of human interferon-gamma (IFN-γ) upon increasing the 
percentage of CHO in S phase (Fox et al. 2005). There are a number of G1 phase arrest 
based approaches to regulate the cell growth and productivity and are discussed in the 
following sections.  
1.6.1.1 Cell engineering based approaches 
Currently most cell engineering based approaches to control proliferation and enhance 
productivity are at the proof of concept stage and do not form a major part of most 
industrial production runs. These studies have allowed researchers to specifically identify 
molecules which are important for regulation of proliferation (Table 2). 
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Table 2: Effect of cell engineering on cell cycle and productivity 
Productivity (fold change) Contributor Cell line and recombinant product Effectors 
Qp Y 
(Fussenegger et al. 1997) CHO Secreted alkaline phosphatase (SEAP) p21CIP1, p27KIP1 or p53175P 10 ND 
(Fussenegger et al. 1998) CHO SEAP p21CIP1 10 to 15 ND 
(Mazur et al. 1998) CHO SEAP p21CIP1, p27KIP1 or p53175P 10 to 15  
(Fussenegger et al. 1998) CHO SEAP p21CIP1 + Bcl-2 30 ND 
(Kaufmann et al. 2001) CHO SEAP 
p27KIP1 and reduced 
temperature culture (300C) 2 to 3 ND 
(Watanabe et al. 2002) NS0 human-mouse chimeric IgG4 antibody p21CIP1 >4 ND 
(Meents et al. 2002) CHO soluble intercellular adhesion molecule (sICAM) p27KIP1 5 NC 
(Ibarra et al. 2003) NS0 Chimeric antibody p21CIP1 4 ND 
(Carvalhal et al. 2003) CHO SEAP p27KIP1 4 NC 
(Bi et al. 2004) CHO human-mouse chimeric IgG4 antibody p21CIP1 ~4 NC 
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1.6.1.1.1 p21 
Cyclin dependent kinases (CDKs) are key components of the pathways that control cell 
cycle transition (Hengst et al. 1994, Sugimoto et al. 2002) and therefore are important 
targets for achieving control of cell proliferation. Cyclins, phosphorylation and the 
formation of ternary complexes with cyclin dependent kinase inhibitors (CKI), such as 
p21CIP1 and p27KIP1, direct CDK activity (Grana and Reddy 1995). p21CIP1 can be induced 
by either tumour suppressor gene p53 or tumor growth factor-β (TGF-β) (Reynisdottir et al. 
1995). At elevated intracellular concentrations, p21CIP1 binds to cyclin-CDK complexes and 
inhibits the progression of cell cycle at the G1/S transition phase (Bi et al. 2004). p21CIP1-
arrested CHO cells were ~4-fold bigger than proliferating CHO cells, metabolically more 
active and demonstrated a corresponding increase in protein synthesis (Bi et al. 2004). 
Similarly, specific productivity of chimeric IgG4 antibody was found to be increased by 4-
fold in NS0 cells following p21CIP1 arrest (Watanabe et al. 2002, Ibarra et al. 2003). 
1.6.1.1.2 p27 
p27KIP1 evokes G1-cell cycle arrest by binding to cyclin E/CDK2, Cyclin A/CDK2 and 
cyclinD/CDK4, all of which are required for transition of cells from G1 to S phase 
(Toyoshima and Hunter 1994). TGF-β-treated Mv1Lu mink lung epithelial cells and human 
keratinocytes were reported to have increased p27KIP1 levels resulting in cell cycle arrest 
(Reynisdottir et al. 1995, Sgambato et al. 2000). The use of p27KIP1 under the control of the 
Tet-switch (tetracycline-responsive promoter phCMV–1) facilitated a growth-arrested 
extended production phase of at least 7 days and enhanced volumetric SEAP production in 
CHO cells (Mazur et al. 1999). p27KIP1 arrest-induced increase in specific productivity was 
linked to higher expenditure of cellular energy as demonstrated by increased nutrient 
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consumption (oxygen, glutamine and glucose) and waste production (lactate and ammonia) 
(Carvalhal et al. 2003). 
1.6.1.1.3 p53 
p53, besides promoting p21CIP1 expression, also induces other effectors of cell-cycle arrest 
such as GADD45 and the insulin-like growth factor binding protein 3 (IGF-BP3), all of 
which exert a cell-cycle block at G1-phase (Mazur et al. 1998, el-Deiry et al. 1994, 
Buckbinder et al. 1995, Rowan et al. 1996) making p53 one of the most important growth 
suppressors in eukaryotes. However it also induces apoptosis in some cell lines (el-Deiry et 
al. 1993, Ko and Prives 1996). A p53 mutant, p53175P, has been generated which causes 
cell-cycle arrest but not apoptosis in primary rat embryo fibroblasts (Rowan et al. 1996). 
p53175P has been shown to cause cell cycle arrest and improve cell specific productivity 
comparable to p21CIP1 or p27KIP1 (Fussenegger et al. 1997, Mazur et al. 1998). 
1.6.1.2.4 Bcl2 
Apart from CDKs and CKIs, expression of Bcl-2 can also cause cell cycle arrest in G1- 
phase of murine hybridoma cells (Kim et al. 2001, Simpson et al. 1999). About 80% of 
hybridoma cells expressing Bcl-2 accumulated in G1 phase of the cell cycle (Simpson et al. 
1999). The duration of G1-phase was increased by 75% due to Bcl-2 expression in NS0 
cells, although cell cycle arrest occurred in the G2 phase (Tey and Al-Rubeai 2005). Bcl-2 
is known for its anti-apoptotic activity, however its cell cycle modulation activity has been 
reported to be distinct from its anti-apoptotic domain (Huang et al. 1997). 
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1.6.1.2 Low temperature cultivation of mammalian cells 
Low culture temperature has been shown to reduce the growth rate and increase culture 
longevity and specific productivity in CHO cells expressing a wide range of recombinant 
proteins (Al-Fageeh et al. 2006, Al-Fageeh and Smales 2006, Sonna et al. 2002). A shift in 
the proportion of cells from the S to the G1 phase of the cell cycle has been observed at 
reduced temperatures which results in a state close to growth arrest and has been shown to 
improve productivity (Table 3). For example, 80% of secreted alkaline phosphatase (SEAP) 
and 76% of erythropoietin (EPO) producing CHO lines accumulate in G0/G1 phase of the 
cell cycle following reduction of the culture temperature to 300C with associated increases 
in productivity (Kaufmann et al. 1999, Yoon et al. 2003). The quality of recombinant 
products, with regard to isoform pattern, sialic acid content, and in vivo biological activity, 
is maintained at reduced temperatures (Hendrick et al. 2001, Clark et al. 2004, Bollati-
Fogolin et al. 2005), while proteases activity appears unaltered (Clark et al. 2004). 
Low culture temperature results in reduced metabolism (glucose/medium consumption, 
oxygen uptake, lactate production and ammonia production) and shear sensitivity (Moore et 
al. 1997, Chuppa et al. 1997, Jorjani and Ozturk 1999, Marchant et al. 2008). The specific 
glucose and oxygen uptake rates were observed to be reduced extensively at low 
temperatures compared to 37°C (Marchant et al. 2008, Sureshkumar and Mutharasan 1991, 
Fox et al. 2004). The reduced metabolic rates at low temperature contribute to reduced 
lactic acid (and ammonia) formation in the culture over time. This enabled significant 
reductions in the amount of NaHCO3 required for pH control and consequently, in pCO2 
and osmolality levels in culture which often reach inhibitory levels in high density cultures. 
Thus, reduced metabolic activity contributes to delayed initiation of apoptosis and helps in 
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extending the duration of stationary (or production) phase at reduced temperature (Al-
Fageeh et al. 2006, Al-Fageeh and Smales 2006, Sonna et al. 2002). Apart from this, the 
effect of reduced temperature on cells is likely to be multifactorial as it also combines the 
effect of changes in oxygen concentration due to the higher dissolved oxygen concentration 
at reduced temperatures (Ohsaka et al. 2002). 
For the above reasons, many processes employ a biphasic culture process for recombinant 
protein production (Kaufmann et al. 1999, Baik et al. 2006, Trummer et al. 2006). This 
culture process consists of two phases: an initial proliferation phase designed to maximize 
biomass at 370C, followed by an extended production phase, at reduced temperature (28–
330C), during which the cells remain growth arrested while the production of heterologous 
proteins is maintained at a high and stable level (Table 3). 
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Table 3: Effect of reduced temperature on cell cycle and productivity in CHO 
Productivity 
(fold change) 
Contributor 
Product 
expressed in 
CHO Media Type 
Culture 
Vessel 
Reduced 
Temperat
ure (0C) 
Cell cycle 
distribution in 
G0/G1 (%) Qp Y 
(Moore et al. 
1997) Chimeric Fab 
DMEM/HAM’s F-12 (1:1 mixture) + 
1g/L Pluronic F68, 0.2ml/L antifoam 
emulsion 
2L 
Bioreactor 30a 87 ND ND 
(Kaufmann et al. 
1999) SEAP FMX-8 medium + 10% FCS T-25 flask 30a 80 1.7 3.4 
T-25 flask 30b 77 NC NC 
(Yoon et al. 
2003) 
Anti-4-1BB 
Antibody 
IMDM+10%FBS replaced with SF2 
SFM in exponential phase followed by 
temperature-shifts T-25 flask 33b 67 NC 3.9D 
T-75 flask 30a 76 5.6 2.5 
(Yoon et al. 
2003) EPO 
IMDM+10%FBS replaced with SF2 
SFM in exponential phase followed by 
temperature-shifts T-75 flask 33a 67 4 0.86D 
(Fogolin et al. hGM-CSF ZKT-1 medium + 5% FCS Spinner 33a 65 2.1 2.3 
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2004) flasks 
(Trummer et al. 
2006) Epo-Fc 
DMEM/HAM’s F-12 (1:1 mixture) + 
0.58 g/L L-glutamine, an in-house 
developed protein-free supplement, 
0.25% soy peptone, 0.1% Pluronic F68, 
and 0.096 mM MTX 
0.5L 
Bioreactor 30a 65 1.85 1.3 
(Yee et al. 
2008) IgG 
DMEM/HAM’s F-12 (1:1 mixture) + 
0.3 g/L ethanolamine, 19 mg/L L-
ascorbic acid, 4.84 mg/L sodium 
selenite, 6.2 mM putrescine, 1.85 mg/L 
mercaptoethanol, and 5 mg/L 
apotransferin. 
Spinner 
flasks 33a ND 1.4 1.2 
a: Temperature-shift from 370C; b: Continuous Reduced Temperature Culture; Qp: Cell Specific Productivity; Y: Overall Volumetric Yield; ND: 
Not Determined; NC: No Change; D: Down Regulated   
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The mechanisms whereby cells at lower temperatures improve productivity are still poorly 
understood. The recent studies have demonstrated that reduced culture temperature invokes 
a highly coordinated response in transcription and translational machinery to synthesize 
selective proteins which may be involve in regulation of cell growth, viability and protein 
productivity of cells (Al-Fageeh et al. 2006, Al-Fageeh and Smales 2006, Sonna et al. 
2002).  
1.6.1.2.1 Effects of low temperature on transcription 
Reduced culture temperature alters expression of transcription factors leading to the global 
inhibition of transcription (Sonna et al. 2002, Roobol et al. 2009). The mechanism of this 
reduction in global transcription is poorly known. Low temperature is known to stabilize 
the secondary structures of RNA and DNA resulting in reduced DNA replication, 
transcription and translation (Phadtare et al. 1999). Moreover, a few proteins could bind to 
its own mRNA to destabilize the elongation complex of RNA polymerase which causes 
attenuation of transcription and translation (Bae et al. 1997).  
Increased mRNA levels of specific genes have been observed at low temperature 
suggesting that cells transcribe genes selectively at low temperature (Sonna et al. 2002, 
Yoon et al. 2003, Marchant et al. 2008). However, the mechanism of this selective 
transcription is unknown. The expression of interferon-γ mRNA was found to be increased 
in CHO cells due to its enhanced transcription at low temperature (Fox et al. 2005). 
Similarly, the level of EPO mRNA was also observed to be increased by ≥2 fold at low 
temperatures (31 and 330C) due to increased transcription compared to standard culture 
(370C) in the lag and log phases of culture and this contributed into increased productivity 
(Yoon et al. 2003). The increased mRNA stability has also observed at low temperature in 
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CHO cells (Sonna et al. 2002). The mRNA for cold shock proteins have been observed to 
contain point mutations in their 5’UTR regions which provide resistance to the RNAase 
and stabilize mRNAs at low temperature (Fang et al. 1997). The cold shock proteins, such 
as CIRP, has also been observed to bind to the succeptible mRNAs at 3’ UTR and expected 
to facilitate increased stability at low temperature (Yang and Carrier 2001). This suggests 
that the increased level of gene of interest either due to increased transcription or mRNA 
stability is one of the crucial factors for the enhanced cell specific productivity at low 
culture temperature.  
A shift in the transcription of splice variants of amyloid precursor protein has been 
observed in a normal human fetal astrocytic cell line (CC2565) following heat shock 
(Shepherd et al. 2000). A number of proteins has been identified at multiple location on the 
2D-gel in response to hypothermic conditions which could be a alternative splice variant of 
proteins rather than being a post-translationally modified variants (Sonna et al. 2002, Baik 
et al. 2006). Therefore, CHO cells could also be suspected to perform the alternative 
splicing of proteins at low temperature (Sonna et al. 2002). 
1.6.1.2.2 Effects of low temperature on translation 
Low temperature has been observed to inhibit global cap-dependent protein translation 
(Roobol et al. 2009, Phadtare et al. 1999, Wassmann et al. 1998). The expression of 
number of proteins, including translation initiation factors (e.g. EIF3i) and molecular 
chaperons (e.g. CCT), was observed to be reduced in CHO cells at low temperature 
(Roobol et al. 2009). Cells remain metabolically active at low temperature and induce the 
synthesis of small number of proteins using alternative translation pathway(s), possibly by 
cap-independent translation, enabling cells to more effectively tolerate hypothermic 
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conditions (Al-Fageeh et al. 2006, Kaufmann et al. 1999, Baik et al. 2006, Yee et al. 2008). 
Cap-independent translation has been observed to be activated under various stress 
conditions, such as hypoxia or hypothermia, however its molecular mechanism is still 
unknown. These include cold-inducible RNA binding protein (CIRP, also known as hnRNP 
A18) (Nishiyama et al. 1997b) and RNA binding motif protein 3 (RBM3) (Yee et al. 2008, 
Danno et al. 2000).  
CIRP and RBM3 have been studied extensively. Both are involved in the modulation of 
transcription and translation by acting as RNA chaperones (Sonna et al. 2002, Nishiyama et 
al. 1997b, Danno et al. 2000, Dresios et al. 2005). Both proteins are highly similar and 
belong to the glycine rich RNA-binding protein family that are characterized by a 
consensus sequence RNA-binding domain (CS-RBD) at the N-terminus and a glycine-rich 
domain at the C-terminus (Derry et al. 1995). CIRP was the first protein identified that was 
induced following reduction of temperature in mammalian cells (Nishiyama et al. 1997b). 
Apart from CHO, CIRP has been detected in mouse, rat and human cells (Nishiyama et al. 
1997a, Xue and Rao 1981). The expression of CIRP has also been observed to increase 
when cells are exposed to other stress conditions, such as ultraviolet radiation (Yang and 
Carrier 2001) or hypoxia (Fujita 1999), although heat stress does not affect CIRP levels 
(Nishiyama et al. 1997b). Inhibition of CIRP expression using antisense oligonucleotides 
allowed the reversal of cold induced growth arrest in mouse fibroblasts cells (BALB/3T3) 
indicating that CIRP is at least a component of the low temperature induced growth 
suppression (Nishiyama et al. 1997b). CIRP also specifically binds to the 3’ untranslated 
region (UTR) of susceptible RNAs protecting and restoring their native confirmation 
during stressful conditions and this binding could improve both the efficiency of IRES-
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mediated cap-independent translation and RNA stability (Yang and Carrier 2001, Chappell 
et al. 2001). In recent studies, 4-fold increases were observed in CIRP expression in both 
EPO and FSH expressing CHO cells at 320C in comparison to standard 370C culture (Yoon 
et al. 2006). No significant permanent change (decrease or increase) in CIRP expression 
was observed through further adaptation of both cell lines to reduced temperature, which 
may be because the effect of cold shock was eliminated during the adaptation process. The 
growth rates of low temperature-adapted CHO cells were improved by 73% and 20%, 
respectively, despite static CIRP levels. It is clear therefore that other factors are involved 
in the control of cell growth at reduced temperature (Yoon et al. 2006). 
RBM3 is another well-studied protein that is induced in mammalian cells at reduced 
temperature. The RBM3 gene resides on the Xp11.2 region in humans and codes for a 
protein very close in structure to other human RNA-binding proteins and shares 94% 
identity in amino acid sequence with mouse RBM3 (Danno et al. 2000, Derry et al. 1995). 
RBM3 is increased at reduced temperature in various cells, i.e. HepG2, NC65, HeLa, T24, 
K562, TAMA26 and CHO cells (Yee et al. 2008, Danno et al. 2000). RBM3 has been 
found to be involved in cytokine-dependent proliferation (Baghdoyan et al. 2000), poxvirus 
replication (Wright et al. 2001), development of cancer (Baldi et al. 2003) and apoptosis 
(Kita et al. 2002). Expression of RBM3 at reduced temperature was shown to result in 
higher relative levels of 80S monosomes and polysomes consistent with an increased 
association of ribosomal subunits during the initiation step of protein synthesis (Dresios et 
al. 2005). A tight physical association of RBM3 with 60S ribosomal subunits that did not 
require RNA or nascent polypeptide chains has also been reported. Several deletion and 
mutational analysis experiments on a putative internal ribosome entry site (IRES) within 
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the 720 bp 5’ leader sequence of the RBM3 mRNA revealed at least nine discrete cis-acting 
sequences, including a 22-nt IRES module (a 10-nt enhancer and two inhibitory sequences), 
and four of them probably bind specifically to distinct cytoplasmic proteins (Chappell and 
Mauro 2003). As a result of these findings, it is thought that the 5’-UTR of RBM3 mRNA 
contains a number of specialized sequences that facilitate cap-independent translation to 
ensure mRNA translation upon cold shock despite general (cap-dependent) mRNA 
translation being compromised (Chappell et al. 2001, Chappell and Mauro 2003). 
Decreased levels of microRNAs were also reported in mouse N2a neuroblastoma cells 
expressing an RBM3-c-Myc fusion protein, indicating that RBM3 can interact with the 
miRNA fraction and hence could regulate global levels of protein synthesis (Dresios et al. 
2005). RBM3, like CIRP, can be regulated by changes in oxygen levels which further 
indicates a link between the low-temperature and oxygen-response pathways (Wellmann et 
al. 2004). 
Therefore, the proteins synthesized by cells at low temperature using IRES-mediated cap-
independent translation may facilitate transcription and translation of selective proteins by 
acting as chaperones or translational factors (Sonna et al. 2002, Roobol et al. 2009). 
Increased stability of proteins has been observed at subphysiological temperatures and this 
further help to regulate low temperature-induced phenotypes (Roobol et al. 2009). The half-
life of p53 was observed to be ≥2 fold improved at low temperature in CHO cells which 
could contribute to p53-mediated cell cycle arrest in hypothermia (Roobol et al. 2009). The 
mutations in the low-temperature-induced proteins could be one of the possible 
mechanisms used by cells to improve the stability of proteins without compromising 
activity at hypothermic conditions (Roobol et al. 2009, Schindler et al. 1998). The 
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proteases activity in culture medium at reduced temperature has also been observed to be 
very similar to cultures maintained at standard temperature (370C) suggesting the 
independency of protein stability at low temperature with protease activity (Clark et al. 
2004). Therefore, selective translation and improved stability of proteins are one of the 
critical factors that help to regulate various cellular phenotypes, such as growth, viability, 
secretion and productivity, at low temperature. 
 
The comparison of cell cycle arrest through either reduced culture temperature or 
heterologous gene expression has revealed that temperature-shift is currently superior and it 
is also a more practical approach. Direct comparisons include the example where p27-
mediated growth arrest greatly enhances specific productivity (~15-fold) while low 
temperature ensures complete and sustained growth arrest leading to a higher overall 
volumetric productivity (Mazur et al. 1998, Kaufmann et al. 2001). In studies where the 
expression of p27 was carried out at low temperature, it was found that the temperature 
effect was dominant (Kaufmann et al. 2001). Arresting cells through reduction of the 
temperature also has the advantage that all cells are similarly affected whereas engineering 
approaches allow for the possibility of clones which escape growth suppression (Mazur et 
al. 1998). Mutation or loss of the genes necessary for proliferation control may render the 
situation worse and could provide a substantial growth advantage to mutant cells which can 
lead to overgrowth of the arrested cells and subsequent loss in product yield (Fussenegger 
et al. 1997, Fussenegger et al. 1998, Kaufmann et al. 2001). Although the effects of low 
culture temperature on the cellular productivity of recombinant proteins have been 
observed to be variable and depends on the temperature, cell line, clone, expression system 
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and/or protein, reduced cell growth was observed in cases suggesting it as a universal 
phenomenon (Al-Fageeh et al. 2006, Al-Fageeh and Smales 2006, Sonna et al. 2002). 
Therefore use of temperature-shift for recombinant protein production is the method of 
choice employed in industrial processes. 
1.6.1.3 Chemical approaches for cell cycle arrest 
1.6.1.3.1 NaBu 
Sodium butyrate (NaBu) has been used to improve recombinant protein production in 
mammalian cells (Hendrick et al. 2001, Kim and Lee 2002, Lee and Lee 2003). It exerts 
various effects on cells including G1-phase cell cycle arrest (Hendrick et al. 2001, Kim and 
Lee 2002), cell differentiation (Garcia-Bermejo et al. 1997) and apoptosis (Kim and Lee 
2002). Approximately 67% of HeLa cells and 54% of CHO cells were found to accumulate 
in the G1-phase following NaBu treatment (Xue and Rao 1981, Hendrick et al. 2001). The 
specific and volumetric productivity were also increased (Hendrick et al. 2001, Lee and 
Lee 2003, Palermo et al. 1991, Kim and Lee 2001). However increased apoptosis was also 
observed in these cultures therefore undermining the beneficial effects of improved 
productivity (Xue and Rao 1981, Kim and Lee 2001 & 2002, Chang et al. 1999). The use 
of anti-apoptotic factors such as Bcl-2 and caspase inhibitors have been shown to improve 
productivity in the presence of NaBu (Kim and Lee 2001 & 2002, Li and Elsasser 2005). 
1.6.1.3.2 Pentanoic Acid 
Pentanoic acid has been reported as an alternative to NaBu as it has comparable enhancing 
effects on protein production with lower associated growth suppression and apoptosis 
compared with NaBu (Liu et al. 2001). The molecular mechanisms underlying the 
stimulation of protein expression and growth suppression effects by pentanoate are not 
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clear. NaBu and pentanoate could have similar mechanism as they share similar carboxyl 
carbon  conformation, inhibit histone deacetylase, and suppress cell growth (Liu et al. 
2001). 
1.6.1.3.3 DMSO 
Dimethyl sulfoxide (DMSO) has been shown to induce an efficient and reversible G1 phase 
arrest in CHO cells (Fiore et al. 2002), human lymphoid cell lines (Sawai et al. 1990) and 
mouse fibroblasts (Srinivas et al. 1991). DMSO-induced growth arrest is associated with 
restored contact inhibition of cell growth and prevention of density dependent-apoptosis 
(Fiore and Degrassi 1999). Addition of 1–2% DMSO to cultures efficiently and reversibly 
arrested up to 90% of CHO cells (Fiore and Degrassi 1999) and 85% of hybridoma cells in 
G1-phase (Ponzio et al. 1998). Addition of DMSO to CHO cells has been shown to 
increase CDK and/or CKI activity and p27KIP1 and Bcl-2 expression and this results in 
growth arrest, improved cell-adhesion and reduced apoptosis (Fiore and Degrassi 1999). 
However, higher concentrations of DMSO (30%) caused mutagenic effects (Hakura et al. 
1993).  
1.6.1.3.4 Quinidine and thymidine 
Quinidine and thymidine, both cell cycle inhibitors, have also been used for regulating the 
cell cycle distribution of CHO cells (Alrubeai et al. 1992, Andersen et al. 2000). Quinidine 
and thymidine inhibit potassium channels in cells (Alrubeai et al. 1992, Andersen et al. 
2000, Wang et al. 1998). The level of potassium channel activity has been shown to be 
different in the proliferating and quiescent stage of cell cycle, and reduced potassium 
channel activity is hypothesized to result in cell cycle arrest (Wang et al. 1998). Following 
quinidine treatment, 67% of tPA-producing CHO cells were arrested in G1-phase of cell 
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cycle, however 57% cells were arrested in S phase after thymidine treatment (Andersen et 
al. 2000). 
1.6.2 Media formulation/nutrient control based approaches 
Besides fulfilling the nutritional requirements of cells, media formulation and its utilization 
have been implemented as strategies for the regulation of cell proliferation and recombinant 
protein production. Inefficient use (higher uptake than required for normal cell growth) of 
glucose and glutamine leads to rapid biomass generation, nutrient depletion and by-product 
accumulation (lactate and ammonium ions, etc.) which often have inhibitory effects on 
culture longevity and productivity (Ozturk et al. 1992, Zeng et al. 1998, Zeng and Deckwer 
1999). Finding alternative compounds that can be used efficiently can lead to 
reduced/arrested cell growth and to improved culture longevity and overall productivity 
(Altamirano et al. 2001). The substitution of glucose with galactose (a slow metabolising 
sugar) and glutamine with glutamate (slow transportation rate in to cell and has only one 
amino group) reduced the growth rate and improved culture longevity in batch cultures of 
CHO cells (Altamirano et al. 2000). The regulation of the glucose feed rate in culture also 
increased culture longevity and t-PA yield in CHO cells without affecting cellular specific 
productivity (Altamirano et al. 2001). Therefore, nutritional-shift-based biphasic cultures 
that include replacement of glucose with galactose, glutamine with glutamate or different 
feed rates once cells achived high biomass has been shown to increase culture longevity 
and volumetric productivity (Altamirano et al. 2001).  
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1.6.3 Effect of Micro-environmental Factors on cell growth and productivity 
The micro-environmental factors have significant impact on cell growth and protein 
product and therefore have always been given enough consideration during optimization of 
a bioproduction process.  
1.6.3.1 Dissolved Oxygen (DO) 
Oxygen is a basic requirement for all aerobic organisms and O2 uptake rate has always been 
a key process optimization variable as nutrient or oxygen limitation can induce apoptosis 
(Simpson et al. 1999, Lai et al. 1982). DO ranging from 20% and 80% did not affect 
growth of a murine hybridoma cell line while the death rates were lowest at 20-50% air 
saturation (Ozturk and Palsson 1991). DO may affect the productivity of cells as the 
productivity of human follicle stimulating hormone (hFSH) in CHO cells was observed to 
greatly vary under different DO levels (10-90%) and of NaBu (0-1.5mM) (Chotigeat et al. 
1994).  
1.6.3.2 Culture pH 
Culture pH is recognized as one of the most important process parameters in mammalian 
cell culture. It has effects on cell growth, metabolism, recombinant protein synthesis and 
protein quality (Borys et al. 1993, Yoon et al. 2005). Although close to physiological pH 
environment is generally suitable for mammalian cell growth, the optimal pH differs 
slightly among cell lines, and some cell lines are less sensitive to deviations from the 
optimal pH than others (Kurano et al. 1990b).  
1.6.3.3 Metabolic byproducts 
One goal in the optimization of mammalian cell culture processes is to protect cells from 
inhibitory conditions that may arise during culture, such as nutrient deprivation, ammonia 
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and lactate accumulation and elevated osmolality and pCO2, as they can affect cell growth 
and production.  
Ammonia can readily diffuse across the cell membrane and hence, elevated levels of 
Ammonia can decrease intracellular pH (pHi) levels which negatively affects both cell 
growth and recombinant protein productivity. t-PA production has been observed to be 
reduced under elevated ammonium conditions (Hansen and Emborg 1994). Ammonia also 
negatively affects the recombinant protein glycosylation profile, thus altering product 
quality (Chen and Harcum 2005).  
Lactate build-up leads to the acidification of the culture environment and could inhibit cell 
growth in culture (Hassell et al. 1991, Lao and Toth 1997). The accumulation of lactate is 
often a critical limiting factor of a cell culture process especially when the cell density is 
high. Up to 75% reduction in cell growth rates have been reported with addition of 60mM 
lactate in CHO cells (Hassell et al. 1991, Tsao et al. 2005). The increased level of lactate 
and osmolality have additive inhibitory effects on cell growth (Lao and Toth 1997).  
The elevated osmolality has been reported to decrease cell growth mainly due to apoptosis 
(Zhu et al. 2005). Cell culture medium is typically designed to have an osmolality in the 
range of 260-320 mOsm/kg, mimicking the osmolality of serum (290 mOsm/kg). 
Information on the response of CHO cells to changes in osmolality is scarce. The 
combination of pCO2 and osmolality has been observed to effect cells more extensively in 
comparison to osmolality alone (Zhu et al. 2005, Kimura and Miller 1996, Ryu et al. 2000).  
Elevated pCO2 can reduce intracellular pH (pHi) and can affect cell growth and 
recombinant protein productivity. The physiological range for pCO2 is 31-54mm Hg. Up to 
five times increased pCO2 levels have been observed for cultures oxygenated with a low 
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flow rate and small bubbles of O2 (Kimura and Miller 1996). Elevated pCO2 was observed 
to inhibit glycolysis (Kimura and Miller 1996, deZengotita et al. 2002) which reduced the 
growth and productivity of CHO cells (Kimura and Miller 1996). The quality of product 
may also be compromised due to alterations in the carbohydrate moeities (N-
glycolylneuraminic and polysialation) at elevated pCO2 level (Zanghi et al. 1999).  
Therefore, optimization of culture conditions for reduced waste accumulation and their 
consequences could help to improve the growth and productivity of bioprocesses. 
 
1.7 miRNAs: novel regulators of cellular behaviours 
MicroRNAs (miRNAs) are endogenous, small (~22 nt), usually single-stranded and non-
coding RNAs (ncRNAs) that can play important regulatory roles in animals and plants by 
targeting mRNAs for cleavage or translational repression (Bartel 2004). A single miRNA 
can regulate the expression of a number of gene targets through binding of the 3’ 
untranslated regions (UTRs). For example miRNA-21 has been found to regulate more than 
one phenotype including apoptosis and proliferation (Cheng et al. 2005). In addition, the 
3’UTRs of many genes contain putative binding sites for a number of miRNAs. The cold 
inducible protein, RNA binding motif 3 (RBM3) that increases global translation under 
conditions of low culture temperature, has been shown to interact with small RNA species 
suggesting the involvement of miRNA regulation in the low temperature response (Dresios 
et al. 2005). As discussed, low culture temperature has been employed in industry to 
increase the productivity, viability and stationary phase duration of production CHO cell 
lines (Al-Fageeh et al. 2006, Baik et al. 2006). miRNAs do not rely on the cellular 
translational machinery to exert their effects on the cell and therefore do not cause 
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metabolic burden on cellular machinery. The expression of miRNAs can be easily regulated 
by transfecting small genetic constructs (mature miRNAs) or antagomirs, small single-
stranded RNA molecules with complementarity to the mature target miRNA. It has been 
observed that the overall similarity at miRNA level is much higher between species in 
comparison to proteins (Berezikov et al. 2005). For these reasons, miRNAs may offer great 
potential to regulate cell growth and productivity of CHO cells in production cultures 
(Gammell 2007, Muller et al. 2008).  
1.7.1 Discovery of miRNA 
The first miRNAs, Lin-4, was identified in Caenorhabditis elegans in 1993 (Lee et al. 
1993). Lin-4 was shown to be involved in disrupting the post-embryonic development in 
Caenorhabditis elegans through repressing the lin-14 (a gene that also works in the same 
developmental pathway) by binding to 3’UTR of lin-14 with partial complementarity. A 
second miRNA, let-7, was also discovered in Caenorhabditis elegans (Reinhart et al. 
2000). Similarly to lin-4, let-7 miRNA recognized sequences present in the 3’ UTR of lin-
41 mRNA and repressed LIN-41 protein levels. These findings encouraged others to 
investigate the presence of miRNAs in different species and thereafter a number of 
miRNAs were reported in various species. miRNAs have been found to be highly 
conserved throughout evolution, from worms, through fly and up to humans (Ambros 
2003). According to current in-silico estimations, miRNAs appear quite abundant and 
might account for up to 3% of all genes in the genome (Berezikov et al. 2005). 
1.7.2 miRNA Biogenesis and Processing 
It has been observed that all the elements required for the regulation and initiation of 
transcription of miRNAs are located within a short fragment of ~800bp length (Lee et al. 
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1993). However, little is known regarding these regulatory transcriptional processes for 
miRNA genes. Some miRNAs that reside in introns are likely to share their regulatory 
elements and primary transcript with their pre-mRNA host genes. For the remaining 
miRNA genes, presumably transcribed from their own promoters, no primary transcripts 
have been fully defined. Nonetheless, these primary miRNA transcripts, called pri-miRNAs 
(Lee et al. 2002), are generally thought to be much longer than the conserved stem loops 
currently used to define miRNA genes, as suggested by the following: (1) clustered miRNA 
stem loops are transcribed from a single primary transcript (Lagos-Quintana et al. 2001), 
(2) matches between miRNAs and lengthy ESTs in the databases (Lagos-Quintana et al. 
2002), and (3) RT-PCR experiments amplifying large fragments of the long primary 
miRNAs (pri-miRNAs) (Lee et al. 2002).  
Most miRNAs are transcribed by RNA polymersase II as pri-miRNAs, though some are 
transcribed by RNA polymersase III (Ohler et al. 2004, Cai et al. 2004). The miRNA 
portion of the pri-miRNA transcript likely forms a hairpin with signals for dsRNA-specific 
nuclease cleavage. The pri-miRNA is then cleaved at its flanks by a dsRNA-specific  
nuclear ribonuclease III (RNase III) endonuclease, Drosha, yielding stem loop structure of 
about 70 nt termed the precursor miRNA (pre-miRNA) (Figure 1.7.2) (Lee et al. 2002 & 
2003). The pre-miRNAs processed by RNase III contains 5’ phosphate and 3’ hydroxy 
termini and 1–4 nt 3’ single-stranded overhangs. Exportin 5 (Exp 5) facilitates the export of 
miRNAs from nucleus to cytoplasm (Yi et al. 2003). Once the pre-miRNA is in the 
cytoplasm, another RNase III endonuclease, Dicer, processes this pre-miRNA and 
generates the miRNA duplex (~21 nt). Only one of the two strands of miRNA duplex is the 
mature miRNA. The selection of the active strand from the dsRNA appears to be based 
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primarily on the stability of the termini of the two ends of the dsRNA  (Khvorova et al. 
2003, Schwarz et al. 2003). The strand with lower stability base pairing of the 2–4 nt at the 
5' end of the duplex preferentially associates with RNA induced silencing complex (RISC) 
(an another enzyme that is used, like dicer, for the siRNA directed silencing pathway) and 
thus becomes the active miRNA (Schwarz et al. 2003, Hutvagner and Zamore 2002).  
 
 
Figure 1.7.2. miRNA biogenesis and bioprocessing. 
 
1.7.3 Mechanism of miRNAs action 
miRNAs mediate target silencing using both mRNA cleavage and translational repression 
(Figure 1.7.2). In plants, it is more common to observe almost perfect homology between 
miRNA strands and the mRNA target(s), hence the RISC complex behaves as an 
endonuclease and cleaves the target mRNA between the target nucleotides paired to bases 
10 and 11 of the miRNA. The normal situation for animal miRNAs however is that 
homology between the miRNA and the target mRNA is typically restricted to the 5’ end of 
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the miRNA (Lewis et al. 2003, Lewis et al. 2005, Brennecke et al. 2005). In this situation, 
the bound miRNA-RISC complex inhibits translation of the target mRNA either at the level 
of translational elongation or initiation of translation (Olsen and Ambros 1999, Pillai et al. 
2005). The molecular mechanism of miRNA-mediated translational repression is unknown.  
1.7.4 Effects of miRNAs on cellular phenotypes 
Research into the regulation of gene expression through the action of miRNAs has 
increased hugely over the last 4 years. The number of identified miRNA in the Sanger 
repository is increasing exponentially. Recently miRNAs have been found to be critical for 
development (Ambros 2003), cell proliferation (Gammell 2007, Brennecke et al. 2003), 
apoptosis (Xu et al. 2007) and metabolism (Gauthier and Wollheim 2006). However, the 
miRNAs regulating these characteristics have not been functionally validated in CHO cells. 
The regulation of cell growth, apoptosis and metabolism are all pre-requisite characteristics 
for improving the recombinant protein production of production cell lines in bioreactors. 
Therefore miRNAs could serve as a potential targets for this purpose.   
1.7.4.1 Regulation of cell growth 
Growth control in bioreactors is crucial for efficient protein production. The use of biphasic 
culture strategies to control growth are commonly employed whereby cells are initially 
grown in conditions to promote high proliferation rates to maximize viable biomass and 
subsequently cell division is arrested (typically through reduction of the culture 
temperature), to encourage productivity and reduce apoptosis (Al-Fageeh et al. 2006, Baik 
et al. 2006). A number of miRNAs have been identified that regulate the expression of well 
known growth regulatory proteins and many of these proteins have already been employed 
in cell-engineering based approaches to improve growth and productivity of CHO cells.  
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Let-4 and Let-7 control the timing of proliferation and differentiation in C. elegans and 
abnormalities in miRNAs coding for Let-4 and Let-7 can lead to uncontrolled cell growth 
and other developmental abnormalities (Lee et al. 1993, Reinhart et al. 2000, Ambros 
2003). The mammalian homologues of these genes are also involved in the regulation of 
cell proliferation. The depletion of the miR-125b (Lin-4 homologue) resulted in reduced 
proliferation of human cancer cells (Lee et al. 2005), whereas the over expression of Let-7 
suppressed the growth of DLD-1 colon cancer and A549 lung adenocarcinoma cells (Akao 
et al. 2006, Takamizawa et al. 2004). Let-7 has also been shown to represses Ras and c-
Myc expression (Akao et al. 2006, Johnson et al. 2005). Ras and c-Myc are well known 
regulators of cell growth. The expression of c-Myc has already been implemented in the 
regulation of CHO cell growth in production cultures (Ifandi and Al-Rubeai 2005, Katakura 
et al. 1999, Miura et al. 2001). c-Myc was also shown recently to activate the expression of 
miR-17 cluster, including miR-17-5p and miR-20a, and the transcription factor E2F1 
(O'Donnell et al. 2005). miR-17-5p and miR-20a were observed to negatively regulate the 
expression of E2F1. E2F1 is involved in the control of cellular proliferation and over 
expression of E2F1 has been associated with growth arrest (Johnson et al. 1993). Therefore 
the organized function of c-Myc and its associated miRNA and mRNA targets is required 
to control cell growth in a production culture.  
Inhibition of miR-7 has been found to down regulate the cell growth of the lung carcinoma 
cell line, A549 (Cheng et al. 2005). miR-7 exerted its effects on cell growth through EGF 
receptor (EGFR) signaling that triggers extra-cellular-signal regulated kinases (ERK)-
mediated degradation of a transcription factor (Li and Carthew 2005). ERK can be 
activated by growth factors and has an important role in the regulation of cell proliferation 
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(Nishimoto and Nishida 2006). miR-143 has also been found to reduce the cell growth of 
human adipocytes through interacting with ERK5 (Esau et al. 2004). ERK5 is a member of 
the mitogen activated protein kinase (MAPK) family and is similar to ERK1/2. miR-221 
and miR-222 are also involved in the inhibition of proliferation of human erythroleukemic 
cells (Felli et al. 2005).  
A number of other miRNAs have been identified in a large-scale screening experiment that 
are involved in the regulation of growth in HeLa and A549 cells (Cheng et al. 2005). The 
effect of miRNAs can be dependent on other factors including cell type. For example 
inhibition of miR-24 resulted in a significant increase in the specific growth rate of HeLa 
cells, whereas it down regulated cell growth in the case of A549. The inhibition of miR-21 
also resulted in increased growth of HeLa cells (Cheng et al. 2005), whereas over 
expression of miR-21 was found to improve cellular growth of the breast cancer cell line, 
MCF-7 (Si et al. 2007). Similarly, miR-34 induces cell-cycle arrest in G1 phase in both 
normal and tumor cells (He et al. 2007) but supports cell proliferation in renal 
carcinogenesis induced by oxidative stress in rats (Dutta et al. 2007). Although miRNAs 
are highly conserved among different species and expression of miRNAs can be expected 
to exert similar type of effect(s) in CHO cells, varying results indicates the need for CHO-
specific screening of each individual miRNA target for regulation of growth in specific 
states of a production process. 
1.7.4.2 Regulation of Apoptosis 
Apoptosis or programmed cell death is an obstacle to maintain high viable cell densities 
over time to improve the yield of bioprocess. Apoptosis in bioreactors is a result of a 
number of stressful conditions that emerge as a result of the production process, including 
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nutrient limitation, mechanical agitation, oxygen depletion and waste accumulation (al-
Rubeai and Singh 1998). Cell death through apoptosis can negatively affect the quality of 
product and overall productivity (Fussenegger et al. 1998). For these reasons, a number of 
apoptotic regulators have been identified and engineered into CHO cells to improve 
productivity. However identification of miRNAs regulating these processes may further 
improve the control of cell death in the production process.  
miR-21, apart from its role in cell growth, increases apoptotic cell death in MCF-7 breast 
cancer cells (Cheng et al. 2005, Si et al. 2007). Phosphatase and tensin homology deleted 
from chromosome 10 (PTEN) and Bcl-2 have been found to be the direct targets of miR-21 
(Si et al. 2007, Ji et al. 2007). The inhibition of miR-21 expression was found to up 
regulate their expression while over expression of miR-21 was found to down regulate the 
expression of PTEN (Si et al. 2007). Bcl-2, a well known anti-apoptotic protein, inhibits 
apoptosis through the maintenance of mitochondrial membrane integrity and by binding to 
pro-apoptotic Bcl family members. The expression of Bcl-2 was down regulated upon 
inhibition of miR-21 and was up regulated after over expression of miR-21 in vascular 
smooth muscle cells (Ji et al. 2007). The inhibition observed in cell growth after inhibition 
of miR-21 expression has a direct correlation with increased apoptosis associated with 
down regulation of bcl-2 expression. The tumor suppressor protein, programmed cell death 
4 (PDCD4), is another target for miR-21 and down regulation of PDCD4 by miR-21 caused 
an increase in apoptosis in MCF-7 breast cancer cells (Frankel et al. 2008).  
Furthermore, miR-15 and miR-16 have been identified as negative regulators of the 
apoptotic suppressor Bcl-2 at a posttranscriptional level and thus induces apoptosis in 
malignant B cells (Cimmino et al. 2005). The inhibition of miR-7 was shown to increase 
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apoptosis whereas inhibition of miR-214 decreased the level of apoptosis in HeLa cells 
(Cheng et al. 2005). The expression of miR-1 also affects the level of apoptosis in 
cardiomyocytes (Xu et al. 2007). HSP60 and HSP70 work as direct targets for miR-1 and 
can be inhibited by miR-1 at a post-translational level without changing their transcript 
levels. The inhibition of HSP60 and HSP70 could reduce the expression of Bcl-2 proteins 
and enhance caspase activity leading to apoptosis in culture (Xu et al. 2007). miR-133 has 
anti-apoptotic effects and represses caspase-9 expression at both the protein and mRNA 
levels. miR-34a can regulate the activity of p53 (Raver-Shapira et al. 2007). p53 is a potent 
tumor suppressor, whose biological effects are largely due to its function as a 
transcriptional regulator. The depletion of miR-34a expression strongly attenuates p53-
mediated apoptosis in cells exposed to genotoxic stress, whereas over expression of miR-
34a mildly increases apoptosis. Hence, miR-34a has a direct interaction with p53 and can 
influence some of the pro-apoptotic biological effects of p53 in cells. The over expression 
of miR-224 was shown to inhibit the expression of apoptosis inhibitor 5 (API-5) which 
ultimately increased apoptosis in the human colon cancer cell line, HCT116 (Wang et al. 
2008). 
1.7.4.3 Stress resistance 
Stress, depending on its type i.e. micro-environmental (thermal, shear or oxidative), 
nutritional (amino-acid(s) or nutrient(s) starvation) or physiological (transcriptional, 
translational or post-translational), as discussed before does not only lead to apoptosis and 
cell death but, at sub-lethal levels, can also modulate both the output of recombinant protein 
and its quality. Cells have been observed to induce expression of certain proteins such as 
CIRP, RBM3, PDI and ER chaperones etc, in response to stress conditions (Wellmann et 
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al. 2004, Sugimoto and Jiang 2008, Zhang et al. 2008). A number of miRNAs (miR-15b, 
miR-16, miR-20a and miR-20b) have been observed to be down-regulated significantly in 
hypoxic conditions in the human nasopharyngeal carcinoma cell line, CNE (Hua et al. 
2006). Another investigation revealed the induction of miR-23, miR-24, miR-26, miR-27, 
miR-103, miR-107, miR-181, miR-210 and miR-213 in response to low oxygen in a panel 
of four human cancer cell lines (MDA-MB231, MCF7, HT29, and HCT116) (Kulshreshtha 
et al. 2007). The expression of miR-26, miR-107 and miR-210 was found to decrease pro-
apoptotic signalling in a hypoxic environment. Interestingly, the vast majority of hypoxia-
induced microRNAs are also over expressed in a variety of human tumors. 
1.7.4.4 Regulation of cellular metabolism 
In a typical production system, glucose is used as an energy source by the producer cells 
and is converted into lactate. Glutamine is consequently shuffled into the tricarboxylic acid 
(TCA) cycle, releasing excessive amounts of ammonia. The accumulation of these 
byproducts may trigger cell death and additionally affects the quality of the secreted 
product in terms of reduced and incorrect glycosylation (Yang and Butler 2000). Therefore 
efforts are being consistently made to balance the nutrient supply as well as waste 
accumulation in culture. A few different miRNAs have been reported to be involved in the 
regulation of cellular metabolism. miR-375 has been described as a key regulator of 
glucose homeostasis and insulin secretion in pancreatic cell lines (Gauthier and Wollheim 
2006, Poy et al. 2007). Over expression of miR-375 in these cells resulted in decreased 
glucose-induced insulin secretion with no alterations in glucose-mediated production of 
ATP or a rise in intracellular Ca2+
 
(Poy et al. 2007). In addition, repression of miR-375 
increased glucose-stimulated secretion of insulin. These results suggested that miR-375 
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regulates a late step of insulin exocytosis. A correlation between inhibition of miR-122 and 
the down regulation of genes involved in cholesterol synthesis has also been observed 
indicating that miR-122 may negatively regulate a transcriptional repressor (Krutzfeldt et 
al. 2005). Furthermore, miR-29b controls the metabolism of amino acids in mammalian 
cells by regulating the catabolism of branched-chain amino acids (BCCAs) in HEK293 
cells (Mersey et al. 2005). miR-277 was observed to work as a metabolic switch controlling 
amino acid catabolism (valine, leucine and isoleucine) in flies (Stark et al. 2003). The 
degradation of these essential amino acids is presumably regulated under conditions of 
starvation or excess dietary intake. Clearly, a better understanding of miRNA-mediated 
regulation of metabolism could help to improve the productivity of mammalian cell 
factories. 
1.7.4.5 Regulation of secretory pathways 
Optimizing secretion, after optimizing transcription and translation, of the recombinant 
protein product from the producer cells is another important aspect of improving the 
product yield. A number of target proteins have been engineered to improve the secretion 
process in cells. For example, the over expression of XBP-1 regulates several factors 
involved in secretion and exerts positive effects on productivity. Other potential targets 
include, coat protein complex I (COPI) and PDI (Barlowe 2000, Pfeffer 2007, Robinson et 
al. 1994). miR-375, miR-124 and let-7b, are also involved in the regulation of secretory 
pathways (Poy et al. 2007). miR-124 and let-7b suppress the translation of mRNA 
encoding myotrophin (MTPN) (Poy et al. 2007). Normally, MTPN interacts with 
cytoskeletal elements and is thought to open the F-actin mesh, allowing access of the 
secretory granules to exocytotic sites. miR-124a increases secretion of insulin by regulating 
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vesicle fusion proteins, such as the target SNARE protein SNAP25, the small GTPase, 
Rab3A and the secretory regulator, synapsin-1A (Lovis et al. 2008). Therefore, these 
miRNAs might present targets for altering the secretory potential of CHO cells but again, it 
remains to be determined to what extent these functions are cell-type specific. 
1.8 Secretome of CHO-K1 Cells 
In 1986, human tissue plasminogen activator (tPA) was the first recombinant therapeutic 
protein product approved for production in mammalian cells and since then the number of 
such proteins have increased greatly (Wurm 2004). These recombinant therapeutic protein 
products are secreted from producer cells. Depending on the nature of the product and 
culture process, crude recombinant proteins are typically harvested in late exponential or 
early stationary phase of growth. These crude proteins are then subjected to a multi-step 
purification process to purify the recombinant product from the culture medium which also 
contains contaminants such as host cell proteins (HCP) and nucleic acids (de Oliveira et al. 
1999). HCP includes all the peptides or proteins secreted by viable cells or leaked into the 
culture medium by cell damage over the culture time.  
A number of secretory peptides/proteins from mammalian cells have been reported to play 
a critical role in the regulation of various cellular phenotypes, i.e. growth and 
differentiation in culture. Apolipoprotein E (ApoE) is involved in cholesterol transport and 
metabolism and can be both endogenous or secretory in nature (Chen et al. 2005, Greenow 
et al. 2005). Recently, inhibition of the expression of ApoE has been show to regulate cell 
growth by inducing G2-phase cell-cycle arrest and apoptosis in the ovarian cancer cell line, 
OVCAR3 (Chen et al. 2005, Greenow et al. 2005). Perlecan (heparan sulfate proteoglycan 
2) is a secretory protein observed to regulate cell proliferation in mouse fibroblast cells, 
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NIH/3T3 (Aviezer et al. 1997) and increased levels have been reported in cancer (Sharma 
et al. 1998, Cohen et al. 1994). The expression of perlecan has been observed to be induced 
by transforming growth factor-β (Iozzo et al. 1997) and can regulate cell growth by acting 
as a co-receptor for basic fibroblast growth factor (FGF2) (Sharma et al. 1998). The 
inhibition of perlecan reduced the growth of colon carcinoma cells, whereas exogenous 
expression was able to reconstitute the effect (Sharma et al. 1998). Lysyl oxidase (LOX) is 
a secreted amino oxidase that oxidizes primary amines to reactive aldehydes (Kirschmann 
et al. 2002). This family of enzymes is involved in the regulation of biogenesis of 
connective tissue, development, cell growth and tumor suppression. Recently four new 
proteins designated lysyl oxidase-like proteins have been described (LOXL, LOXL2, 
LOXL3 and LOXL4) that are functionally similar but genetically distinct from the LOX 
family of proteins. Fibronectin is one of the well known secretory proteins that promotes 
cell growth (Williams et al. 2008). MCF-10A cells cultured with an excess of fibronectin 
were prominently growing whereas cells deprived of it were found to be growth arrested 
(Williams et al. 2008). Fibronection can also induce the secretion of matrix 
metalloproteinase (MMP)-9 in culture (Thant et al. 2000) and increased MMPs activity in 
culture may have potential to alter the recombinant proteins in culture as MMPs can 
mediate the cleavage of proteins.  
Many reports have shown the secretion of transferrin from actively growing primary or 
established cell lines (Vandewalle et al. 1989, Dowling et al. 2007, Gronborg et al. 2006). 
Non-dividing cells can have extremely low levels of transferrin receptor expression, 
whereas rapidly proliferating cells, for example carcinoma cell lines, can express up to 
100,000 transferrin receptors per cell (Inoue et al. 1993). Transferrin has been linked with 
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the regulation of cell growth in culture (Laskey et al. 1988, Chun et al. 2003, Sunstrom et 
al. 2000). It has been observed that transferrin alone does not promote survival or 
proliferation of CHO cells, however in the presence of IGF-1, it can improve cells survival 
and proliferation (Sunstrom et al. 2000). Exogenous transferrin was also found to improve 
the growth and survival of CHO DG44 in another study (Chun et al. 2003).  
Secreted peptides/proteins in culture media can also contribute to the accumulation of waste 
products in culture and could alter pH and osmolality, specially during the later stage of 
culture to ultimately initiate apoptosis (Chuppa et al. 1997, Zhu et al. 2005, Kurano et al. 
1990a, Olsnes et al. 2003). This could result in reduced cell growth in culture. The culture-
environment has also been shown to alter post-translational modifications of recombinant 
protein products and therefore it can be expected that secreted proteins may also be 
contributing towards the regulation of PTMs in a production process (Yoon et al. 2005, 
Zanghi et al. 1999, Kimura and Miller 1997).  
The most common method for HCP removal is affinity chromatography and the purified 
product is assessed for purity using immunoassay (Rathore et al. 2003, Krawitz et al. 2006, 
Denizli and Piskin 1995, Ouyang et al. 2007). The antibodies used in immunoassays are 
raised against a total cell protein mixture of non-product-expressing cells and hence these 
antibodies measure the population of non-product proteins from the host cell. It is possible 
that the antibody affinity to HCP may vary due to change in nature and composition of 
HCP at different phases of growth (e.g. logarithmic or stationary) and this may reduce the 
specificity of product recovery (Denizli and Piskin 1995, Ouyang et al. 2007). Therefore 
investigation of secreted proteins from CHO cells at different phases of culture represents a 
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valuable resource to design better culture and media for production processes from CHO, 
hybridoma and/or NS0 cells. 
 
1.9 Recent developments in ‘Omics’ technology 
Within the past decade, Omics have moved from being technology-driven to application-
oriented high-output assay systems. The driving force behind this is the quest for increased 
understanding of molecular mechanisms of biologically-important phenomenon. This has 
resulted in the development of a number of exciting tools in proteomics (protein-arrays, 
2D-DIGE etc.) as well as in genomics (expression microarrays, miRNA-arrays etc.) that 
has enabled researchers to meet their defined goals more efficiently.   
1.9.1 Proteomics Analysis 
Genomic technologies such as microarrays are being extensively used to detect the changes 
in gene expression associated with a specific test condition, for example, diseased versus 
normal phenotypes. Microarrays contain specific oligodeoxynucleotide probes that bind to 
specific targets and enable identification of alterations in the expression of targets in 
response to any treatment. Genomic techniques typically rely on the information of DNA 
molecules in the nucleus of cells, however several studies have shown that differential 
mRNA expression does not always correlate with protein expression (Gygi et al. 1999, 
Anderson and Seilhamer 1997). There are number of processes that can regulate a DNA 
molecule to exert its biological effect on cells, such as rate of transcription and translation, 
efficient post-translational modification and transportation of protein to its appropriate 
location in the cell. Investigations at the protein level are beneficial as proteins are directly 
involved in exerting their effects on cells, although a combination of both approaches could 
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provide a clearer view of cellular processes. However, the majority of proteomic techniques 
are costly and labor intensive and also may have problem with sensitivity and specificity 
(Haynes and Yates 2000).   
There are a number of proteomic techniques available to analyse the proteome of cellular 
systems. For example, Two-dimensional difference gel electrophoresis (2D-DIGE), Surface 
Enhanced Laser Desorption/Ionisation Time of Flight (SELDI-ToF), isobaric tag labelling 
technologies such as ICAT (Isotope Coded Affinity Tags), iTRAQTM (Isobaric Tagging for 
Relative and Absolute Protein Quantitation), Matrix-assisted laser desorption/ionization 
time of flight mass spectrometry (MALDI-ToF MS) and Liquid chromatography-mass 
spectrometry (LC-MS/MS) etc. In this investigation 2D-DIGE coupled with MALDI-ToF 
MS and SELDI-ToF MS were used. 
1.9.1.1 Two-dimensional difference gel electrophoresis (2D-DIGE)  
Two-dimensional difference gel electrophoresis (2D-DIGE) allows the quantitative protein 
expression profiling across many samples in a reproducible, sensitive and high-throughout 
manner. This is a modified version of conventional Two-dimensional polyacrylamide gel 
electrophoresis (2D-PAGE) combining two different unrelated protein separation steps, i.e. 
proteins separates according to their isoelectric points (pI) in the first dimension step 
(isoelectric focusing, IEF), and then on the basis of molecular weight in the second 
dimension step (SDS-polyacrylamide gel electrophoresis, SDS-PAGE). While 2D-PAGE is 
the most widely used proteomics technique, challenges remains due to its low sensitivity 
and reproducibility (Bunai and Yamane 2005). For example, 2D-PAGE shows poor 
separation of hydrophobic and very acidic, alkaline and larger proteins. Low abundant and 
small proteins are also very difficult to investigate using 2D-PAGE-based approuches due 
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to compromised sensitivity. Apart from this, in 2D-PAGE, only one sample can be 
separated on single gel and this contributes to gel-to-gel variation. 
Modified 2D-gel electrophoresis, 2D-DIGE offers great potential due to increased 
throughput, ease of use, reproducibility, and accurate quantitation of protein expression 
differences (Unlu et al. 1997). This system enables the separation of two or three 
fluorescently labelled protein samples (Cy2, Cy3 and Cy5) on the same gel (Figure 1.9.1.1) 
and therefore minimizes gel-to-gel variation. However, 2D-DIGE is also unable to analyse 
very low or high abundand proteins and very alkaline, acidic and/or hydrophobic proteins. 
The CyDye DIGE Fluor dyes (Cy2, Cy3 and Cy5) are matched for mass and charge but 
possess distinct excitation and emission spectra. The Cy dyes minimally label the lysine 
residues of proteins; the dyes undergo nucleophilic substitution reaction with the epsilon-
amino group of lysine residues on the protein resulting in the formation of an amide bond. 
The dye : protein ratio is optimised so that only 3-5% of the protein is labelled. This 
method ensures that proteins with a single dye molecule are visualised, resulting in co-
migration of proteins originating from separate samples. Consequently, the same protein 
labelled with any of the dyes will migrate to the same position on the 2D gel. By using 
different dyes to separately label proteins isolated from normal or treated cells, proteins can 
be co-separated and quantitated by scanning gels at three different set of wavelengths, i.e. 
Cy2 at 488nm, Cy3 at 532nm and Cy5 at 633. The inclusion of a pooled internal standard 
(Cy2), containing every protein from all samples is used to match protein patterns across all 
of the gels. This feature, reduces inter-gel variation, allows normalization of individual 
experiments and accurate quantification of differences between samples with statistical 
significance (Unlu et al. 1997, Alban et al. 2003, Gharbi et al. 2002).  
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Figure 1.9.1.1. Schematic representation of 2D-DIGE approach. 
 
Advanced image analysis software, e.g. DeCyder, further aid the efficiency of identifying 
real changes in protein expression as it allows to define landmarks during spot matching 
and also uses advanced spot normalization algorithms. The biological variation analysis 
module of DeCyder (BVA) can processes multiple gel images and quantatively compares 
protein abundance across gels to identify statistically significant difference in control and 
test conditions. Differentially expressed protein spots observed using DeCyder can be 
identified by Mass Spectrometry techniques such as MALDI-ToF MS by generating 
peptide mass fingerprints (PMF) and subsequent database searching. 
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1.9.1.2 Matrix assisted Laser Desorption/Ionisation Time-of-flight Mass spectrometry 
(MALDI-ToF MS) 
Matrix assisted Laser Desorption/Ionisation Time-of-flight Mass spectrometry (MALDI-
ToF MS) involves the precipitation of sample molecules with an excess of matrix material 
(α-cyano-4-hydroxycinnamic acid or dihydroxybenzoic acid). The precipitant is then 
bombarded with a laser pulse and imparts energy. The matrix materials have absorbances at 
the wavelength of the laser and are subject to desorption and ionisation accompanied by 
fragmentation. The MS measures the mass-to-charge ratio (m/z) of the protein, peptide or 
peptide fragments. The time-of-flight (ToF) analyzer separates ions according to their m/z 
ratios by measuring the time it takes for ions to travel through a field-free region known as 
the flight or drift tube. The laser is set in such a way that it always generates single charged 
ions and therefore m/z represents the approximate molecular weight of protein target. The 
smaller ions possess a higher velocity relative to the larger/heavier ions. Separated ion 
fractions arriving at the end of the drift tube are detected by an appropriate recorder that 
produces a signal upon the impact of each ion group. The ToF mass spectrum is a recording 
of the detector signal as a function of time. This peptide mass fingerprint can then be used 
to search databases such as Profound, Mascot etc, to identify the protein (Blackstock and 
Weir 1999, Yates 2000). 
1.9.1.3 Surface-enhanced laser desorption/ionization time-of-flight mass spectrometry 
(SELDI-ToF-MS) 
SELDI-ToF MS represents the successful combination of retentate chromatography and 
mass spectrometry. SELDI-TOF-MS can be considered as an extension of the MALDI-
ToF-MS as they shares similar mechanisms of action. Proteins to be analyzed are 
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cocrystallized with UV-absorbing compounds (sinnapinic acid) and vaporized by a pulsed-
UV laser beam. Ionized proteins are then accelerated in an electric field, and the mass to 
charge ratios of the different protein ion species can be deduced from their velocity. The 
biggest difference is that SELDI uses chromatographic surfaces as sample targets. These 
surfaces include a variety of chemically (anionic, cationic, hydrophobic, hydrophilic, metal 
affinity capture, etc.) or bio-chemically (immobilized antibody, receptor, DNA, enzyme, 
etc.) defined chromatographic surfaces. SELDI allows proteins/peptides to be profiled from 
different biological origins i.e. cell lysates, conditioned media and serum (Dowling et al. 
2007, Shiwa et al. 2003, Langbein 2008).  
SELDI is a highly sensitive technique and therefore a small amount of sample of interest is 
loaded onto chromatographic arrays. The proteins from crude samples selectively bind to 
the surfaces by adsorption, partition, electrostatic or affinity based interactions according to 
their nature. After a short incubation period, unbound proteins and unspecific substances 
are washed away with an appropriate buffer and water. The ToF reader records the time of 
flight and calculates the accurate molecular weight of proteins/peptides in the form of a 
spectral map containing mass to charge ratios (m/z) and intensities corresponding to each 
bound proteins/peptides. Biomarker wizard software analyses the spectral map and detects 
differentially expressed protein/peptides with statistical significance. An increase in 
published research using SELDI-ToF in the past few years itself has demonstrated its 
potential for the early detection of cancer especially for low molecular weight cancer-
associated proteins (Wright 2002, Espejel and Roa 2008). Recently, SELDI-ToF-MS has 
been used to investigate the efficiency of purification process as well as to ensure the 
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quality (glycosylation and other post translational modification) of products (Wierling et al. 
2007).  
1.9.1.4 Proteomics and protein production in mammalian cells 
A number of proteomics studies have been published recently that mainly focus on how to 
improve the efficiency of biopharmaceutical production using mammalian cell lines such as 
CHO or NS0 (Kaufmann et al. 1999, Baik et al. 2006, Nissom et al. 2006, Yee et al. 2008, 
Underhill and Smales 2007, Smales et al. 2004). Protein profiling using iTRAQ, nano LC 
and mass spectrometry have shown a significant increase in expression of proteins related 
to transcription and translation (Hmgb1), chaperones (Hspd1), and cellular growth 
(S100a11) in a high producer CHO cell line (Nissom et al. 2006). In a another similar 
investigation, ER luminal chaperones (ENPL, BiP and PDI) and proteins involved in 
mRNA translation (TCTP) and oxidative stress (PDX1) were observed to be up regulated in 
NS0 using 2D-PAGE (Smales et al. 2004). ENPL, BiP and PDI are known to be involved 
in recombinant protein synthesis and assembly (Meunier et al. 2002). PDI and BiP were 
also found to be increased with increased levels of Mab productivity in the microsomal 
fraction from the NS0 cells (Alete et al. 2005). Increased levels of the molecular chaperone 
(BiP) has also been observed in NaBu-treated CHO cells indicating their potential role in 
improving recombinant protein production in mammalian cells (Van Dyk et al. 2003). An 
abundance of ER chaperone (BiP, PDI, Calr) and non-ER chaperone (CCT2, GRP78, 
TCP1) proteins have also been observed in the NS0 cells with increased productivity of 
Mab (Dinnis et al. 2006).  
A number of proteins involved in the regulation of cell structure (especially vimentin) have 
recently been observed to be differentially regulated in CHO cells following temperature-
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shift from 370C to low temperature (Baik et al. 2006, Underhill and Smales 2007). 
Vimentin was down regulated in high producer CHO cells (Meleady et al. 2008). ACTB 
was also observed to be differentially regulated in response to the metabolic shifts in mouse 
hybridoma cell line MAK (Seow et al. 2001), to temperature-shift in CHO cells (Baik et al. 
2006, Underhill and Smales 2007) and to NaBu treatments in CHO cells (Yee et al. 2008). 
Low temperature and metabolic shift have been used to regulate growth and productivity in 
culture. The cytoskeletal proteins (ACTB, TUBB5, Cofilin) were observed to be abundant 
in NS0 cells with increased productivity of Mab (Dinnis et al. 2006). Therefore 
reorganisation of cytoskeleton is critical to improve growth and/or productivity of culture. 
Proteomic profiling of CHO cells has also identified a number of metabolic proteins to be 
associated with the regulation of growth and productivity in culture. GAPDH, a glycolytic 
enzyme, has been observerd to be up regulated in CHO cells cultured at low temperature 
(Baik et al. 2006, Underhill and Smales 2007) and in MAK cells following metabolic shift 
(Seow et al. 2001). Apart from GAPDH, abundance of various other metabolic proteins 
(i.e. ENO1 and TPI) have been reported in high producer cells (Dinnis et al. 2006). ENO1 
was also observed to be up regulated in high producer CHO cells (Meleady et al. 2008). 
Nucleoside diphosphate kinase A (NDKA), a ubiquitous enzyme catalyzing the non-
specific interconversion of nucleoside triphosphates was observed to be abundant in high 
producer NS0 cells (Smales et al. 2004). NDKA was also observed to increased in high 
producer NS0 cells. NDKA is involved in numerous core cellular processes such as 
DNA/RNA synthesis, protein synthesis, cellular signaling and glycosylation.  
The number of proteins associated with transcription and translation have also been 
observed with respect to increased productivity. The expression of TCTP (translationally 
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controlled tumor protein) was observed to be increased in high producer NS0 cells (Smales 
et al. 2004). TCTP is involved in facilitating the elongation phase of mRNA translation in 
association with eEF1A. eEF1 has also been observed to be increased in high producer 
CHO cells (Meleady et al. 2008). Another translation associated protein, alanyl tRNA 
synthetase, was also observed to be up regulated. This protein is a specific component of 
the gene-expression machinery by which aminoacyl tRNAs translate mRNA into an amino 
acid sequence on the ribosome, attaching alanine to its corresponding transfer tRNA during 
protein synthesis. Therefore increased expression of translation associated proteins have 
been reported to be associated with increased protein production in culture.  
Taken together, the changes observed in the expression of chaperons, structural proteins 
and metabolic proteins suggests that the cellular cytoskeletal apparatus interacts 
functionally with the translational apparatus and this highly cordinated interaction plays an 
important part in improving recombinant proteins production in mammalian cells. 
1.9.2 miRNA Arrays 
miRNA-arrays are recently developed high quality microarrays that can contain probes for 
miRNAs from human, rat and mouse. miRNAs are highly conserved during evolution and 
therefore these probes are believed to specifically bind to and amplify their complementary 
parts in the samples. Sequences used in the design of the probes and array were mainly 
taken from miRBase Sequence Database, which is curated by the Sanger Institute 
(http://microrna.sanger.ac.uk/sequences). Detection of these amplifications enable us to 
quantify the expression level of miRNAs. Two types of miRNA-arrays (mirVana miRNA 
bioarray and miRNA TaqMan Low Density Arrays) were used in this investigation. The 
mirVanaTM miRNA bioarrays were the first commercially available miRNA arrays 
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launched in late 2005 by Ambion. The mirVana miRNA bioarrays include a comprehensive 
panel of known human, mouse and rat miRNAs as well as Ambion’s proprietary, non-
published microRNAs, Ambi-miRs. The miRNA-bioarray uses similar technology to gene 
microarray technology. Both processes include RNA isolation, labeling, hybridization to 
the array and washing to provide a robust, reproducible platform for expression profile 
analysis. The results for individual targets can be validated using real-time RT-PCR with 
TaqMan® MicroRNA Assays. miRNA TaqMan Low Density Arrays (miRNA-TLDA) 
(Applied Biosystems) are qRT-PCR based highly sensitive, specific and reproducible 
genomic tools to detect the expression of miRNA genes in a wide variety of samples such 
as serum or tumors etc. All of the miRNA species in the samples are first transcribed using 
a pool of primers and then applied to the miRNA-TLDA card to amplify miRNA genes. 
Eight samples can be analyzed on one card at a time and this minimizes the variation within 
the samples due to similar processing conditions. miRNA-TLDA is itself an RT-PCR based 
reaction and therefore validation of expression is not necessary.  
miRNA-arrays has been extensively used to investigate the differential expression of 
miRNA in various diseases i.e. cancer and diabetes etc, however its potential in bioprocess-
related research has not been explored yet. The genome of CHO cells has still not been 
completely sequenced and therefore not available publicly. Due to this, no validated 
miRNA-array is available to date for CHO cells. Since the miRNA are well conserved 
during evolution and CHO cells have sequence similarities with human, mouse and rat, 
miRNAs arrays containing probes from these orthologous species could potentially identify 
significant changes in miRNA expressions in CHO cells. This information will open the 
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possibility to recruit miRNAs to regulate growth and recombinant protein productivity of 
mammalian cells. 
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Aims of thesis 
The specific aims of this investigation were as follows: 
 
• To establish non-producer and SEAP-producer CHO-K1 cells in low serum 
supplemented or serum-free medium (SFM) in suspension culture.  
Most of the recombinant protein production in industry is performed in suspension cultures. 
As such, we wished to adapt adherent CHO-K1 cells to grow in suspension culture as a 
suitable model system. The presence of serum in culture medium increases the risk of 
contamination (i.e. viral and mycoplasma, etc) and also the difficulty and cost of recovery 
of recombinant protein from the culture media. For this reason, we aimed to establish 
suspension-adapted CHO-K1 cells capable of growing in low serum-supplemented or SFM 
culture conditions. One of the major goals of this thesis was to identify and investigate the 
role of selected protein/miRNA targets in the regulation of cell growth and recombinant 
protein productivity in mammalian cells. Thus, we wished to development of a human 
recombinant protein-secreting model CHO-K1 cell line, capable of growing in low serum-
supplemented or serum-free medium in this work. 
 
• To identify temperature-dependent and independent changes in expressed 
proteins/miRNAs in CHO-K1 cells.  
Low temperature cultivation of CHO-K1 cells can reduce cell growth, metabolism and 
waste accumulation in culture and can maintain viability for extended periods of time. This 
results in increased recombinant protein production. However, the mechanisms regulating 
this phenotype are poorly understood. We wished to identify temperature-dependent and 
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independent differential expression of proteins using 2D-DIGE and miRNAs using 
hybridization-arrays to gain understanding of the relationship between the low temperature 
response of mammalian cells and improved recombinant protein productivity in culture. 
 
• To establish a functional role of selected protein targets in cell growth and 
recombinant protein productivity of CHO-K1 cells.  
Having identified differentially expressed proteins using 2D-DIGE, we aimed to investigate 
whether artificial disregulation of these targets impacted on desired cellular phenotypes. 
The expression of selected protein targets can be inhibited using Small interfering RNA 
(siRNA) transfection. The knockdown of expression of selected protein targets in low-
serum and suspension-adapted SEAP secreting CHO-K1 cells would establish a role for 
these proteins in the regulation of growth and recombinant protein productivity in culture. 
The potential identified targets could be engineered into the cells to improve the efficiency 
of the bioprocess.  
 
• To establish a functional role of selected miRNA targets in cell growth and 
recombinant protein productivity in CHO-K1 cells.  
Since one miRNA can regulate the expression of a number of proteins, we wished to 
investigate effects of selected miRNA targets on growth and productivity of CHO cells. 
Chemically modified, small RNA molecules (Anti-mir and pre-mir) can be transfected into 
cells to specifically inhibit or over express these miRNA targets. The knockdown studies in 
conjunction with over expression studies for selected miRNA targets in low-serum and 
suspension-adapted SEAP secreting CHO-K1 cells would enable us to identify miRNA 
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target(s) that regulate growth and productivity in culture. These potential miRNA targets 
could be useful to design cell engineering approaches to improve growth and productivity.  
 
• To investigate the CHO-K1 cell secretome at distinct phases of the growth cycle 
using SELDI-ToF MS.  
The CHO-K1 cell secretome provides a valuable source of information as it contains 
proteins and peptides that can modulate cell growth in culture. There is a possibility that 
these secreted proteins could also contribute to alterations of the recombinant protein 
product as the extra-cellular environment can have an impact on post-translational 
modifications (PTMs). Moreover, knowledge of secreted host cell proteins could help to 
improve the efficiency of the product recovery process from culture media. Therefore, we 
aimed to identify secreted proteins/peptides in different phase of growth cycle i.e. lag, log 
and stationary phase as it will improve our understanding of the behaviour of CHO cells in 
production culture and may enable us to identify protein/peptide markers associated with 
growth, apoptosis and various other stress conditions in culture. This information could 
then be applied in cell engineering based approaches to improve recombinant protein 
productivity. 
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Section 2 
 
 
 
 
Materials & Methods  
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2.1 Ultrapure water      
Ultrapure water was used in the preparation of all media and solutions. For ultra-
purification, the water was initially pre-treated which involved activated carbon, pre-
filtration and anti-scaling. This water was then purified by a reverse osmosis system (Elga 
USF Maxima Water Purification System) to a standard of 12 - 18 MΩ/cm resistance. 
 
2.2 Glassware 
All glassware and lids were soaked in a 2% (v/v) solution of RBS-25 (VWR International) 
for at least 1 hour (hr). This is a deproteinising agent, which removes proteineous material 
from the bottles. Glassware was scrubbed and rinsed several times in tap water. The bottles 
were then washed by machine using Neodisher detergent, an organic, phosphate-based acid 
detergent. The bottles were then rinsed twice with distilled water, once with ultrapure water 
and sterilised by autoclaving. The spinner vessels were additionally treated with 1M NaOH 
solution over night to further ensure the elimination of cell debris from the inner surface 
and were washed twice with ultrapure water. Spinners were sealed in autoclave bags 
(Stericlin, 0775) and were autoclaved.   
 
2.3 Preparation of cell culture media 
Ultrapure water (UHP) and glassware were autoclaved before use in cell culture as 
described in Section 2.1 & 2.2.  
ATCC medium (1:1 (v/v) of Dulbecco's modified Eagle medium (DMEM) and F-12 Ham 
basal media (Sigma, 56495C)) containing glutamine and sodium pyruvate (Gibco-
Invirogen, 11360-035) and ExCell serum-free medium (Sigma, 14361C) were used in this 
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investigation. ATCC medium was prepared in house. 1X media for DMEM and F-12 Ham 
were prepared as follows- the basal 10X media was added to sterile UHP water, buffered 
with HEPES (N-(2-Hydroxyethyl) piperazine-N-(2-ethanesulfonic acid) and NaHCO3 as 
required and adjusted to pH 7.5 using sterile 1.5 N NaOH or 1.5 N HCl. The media was 
then filtered through sterile 0.22µm bell filters (Gelman, 12158) and stored in sterile 
500mL bottles at 4°C. Sterility checks on all media bottles for bacterial, yeast and fungal 
contamination were made using Trypto Soya Broth (TSB, Oxoid, CM0129) and 
Thioglycolate broths (Oxoid, CM173). All samples for sterility checks were then incubated 
at both 25°C and 37°C. Basal media were stored at 4°C for up to three months in the dark. 
Complete media was then prepared by adding serum as required (Table 2.3). Complete 
media was also stored at 4°C for a maximum of one month in the dark. Fetal calf serum 
(Sigma, F7524), G418 (Sigma, A1720-5G) and Insulin-transferrin-selenium (ITS, Sigma, 
I3146) were added fresh to media. One mililiter of ITS (100x) was added to 99mL of 
media. Sterility testing was also performed for all complete culture media and cell culture 
related solutions by incubating a small aliquot at 37°C for a period of seven days. This 
ensured that no bacterial or fungal contamination was present in the media or the solutions 
at the time of their use. 
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Table 2.3. Preparation of complete media. FCS denotes Fetal Calf Serum, G418 for 
Geneticin Sulfate and ITS for Insulin-Transferrin-Selenium.  
Cell Line Recombinant 
Protein 
Product 
Basal 
Medium 
FCS 
(%) 
G418/ITS Culture 
Type 
CHO-K1 - ATCC 10 - Monolayer 
CHO-K1 - ATCC 10 - Suspension 
CHO-K1 - ATCC 5 - Monolayer 
CHO-K1 - ATCC 5 - Suspension 
CHO-K1 - ATCC 0.5 - Monolayer 
CHO-K1 - ATCC 0.5 - Suspension 
CHO-K1 SEAP ATCC 0.5 G418 (1mg/mL) Monolayer 
CHO-K1 SEAP ATCC 0.5 G418 (1mg/mL) Suspension 
CHO-K1 - ATCC - ITS (1mL/100mL) Suspension 
CHO-K1 - ExCell - - Monolayer 
CHO-K1 - ExCell - - Suspension 
CHO-K1 SEAP ExCell - G418 (1mg/mL) Monolayer 
CHO-K1 SEAP ExCell - G418 (1mg/mL) Suspension 
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2.4 Cells and cell culture 
All cell culture work was carried out in a class II laminar air-flow (LF) cabinet (Holten). 
Before and after use, the LF cabinet was cleaned with 70% industrial methylated spirits 
(IMS). Any items brought into the cabinet were also swabbed down with IMS. At any time, 
only one clone / cell line was used in the LF cabinet. Upon completion of work with any 
given clone / cell line, a 15 minute clearance was given to eliminate any possibilities of 
cross-contamination between the various clones / cell lines. The cabinet was cleaned 
weekly with Virkon (Antech International) and IMS. Details relating to the cell lines used 
for the experiments are provided in Table 2.4.1. All cells were routinely maintained at 37°C 
in an atmosphere of 5% CO2. In the case of biphasic culture, cells were shifted to 310C after 
growing cells at 370C. Cells were fed with fresh media or subcultured in mid-exponential 
phase of culture at every 3-4 days or as required in order to maintain active cell growth.  
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Table 2.4.1.  Description of CHO-K1 cells and variants developed and used in this thesis   
Cell line Cell type Source 
CHO-K1 
Adherent parental Chinese hamster cells growing 
in 5-10% FCS supplemented ATCC medium 
ATCC 
CHO-K1_10s 
CHO-K1 adapted to grow in 10%FCS 
supplemented ATCC medium in suspension 
culture 
NCTCC* 
CHO-K1_5s 
CHO-K1 adapted to grow in 5%FCS 
supplemented ATCC medium in suspension 
culture 
NCTCC* 
CHO-K1_0.5 
CHO-K1 adapted to grow in 0.5%FCS 
supplemented ATCC medium in monolayer 
culture 
NCTCC* 
CHO-K1_0.5s 
CHO-K1 adapted to grow in 0.5%FCS 
supplemented ATCC medium in suspension 
culture 
NCTCC* 
CHO-
K1_SEAP_0.5 
SEAP secreting CHO-K1 adapted to grow in 
0.5%FCS supplemented ATCC medium in 
monolayer culture 
NCTCC* 
CHO-
K1_SEAP_0.5s 
SEAP secreting CHO-K1 adapted to grow in 
0.5%FCS supplemented ATCC medium in 
suspension culture 
NCTCC* 
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CHO-K1_SF 
CHO-K1 adapted to grow in serum free medium 
ExCell in monolayer culture 
NCTCC* 
CHO-K1_SFs 
CHO-K1 adapted to grow in serum free medium 
ExCell in suspension culture 
NCTCC* 
CHO-
K1_SEAP_SF 
SEAP secreting  CHO-K1 adapted to grow in 
serum free medium ExCell in monolayer culture 
NCTCC* 
CHO-
K1_SEAP_SFs 
SEAP secreting CHO-K1 adapted to grow in 
serum free medium ExCell in suspension culture 
NCTCC* 
ATCC: American Type Culture Collection 
NCTCC: National Cell and Tissue Culture Centre 
* CHO-K1 variants developed during the course of these studies at NCTCC. 
 
2.4.1 Subculturing of cell lines 
Cells were grown in adherent and suspension culture. The following method was used to 
subculture cells. 
2.4.1.1 Anchorage dependent cells 
Spent cell culture medium was removed from the tissue culture flask and discarded into a 
sterile bottle. The flask was then rinsed out with 2-5mL of trypsin/EDTA solution (0.25% 
trypsin (Gibco, 043-05090) and 0.01% EDTA (Sigma, E9884) solution in PBS (Oxoid, 
BRI4a)) to ensure the removal of any residual media. Depending on the size of the flask, 2-
5mL of trypsin was then added and incubated at 37°C for approximately 2-5 minutes until 
all of the cells detached from the inside surface of the flask. The detachment of cells was 
monitored by microscopic observation. A 10mL volume of complete media or trypsin 
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inhibitor solution was added to the flask to deactivate trypsin. The trypsin inhibitor solution 
was prepared by dissolving trypsin inhibitor (Sigma, T6522) in sterile PBS to achieve 
concentration of 1mg/mL and was used after filter (0.2µm) sterilization at 1:1 ratio (v/v) to 
inhibit the trypsin in culture. The cell suspension was removed from the flask and placed in 
a 30mL sterile universal container (Sterilin, 128a) and centrifuged at 1000rpm for 5 
minutes. The supernatant was then discarded from the universal and the pellet was 
resuspended gently in fresh complete medium. A cell count was performed and an aliquot 
of cells was used to seed a flask to achieve the required density. All cell waste and media 
exposed to cells were autoclaved before disposal. 
2.4.1.2 Suspension Cells 
Cells were sampled from the suspension culture in 30mL sterile universal containers and 
were centrifuged at 1000rpm for 5 minutes. The supernatant, conditioned medium, was 
collected in another sterile container(s) and pellet was resuspended in fresh complete 
culture medium. Cells were counted and were seeded in fresh spinner vessel(s) (Techne) at 
a seeding density of 2x105 cells/mL in 100mL working volume supplemented with 10% 
conditioned medium. All cell waste and media exposed to cells were autoclaved before 
disposal. 
2.4.2 Cell adaptation 
Cells were adapted to grow in suspension as well as in low or serum free culture medium as 
this is more relevant cell model to industrial production process.  
2.4.2.1 Suspension Culture 
Adherent CHO-K1 cells growing in 10% fetal bovine serum (Sigma) supplemented ATCC 
medium were cultured in 250mL spinner (Techne) with a working volume of 100mL and 
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maintained at 60rpm in an incubator at 370C to adapt to grow in suspension culture. 
Cultures were gassed each day with ‘Mixture of gasess’ (Air products, 21179) containing 
CO2, O2 and N2. Cell counts were performed every alternate day. Cells were subcultured 
once they reached the density of ≥1 × 106 cells/mL. For this, appropriate sample was 
collected from the spinner and centrifuged at 1000rpm for 5 minutes. The supernatant was 
used as conditioned media and pelleted cells were resuspended in fresh media and were 
used to seed the culture at 2x105 cells/mL. Of this cell-free conditioned media, 10% was 
also added into the culture medium during subculturing. Cells (1x105 cells/mL) from 
exponentially growing cultures were inoculated in a separate spinner to monitor the 
improvement in growth behaviour of cells. Cell counts were performed every day over 
144hrs of culture using the trypan blue dye-exclusion method and a hemocytometer.  
2.4.2.2 Adherent Culture 
For adherent culture, suspension-adapted CHO-K1 cells were seeded at 3 x 105 cells/mL in 
three T-75 cm2 culture flasks in 10mL of culture medium. Cell counts were performed 
every 2nd and 4th day of culture. If cells achieved ≥1 x 106 cells/mL within 4 days, they 
were transferred to medium with further reduced serum. If cells failed, the medium was 
replaced in the 3rd flask and once cells became confluent, the work flow was followed until 
they met the set criteria of adaptation. The used culture medium was collected and 
centrifuged at 1000rpm for 5min to get cell-free conditioned media. A volume of 10% 
conditioned medium was included at each subculture. This procedure was repeated until 
cells were adapted.  
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2.4.3 Assessment of cell number and viability 
Prior to cell counts, cells were prepared by subculturing adherent cells or direct sampling 
for suspension cells as described in Section 2.4.1. An aliquot of the cell suspension was 
then added to trypan blue (Gibco, 525) at a ratio of 1:1. The mixture was incubated for 2-3 
minutes at room temperature. An aliquot (10µL) was then applied to the chamber of a glass 
coverslip-enclosed haemocytometer. For each of the four grids of the haemocytometer, 
cells in the 16 squares were counted. The average of the four grids was multiplied by a 
factor of 104, volume of the grid, and the relevant dilution factor to determine the average 
cell number per mL in the original cell suspension. Viable cells excluded the trypan blue 
dye as their membranes remained intact and therefore remained unstained while non-viable 
cells stained blue. On this basis, the percentage viability of culture was calculated by 
counting non-viable cells and viable cells in the sample. 
2.4.4 Cryopreservation of cells 
Cells were preserved with 5% DMSO (Sigma, D5879). For the cells that were being 
cultured in 10% or 5% FCS supplemented ATCC medium, 10% DMSO solution was made 
in serum while for the cells that were adapted to grow in low-serum or serum-free culture 
condition, 10% DMSO solution was prepared in complete culture medium (serum-free or 
serum-supplemented). The filter (Gelman, 121-58) sterilized 10% DMSO solution and 
complete medium was then kept at 40C for 1 hour (hr). Cells for cryopreservation were 
harvested in the log phase of growth and counted as described in section 2.2 and 2.3. Cells 
were centrifuged and pellets were resuspended in a suitable volume of serum or culture 
medium. An equal volume of a 10% DMSO solution was added drop-wise with mixing to 
the cell suspension. The suspension was then aliquoted in 1 mL volumes to pre-labelled 
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cryovials (Greiner, 201151) and immediately placed at -800C. After 6-12 hrs, cryovials 
were transferred to the liquid nitrogen tank for long term storage at -196°C. 
2.4.5 Thawing of cryopreserved cells 
A volume of 10mL of fresh pre-warmed complete medium was added to a sterile universal. 
The cryopreserved cells were removed from the liquid nitrogen and thawed at 37°C 
quickly. The ice-cold cells were removed from the vials and transferred to the aliquoted 
medium in the sterile universal. The resulting cell suspension was centrifuged at 1,000rpm 
for 5 minutes. The supernatant was removed and the pellet was resuspended in fresh pre-
warmed complete medium. An assessment of cell viability on thawing was then carried out 
(section 2.4.3). Thawed cells were then added to the appropriate culture flask, i.e. spinner 
or T-flask, with a suitable volume of complete culture medium and allowed to grow at 
370C. In the case of adherent cells, flasks were re-fed with fresh media to remove any non-
viable cells on the following day. 
 
2.5 Establishment of SEAP-secreting CHO-K1 cells  
The SEAP secreting CHO-K1 cells were established as the model cell line to investigate the 
effects of selected miRNA or protein targets on cell growth and recombinant protein 
production. For this, a SEAP coding gene was inserted in to pcDNA3.1 and this plasmid 
was transfected into CHO-K1 cells. 
2.5.1 Plasmids 
pSEAP2-Control was a kind gift from Professor Martin Fussenegger (Institute for Chemical 
and Bioengineering, ETH Zurich, Zurich, Switzerland). pcDNA3.1 was obtained from 
Invitrogen. 
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2.5.2 Transformation of competent cells 
A bacterial cell suspension (100 µl) of competent JM109 (Promega, L2001) was mixed 
with ~20 ng DNA and placed on ice for 40 min after which the mixture was heat-shocked 
at 42oC for 90 seconds and then placed on ice for 3 minutes. A volume of 1mL of LB broth 
((10 g Tryptone (Oxoid, L42), 5 g Yeast Extract (Oxoid, L21), 5 g NaCl (Merck, 
K1880814))/litre, autoclaved before use) was added to the competent cell suspension and 
incubated at 37oC for 1 hour. Different volumes of this suspension were spread on selecting 
agar plates (LB agar containing 100 mg/mL Ampicillin) and incubated overnight at 37oC. 
Single colonies that grew on these selecting plates were transferred into 5 mL LB broth 
containing 100mg/mL of Ampicillin (Invitrogen, Q100-17) and grown overnight with 
agitation at 37oC. Cells were then subjected to a DNA mini preparation (see section 2.5.3) 
or inoculated into 250 ml LB broth containing Ampicillin (100mg/mL) in a 1 L baffled 
flask with shaking overnight at 37oC for large scale preparation (section 2.5.3.4). 
2.5.3 DNA miniprep of plasmid DNA 
The Qiagen Plasmid DNA Extraction Kit (Qiagen, 12262) was used according to the 
manufacturer’s instructions to isolate plasmid DNA from a 5 mL culture grown overnight 
in LB broth containing selection antibiotic with shaking at 37oC. After incubation, the cells 
were pelleted by centrifugation at 8000rpm for 3 minutes. Pelleted cells were resuspended 
in 250 µL of buffer P1 and the cell suspension was transferred to a microcentrifuge tube. 
To this solution, 250 µL of buffer P2 were added and mixed gently. A volume of 350 µL of 
buffer N3 was then added to the solution and the tube was mixed immediately. This 
mixture was centrifuged for 10 minutes at 13,000 rpm. The supernatant was applied to a 
QIAprep spin column and centrifuged for 60 seconds. The flow-through was discarded. The 
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column was washed by adding 500 µL of buffer PB and centrifuged for 60 seconds. Again, 
the flow through was discarded. This step was repeated with 750 µL of buffer PB. The 
column was centrifuged for a further 60 seconds to remove the remaining wash buffer and 
was then placed in a clean microcentrifuge tube. To elute the DNA, 50 µL of buffer EB 
were added to the column. The column was allowed to stand for 60 seconds and then 
centrifuged for 60 seconds. The concentration of eluted DNA was determined using a 
NanoDrop spectrophotometer by measuring the OD260nm. Plasmid was stored at –20oC until 
required. 
2.5.4 DNA maxiprep of plasmid DNA 
Plasmid DNA was purified using an Endofree Plasmid Maxi kit (Qiagen, 12362). 
Following the growth of plasmid culture in 270 mL Ampicillin-containing LB broth in 1L 
baffled flask with shaking overnight at 37oC, the culture was split into 2 x 250 mL 
centrifuge bottles and spun at 3,500 rpm for 15 minutes at 4oC. Pellets were processed 
immediately or stored at –20oC until required. The bacterial pellet was resuspended in 10 
mL of buffer P1. To this suspension, 10 mL of buffer P2 was added, mixed gently and 
incubated at room temperature for 5 minutes. A volume of 10 mL of chilled buffer P3 was 
then added to the lysate and mixed gently and immediately. The lysate was poured into the 
barrel of a QIAfilter cartridge and incubated at room temperature for 10 minutes. The cap 
from the QIA filter outlet nozzle was then removed and the plunger gently inserted into the 
cartridge. The cell lysate was filtered into a 50 mL tube. To the lysate, 2.5 mL of buffer ER 
were added and mixed by inverting repeatedly. This mixture was incubated on ice for 30 
minutes. A Qiagen-tip 500 column was equilibrated by applying 10 mL of buffer QBT and 
the column was allowed to empty by gravity flow. The filtered lysate was then applied to 
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the Qiagen-tip and also allowed to enter the resin by gravity flow. The Qiagen-tip was 
washed twice with 30 mL of buffer QC. The DNA was then eluted by the addition of 15 
mL of buffer QN in a 30 mL tube. The DNA was precipitated by adding 10.5 mL of 
isopropanol to the DNA solution, which was then mixed and centrifuged at ~10,000 rpm 
for 30 minutes at 40C. The DNA pellet was washed with 5 ml of 70% ethanol and again 
centrifuged at ~10,000rpm for 10 minutes. The pellet was then air-dried and dissolved in 
500 µL buffer TE. The DNA concentration was determined by measuring the OD260nm using 
a Nanodrop spectrophotometer. 
2.5.5 SEAP plasmid construction 
A volume of 1 µg of pcDNA3.1-SEAP was digested with 1 µL of HindIII (Biolabs, 
R0104S, 10X) and SalI (Biolabs, R0138S, 10X) while pcDNA3.1 was digested with 1 µL 
of HindIII and XhoI (Biolabs, R0146S, 10X) overnight at 370C. The digested mixture was 
separated using 1% (v/v) agarose gel electrophoresis at 60V. The band at ~2 kb and ~5.4 kb 
were cut out from the gel and DNA was retrieved by centrifugation at 13000rpm for 1 
minute. using a GenElute Agarose Spin Column. DNA was then purified using MinElute 
(Qiagen, 28004). Five volumes of Buffer PB were added to the DNA sample. The mixture 
was applied to a MinElute column for 1 minute and the supernatant was removed by 
centrifugation at 13000rpm for 1 minute. The column was washed with 750µL of Buffer 
PE. The DNA was eluted into a fresh tube using 10µL of Buffer EB. DNA was then 
quantified using a NanoDrop Spectrophotometer. Fragments of ~2 kb and ~5.4 kb were 
ligated over night at 370C. The ligated plasmid was transformed into the competent 
bacterial cells. After miniprep as described in Section 2.5.3.3, 1 µg of plasmid was digested 
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using 1 µL of EcoRI (Biolabs, R0101S, 10X) and BamHI (Biolabs, R0136S, 10X) and 
were separated by 1% (v/v) agarose gel electrophoresis at 60V. 
2.5.6 pcDNA3.1-SEAP transfection 
Low serum adapted CHO-K1 cells (1x105 cells/mL) were seeded in 4x T-25 cm2 culture 
flasks. Once they reached 70-80%, the culture medium was replaced ~6 hrs before 
transfection. In separate round bottom tubes, 1µg of pcDNA3.1-SEAP and of empty vector 
pcDNA3.1 were incubated at room temperature with 100µL in serum-free medium 
(OptiMEM, Gibco, 31985) for 5 minutes. A volume of 4µL of Lipofectamine 2000 
(Invitrogen, 11668019), transfection reagent, was also incubated in 200µL of OptiMEM in 
the same conditions and 100µL each was added to both plasmid complexes. Both solutions 
were combined, mixed gently and allowed to form complexes over a 20 minute time period 
at room temperature. A volume of 200 µL of pcDNA3.1-SEAP complex was added to one 
flask and pcDNA3.1 complex to another and were mixed gently. Two non-transfected 
flasks were considered as controls. The media was changed after 24 hrs of culture and cells 
were allowed to grow for another 24 hrs.  
2.5.7 Selection and isolation of Clones 
G418 (400 µg/mL) was added to culture after 48hrs of transfection except to one of the two 
non-transfected controls. The amount of G418 in the medium was increased every alternate 
day (600, 800 and 1000 µg/mL) to achieve complete elimination of cells in the non-
transfected culture. SEAP Clones were isolated using the limiting dilution method. For this, 
a suspension of cells containing 100 cells/mL was prepared. A volume of 100µL/well (10 
cells/well) of this suspension was inoculated into 8 wells (1 column) of a 96-well culture 
plate. The suspension was further diluted by a factor 10x by adding 90 µL/well media and 
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10 µL/well of cell suspension into the next column to achive 1 cells/well. Cells were further 
diluted in the another column to achive 0.5 cells/well. The concentration of 0.5 cells/well is 
a condition where cell is either present or absent in a particular well. The cells were 
allowed to grow. The well containing single cells were identified under microscope. The 
culture media was replaced routinely after 3-4 days to allow single cell clones to expand 
further. The confluent cultures were transferred to a 24-well. Conditioned media was 
collected after 24hrs from cultures growing in media containing 800µg/mL and 1000µg/mL 
of G418 and after 72hrs of culture from cultures growing in media containing 1000µg/mL 
of G418 to perform SEAP-assays (as described in section 2.5.7) to identify SEAP-secreting 
CHO clones. The identified SEAP-secreting cells were allowed to grow further in T-75 
flasks.  
2.5.7 SEAP Assays 
Cells (1x105 cells/mL) were seeded in 0.5% FCS supplemented ATCC medium containing 
G418 (800 or 1000µg/mL) in 24-well plate with a 0.5mL of working volume. The 
conditioned medium was collected from cells at appropriate time intervals, such as for 
optimizing SEAP-assays after 24hrs and for stability assays after 72hrs or 96hrs of culture. 
The enzymatic assay for the quantification of SEAP was adapted from the method reported 
by Berger et al., (1988) and Lipscomb et al., (2005). The conditioned media was 
centrifuged at 13000rpm for 15minutes. A volume of 50µL of cell-free conditioned media 
were transferred to individual wells of a 96 well flat bottom plate. To each sample, 50µL of 
2X SEAP reaction buffer (containing 10.50 g diethanolamine (100%), 50 µL of 1 M MgCl2 
and 226 mg of L-homoarginine in a total volume of 50 mL) was added. Plates were 
incubated for 10 min at 37°C and then 10 µL of substrate solution (158 mg of p-
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nitrophenolphosphate (Sigma, P4744-10G) in 5 mL of 1X SEAP reaction buffer, made 
fresh for each use) was then added to each well. The change in absorbance per minute 
(OD405/min) was considered as an indicator of the amount of SEAP present in the sample. 
SEAP is a highly glycosylated protein. Therefore, changes observed in this investigation in 
SEAP amount could be due to changes in the SEAP quantity, quality or both. 
2.5.8 Comparison of SEAP-productivity to identify highest and most stable producer 
clone 
To identify the cells with different level of SEAP-secretion and stability in secretion, 
0.5mL of 1x105cells/mL from master culture at different passages (time intervals) were 
seeded in a 24-well plate in 0.5%FCS supplemented ATCC culture medium containing 
G418 (1000µg/mL). The non-producer CHO-K1 cells growing in 0.5%FCS supplemented 
ATCC culture medium were used as control. The conditioned media was taken after 72hrs 
of culture. The viable cells counts were also performed to calculate the cell specific 
productivity (Qp) in culture. Qp was calculated by dividing the total productivity by the 
total viable cells in culture.  
 
2.6 Two-dimensional difference gel electrophoresis (2D-DIGE) 
Two dimentional differential gel electrophoresis (2D-DIGE) is an advanced version of 
classical two-dimensional gel electrophoresis (2D-PAGE). In 2D-DIGE, protein samples 
are labeled with three different fluorescent dyes (Cy2, Cy3 and Cy5) and then separated by 
2D-PAGE. Labeling of different protein samples with different fluorescent dyes and then 
mixing together allows samples to be separated on the same gel and this minimizes gel-to-
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gel variation. The following steps were carried out to perform 2D-DIGE experiment in this 
investigation. 
2.6.1 Cell culture 
Suspension-adapted CHO-K1 cells were seeded at 1x105 cells/mL in 100mL in 10% FCS 
supplemented ATCC medium in 250mL spinner with a working volume of 100mL. Cells 
were maintained in biphasic culture, where cells grown at 370C for 72hrs and then shifted 
to 310C for a further 72hrs, or in standard culture at 370C for 144hrs.  Cultures were rotated 
at 60rpm and gassed everyday with Mixture of Gasses (N2, O2 and CO2). Cell counts and 
viability were measured every day as mentioned in section 2.5.3. The cell samples were 
collected at 72hrs and 144hrs of culture for 2D-DIGE experiment. 
2.6.2 Total protein extraction and quantification 
Cell samples were harvested from culture as appropriate. Cells were then washed twice 
with ice-cold PBS. All procedures from this point forward were performed on ice. A total 
of 3x107 cells were re-suspended in 500µL lysis buffer as described in Table 2.6.1. Re-
suspended sample was then put through a 1 mL syringe with a 21 gauge needle 5 times. 
The sample was placed on an orbital shaker and shaken gently for 1 hour at room 
temperature.  
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Table 2.6.1. Preparation of lysis buffer 
Contents Recipe Required weight/volume for making 
25mL of lysis buffer 
Urea  7M 10.5 g 
Thiourea 2M 3.8 g 
CHAPS  4%  1 g 
Tris  30mM 0.091 g 
Magnesium acetate  5mM 0.027 g 
Water Up to 25mL 
pH 8 – 9 
Aliquot in 1 mL/eppendorf and store at -200C   
 
After incubation, lysates were centrifuged on a bench-top centrifuge at 14,000rpm for 15 
minutes at 4°C. The middle layer of the supernatant containing extracted protein was 
transferred to a fresh chilled eppendorf tube. Samples were then stored in aliquots at -80°C 
until used. A small aliquot of sample was used for protein estimation. 
Protein levels were determined using the Bio-Rad protein assay kit (Bio-Rad, 500-0006) as 
follows. A 2 mg/mL bovine serum albumin (BSA) solution (Sigma, A9543) was used as a 
known standard. Dilutions of BSA stock for 0, 0.125, 0.25, 0.5 and 1.0mg/mL was 
prepared and used for generating a protein standard curve. To each well of a 96-well plate, 
240µL/well of thiourea-compatible Bradford protein assay reagent (Bio-Rad, 500-0205) 
was added, followed by 10µL of protein standard dilution or sample (diluted 1:10). All 
samples were assayed in triplicate. After 5 minutes incubation, the absorbance was assessed 
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at 595nm. The concentration of the protein samples was determined from the plot of the 
absorbance at 595nm versus the concentration of the protein standard.  
2.6.3 Labelling of proteins 
2.6.3.1 Preparation of CyDye dyes for minimal-DIGE protein labelling 
The three CyDye DIGE Fluor Minimal dyes (Cy3, Cy5 and Cy2 (GE Healthcare, 25-8010-
65) were thawed from –20oC to room temperature for 5 minutes. To each microfuge tube 
dimethylformamide (DMF) (Sigma, 22,705-6) was added to generate a concentration of 1 
nmol/µL. Each microfuge tube was vortexed vigorously for 30 seconds to dissolve the dye. 
The tubes were then centrifuged for 30 seconds at 14,000rpm in a microcentrifuge. The 
reconstituted dyes were stored at –20oC for up to 3 months. 
2.6.3.2 Preparation of 10 µL working dye solution (200 pmol/µL) 
On thawing, the dye stock solutions were centrifuged in a microcentrifuge for 30 seconds. 
To make 10 µL of the three working dye solutions, 8 µL of DMF was added to three fresh 
eppendorfs labelled Cy2, Cy3 and Cy5. A volume of 2 µL of each of the reconstituted dye 
stock solutions (200 pmol /µL) was added to their respective tubes. The dyes were stored at 
-20oC in tinfoil in the dark for 3 months. 
2.6.3.3 Protein sample labeling 
The 2D-DIGE experiment was carried out for biological triplicate samples. Technical 
duplicates samples were included in this experiment. A volume of 100 µg of protein from 3 
control (biological triplicate samples at 72hrs of culture) and 3 treated (biological triplicate 
samples at 144hrs of culture) protein samples was placed into 6 separate eppendorf tubes (3 
for Cy3 and the other 3 for Cy5). They were labelled with the minimal dyes as follows, 2 
µL/eppendorf of Cy3 was added to Control samples and 2 µL/eppendorf of Cy5 was added 
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to Treated samples. From each Control and Treated samples, 50 µg was aliquoted into an 
eppendorf and 2 µL of Cy2 was added to it. Each tube was mixed by vortexing, centrifuged 
and then left on ice for 30 minutes in the dark. To stop the reaction, 1 µL of 10 mM lysine 
(per 200pm of dye) was added. The tubes were mixed, centrifuged briefly and left on ice 
for 10 minutes in the dark.  
2.6.4 Preparing the labelled samples for the first dimension 
The protein samples labelled Cy3 (Control) and Cy5 (Treated) from respective biological 
replicates were combined to get 3 eppendorfs each containing 200 µg of Cy3- and Cy5-
labeled protein samples. To each eppendorf, 100 µg of Cy2 labelled internal standard was 
added. An equal volume of 2X sample buffer (2.5 mL rehydration buffer stock solution (7 
M urea, 2 M thiourea, 4% CHAPS, 2% IPG buffer (GE Healthcare, 17-6000-86), 50 mM 
DTT (Sigma, D9163)), was added to the labelled protein samples. The mixture was left on 
ice for at least 10 minutes and then applied to Immobiline DryStrips for isoelectric 
focussing. 
2.6.5 First dimension separation - isoelectric focussing methodology 
Isoelectric focussing of all samples was carried out using immobiline pH gradient (IPG) 
strips (18cm, 4-7pH) (GE Healthcare, 17-1233-01). The protective lid was removed from 
the Immobiline Dry Strip Reswelling tray. The tray was levelled using the spirit level. 
Rehydration buffer (350µL) was slowly pipetted into the centre of each slot. All air bubbles 
generated were removed. The cover film from the IPG strip (GE Healthcare) was removed 
and positioned with the gel side down and lowered. To ensure the entire strip was evenly 
coated with rehydration buffer, the strip was gently lifted and lowered onto the entire 
surface of the solution avoiding trapping air bubbles. Each strip was overlaid with about 3 
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mL IPG Cover Fluid (GE Healthcare, 17-1335-01) starting on both ends of the strip and 
moving to the centre. The protective lid was then replaced and the strips were left at room 
temperature to rehydrate overnight (or at least 12 hours). 
Following the rehydration procedure, the Manifold (GE Healthcare) was placed onto the 
IPGphor unit (GE Healthcare) by inserting the “T” shape into the hollow provided. A 9 mL 
of Cover Fluid was placed into each of the twelve lanes in the tray in order to cover the 
surface. Two wicks (GE Healthcare, 80-6499-14) per strip were placed on tinfoil and 150 
µL of UHP was pipetted onto each one to rehydrate them. The rehydrated strips were 
placed in the correct orientation (+ to anode) and aligned just below the indented mark, to 
allow for the wicks to overlap the strip. The rehydrated wicks were then placed over both 
the cathodic and anodic ends of all the strips. The wicks were checked to ensure they were 
positioned over the gel portion of the strip and avoiding the indent in the lane so as to 
guarantee a good contact with the electrodes. The sample cups (GE Healthcare, 80-6498-
95) were then positioned approximately 1 cm from the cathodic end of the strip and an 
insertion tool was used to securely “click” the cups into place. The electrodes were then 
fitted with their “Cams” open and in direct contact with the wicks. The amount of protein 
loaded per strip was 150µg for DIGE or 400µg for spot picking. The protein samples were 
prepared by centrifuging to remove any insoluble material and the appropriate volume was 
loaded with a pipette tip placed just beneath the surface of the cover fluid. The cover of the 
IPGphor unit was closed and the desired programme selected. The temperature was set for 
20oC with 50µA/strip. The IEF parameters are as follows: step 1: 300 volts for 3 hours 
(step-and-hold), step 2: 600 volts for 3 hours (gradient), step 3: 1000 volts for 3 hours 
(gradient), step 4: 8000 volts for 3 hours (gradient). The IEF was left at 500 volts (step-and 
  
 85 
–hold) until ready for SDS-PAGE step. On completion of the IEF run, the strips were 
drained of the cover fluid and stored in glass tubes at –80oC or used directly in the second 
dimension.  
2.6.6 Second Dimension – SDS polyacrylamide gel electrophoresis 
2.6.6.1 Casting gels in the ETTAN Dalt-12 gel caster 
The 12.5 % acrylamide gel solution was prepared in a glass beaker (acrylamide/bis 30%, 
1.5 M Tris pH 8.8, 10 % SDS). Prior to pouring, 10 % ammonium persulfate and neat 
TEMED were added.  
Two types of plates were used, low fluorescent for DIGE experiments and hinged for 
preparative and silver stained gels. All plates (both normal hinged and low fluorescent) and 
casting equipment were inspected to ensure they were clean. The gel caster frame was 
placed on a level bench leaning on its “legs” so that the back of the caster was open and 
facing the operator. The plates were assembled so that the front and back plates were 
evenly aligned and all seals and hinges in place. A thin spacer was placed in the gel caster 
unit followed by an assembled plate and then a thin spacer and then another plate. The 
plates were positioned in the caster unit so that the lower, front plate was the furthest away 
from the operator and the spacers packed with their curved edges to the top. This layering 
was repeated until all 14 plates and spacers were in place. All plates and spacers were 
checked to ensure they were packed tightly together so as to minimise any gaps and air 
pockets. When the desired amount of plates had been added, the thicker spacers were 
placed next to bring the level marginally over the edge of the back of the caster. The 
backing plate was then added to the caster frame and screwed into place with the 6 screws 
provided. The silicone tubing was added to the outlet of the glass beaker and the glass tube 
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was inserted to the other end of the silicone tubing. The glass tube was inserted into the 
inlet of the reservoir and the glass beaker containing the gel solution was then clamped to a 
retort stand. The gel solution was held in place using arterial clamps on the top tube and the 
tube running down from the reservoir to the caster chamber. The top tube was unclamped 
and the gel solution was allowed to fill the tubing and the reservoir drain. Air bubbles that 
had been generated were dislodged by flicking the tube. When all air bubbles had been 
removed the bottom clamp was released allowing the gel solution into the gel caster. When 
the gel solution reached the indicator line across the top of the caster, the bottom and top 
tubes were reclamped. The displacement solution (0.375M Tris-Cl 1.5M pH8.8, 30% 
glycerol, UHP and bromophenol blue) was added to the reservoir and the glass tubing was 
slowly removed from the reservoir inlet. The clamp was removed from the bottom tube 
allowing the displacement solution into the tube and forcing the remaining gel solution into 
the gel caster. The gels were overlaid with 1 mL of saturated butanol or sprayed with 0.1 % 
SDS solution. The gels were left to set for at least three hours at room temperature. 
Following this, the caster was gently unlocked and the gels removed and rinsed with 
distilled water. If the gels were not used immediately they were stored for up to four days in 
1X running buffer at 4oC. 
If gels were to be used for “spot picking” one of the plates were silanised prior to casting to 
stick the acrylamide mixture. A volume of 2mL of working bind-silane solution (8mL 
ethanol, 200µL glacial acetic acid, 10µL bind-silane (GE Healthcare) and 1.8mL UHP) was 
pipetted over the glass plate and wiped over with a lint free cloth. This was left to air dry 
for 15 minutes, after which 2mL ethanol and 2 mL UHP were each pipetted over the plate 
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and wiped off respectively. The plate was left to air dry for approximately 1 hour 30 
minutes.  
2.6.6.2 Preparing the ETTAN DALT-12 electrophoresis unit 
The electrophoresis chamber was prepared by adding 6.48 litres of UHP and 720 mL of 
10X SDS running buffer. The pump was then turned on to cool the system to 10oC.  
2.6.6.3 Equilibration of focussed Immobiline DryStrips 
The SDS equilibration buffer (30% glycerol, 6M urea, 50nm 1.5M Tris-Cl pH 8.8, 2% 
SDS, bromophenol blue and UHP) which had been prepared, aliquotted into 30 mL 
volumes and frozen at –20oC was allowed to thaw to room temperature. Two SDS 
equilibration buffer solutions with DTT (65 mM) or iodoacetamide (240 mM) (Sigma, 
I1149) were then prepared. Using a forceps, the IPG strips were removed from the IPGphor 
unit, the cover fluid was drained off by holding the strips at an angle and they were placed 
into individual glass tubes with the support film toward the wall. Equilibration buffer (10 
mL containing DTT) was added to each tube and incubated for 15 minutes with gentle 
agitation using an orbital shaker. During this equilibration step, the gel cassettes were 
rinsed with UHP and then the tops rinsed with 1X running buffer. After the first 
equilibration, DTT containing equilibration solution was removed and 5 mL of the 
iodoacetamide containing equilibration buffer was added. The strips were incubated for 15 
minutes with gentle agitation. During this equilibration step, the agarose overlay solution 
(0.5% agarose in running buffer) was prepared and 50 mL of 1X running buffer was placed 
in a glass tube. If the strips had been frozen at this stage they were left at room temperature 
to thaw before the DTT-containing equilibration solution was added. 
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2.6.6.4 Loading the focussed Immobiline DryStrips 
Using a forceps and holding the anode end, the IPG strips were rinsed in 1X SDS 
electrophoresis running buffer and placed between the two glass plates of the gel. The strip 
was pushed down gently using a thin plastic spacer until it came in contact with the surface 
of the gel. Any air bubbles trapped between the gel surface and the strip were gently 
removed. Approximately 1 mL of the 0.5 % agarose overlay solution was applied over the 
IPG strip to seal it in place. 
2.6.6.5 Loading gels into the Ettan DALT-12 electrophoresis unit 
When the running buffer reached the desired temperature (10oC) the loaded gel cassettes 
were wetted with UHP and inserted into the tank through the slots provided in the same 
orientation. When all 12 slots were filled the upper chamber was filled, 2X running buffer 
was added to the upper chamber until the mark on the side of the chamber was reached. The 
cover of the unit was replaced and the required running conditions selected. The unit was 
run for 18–24 hours at 1.5 Watts per gel at 10°C or until the bromophenol blue dye front 
reached the bottom of the gel. When the run was completed, the gel cassettes were removed 
from the tank one at a time using the DALT cassette removal tool and rinsed with UHP to 
remove the running buffer.  
2.6.6.6 Method for scanning DIGE labelled samples 
The Typhoon Variable Mode Imager (GE Healthcare) was turned on and left to warm up 
for 30 minutes prior to scanning. The scanning control software was opened and the 
fluorescence mode was selected. The appropriate emission filters and lasers were then 
selected for the separate dyes (Cy2 520 BP40 Blue (488), Cy3 580 BP30 Green (532) and 
Cy5 670 BP30 Red (633)). The first gel was placed in the scanner and pre-scanned at a 
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1000 pixel resolution in order to obtain the correct photo multiplier tube (PMT) value (to 
prevent saturation of the signal from high abundant spots). Once the correct PMT value was 
found, the gel was scanned at 100 pixel resolution, resulting in the generation of three 
images, one each for Cy2, Cy3 and Cy5. Once the scanning was completed, the gel images 
were imported into the ImageQuant software. All gels were cropped identically to facilitate 
spot matching in the Decyder BVA module. 
2.6.7 Analysis of gel images 
Scanned fluoroscent gel images were analysed using Biological Variation Analysis (BVA) 
module of DeCyder 6.5 software (GE Healthcare). Images were loaded into DeCyder 
software using image loader function. Batch Processor Module of DeCyder was used. The 
experiment design was set up to have all 72hrs samples in one group and 144hrs sample in 
other group. The spots on the gels were then matched across all gels in the experiment. The 
software standardises the relative spot intensity of the Cy5 image and Cy3 image in the 
same or different gels using the intensity of the Cy2 image. The standardised spot intensity 
was then averaged across the triplicate gels. The BVA module calculated the degree of 
difference in the standardized protein abundance between 2 spots from different groups and 
expressed these differences as average ratio. The values by software are displayed in the 
range of -∞ to -1 for decrease in expression and +1 to +∞ for increase in expression. For 
example, a two-fold increase and decrease is represented by +2 and -2, respectively (not by 
2 and 0.5). The ‘average ratio’ has been termed as ‘fold change’ in this thesis. The software 
also calculated the consistency of the differences between samples across all the gels and 
applies statistics to associate a level of confidence (p-value) for each of the differences. The 
spots with statistically significant changes in protein expression (±1.5 fold with p-value ≤ 
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0.05) were considered as differentially expressed proteins. These differentialy expressed 
proteins observed using DeCyder were picked with the ETTAN Spot Picker (GE 
Healthcare) for identification using MALDI-ToF MS (GE Healthcare).  
2.6.8 Staining Methods 
2.6.8.1 Silver staining 2-D Electrophoresis gels  
This method is used to screen protein samples prior to labelling with the Cy Dyes. After 2-
DE, the gels were removed from the plates by very carefully placing a ruler between the 
two plates at the top right hand corner and the top plate removed gradually. Using the ruler, 
the side borders of the gel were cut away in line with the ends of the IPG strip at the top of 
the gel. The strip and agarose were then removed and the gel was lifted gently and placed in 
a gel box containing fixing solution (50mL ethanol, 12.5 mL acetic acid (Lennox) and 62.5 
mL UHP). The gel boxes were placed on an orbital shaker and fixed for at least 1 hour 
(usually overnight). After fixing, the solution was drained from the gels. The gels were then 
washed three times with 150 mL of UHP for 5 minutes each time and drained. The gels 
were next sensitised (60 mL ethanol, 13.6 g sodium acetate, 0.4 g sodium thiosulfate and 
UHP in 200 mL) for 30 minutes on the orbital shaker. 
The gels were then washed three times (for 10 minutes). Following the washes, 200 mL of 
silver staining solution (0.5 g silver nitrate, 80µL formaldehyde and 200mL UHP) was 
added and the boxes returned to the orbital shaker. After 20 minutes the silver solution was 
drained and the gels were washed twice for 5 minutes each with UHP. After the last wash, 
200 ml of developer (5 g sodium carbonate, 40 µL formaldehyde and 200mL UHP) was 
added to each of the boxes. The gels were placed on the orbital shaker and allowed to 
develop. When the desired amount of spots appeared the developer was drained into the 
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silver containing 5 L drum (this precipitated out the silver) and 200 mL of stopping solution 
(2.92g EDTA and 200 mL UHP) was added. The gels were left on the belly dancer for at 
least 10 minutes. The gels were then scanned at 300dpi resolution. 
2.6.8.2 Brilliant blue G Colloidal Coomassie staining 
After electrophoresis, the smaller lower plates that is attached to preparative-gels were 
placed in the boxes containing fixing solution (7% glacial acetic acid in 40% (v/v) 
methanol) for at least one hour. During this step a 1X working solution of Brilliant Blue G 
colloidal coomassie (Sigma, B2025) was prepared by adding 800 mL UHP to the stock 
bottle. When the fixing step had nearly elapsed a solution containing 4 parts of 1X working 
colloidal coomassie solution and 1 part methanol was made, mixed by vortexing for 30 
seconds and then placed on top of the gels. The gels were left to stain for 2 hours. To 
destain, a solution containing 10% acetic acid in 25% methanol was poured over the 
shaking gels for 60 seconds. The gels were then rinsed with 25% methanol for 30 seconds 
and then destained with 25% methanol for 24 hours.  
2.6.9 Spot picking 
Preparative gels (400 µg of protein/gel) for spot picking were focussed and run out on SDS-
PAGE gels. The gels were then stained with colloidal coomassie (section 2.6.8.2). The 
glass surface was dried and two reference markers (GE Healthcare, 18-1143-34) attached to 
the underside of the glass plate before scanning. The resulting image was imported into the 
ImageMaster software (GE Healthcare) and the spots were detected, normalised and the 
reference markers selected. While keeping the shift key depressed, all spots of interest were 
manually selected. The resulting image was saved and exported into the Ettan Spot Picker 
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software (GE Healthcare). Spots that showed differential protein expression in DeCyder 
analysis were picked with the ETTAN Spot Picker (GE Healthcare, 18-1145-28).  
The stained gel was placed in the tray of the Ettan Spot Picker with reference markers (GE 
Healthcare) aligned appropriately and covered with UHP. The imported pick list was 
opened, the syringe primed and the system was set up for picking the spots from the pick 
list. The spots were robotically picked and placed in 96-well plates, which were stored at 
4oC until spot digestion. 
2.6.10 Spot digestion and identification with MALDI-ToF 
The 96-well plate was placed in the Ettan Digester (GE Healthcare, 18-1142-68) to digest 
the protein as follows: Step 1 – the gel plugs were washed three times for 20 minutes each 
with 50µL 50mM ammonium bicarbonate (Sigma, A6141) in 50% methanol. Step 2 – the 
gel plugs were washed twice for 15 minutes with 50µL 70% acetonitrile (Sigma, 34967). 
The gel plugs were left to dry for at least 60 minutes. After drying, the individual gel pieces 
were rehydrated in 10µL digestion buffer (12.5ng sequence-grade trypsin (Promega, 
V5111) per µL of 10% acetonitrile, 40mM ammonium bicarbonate). Exhaustive digestion 
was carried out overnight at 37oC. After digestion, the samples were transferred as follows: 
Step 1 – A volume of 40µL of 0.1% trifluoroacetic acid (Sigma, 302031) in 50% 
acetonitrile was added to the wells, mixed and left for 20 minutes. A volume of 60µL of 
this solution was transferred to a fresh 96-well plate. Step 2 - A volume of 30µL of 0.1% 
trifluoroacetic acid in 50% acetonitrile was added to the wells, mixed and left for 20 
minutes. A volume of 50µL of this solution was transferred to a fresh 96-well plate. The 
liquid in the plate was dried using a Maxi-Dry-Plus vaccum-dryer (Medical Supply Co.). 
After drying, the 96-well plate was placed in the Ettan Spotter (GE Healthcare, 18-1142-
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67) for spotting onto the target plates. A volume of 3µL of 0.5% trifluoroacetic acid in 50% 
acetonitrile was added to the desiccated peptides and mixed 5 times. A volume of 0.3µL of 
this mixture was spotted onto the target plate after which a volume of 0.3µL matrix solution 
(7.5mg/mL a-cyano-4-hydroxycinnamic acid (LaserBio labs, 28166-41-8) in 0.1% 
trifluoroacetic acid in 50% acetonitrile) was mixed and allowed to dry.  
The target plate was placed in the MALDI-ToF MS (GE Healthcare, 11-0010-87) 
instrument. The system was set up as follows: the target plate was disengaged from the 
machine. A new empty run list was opened. In the acquisition mode of the “favorites icon, 
the “spectrum processes”, specifically PepMix 4 (LaserBio labs, C104) was picked and 
“protein digest optimised” were successively selected and dragged to positions 1 and 2-24 
respectively on the target slide. Within the identification section of favorites, “protein 
digest mammalian IAA” was selected and dragged to positions 2-24 on the target slide. The 
run list for slide 1 was saved and associated to position 1 on the previously disengaged tray. 
Selecting process and play then started the MALDI instrument. 
Mass spectra were recorded operating in the positive reflector mode at the following 
parameters: accelerating voltage 20 kV; and pulsed extraction: on (focus mass 2500). 
Internal and external calibration was performed using trypsin autolysis peaks at 842.509 
m/z, 2211.104 m/z and PepMix 4 respectively. Calibration using Pep4 was performed as 
follows: Once two spectra were generated for the PepMix 4 mix (position 1 on the slide), 
the acquisition of spectra was stopped. The first spectrum of sample one was selected and 
the calibrant peaks readjusted for accuracy. The five individual peaks cover the 500-3500 
Da mass range and include bradykinin fragment 1-5 (573.315), angiotensin II human 
(1046.5424), neurotensin (1672.9176) and insulin B chain oxidised (3494.6514). Once 
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calibration was completed it was saved as the new “system calibration”. The MALDI was 
then restarted. The mass spectra generated for each of the proteins were analyzed against all 
mammalian species using MALDI evaluation software (GE Healthcare). Protein 
identification was achieved with the PMF Pro-Found search engine for peptide mass 
fingerprints. 
2.6.11 Western blot Analysis 
2.6.11.1 Gel electrophoresis 
Proteins for analysis by Western blotting were resolved using SDS-polyacrylamide gel 
electrophoresis (SDS-PAGE). Using the Atto dual mini slab kit (AE 6450) the stacking and 
resolving gels were prepared as illustrated in Table 2.6.11. The gels were set in clean 10cm 
x 8cm x 0.75cm gel cassettes, which consisted of 2 glass plates separated by a rubber 
gasket to a width of 1mm. The resolving gel was added to the gel cassette and allowed to 
set. Once the resolving gel had set, the stacking gel was poured on top. A comb was placed 
into the stacking gel after pouring, in order to create wells for sample loading (maximum 
sample loading volume of 15-25µL). 
The acrylamide stock in Table 2.6.11 consists of a 30% (29:1) ratio of acrylamide:bis-
acrylamide (Sigma). In advance of samples being loaded in to the relevant sample wells, 
20µg of protein was diluted in 2X loading buffer (Sigma, S3401). Molecular weight 
markers (New England Biolabs, P7708S) were loaded along side the samples. The gels 
were run at 250V and 45mA until the bromophenol blue dye front was found to have 
reached the end of the gel, at which time sufficient resolution of the molecular weight 
markers was achieved. 
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Table 2.6.11. Preparation protocol for SDS-PAGE gels (2 x 0.75mm gels).  
Components 10% Resolving Gel 5% Stacking Gel 
30% Acrylamide stock (Sigma, 
A3574) 
4.6mL 670µL 
  UHP water 5.6mL 2.7mL 
1.875 M Tris-HCl pH 8.8 3.5mL - 
1.25 M Tris-HCl pH 6.8 - 500µL 
  10% SDS 
(Sigma, L-4509) 
140µL 40µL 
  10% Amonium persulfate*  
(Sigma, A-1433) 
140µL 40µL 
  TEMED* 
(Sigma, T-8133) 
5.6µL 4µL 
* Added immediately before pouring 
 
2.6.11.2 Western blotting 
Once electrophoresis had been completed, the SDS-PAGE gel was equilibrated in transfer 
buffer (25mM Tris (Sigma, T8404), 192mM glycine (Sigma, G-7126), pH 8.3-8.5) for 
approximately 30 minutes. Five sheets of Whatman 3mm filter paper (Whatman, 1001824) 
were soaked in freshly prepared transfer buffer. These were then placed on the cathode 
plate of a semi-dry blotting apparatus (Bio-rad). Air pockets were then removed from 
between the filter paper. Nitrocellulose membrane (GE Healthcare, RPN3032D), which had 
been equilibrated in the same transfer buffer, was placed over the filter paper on the 
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cathode plate. Air pockets were once again removed. The gels were then aligned onto the 
membrane. Five additional sheets of transfer buffer-soaked filter paper were placed on top 
of the gel, all air pockets removed and excess transfer buffer removed from the cathode 
plate. The proteins were transferred from the gel to the membrane at a current of 34mA at 
15V for 30-40 minutes, until all colour markers had transferred. Following protein transfer, 
membranes were stained using Ponceau (Sigma, P7170) to ensure efficient protein transfer. 
The membranes were then blocked overnight using 5% Marvel (Cadburys; Marvel 
skimmed milk) in PBS at 4°C. The membranes were washed with PBS prior to the addition 
of the primary antibody.  Membranes were incubated with primary antibody overnight at 
4°C. Antibodies were prepared in 1% Marvel in TBS. The primary antibody dilutions are 
illustrated in Table 2.6.11.2. The membranes were then rinsed 3 times with TBS containing 
0.5% Tween 20 (Sigma P1379) for a total of 15-30 minutes. Relevant secondary antibody 
(1/1000 dilution of anti-mouse (Dako Cytomation, P0260) or anti-rabbit (Dako 
Cytomation, P0448) or anti-goat (Santa Cruz Biotechnology, Sc2098) IgG peroxidase 
conjugate in 2-5% Marvel-TBS) was added for 1 hour at room temperature. The 
membranes were again washed three times thoroughly in TBS containing 0.5% Tween for 
15 minutes. 
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Table 2.6.11.2 List of primary antibodies and dilutions 
No. Primary Antibody 
(supplier) 
Source Dilution Marvel 
(%) 
1 anti-HNRPC (Sigma, R5028) Mouse 1/5000 5 
2 anti-Vimentin (Sigma, 
MMS-459S) 
Goat 1/1000 5 
3 anti-RBM3 (kindly supplied 
by Peter W. Vanderklish, 
Scripps Research Institute) 
Rabbit 1/1000 2 
4 anti-EIF4A (Abcam, 
ab31217) 
Rabbit 1/1000 5 
5 anti-PFN2 Mouse 1/500 2 
6 anti-Tubulin (Abcam, 
ab55611) 
Mouse 1/1000 2 
7 Anti-GAPDH (Sigma, 
G8795) 
Mouse 1/5000 5 
 
2.6.11.3 Enhanced chemiluminescence detection 
Immunoblots were developed using an Enhanced Chemiluminescence kit (GE Healthcare, 
RPN2106), which facilitated the detection of bound peroxidase-conjugated secondary 
antibody. Following the final washing, membranes were subjected to ECL. A layer of 
parafilm was flattened over a glass plate and the membrane placed gently upon the plate.  A 
volume of 3 mL of a freshly prepared 1:1 (v/v) mixture of ECL reagent A and B was used 
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to cover the membrane. The ECL reagent mixture was completely removed after a period 
of one minute and the membrane were covered with transparent film. All excess air bubbles 
were removed. The membrane was then exposed to autoradiographic film (Roche, 
11666916001) for various times (from 10 seconds to 30 minutes depending on the intensity 
of the signal). The exposed autoradiographic film was developed for 3 minutes in developer 
solution (Kodak, LX24, diluted 1:5 in water). The film was then washed in water for 15 
seconds and transferred to a fixative solution (Kodak, FX-40, diluted 1:5 in water) for 5 
minutes. The film was washed with water for 5-10 minutes and left to dry at room 
temperature. 
2.6.12 siRNA design for selected protein targets  
2.6.12.1 Primer design 
mRNA sequences for protein targets from orthologous species (human, rat, mouse, chicken, 
chimpanzee, cow, horse, rhesus monkey, pig and rabbit) were retrieved from NCBI 
(http://www.ncbi.nlm.nih.gov/) (Table 2.6.12.1). The sequences were aligned using 
ClustalW (http://www.ebi.ac.uk/Tools/clustalw2/index.html). The conserved regions were 
searched and reverse and forward primers were designed to amplify fragments ranging 
from ~300 to 1500 base pairs. 
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Table 2.6.12.1. Sequences for protein targets from orthologous species used for identifying 
conserved regions for designing PCR Primers. 
No. Protein Target Orthologous Sequences (Accession Number) 
1 EIF4A NM144958, NM204549, NM199372, NM001416, 
NM001098575, XM001109801, NM001034228, 
XM001504774,  
2 HNRPC NM001077442, XM001151919, XM001096688, 
NM001082038, NM001034395, XM001505154, NM016884, 
NM001025633 
3 Importin-α NM010655, NM053483, NM002266, XM001170686, 
NM001034449, XM001500180, NM001006209, 
XM001093937 
4 LGALS1 NM008495, NM019904, NM002305, XM001162066, 
XM001083427, NM175782, AY604429, NM205495 
5 PFN2 NM002628, XM001252022, XM516998, NM001079760, 
NM019410, NM030873, XM001491165, XM001102817 
 
2.6.12.2 Reverse Transcription  
Reverse transcriptase (RT) reactions were set up on benches using micropipettes, which 
were specifically allocated to this work. 
To form the cDNA, the following reagents were mixed to make RT-master-mix in a 0.5 mL 
eppendorf.  
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10µL of 5X buffer (100mM-Tris/HCl, pH 9.0, 50mM-KCl, 1% Triton X-100) (Sigma, 
P-2317) 
4 µL 25X dNTPs (10mM of each dNTP) (Sigma, DNTP-100) 
5 µL 10X reverse transcriptase (Sigma, M-1302) 
5 µL 10X RNAse inhibitors (40U/µL) (Sigma, R-2520) 
26 µL DEPC water 
A volume of 9µL of RT-master-mix was mixed with 1µL of reverse primer in pre-labeled 
0.5 mL eppendorf and then 10µL of RNA sample was added. This was repeated for all 
protein targets using their respective primer. The solutions were mixed and the RT reaction 
was carried out by incubating the eppendorfs at 37°C for 1 hour. The RT enzyme was 
inactivated by heating to 95°C for 3 minutes. The cDNA was stored at -20°C until required 
for use in PCR reactions. 
2.6.12.3 Polymerase Chain Reaction (PCR) amplification of cDNA 
The cDNA formed in the above reaction was used for subsequent analysis by PCR. 
Polymerase chain reaction (PCR) was performed using Platinum Supermix HiFi 
(Invitrogen). As for the RT reactions, 0.5 mL eppendorf tubes were used.  
45µL Platinum Supermix HiFi (Invitrogen, 12532-016) 
2µL Forward primer 
2µL Reverse primer 
1µL cDNA 
The samples were mixed by pipetting two or three times and were amplified using:  
  95°C for 3 min -   denaturation 
35 cycles: 94°C for 30 sec.  -  denaturation 
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  55°C for 30 sec.  -  annealing 
  72°C for 1 min.  -  extension    
And finally, 
  72°C for 7 min.    extension 
Following amplification, the PCR products were stored at 4°C for analysis by gel 
electrophoresis after purification as described in Section 2.5.5.  
2.6.12.4 DNA Quantitation 
Purified DNA samples were quantitated using Nanodrop spectrophotometer. Before 
applying the DNA sample the pedestal was wiped down using a lint-free tissue dampened 
with UHP. A volume of 1µL of UHP was then loaded onto the lower measurement 
pedestal. The upper sample arm was then brought down so as to be in contact with the 
solution. “Nucleic acid” and “DNA” was selected on the Nanodrop software to read the 
samples at 260nm. After the equipment was initialised the “blank” option was chosen, and 
after a straight line appeared on the screen the “measure” option was selected. The 
concentration of DNA was calculated by software using the following formula: 
   OD260nm x Dilution factor x 40 = µg/mL RNA 
A260/A280 ratio for each sample was also recorded. An A260/A280 ratio of 1.8-2 is indicative of 
pure DNA, although DNA with ratios from 1.7 – 2.1 were routinely observed and used in 
subsequent experiments.  
All sample readings were automatically saved as tab delimited files which could be viewed 
using Microsoft excel. The upper and lower pedestals were cleaned with a clean dry wipe 
between samples. When finished, the pedestal was cleaned with a wipe dampened with 
UHP followed by drying with a dry wipe.  
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2.6.12.5 Sequencing of amplified cDNA fragments 
Purified DNA samples were quantitated using Nanodrop spectrophotometer. These samples 
and primers used for RT-PCR were then sent to ‘Eurofins MWG Operon’ for sequencing.  
2.6.12.6 siRNA design for protein targets 
The sequence information was sent to Applied Biosystems in order to design 2 siRNA 
molecules for each target (table 2.6.12) using Silencer Select algorithm.  
 
Table 2.6.12 Sequences of siRNAs designed  
Target siRNA siRNA Sequence 
siRNA 1 sense GCAGUAAUCUUUAUCAAUAtt 
antisense UAUUGAUAAAGAUUACUGCtt 
EIF4A 
siRNA 2 sense GGAUUCUUGUCAAGAAAGAtt 
antisense UCUUUCUUGACAAGAAUCCga 
siRNA 1 sense AGAUAAAACAAAAAGUGGAtt 
antisense UCCACUUUUUGUUUUAUCUga 
HNRPC 
siRNA 2 sense AAAGUGGAUUUAAUUCAAAtt 
antisense UUUGAAUUAAAUCCACUUUtg 
siRNA 1 sense CACUUUGUCUUAGCAAUUAtt 
antisense UAAUUGCUAAGACAAAGUGat 
PFN2 
siRNA 2 sense GGAUACUGAUUACUAAAAUtt 
antisense AUUUUAGUAAUCAGUAUCCca 
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2.7 miRNA-arrays 
miRNA-arrays are high quality microarrays that contains probes from human, mouse and/or 
rat for miRNA detection in the samples. Total RNA was isolated from CHO cells and after 
quality assurance was applied to miRNA-arrays to identify differential expression in 
response to low temperature culture. 
2.7.1 Cell Culture 
Suspension-adapted CHO-K1 cells were seeded at 1x105 cells/mL in 100mL in 10% FCS 
supplemented ATCC medium in 250mL spinner with a working volume of 100mL. Cells 
were maintained in biphasic culture, where cells grown at 370C for 72hrs and then shifted 
to 310C for a further 72hrs or 24hrs, or in standard culture at 370C for 144hrs or 96hrs. 
Cultures were rotated at 60rpm and gassed everyday with Mixture of Gasses (N2, O2 and 
CO2). Cell counts and viability were measured every day as mentioned in section 2.4.3. The 
cell samples were collected for biphasic cultures at 72hrs, 96hrs and 144hrs of culture. 
2.7.2 Total RNA isolation and quantification 
Total RNA was isolated using mirVana™ miRNA isolation Kit (Ambion, AM1561). A 
volume of 0.5-1x106 cells were sampled and washed twice using ice-cold PBS. The cell lysis 
was performed in ice. The cells were gently resuspended in 300-600µL of Lysis/Binding 
Buffer for lysis. A 1/10th volume of miRNA Homogenate Additive was added to the cell 
lysate and incubated for 10min on ice. To each sample, 300-600 µL of Acid-
Phenol:Chloroform was added and shaken vigorously for 30 seconds. The sample was 
centrifuged at 13000rpm for 15 mins at 4oC in a microfuge. This step separated the mixture 
into 3 phases with the RNA contained in the colourless upper aqueous layer. The aqueous 
layer was transferred to a new eppendorf and 1.25 volume of 100% ethanol was added to 
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each sample and mixed.  The sample was filtered by centrifuging at 13000rpm for 10 min 
at 4oC. This allowed RNA to bind on the membrane of filter. The bound RNA was washed 
once with miRNA Wash Solution 1 and twice with Wash Solution 2/3. RNA was then 
eluted using 100µL of Elution Solution in fresh eppendorf. 
RNA was quantified using Nanodrop spectrophotometer at 260nm. The method for using 
Nanodrop spectrophotometer has been described in section 2.6.12.4. RNA samples were 
diluted to 500 ng/µL and stored at –80oC. 
2.7.3 Determination of RNA purity using Bioanalyser 
The Agilent 2100 Bioanalyser is a microfluidics-based platform for the analysis of proteins, 
DNA and RNA. The miniature chips are made from glass and contain a network of 
interconnected channels and reservoirs. The RNA 6000 Nano LabChip kit enables analysis 
of samples containing as little as 5ng of total RNA. The channels are firstly filled with a gel 
matrix and the sample wells with buffer or sample, there are 12 sample wells per chip 
(Figure 2.7.3). To each well, 1µL of each sample is loaded along with a fluorescent dye 
(marker). An RNA ladder is loaded into another sample well for size comparison. When all 
the samples are loaded, the chip is briefly vortexed and loaded onto the bioanalyser 
machine. The machine is fully automated and electrophoretically separates the samples by 
injecting the individual samples contained in the sample wells into a separation chamber.  
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A B 
 
Figure 2.7.3 The RNA 6000 Nano chip, a picture of the front of the RNA Nano chip (A) 
and a diagram of the microchannels in the chip (B), the sample moves through 
microchannels (1) and is injected into separation chamber (2) were components are 
electrophoretically separated (3) and detected by their fluorescence and translated into gel-
like images and electropherograms. Both pictures available from 
http://www.agilent.com/chem/labonachip..  
 
The fluorescensce was measured and presented in the form of peaks for 18S and 28S 
ribosomal RNA peaks. Higher 28S peaks than the 18S peak is an indication of good quality 
of RNA. As RNA degrades, the 28S RNA peak decreases and smaller fragments appear.  
2.7.4 miRNA bioarray  
2.7.4.1 Sample Processing 
Samples for miRNA profiling studies were processed by Asuragen according to the 
company’s standard operating procedures. The microRNA enriched fraction was obtained 
by passing 10µg of total RNA through a flashPAGE™ Fractionator apparatus (Ambion) 
and cleaned and concentrated using the flashPAGE™ Reaction Clean-Up Kit (Ambion). 
The 3’ ends of the RNA molecules were tailed and labelled using the mirVana™ miRNA 
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Labeling Kit (Ambion, AM1562) according to the manufacturer’s instructions. Amine-
modified nucleotides were incorporated during the poly (A) polymerase mediated tailing 
reaction, and Cy5 succinimide esters (GE Healthcare) were conjugated to the amine 
moieties on the microRNAs. Hybridization to the mirVana™ miRNA Bioarrays (Ambion, 
P/N 4392878) was performed using the mirVana™ miRNA Bioarray Essentials Kit 
(Ambion, AM1567). The Cy5 fluorescence on the arrays was scanned at an excitation 
wavelength of 635nm using a GenePix 4200AL scanner (Molecular Devices). The 
fluorescent signal associated with the probes and local background was extracted using 
GenePix Pro (version 6.0, Molecular Devices).  
2.7.4.2 Data analysis 
Thresholding and signal scaling were generated using algorithms selected by Asuragen, as 
implemented as part of the miRNA Standard Service Premium Analysis (miSSP package).  
The background adjusted fluorescent values generated by GenePix Pro were normalized for 
each miRNA using a variation stabilization transformation method (Huber et al. 2002). 
Each miRNA-bioarray contains 22 control probes, of which 12 serve as negative controls. 
These probes aid the normalization of miRNA-bioarray data.  
Hierarchical clustering was performed to investigate the relationship between replicate 
samples and to investigate if all CHO samples are unique in their miRNA profiles in 
comparison to other human samples tested. The list of miRNA expression data were loaded 
in to the software and it represented the relationship among samples in the form of 
dendrogram. This method was useful in its ability to represent varying degrees of similarity 
and distant relationships among groups of closely related miRNAs.  
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Pair-wise comparisons were also carried out on differentially expressed genes identified by 
ANOVA to see how they differ from each other. For each pair of treatments, a two-sample 
t-test was carried out for every gene and multiplicity correction was followed to control the 
false discovery rate (FDR) using a step-up approach using an FDR of 5%. This method is 
referred to as “protected Least Significant Difference (LSD)”. The detailed miRNA lists 
and associated information such as fold-change and p-values are reported. 
2.7.5 PCR based miRNA Taqman Low Density Arrays  
TaqMan® Low Density Arrays (Applied Biosystems, 4334812) are 384-well micro fluidic 
cards designed for analyzing gene expression patterns of up to 8 samples in parallel across 
a defined set of gene targets (Figure 2.7.5). TaqMan® Low Density Array is real-time 
PCR-based highly sensitive and reproducible array that contains probes for human miRNA 
signatures.  
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Figure 2.7.5. Schematic representation of using miRNA TaqMan® Low Density Array. 
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2.7.5.1 Reverse Transcription 
The RT-master mix was prepared as described below 
 
Component Volume for One 
RT Reaction (µL)  
Volume for One Sample (8 RT 
Reactions) with 12.5% 
Excess(µL) 
100 mM dNTPs 0.20 2.0 
MultiScribe™ Reverse 
Transcriptase, 50 U/µL 
2.00 20 
10x Reverse Transcription 
(RT) Buffer 
1.00 10 
RNAse Inhibitor, 20 U/µL 0.125 1.25 
Nuclease-free water 3.675 36.75 
Total 7 70 
 
A volume of 7 µL of RT-master mix was added to each well (as required) of 396-well of 
MicroAmp™ optical reaction plate. To each well, 2µL of RNA sample (100ng) and 1µL of 
Multiplex RT Human Primer Pool (10X) were added. Samples were mixed gently and were 
incubated on ice for 10 minutes. Multiplex reverse transcription was performed using the 
thermal cycler to the 9600 Emulation mode and final volume of reaction to 10µL in 
HT7900 RT-PCR machine, then programmed as follows:  
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Step Type  Time (min)  Temperature (°C)  
HOLD  30  16  
HOLD  30  42  
HOLD  5  85  
HOLD  ∞  4  
 
2.7.5.2 PCR 
RT reaction was diluted 62.5-fold by adding 615 µL of nuclease-free water to 10 µL RT 
reaction and thereafter RT reaction-specific PCR mix was prepared for each RT reaction as 
follows  
Component Volume (µL) per Fill Reservoir 
Diluted RT Reaction  50.0  
TaqMan 2X Universal PCR Master Mix (No 
AmpErase® UNG)  
50.0  
Total Volume  100.0  
 
A volume of 100µl of RT reaction-specific PCR mix was loaded in to the filling ports 
(Figure 2.7.5) of the TLDA as shown bellow 
TaqMan 
Array  
Fill 
Port 1  
Fill 
Port 2  
Fill 
Port 3  
Fill 
Port 4  
Fill 
Port 5  
Fill 
Port 6  
Fill 
Port 7  
Fill 
Port 8  
Multiplex 
RT pool  
1  2  3  4  5  6  7  8  
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Arrays were incubated for 10min on ice and were loaded on HT7900 real time PCR 
machine. The following protocol was used. 
 
AmpliTaq Gold® 
Enzyme Activation 
PCR 
CYCLE (40 cycles) 
Step 
HOLD 
Denature Anneal/Extend 
Time 10 min 15 sec 60 sec 
Temp ( °C) 95 95 
 
2.7.5.3 Data Analysis 
Data was analysed using Real-Time StatMiner™ Software from Integromics. miR-let-7c 
(human) was used as an endogenous control in this investigation. Cycle time (Ct) ≤30 and 
p-value ≤0.05 were used as cut-off criteria for identifying differential expression of 
miRNAs. 
2.7.6 qRT-PCR validation 
2.7.6.1 qRT-PCR validation using mirVana Assays  
For the detection and quantification of specific miRNAs, the mirVana™ qRT-PCR miRNA 
detection kits (Ambion, AM1558) and primer sets were used according to manufacturer’s 
instructions. In all cases SuperTaq™ (Ambion, AM2052) was used for polymerisation 
reactions. Per reaction, 2.5ng of RNA was used in qRT-PCR. PCR-primer for 5S 
endogenous control were diluted by 1/10 factor. Both RT and PCR reactions were carried 
out using an ABI 7500 Real-Time PCR System (Applied Biosystems) as described in 
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Section 2.6.4.3 & 2.8.2.1. Detection and normalisation was facilitated using SYBR green 
and ROX normalisation dyes (Invitrogen). Biological replicate results were checked for 
statistical significance using a student’s t-test with a p-value cut-off of ≤0.05. 
2.7.6.2 singleplex qRT-PCR validation using Taqman miRNA assays 
2.7.6.2.1 Reverse Transcription (RT) 
RT-master mix for each reaction was prepared separately using a kit from Applied 
Biosystems (ABI, 4366596) as follows; 
Component Master Mix  
15-µL (1 Reaction) 
100mM dNTPs (with dTTP) 0.15 
MultiScribe™ Reverse Transcriptase, 50 U/µL 1.00 
10X Reverse Transcription Buffer  1.50 
RNase Inhibitor, 20U/µL  0.19 
RT primer (RNUB6: ABI-4373381, miR-7: ABI-
4373014, miR-200c: ABI-4373096) 
3 
Nuclease-free water  6.16 
Total  12.00 
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An aliquot of 12 µL of RT-master mix was transferred in to a 0.5mL eppendorf and 3 µL of 
RNA sample (10ng) was added to each tube. RT was performed using following parameters 
in hybrid thermocycler 
Step Type Time(min) Temperature (°C) 
HOLD  30  16 
HOLD  30  42 
HOLD  5  85 
HOLD  ∞  4 
 
2.7.6.2.2 PCR 
PCR-master mix was prepared for each reaction as follows  
Component Volume (µL) 20-µL (1 Reaction) 
TaqMan MicroRNA Assay (20X) 1.00 
Product from RT reaction (Minimum 
1:15 Dilution) 
4 
TaqMan 2X Universal PCR Master Mix, 
No AmpErase UNGa (ABI, 4324018) 
10.00 
Nuclease-free water 5 
Total Volume 16 
 
To each well of a MicroAmp™ optical reaction plate, 16 µL of PCR-master mix was 
loaded. From RT reaction, 4 µL of Product was added to PCR-master mix. The plate was 
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sealed and then incubated for 10min on ice. PCR was performed using 9600 emulsion 
mode of thermocycler with reaction volume of 20 µL in HT7600 real time PCR machine. 
AmpliTaq Gold® 
Enzyme Activation 
PCR 
CYCLE (40 cycles) 
Step 
HOLD 
Denature Anneal/Extend 
Time 10 min 15 sec 60 sec 
Temp ( °C) 95 95 
 
2.7.7 Isolation and cloning of the Cricetulus griseus miRNAs  
Primers were designed for cloning C. griseus miR-21 based on alignment of the 
corresponding genomic regions flanking the pre-miR-21 sequence from Mus musculus, 
Rattus norvigicus and Homo sapiens. The primers used were 
5′atgtttgctttgctttaaaccctgcctgagca3′ and 5′ctgcaaaccatgatgctgggtaatgtttga3′. Genomic DNA 
was extracted from approximately 5 × 106 CHO-K1 cells (Whole blood extraction kit, 
Nucleon, 44100) and eluted in 100 µL water. A volume of 1.5 µL ( 100 ng) DNA was 
used as a template for PCR. The reaction also contained 400 nM of each primer, 1 µL 
DMSO and 20.5 µL Platinum Supermix (Invitrogen). Cycling conditions were: 
   95°C for 3 min -   denaturation 
30 cycles: 94°C for 30 sec.  -  denaturation 
  53°C for 30 sec.  -  annealing 
  72°C for 45 sec.  -  extension    
And finally, 
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  72°C for 7 min.    extension 
PCR product was checked on an agarose gel for a specific band of appropriate length (ca. 
220 bp) and the remainder of the mix cleaned up (Qiagen PCR cleanup kit, 28704) for 
sequencing. Sequencing was performed on both strands using the cloning primers (MWG 
Biotech, Germany). 
 
2.8 Functional Analysis of effects of selected miRNA or protein targets 
RNA interference (RNAi) was carried out using small interfering RNAs (siRNAs) to 
silence the expression of specific genes. Chemically synthesized  small RNAs were used to 
suppress or induce the expression of selected miRNAs. The siRNAs/miRNAs used in this 
investigation were purchased from Applied Biosystems. These siRNAs/miRNAs were 
transfected into the cells using the transfection agent siPORTTM NeoFXTM (Ambion, 
AM4511). All transfections were performed using filtered-cap spin tubes (Sartorius) in a 
2mL working volume.  
2.8.1 siRNA/miRNA transfection 
The siRNA used in this investigation were generated as described in Section 2.6.12. 
miRNA were purchased from Applied biosystems. The details are AM-Control 
(AM17010), PM-Control (AM17110), AM-miR-7 (AM10047), PM-miR-7 (PM10047), 
AM-miR-24 (AM10737), PM-miR-24 (PM10737). Solutions of siRNAs and miRNAs at a 
final concentration of 30nM/mL were prepared in 100µL (per tube) of OptiMEM (GibcoTM, 
31985) and incubated at room temperature for 10 minutes. NeoFX solution at 2µL/mL was 
also prepared in 100 µL(per tube) of OptiMEM in parallel and incubated at room 
temperature for 10 minutes. A volume of 100µL of the siRNA/miRNA were topped on the 
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100µL of neoFX solution to form complexes for another 10 min. To each tube, 200µL of 
complex was added and was mixed with the cell suspension to achieve 1x105cells/mL. The 
tubes were mixed gently and incubated at 175rpm agitation speed at 37°C for 96hrs or 
144hrs, 310C for 144hrs or 310C for 72hrs after 24hrs of transfection at 370C. The 
efficiency of inhibition or induction of targets were confirmed using Western blot analysis 
or singleplex qRT-PCR after 96hrs culture. 
2.8.2 Guava ViaCount® Assay 
The assay provides more accurate than hemocytometer counting or impedence-based 
counting. The ViaCount Assay distinguishes viable and non-viable cells based on 
differential permeabilities of two DNA-binding dyes in the Guava ViaCount® Reagent 
(Guava Technologies, 4000-0041). The nuclear dye stains only nucleated cells, while the 
viability dye brightly stains dying cells. ViaCount reagent was allowed to come at room 
temperature. A volume of 100 µL of cell suspension was mixed with 100 µL of ViaCount 
reagent and incubated for 10 min at room temperature. The samples were then analyzed 
using Guava flow cytometer. 
2.8.3 SEAP Assays 
Samples were harvested after 96hrs of transfection and were analyzed for SEAP 
productivity as described in Section 2.5.7. 
 
2.9 SELDI-ToF MS 
SELDI-ToF MS is a highly sensitive proteomics tool being used to identify differential 
expression of proteins in a given sample. Protein samples from conditioned media of low-
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serum adapted CHO-K1 cells representing different phases of growth cycle were analyzed 
using SELDI-ToF MS to identify secreted growth specific proteins/peptides in culture.    
2.9.1 Cell culture 
Low serum-adapted cells (0.5% FCS) were seeded at 1x105cells/mL in ATCC medium in 
T-75 flasks using 10mL of working volume for a period of 144hrs. The conditioned 
medium (used medium) was collected from four biological replicate samples at every 24hrs 
and centrifuged at 1000rpm for 15-20 min at 40C. The supernatant was carefully collected 
and stored at -800C until used.     
2.9.2 Preparation and analysis of chip surfaces 
Conditioned media samples were concentrated using 5000 MW cut-off centricons 
(Millipore, UFC8005). A volume of 10mL of conditioned media was centrifuged at 4000g 
at 40C reduce sample size to ~1mL to concentrate media by a factor of ~10. The protein 
concentrated in this conditioned media was estimated as described in section 2.6.2. Prior to 
full profiling analysis, optimization studies were performed with the day 4 sample using 10 
µg and 50 µg of extracted protein from conditioned media samples on four different 
chromatographic surfaces to see which protein concentration and Protein Chip array (Bio-
Rad) gave optimal results. The following Protein Chip arrays were selected, an IMAC30 
(immobilized metal affinity capture) (Bio-Rad, C730078) activated with copper ions, 
CM10 (weak cation-exchange) (Bio-Rad, C530075) with 20 mM Tris pH 4.5, Q10 (strong 
anion-exchange) (Bio-Rad, C5730080) with 50 mM Tris pH 8.0 and H50 (reversed-phase 
hydrophobic surface) (Bio-Rad, C5730065) with 10% acetonitrile/0.1% trifluoroacetic acid. 
The IMAC30 and Q10 ProteinChip 8-spot arrays provided better profiles under these 
conditions in terms of number and resolution of peaks and therefore were selected for the 
  
 118 
final profiling studies. IMAC30 arrays were coated with 5 µL of 100 mM CuSO4 for a total 
of 30 minutes (2x15 minute applications) and then rinsed with high-performance liquid 
chromatography (HPLC) grade water. The copper ions were charged by applying 50 µL of 
100 mM sodium acetate for 5 minutes. Each array was placed in a Bioprocessor (Bio-Rad) 
and the IMAC-Cu2+ arrays were washed twice with 250 µL of 250 mM sodium chloride 
containing 0.1% Triton X-100, and Q10 arrays were washed twice with 50 mM Tris pH 
8.0.  From each sample, 10 µg of protein was diluted in binding buffers. To the spots of the 
arrays, 250 µL of diluted samples were applied. The arrays were placed on a shaker and 
gently agitated for 90 minutes to allow for interaction of proteins with the array surface. 
After removing the samples, the IMAC-Cu2+ arrays were washed twice with 250 µL of 250 
mM sodium chloride containing 0.1% Triton X-100, and Q10 arrays with 50mM Tris pH 
8.0 for 5 minutes, followed by a brief HPLC-grade water wash. An aliquot of 0.8 µL of 
saturated sinapinic acid (SPA (Bio-Rad, C3000002) dissolved in 50% acetonitrile 
containing 0.5% trifluoroacetic acid) was then added to each of the spots, allowed to dry 
and repeated. The IMAC-Cu2+ and Q10 ProteinChip arrays were then analyzed in a 
Ciphergen Series PBS-IIC ProteinChip® System, and time-of-flight (ToF) data was 
generated by averaging a total of 220 laser shots collected at a laser intensity of 200, a 
detector sensitivity of 8 and molecular mass range from 5–20,000 Da for low molecular 
weight range and 20,000-100,000 Da for high molecular weight range. 
2.9.3 Analysis of differential expression of Proteins/peptides 
Molecular weights were calibrated externally using an all-in-1 protein standard (Bio-Rad, 
N76006). All data was analyzed using Biomarker Wizards Software, version 3.1 (Bio-Rad).  
After automatic baseline noise correction, all of the spectra were normalized together by the 
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‘‘total ion content’’ method as described by the manufacturer, i.e. with an m/z between 
5,000 and 100,000. The peaks with an m/z value < 5000 were excluded, as these peaks were 
mainly ion noise from the matrix (sinapinic acid), and 5kDa cut-off centricons were used to 
concentrate the samples in this analysis.  Peak clusters were generated by automatically 
detecting qualified mass peaks with a signal to noise ratio (S/N) >5 in the first pass, 
completed with a second-pass peak selection of S/N >3, with a 0.3% mass error for 5000-
20,000 Da, and the same for 20,000-100,000 Da. Statistically significant peaks were 
considered to be those with p <0.05.   
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Section 3.0 
 
 
 
 
Results 
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3.1 Establishment of a recombinant protein-secreting CHO-K1 cells 
3.1.1 Cell Adaptation 
The industrial production of therapeutically important recombinant protein is mostly 
performed in suspension culture and preferably using reduced serum or serum-free culture 
medium. CHO-K1 cells were therefore adapted to grow in suspension and in reduced serum 
and serum-free culture medium.  
Cells typically have a preference to grow in a specific type of culture condition, i.e. 
monolayer, suspension and/or in the presence of serum or particular nutrients, etc. Cells can 
respond to the change(s) in their growth environment. When cells are initially exposed to 
new culture conditions, they react to this new stimulus. This exposure induces a reaction 
that modifies the cellular machinery to help the survival of the cell in the new environment. 
However the mechanisms of CHO cell adaptation at the molecular level are not well 
understood. The intensity of the cellular response to new conditions declines gradually. In 
this way cells adjust their sensitivity to the new environment in terms of growth and 
survival, and this process is called adaptation. Cell adaptation is a time-consuming process 
and its efficiency and success can be cell, clone- or change-specific; for example, cells 
respond differently to the gradual or immediate removal of serum from culture medium.   
 
3.1.1.1 Suspension Culture 
Adherent CHO-K1 cells were obtained from the American type culture collection (ATCC) 
and were maintained in 10% FCS supplemented ATCC medium (1 : 1 ration (v/v) of 
DMEM and Ham’s F12) in T-75cm2 flasks at 370C in humidified incubators containing 5% 
CO2. To adapt adherent CHO-K1 cells to grow in suspension, exponentially growing cells 
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were inoculated at 2x105 cells/mL in spinner vessels at a final volume of 100 mL of culture 
medium and maintained at 60rpm. The growth behavior of cells was monitored during the 
process of adaptation by seeding exponentially growing cells at 1x105 cells/mL in a 
separate spinner vessel. Cell counts were performed using a hemacytometer and viabilities 
were measured using the trypan blue exclusion method at every 24hrs for 144hrs of this 
culture. Results indicate that during adaptation, the growth behaviour of the cell improved 
with time. The cells in passage 1 (P-1) (at early stage of adaptation) were continuously 
growing through out the culture period and achieved a maximum viable cell density of 
1.63x106 cells/mL at 144hrs of culture, whereas the cells at P-42 reached 1.99x106 cells/mL 
within 96hrs (Figure 3.1.1A). The cultures maintained high viability (≥94%) throughout the 
adaptation (Figure 3.1.1B). The viability of cells in P-1 was reduced to 98% at 72 hrs of 
culture and improved >99% at the end of the culture. Comparably, the cells at P-42 were 
98% viable at 72 hrs of culture (Figure 3.1.1B).  
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Figure 3.1.1. Comparison of the viable cell number (A) and viability percentage (B) of CHO-K1 cells during the process of cell 
adaptation to grow in suspension culture (n=1). P represents passage number of cells. 
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3.1.1.2 Serum-Free Medium (SFM) 
To adapt suspension-adapted CHO-K1 cells to grow in serum-free culture conditions, 
serum was gradually reduced in the culture medium over time. The following work-flow 
was used to adapt CHO-K1 to serum-free conditions. For adherent culture, cells were 
seeded at 3x105 cells/mL in three T-75 cm2 culture flasks in 10mL of culture medium. Cell 
counts were performed every 2nd and 4th day of culture. For suspension culture, cells were 
seeded at 2 x105 cells/mL in spinner flasks and were counted. If cells achieved ≥1x106 
cells/mL within 4 days, they were transferred to medium with reduced serum. This criterion 
was selected as these cells had a doubling time of ~24hrs and therefore if cells are able to 
reach ≥ 1x 106 cells/mL within 4 days of culture, it is a sign that the cells are healthy and 
would be able to cope well with the adaptation process. If cells failed to reach ≥1x106 
cells/mL within 4 days, the medium was replaced in the 3rd flask, and once cells became 
confluent, the work flow was followed until they met the set criteria of adaptation. The cell-
free conditioned medium that contains a number of unknown growth factors secreted by 
cells was also collected at every sub-culture. A volume of 10% conditioned medium was 
included at each subculture to support cell growth in stressed conditions which occurred 
due to the gradual decrease in serum in culture medium during adaptation. The procedure 
for adaptation was repeated until cells were adapted.  
Suspension-adapted CHO-K1 cells, growing in 10% FCS supplemented ATCC culture 
medium, were used for SFM adaptation. Cells were initially adapted to reduced serum 
levels in adherent culture and were then re-adapted to suspension culture in reduced serum 
or serum-free medium. Cells took only one cycle of the above described work flow (4 days) 
to adjust up to the 1% serum level in culture medium suggesting that even 1% serum in the 
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medium may provide a sufficient nourishment and protection for the growth of CHO cells. 
After 1% FCS level in the medium, the time taken by cells to reach the set criteria increased 
gradually. It took 10 days in 0.5 % FCS and 34 days in a commercially available serum-free 
medium (ExCell) (Figure 3.1.2). Cells took 22 days to adapt to grow in 0.5% FCS 
supplemented medium from 10% FCS supplemented medium. Cells adapted to grow in 
0.5% FCS supplemented medium were then transferred to a very simplified and low protein 
containing SFM (Insulin-Transferrin-Selenium (ITS) supplemented ATCC medium) and to 
ExCell medium. Using this protocol, CHO-K1 cells have been adapted to grow in adherent 
culture in 0.5% FCS-supplemented ATCC medium and ExCell medium as well as in 
suspension culture in these both culture media. However, cells did not successfully adapt to 
grow in ITS supplemented medium in adherent culture and were therefore discarded after 
~4 months of culture. Cells could be re-tried to adapt to grow in ITS supplemented medium 
by using higher initial cell density (>3x106 cells/mL) or by gradually removing the 
important nutrient factors one by one from the culture medium in order to slowly adapt the 
cells to grow in such a simplified medium.  
  
 126 
0.00E+00
5.00E+05
1.00E+06
1.50E+06
2.00E+06
2.50E+06
3.00E+06
3.50E+06
0 2 4 4 6 6 8 10 10 12 14 14 16 18 18 20 22 22 26 22 24 26 22 24 26 48 48 50 52 52 54 56 56 60 64 68
Days
V
i
a
b
l
e
 
C
e
l
l
s
/
m
L
Serum SFM
5
%
F
C
S
2
.
5
%
F
C
S
1
%
F
C
S
0
.
5
%
F
C
S
S
F
M
 
(
I
T
S
)
S
F
M
 
(
E
x
C
e
l
l
)
0
.
5
%
F
C
S
 
(
S
u
s
p
e
n
s
i
o
n
)
S
F
M
 
(
E
x
C
e
l
l
)
 
(
S
u
s
p
e
n
s
i
o
n
)
Figure 3.1.2. Adaptation of suspension-adapted CHO-K1 cells to serum-free culture medium (SFM). SFM(ITS) is Insulin-Transferrin-
Selenium supplemented serum-free ATCC medium whereas SFM(ExCell) is a commercially available serum-free medium from 
Sigma. The cell adaptation was performed using adherent and suspension culture. Cells adapted to grow in suspension culture have 
been marked in the figure. FCS denotes fetal calf serum. Red circle represents subculture points. 
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3.1.2 Establishment of SEAP-secreting CHO-K1 cells 
We were interested to investigate the impact of selected protein and miRNA targets on the 
growth and recombinant productivity of mammalian cells. CHO-K1 cells were therefore 
engineered to express a model recombinant protein product, secreted alkaline phosphatase 
(SEAP). SEAP is a highly glycosylated recombinant protein. The cells secreting SEAP 
were isolated and adapted to grow in suspension culture and were then used in further 
investigations.  
 
3.1.2.1 SEAP plasmid construction 
The pSEAP2-control vector was a kind gift from Professor Martin Fussenegger (Institute 
for Chemical and Bioengineering, ETH Zurich, Zurich, Switzerland). pSEAP2-control did 
not contain an eukaryotic selection marker and therefore was only suitable for transient 
expression studies (Figure 3.1.2.1A). pcDNA3.1 contains CMV promoter to drive the 
expression of gene of interest and has an eukaryotic selection marker, neomycin resistance 
gene (neor) (Figure 3.1.2.1B). The SEAP coding gene was isolated from the pSEAP2-
control and was inserted into the pcDNA3.1 to generate pcDNA3.1-SEAP2. 
The pSEAP2-control was transformed into competent bacterial cells and was amplified and 
purified. pSEAP2-control was digested with HindIII and SalI restriction enzymes to isolate 
the SEAP coding sequence (Figure 3.1.2.2). pcDNA3.1 was also digested with HindIII and 
XhoI to accept the SEAP insert. Digests of both, pSEAP2-control and pcDNA3.1, were 
separated on 2% (w/v) agarose gels (Figure 3.1.2.2) and the bands of interest, SEAP-
HindIII/SalI (~2kb) and pcDNA3.1-HindIII/XhoI (~5.4kb), were retrieved from the gel and 
purified. These fragments were quantified using a NanoDrop spectrophotometer and were 
re-checked on a 2% (w/v) agarose gel for purity. The purified SEAP-HindIII/SalI fragment 
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and pcDNA3.1-HindIII/XhoI backbone were then ligated to construct pcDNA-SEAP2. 
Competent cells were transformed and plated out on agar under selection pressure 
(100µg/mL of ampicillin). Several clones were picked, plasmids were minipreped for 
digestion using EcoRI/BamHI and then separated on 2% (w/v) agarose gel. As expected, 
bands at ~0.2, 2 and 3kb were observed which indicated the successful construction of 
pcDNA-SEAP2. A MaxiPrep was performed to generate large quantities of pcDNA-SEAP2 
for stable transfection. 
  
 129 
 
Figure 3.1.2.1. Restriction maps and multiple cloning sites of pSEAP2-Control and pcDNA3.1 (+/-) vectors. A represents pSEAP2-
Control vector and B represents pcDNA3.1 (+/-) vector. 
A B 
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Figure 3.1.2.2. Construction of pcDNA-SEAP2 from pSEAP2-Control and pcDNA3.1. pSEAP2-Control was digested with HindIII 
and SalI. pcDNA3.1 was digested with HindIII and XhoI. Digests were separated using agarose gel electrophoresis. The purified 
fragment coding for SEAP was then ligated into the purified pcDNA3.1 backbone to construct pcDNA-SEAP2. Minipreped pcDNA-
SEAP2 was also digested with EcoRI and BamHI and was separated on agarose gel again to ensure efficiency of plasmid construction.  
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3.1.2.2 Transfection of pcDNA3.1-SEAP2 and selection of transfectant CHO-K1 cells 
CHO-K1 cells that were adapted to grow in 0.5% (v/v) FCS supplemented medium in 
adherent culture were transfected with pcDNA-SEAP2. The cells were seeded at 1x105 
cells/mL in 4x T-25 culture flasks. Once cells reached 70-80% confluency, the culture 
media was replaced. One flask was transfected with pcDNA3.1 and one flask with pcDNA-
SEAP2 using Lipofectamine 2000 transfection reagent. Two flasks were maintained as non-
transfected controls in this investigation. The media was changed after 24 hrs of culture in 
all flasks and cells were allowed to grow for another 24 hrs. Transfectants were selected 
using G418 in the culture medium. Clonal populations were clearly visible in transfected 
culture in the presence of G418 (800µg/mL) in the medium, whereas the cells in non-
transfected culture died (Figure 3.1.2.3). This is because pcDNA3.1 and pcDNA-SEAP2 
contain neor which enabled transfected cells to survive in the presence of G418. These 
clonal populations were allowed to grow and were used to isolate single cell clones 
secreting SEAP in culture. 
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Figure 3.1.2.3. Transfection of pcDNA-SEAP2 in CHO-K1 cells adapted to grow in 0.5% FCS supplemented culture medium in 
monolayer. Media was replaced after 24hrs of transfection. G418 was added after 24hrs of media replacement. pcDNA3.1 and 
pcDNA-SEAP2 contain neor gene and therefore clonal populations were only observed in transfected culture. 
pcDNA3.1 pcDNA-SEAP2
NeorNeor
CHO-K1 Cells
No Transfection
(Control)
No Transfection
(Control)
Medium replaced after 24hrs
Medium replaced after 24hrs
Medium replaced after next 24hrs
Medium replaced after further 24hrs with G418 selection pressure (800µg/ml) 
Transfected Clonal Population
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3.1.2.3 Selection and isolation of suitable clones 
Single cell clones were isolated from mixed populations of transfected cells using the 
limiting dilution method as described in Section 2.5.7. For this, cells were serial-diluted to 
achieve 1 cell/well in a 96-well culture plate using 0.5% FCS supplemented culture media 
containing G418 (800µg/mL). Single cell clones were identified using microscope. 
Twenty-four single cell clones were isolated from the mixed population and were 
transferred to a 24-well culture plate for further growth and expansion once cultures 
became confluent in the 96-well plate.  
The conditioned media from these clones were collected under different culture conditions 
(different time points (24 & 72hrs) and G418 concentrations (800 & 1000 µg/mL)) and 
were analysed for SEAP production (Figure 3.1.2.4). The reason for selecting different time 
points was directed by the fact that clones may vary in their growth rates and productivity. 
Slow growing clones may have high productivity but as the productivity is directly 
dependent on the number of producer cells, it might not be detected at early stage of culture 
(24hrs). The culture of clones for 72hrs will allow these slow growing cells to grow up to 
detectable limits and therefore might enable us to identify slow growing high-producer 
clones. The use of different G418 concentrations (800 & 1000 µg/mL) helped us to 
improve the productivity as well as ensuring the elimination of non-transfected clones in 
this investigation. At the same time, the use of different time points and G418 concentration 
allowed us to optimize the time point for SEAP assays for the cells.  
SEAP was quantified by measuring the change in absorbance per minute (OD/min) 
reflecting alteration in enzymatic activity (Section 2.5.8). SEAP is a glycosylated protein 
and therefore, alternation in SEAP level observed in this study could be due to change in 
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SEAP quantity, quality or both. From the 3 tested conditions, 1000 µg/mL of G418 at 72 
hrs was found to be the optimum condition for the SEAP assay as 72hrs of culture was 
sufficient time for CHO cells to grow and secrete SEAP into the culture medium. Six 
clones (3H3(16), 4A10(19), 4D10(21), 4H9(22), 5A10(23) and 5F12(24)) were identified 
as SEAP producers (Figure 3.1.2.4). The clone 4A10(19) was observed to be the highest 
producer in all culture conditions tested in this investigation. 
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Figure 3.1.2.4. Identification of SEAP producer CHO-K1 clones in the single cell clones 
isolated from the mixed population. Conditioned medium from non-producer CHO-K1 
cells was used as a control. Error bars represent standard deviation calculated from data 
obtained from three independent biological samples. 
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These six SEAP-secreting clones were investigated for their SEAP productivity to identify 
clones with different levels of SEAP productivity for future investigations. For this, all 
clones were seeded at 1x105 cells/mL in 0.5% FCS supplemented culture medium 
containing G418 (1000 µg/mL) in a 24-well plate with a working volume of 0.5mL/well. 
Non-producer CHO-K1 cells were also seeded in 0.5% FCS supplemented culture medium 
as a control culture. The conditioned media were collected after 72hrs of culture and 
investigated for SEAP activity. The conditioned medium from a transiently tranfected 
known SEAP-secreting CHO cells was also used as a positive control in this investigation 
and this enabled us to identify a suitable producer clone. The SEAP productivity was 
highest, consistent and comparable to the positive control for only 1 clone, clone-19 (Figure 
3.1.2.5). The remaining five clones secreted low levels of SEAP. All clones tested in this 
investigation were observed, using microscope, to be comparable in biomass (40-60% 
confluency) at the time of sample collection for SEAP assays. 
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Figure 3.1.2.5. Comparison of SEAP productivity of six SEAP-secreting clones isolated 
from the mixed population. Conditioned medium from CHO cells transiently transfected 
with SEAP was used as a positive control. Conditioned medium from non-producer CHO-
K1 cells was used as a negative control. Error bars represent standard deviation calculated 
from data obtained from three independent biological samples. 
 
 
 
 
 
 
 
 
 
 
  
 137 
Since only 1 clone (clone 19) was observed to secrete SEAP in culture, additional single 
cell subclones were isolated from this clone in order to establish a wide range of SEAP-
producing CHO clones, i.e. low and high producer, for future investigations. A total of 16 
subclones were isolated from clone 19 using the limiting dilution method (Section 2.5.7) 
and compared for their SEAP productivity. For this, subclones were seeded at 
1x105cells/mL in 24-well plate with a working volume of 0.5mL/well. Non-producer CHO-
K1 cells were also seeded in 0.5% FCS supplemented culture medium as a control culture. 
The conditioned media were collected after 72hrs of culture and were investigated for 
SEAP activity. From these 16 subclones, 2 subclone 3 (3s) and 12 (12s)) were observed to 
secrete comparable SEAP into the culture compared with the positive control (conditioned 
media from transiently transfected SEAP secreting CHO cells) (Figure 3.1.2.5-6). The cell 
growth was observed visually to be comparable within all subclones (40-60% confluent) at 
the time of sample collection for SEAP assays. These 2 subclones were also considered for 
further investigations.  
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Figure 3.1.2.6. Identification of SEAP producer subclones isolated from clone 19. 
Conditioned medium from non-producer CHO-K1 cells was used as control. Error bars 
represent standard deviation calculated from data obtained from three independent 
biological samples. 
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3.1.2.4 Identification of clones with different levels of SEAP productivity 
All clones (19, 3s and 12s) were then compared for their SEAP productivity in order to 
identify the highest producer clone for further work (Figure 3.1.2.7). Clones were seeded at 
1x105 cells/mL in 0.5% FCS supplemented culture medium containing G418 (1000µg/mL) 
in a 24-well plate. Non-producer CHO-K1 cells were also seeded in 0.5% FCS 
supplemented culture medium as a control culture. The working volume was maintained at 
0.5mL/well. The conditioned media were collected at 72hrs of culture and were analyzed 
for SEAP activity. The cell counts were also performed. This experiment was performed 
using cells from 3 consecutive passages (P-3, P-4 and P-5) to improve the efficiency of the 
clone identification process. The highest total productivity was observed for subclone 12s 
followed by subclone 3s and clone 19 respectively at all passages (Figure 3.1.2.7B). A 
similar pattern was confirmed by analysis of the cell specific productivity (Figure 
3.1.2.7C). The cell specific productivity was calculated by dividing the total productivity by 
cell number. This established subclone 12s as the best producer clone identified in this 
investigation followed by subclone 3s as a medium producer. Both clones were scaled-up 
by growing firstly in a 6-well plate and then scaled upto T-75 flasks.  
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Figure 3.1.2.7. Comparison of SEAP productivity of clone 19 and subclones 3s and 12s to 
identify different levels of SEAP secreted by the 3 clones over 3 consecutive passages. 
Non-producer CHO-K1 cells were used as a control. A represents viable cell counts, B total 
productivity, and C specific productivity of cells. Error bars represent standard deviation 
calculated from data obtained from three independent biological samples. 
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3.1.2.5 Investigation of stability in SEAP productivity of clones 
SEAP-secreting cells were routinely seeded at 3x105 cells/mL in 0.5% FCS supplemented 
culture medium in the presence of G418 (1000µg/mL) in T-75 flasks and were 
subcultured in the exponential phase (3rd or 4th day) of culture. From this master culture, 
exponentially growing cells were seeded at 1x105 cells/mL in 0.5% FCS supplemented 
culture medium containing G418 (1000µg/mL) in a 24-well plate with 0.5mL working 
volume over a period of 27 days to investigate the stability of SEAP productivity of both 
subclones 12s and 3s. Non-producer CHO-K1 cells were also seeded in 0.5% FCS 
supplemented culture medium as a control culture. The conditioned media were collected 
at 72hrs of culture and were analyzed for SEAP activity. Cell counts were also performed 
at 72hrs of culture. The cell specific productivity was found to be comparable through out 
the test period (Figure 3.1.2.8) which suggests that both clones are quite stable in their 
SEAP productivity for the testing period in this study.  
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Figure 3.1.2.8. Investigation of the stability of SEAP productivity of subclones 3s and 12s 
over a period of 27 days. Non-producer CHO-K1 cells were used as a control. A 
represents viable cell counts, B total productivity and C specific productivity of cells. 
Error bars represent standard deviation calculated from data obtained from three 
independent biological samples. 
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3.1.2.5 Suspension-adaptation of SEAP-secreting clones 
Both subclones, 3s and 12s, were subjected to adaption to grow in suspension culture and 
then to SFM conditions. Cells were seeded to achieve 2x105 cells/mL density in 100mL 
of 0.5% FCS supplemented culture medium in the presence of G418 (1000µg/mL) in 
spinner flask. The cells were rotated at 60rpm and were gassed with mixture of gasses 
(O2, N2 and CO2) everyday. The cell counts were performed on 2nd and 4th day of culture. 
Both clones achived ≥1x106 cells/mL within 4 days and therefore were adapted to 
suspension culture (Figure 3.1.2.9). Attempts were made to adapt these suspension-
adapted clones to grow in serum-free ExCell medium. Both clones were unable to adapt 
to ExCell medium in the period tested (30 days). These clones could be re-tried for SFM 
adaption by using a higher initial cell density (seeding density) or by adapting cells first 
to 0.25% FCS-supplemented medium. Clone 12s that had been adapted to grow in 0.5% 
serum supplemented medium in suspension culture was selected for further studies. 
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Figure 3.1.2.8. Adaptation of SEAP-secreting CHO-K1 subclones to suspension culture 
and serum-free culture conditions (SFM). Cells were transferred to SFM (Excell) on 4th 
day of culture. SFM (ExCell) represents commercially available serum-free medium, 
ExCell. 
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3.2 Investigation of low temperature-induced differential expression of proteins in 
CHO-K1 cells using 2D-DIGE 
As described in section 1.5, low temperature cultivation of CHO cells can arrest cell 
growth and maintain high viability for a longer period of time and this results in an 
extended production phase and contributes to increased recombinant protein production. 
However, the mechanisms regulating these cellular phenotypes are still poorly understood. 
Therefore suspension-adapted CHO-K1 cells were cultured in a low temperature based 
biphasic culture process and analysed for differential expression of proteins following 
temperature-shift using 2D-DIGE.  
 
3.2.1 Cell Culture 
Suspension-adapted CHO-K1 cells were seeded at 1x105 cells/mL in spinner flasks and 
maintained at 370C for 144hrs or for 72hrs at 370C followed by a temperature-shift to 310C 
for a further 72hrs. The temperature-shift was performed after 72hrs of culture because it 
represents the mid-exponential phase of cell growth. The temperature of 310C was selected 
as it represents the average temperature employed by others performing similar studies, 
i.e. 28-330C. As can be seen in Figure 3.2.1, the cells that were temperature-shifted 
immediately ceased logarithmic growth and did not exceed a peak viable cell density of 
1.45 x106 ± 0.013 cells/mL, whereas the cells cultured at 370C continued in logarithmic 
growth for a further 48hrs and achieved a peak viable density of 2.02 x 106 ± 0.11 
cells/mL. The cells that were temperature-shifted displayed a steady, if slightly increasing, 
viable cell density throughout, whereas the cells maintained at 370C had entered the late 
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stationary/death phase of the growth cycle by 144hrs (Figure 3.2.1A&B). Cultures were 
sampled at 72hrs and 144hrs for protein extraction from 3 independent experiments. 
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Figure 3.2.1. Comparison of the viable cell number (A) and percentage viability (B) of CHO-K1 cells cultured using either a biphasic 
temperature-shifted culture  ( )  or using a standard culture at 370C ( ). Error bars represent the standard deviation calculated 
from three biological replicate cultures. ‘*’ indicates statistically significant (p-value ≤ 0.02) differences in cell growth and viability.
  
 148 
3.2.2 Quality analysis of Protein Samples 
A total of 50 µg of proteins from biological triplicate samples representing 72hrs and 
144hrs of culture for temperature-shifted and standard culture conditions were separated 
using 2D-PAGE. The gels were stained with silver stain initially to check the quality of 
protein samples before performing 2D-DIGE. Results indicated that the protein samples 
were of satisfactory quality as the spots were distinctly separated and all biological samples 
broadly showed a similar initial profile (Figure 3.2.2).  
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Figure 3.2.2. Quality analysis of protein samples. Figure represents silver stained images of 
3 biological proteins samples separated using 2D gel electrophoresis.   
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3.2.3 Analysis of differential expression of spots 
A 2D-DIGE experiment was carried out to identify the differential expression of cellular 
proteins between temperature-shifted and standard cultures of CHO-K1 cells. For this, 3 
independent biological samples representing 72 and 144hrs of culture from CHO-K1 cells 
grown in temperature-shifted and non-shifted conditions were prepared separately.  
A total of 50µg of protein from each of the cell samples were labelled with fluorescent dyes 
(Table 3.2.3) and were separated using 2D gel electrophoresis (section 2.6.3-6). Protein 
expression maps (PEMs) for the biological triplicate samples were generated using 2D-
DIGE for both temperature-shifted cultures and standard cultures. The 72hrs and 144hrs 
PEMs were then compared using the Biological Variation Analysis (BVA) module of 
DeCyder 6.5 software. This was aided by the use of a pooled internal standard labelled with 
Cy2 which facilitated spot matching and relative spot quantitation while minimizing gel-to-
gel variation. Spots originating from dust particles and gel impurities in each gel image 
were checked and removed manually to improve the quantitation and matching process. 
Landmarks, which aid the gel-to-gel spot matching process, were also defined in the gel to 
increase the accuracy of the matching algorithm. Manual checks were carried out to allow 
for cases where spots were detected more than once (due to spot splits by the spot detection 
algorithms). These spots were then merged back to improve spot matching. After spot 
matching and filtering, an average of 2852 and 2885 spots were detected for the 
temperature-shifted and standard culture experiments respectively. The average ratio, 
which was considered as fold change in this investigation, was calculated using DeCyder 
software by comparing the normalized spot abundances between two different groups such 
as 72hrs of culture vs. 144hrs of culture (Section 2.6.7). Spots that were 1.5 fold up/down 
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regulated at 144hrs compared to 72hrs with a t-test score of ≤ 0.05 and present on all gels in 
the experiment were considered differentially expressed (DE). A total of 201 DE spots (118 
up regulated and 83 down regulated) were observed in the temperature-shift experiment and 
404 DE spots (210 up regulated and 194 down regulated) were observed in the standard 
culture experiment. 
 
Table 3.2.3. Ettan 2D-DIGE experimental design used for the analysis of differential 
protein expression for temperature-shifted and standard culture of CHO-K1 cells. 
Culture 
Condition 
Gel 
number 
Cy2 Cy3 Cy5 
1 Pooled internal 
standard  
Biological Sample-
1 for 72hrs culture 
Biological Sample-1 
for 144hrs culture 
2 Pooled internal 
standard 
Biological Sample-
2 for 72hrs culture 
Biological Sample-2 
for 144hrs culture 
Temperature-
shift 
3 Pooled internal 
standard 
Biological Sample-
3 for 72hrs culture 
Biological Sample-3 
for 144hrs culture 
4 Pooled internal 
standard 
Biological Sample-
1 for 72hrs culture 
Biological Sample-1 
for 144hrs culture 
5 Pooled internal 
standard 
Biological Sample-
2 for 72hrs culture 
Biological Sample-2 
for 144hrs culture 
Standard 
Culture 
6 Pooled internal 
standard 
Biological Sample-
3 for 72hrs culture 
Biological Sample-3 
for 144hrs culture 
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3.2.4 Analysis of differentially expressed proteins 
The spots observed differentially expressed in temperature-shifted or standard culture were 
identified using MALDI-ToF MS. These identified proteins were then analyzed together to 
identify temperature-dependent and independent changes in expression of proteins. This 
enabled us to identify proteins that may have a possible role in the regulation of cell growth 
and apoptosis and hence have the potential to improve recombinant protein production in 
culture. 
3.2.4.1 Spot identification 
Following spot picking and tryptic digestion, protein identification was carried out using 
MALDI-ToF MS (section 2.6.10). All identified proteins had an expectation value of 0.01 
or better. The expectation value for proteins was determined by Ettan MALDI-ToF Pro 
evaluation software (GE Healthcare) using the Profound database search engine for peptide 
mass fingerprints. An expectation value of 0.01 or better means that there is ≤ 1% chance 
that the identification is random. Although many spots resulted in high quality spectra, they 
were not identified which may be due to insufficient amounts of protein, modification 
and/or variation of the amino acid sequences in CHO proteins or the lack of CHO proteins 
in the protein databases. Despite this, a total of 53 differentially expressed proteins were 
identified in this investigation (Figure 3.2.4.1). These proteins were comprised from the list 
of proteins differentially expressed in three different comparison groups, 72hrs at 370C vs. 
144hrs at 310C (temperature-shifted culture), 72hrs at 370C vs. 144hrs at 370C (standard 
culture), and 144hrs at 370C vs. 144hrs at 310C (stationary culture). The representative 
spectra of 3 of these identified proteins (vimentin, HNRPC and GAPDH) are presented in 
Figure 3.2.4.2. 
  
 153 
 
 
Figure 3.2.4.1. Representative overlapping 2D-DIGE expression map of CHO-K1 proteins 
labelled with fluorescent dyes (Cy2, Cy3 and Cy5). The location of differentially expressed 
proteins identified using MALDI-ToF MS are indicated by arrows. 
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A
B
C
 
Figure 3.2.4.2. MALDI-ToF generated spectra of heterogeneous nuclear ribonucleoprotein 
C (HNRPC) (A), Vimentin (VIM) (B) and Glyceraldehyde-3-phosphate dehydrogenase 
(GAPDH) (C). Trypsin gives peaks at specific molecular weight (842.51, 1045.5 and 
2211.1 m/z) that can be used as calibrants in the MS spectra. Peaks other than trypsin are 
from target proteins. Trypsin calibration peaks are represented by ♦ and peaks belonging to 
the identified proteins by ▲. 
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3.2.4.2 Temperature-shifted culture (72hrs at 370C vs. 144hrs at 310C) 
The protein expression maps (PEMs) for cells at 72hrs at 370C were compared with the 
PEMs for cells that were shifted to 310C for a further 72hrs after culturing for 72hrs at 
370C. The differentially expressed proteins identified in this comparison could be 
associated with the regulation of low-temperature induced phenotypes such as reduced 
growth and medium consumption and improved viability and recombinant protein 
productivity in CHO culture.  
 
72hrs at 370C
144hrs at 310C
144hrs at 370C
Tem
pera
ture
 
shift
ed C
ultur
e
Standard
 Culture
Identified
 DE
 proteins=30
(9
 up
 and
 21
 down
 regulated
 at
 144hrs)
Iden
tified
 
DE p
rote
ins=
35
(22 up
 
and 
13 d
own
 
regu
lated
 
at 14
4hrs
)
Identified DE proteins=21
(17 up and 4 down regulated 
at 144hrs at 310C)
Stationary Culture1
2
3
 
Figure 3.2.4.3. A figure describing the different comparison groups and the number of 
identified differentially expressed (DE) proteins. The temperature-shifted culture (72hrs at 
370C vs. 144hrs at 310C) are represented by 1, the standard culture (72hrs at 370C vs. 
144hrs at 370C) are represented by 2 and the stationary culture (144hrs at 310C vs. 144hrs 
at 370C) by 3. 
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Of the 53 identified proteins, 35 proteins were differentially regulated in temperature-
shifted cells at 144hrs at 310C in comparison to cells maintained at 72hrs at 370C (Figure 
3.2.4.3 and Table 3.2.4), of which 22 proteins were up regulated and 13 were down 
regulated at 144hrs at 310C. The list of differentially expressed proteins observed in 
temperature-shifted culture (72hrs at 370C vs. 144hrs at 310C) were compared with the list 
of differentially expressed proteins observed in standard culture (72hrs at 370C vs. 144hrs 
at 370C). This enabled us to identify temperature-dependent and -independent protein 
changes. Of the 35 proteins, 23 proteins were only differentially regulated in temperature-
shifted cultures (72hrs at 370C vs. 144hrs at 310C), of which 18 proteins were up regulated 
and 5 proteins were down regulated at 144hrs at 310C. For example, HNRPC, a protein 
involved in the regulation of protein translation was reduced by 1.52 fold in cells at 144hrs 
at 310C following reduction of culture temperature in comparison to cells at 72hrs at 370C. 
GANAB, a glycan-processing enzyme that is involved in glycoprotein quality control in the 
endoplasmic reticulum (Totani et al. 2006), was increased by 2.19 fold in cultures at 144hrs 
at 310C following temperature-shift compared to cultures at 72hrs at 370C. PFN2 is 
involved in the regulation of normal actin polymerization in response to thermal stress and 
this protein was 1.69 fold up regulated in cells at 144hrs at 310C in biphasic cultures in 
comparison to cells at 72hrs at 370C. The expression of HNRPC, GANAB and PFN2 was 
unchanged when the cells were maintained at standard culture (72hrs at 370C vs. 144hrs at 
370C) suggesting these changes to be temperature-induced changes in expression of these 
proteins.  
The identified temperature-dependent proteins were involved in the regulation of a wide 
range of biological functions such as transcription, translation, cell adhesion, structure, 
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growth and apoptosis, etc (Table 3.2.4). For example, RRN3 is a transcription factor and its 
expression was reduced by 1.53 fold in cells at 144hrs at 310C following temperature-shift 
in comparison to cells at 72hrs at 370C whereas it was unchanged in standard culture (72hrs 
at 370C vs. 144hrs at 370C). EIF4A is a translation initiation factor and was increased by 
1.81 fold in cells at 144hrs at 310C compared to cells at 72hrs at 370C. The expression of 
EIF4A remained unaltered in standard culture (72hrs at 370C vs. 144hrs at 370C). Importin-
α is involved in the regulation of transport of growth- and apoptosis-related factors into the 
nucleus and was 1.8 fold down regulated in cells at 144hrs at 310C in biphasic culture in 
comparison to cells at 72hrs at 370C, whereas it was unchanged in standard culture (72hrs 
at 370C vs. 144hrs at 370C). LGALS1, a cell adhesion protein, was 1.62 fold up regulated in 
cells at 144hrs at 310C compared to cells at 72hrs at 370C in biphasic culture and was not 
changed in standard culture (72hrs at 370C vs. 144hrs at 370C). Vimentin is a structural 
protein and was increased by 2.05 fold in cells at 144hrs at 310C in response to low 
temperature compared cells at 72hrs at 370C while it was not changed in standard culture 
(72hrs at 370C vs. 144hrs at 370C). 
On the other hand, there were a few proteins that were similarly affected in both 
temperature-shifted and non-shifted cultures indicating the temperature-independent 
changes. Activator of 90 kDa heat shock protein ATPase homolog 1 (AHSA1) was 
differentially expressed in both experiments. It was reduced by 1.69 fold in cells at 144hrs 
at 310C following temperature-shift compared to cells at 72hrs at 370C and 1.73 fold down 
regulated in cells at 144hrs at 370C in standard culture in comparison to cells at 72hrs at 
370C. Similarly, TXNL2 was 1.8 fold down regulated at 144hrs in both temperature-shifted 
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(72hrs 370C vs. 144hrs at 310C) and standard culture (72hrs 370C vs. 144hrs at 370C) and 
hence these changes could be temperature-independent alterations in protein expression.  
Two proteins, ALDH and DPYSL2, were identified at more than one location on the gel. 
ALDH was 1.98 and 1.63 fold up regulated at both spots respectively in cells at 144hrs at 
310C in temperature-shifted culture compared to cells at 72hrs at 370C and was not 
differentially regulated in standard culture (72hrs 370C vs. 144hrs at 370C). DPYSL2 was 
up regulated at 144hrs at one spot by 2.58 fold in temperature-shifted (72hrs 370C vs. 
144hrs at 310C) and by 1.97 fold in standard culture (72hrs 370C vs. 144hrs at 370C). At 
another spot, this protein was 2.51 fold down regulated in cells at 144hrs at 310C following 
temperature-shift in comparison to cells at 72hrs at 370C and was unchanged in standard 
culture (72hrs 370C vs. 144hrs at 370C). This could be possibly due to some form of post-
translational modification (PTM) of these proteins in response to low temperature culture. 
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Table 3.2.4 MALDI-ToF MS identification of proteins that were differentially expressed at 144hrs compared to 72hrs using either 
temperature-shifted or standard culture.  
Temperature-shift Standard Culture 
N
u
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e
r
 
Protein ID Protein Description  
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Fold 
Changeb 
t-test score Fold 
Changeb  
t-test score 
Structural 
1 gi|1407651 LIM and SH3 domain protein 
Lasp-1 LASP1 0.005 6 33.2 2.06  7.20E-09 NDE NDE 
2 gi|2078001 Vimentin  VIM 0 19 44.6 2.05  3.70E-07 NDE NDE 
3 gi|55391513 Calponin 3, acidic  CNN3 0.008 6 19.7 -1.96 7.20E-09 -3.37 2.80E-10 
4 gi|55621900 PREDICTED: similar to profilin 2 
isoform b PFN2 0 5 39.3 1.69  1.00E-03 NDE NDE 
5 gi|2624850 Chain A, Structure Of Bovine --- 0.002 10 44.8 -1.59 3.60E-08 -1.53 1.20E-11 
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Beta-Actin-Profilin Complex 
(1HLUA) 
6 gi|16304154  Beta actin ACTB 0.003 5 17.9 NDE NDE -1.97 4.50E-09 
7c gi|60389477  Beta actin ACTB 0.001 8 30.7 NDE NDE -1.74 4.20E-10 
8 
gi|54695812  
Capping protein (actin filament) 
muscle Z-line, beta CAPZB 0.005 8 26.5 NDE NDE -1.5 1.90E-05 
9 gi|224839  Tubulin T beta15 TUBB2B 0.009 7 18 NDE NDE -2.02 2.00E-08 
Metabolism 
1 gi|16073616 Aldehyde dehydrogenase ALDH 0 6 18.7 1.98  5.50E-08 NDE NDE 
2d gi|16073616 Aldehyde dehydrogenase ALDH 0.004 9 22.1 1.63 5.80E-06 NDE NDE 
3 
gi|28386049  
Aldehyde dehydrogenase family 1, 
subfamily A1 ALDH1A1 0.001 8 20 NDE NDE -1.64 0.00011 
4 gi|2897818 Huntingtin interacting protein-2  HIP2 0.006 5 28.5 1.97  1.40E-06 NDE NDE 
5 gi|56783068 Glyceraldehyde-3-phosphate 
dehydrogenase  GAPDH 0.004 5 22.3 1.8  4.00E-07 NDE NDE 
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6 gi|206428 Phosphoribosylphosphate 
synthetase (PRPS2) precursor PRPS2 0 5 21.7 1.53 1.6E-06 NDE NDE 
7 gi|55635845 PREDICTED: similar to NADH 
dehydrogenase (ubiquinone) Fe-S 
protein 3, 30kDa (NADH-
coenzyme Q reductase) NDUFS3 0.007 7 25.5 1.51 2.30E-07 NDE NDE 
8 gi|57110953 PREDICTED: similar to NADH 
dehydrogenase (ubiquinone) Fe-S 
protein 1, 75kDa precursor  NDUFS1 0.008 8 12.2 2  8.40E-08 1.59  
3.80E-06 
9 gi|76611941 PREDICTED: similar to UDP-N-
acetylhexosamine 
pyrophosphorylase (Antigen X)  AGX 0.002 6 12.8 -1.93 1.70E-06 NDE NDE 
10 gi|31982520 Acetyl-Coenzyme A 
dehydrogenase, long-chain  ACADL 0.005 10 24.2 1.88 7.8E-008 NDE NDE 
11 gi|6679891 Alpha glucosidase 2, alpha neutral GANAB 0.009 12 11.9 2.19 5.60E-09 NDE NDE 
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subunit  
12 gi|5759173 Succinate dehydrogenase 
flavoprotein subunit  SDHA 0.003 9 19.3 1.7 5.90E-08 1.87  
6.90E-10 
13 gi|71059735  Pyrophosphatase PYP 0.001 8 33.9 NDE NDE -1.58 3.60E-10 
14 gi|38512111 Triosephosphate isomerase 1  TPI1 0.001 8 29.8 NDE NDE 1.51 5.60E-08 
15 
gi|74007151 
PREDICTED: similar to alpha 
enolase ENO1 0.007 9 30.3 NDE NDE 1.51 4.80E-07 
16 
gi|73968432 
PREDICTED: similar to ATP 
synthase beta chain, mitochondrial 
precursor isoform 1 ATP5B 0 10 24.9 NDE NDE -2.28 1.60E-06 
17 gi|25320034  Adenosine kinase ADK 0.006 6 16.1 NDE NDE 1.78 3.50E-12 
Differentiation 
1 gi|57105264 PREDICTED: similar to 
Dihydropyrimidinase related 
protein-2 DPYSL2 0.007 15 11.2 2.58  5.90E-08 1.97 
3.50E-10 
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2e gi|3122018 Dihydropyrimidinase-related 
protein 2   DPYSL2 0.009 5 10.5 -2.51 5.50E-07 NDE NDE 
Signal Transduction 
1 gi|55742832 Annexin A4 ANXA4 0.001 11 35.4 1.95  7.20E-09 NDE NDE 
2 
gi|28876  
Growth factor receptor-bound 
protein 2  GRB2 0.002 5 27.5 NDE NDE -1.72 2.40E-09 
Translation 
1 gi|66910561 Heterogeneous nuclear 
ribonucleoprotein C  HNRPC 0 8 32.9 -1.52 6.9E-07 NDE NDE 
2 
gi|20987331  
Eukaryotic translation initiation 
factor 3, subunit I  EIF3I 0.008 5 20 -1.72 1.70E-08 -2 7.50E-11 
3 gi|73978223 PREDICTED: similar to 
eukaryotic translation initiation 
factor 4A, isoform 1  EIF4A 0 6 21.7 1.81  7.30E-07 NDE NDE 
4 gi|74001995  PREDICTED: similar to EIF4E 0.005 6 30.4 NDE NDE 1.67 0.0013 
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eukaryotic translation initiation 
factor 4E isoform 1 
5 
gi|109296  
Eukaryotic translation initiation 
factor 5A EIF5A 0.001 6 34.4 -1.81 1.30E-07 -2.07 7.50E-08 
6 
gi|56967054  
Chain A, Tu translation elongation 
factor, mitochondrial  TUFM 0.003 7 23.5 NDE NDE 1.56 4.60E-07 
7 gi|73989786  40S ribosomal protein SA (p40)  LOC480358 0 7 41.3 NDE NDE -1.9 2.40E-06 
Transcription 
1 gi|21706613 Rrn3 protein RRN3 0.001 3 5.7 -1.53  7.40E-10 NDE NDE 
2 gi|73966295  PREDICTED: similar to prohibitin  PHB 0.002 4 25.2 NDE NDE -1.66 4.30E-10 
Cell adhesion 
1 gi|12805209 Lectin, galactose binding, soluble 
1 
LGALS1 
0.007 4 32.6 1.62 5.70E-05 NDE NDE 
Stress Response 
1 gi|73963752 PREDICTED: similar to Activator AHSA1 0.003 8 15.5 -1.69  9.70E-09 -1.73  4.60E-10 
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of 90 kDa heat shock protein 
ATPase homolog 1 
Protein binding 
1 gi|78187979 Thioredoxin-like 2  TXNL2 0.009 7 19.3 -1.8  4.60E-08 -1.8 7.90E-09 
2 gi|5542272 Chain A, Importin Alpha, Mouse Importin-α 0.007 5 13.5 -1.8 8.80E-05 NDE NDE 
Secretory pathway 
1 gi|1698802 Menkes disease gene product ATP7A 0.005 6 6.2 1.79  9.30E-07 1.6  9.00E-10 
Protein Folding 
1 gi|13097417 FK506 binding protein 4 FKBP4 0.01 7 13.1 -2.5 7.40E-10 -2.43 1.50E-10 
2 gi|73954621  
 
PREDICTED: similar to heat 
shock protein 8 isoform 3 HSPA8 0.003 7 15.7 -1.9 5.60E-09 -2.09 2.20E-09 
3 
gi|74008872 
PREDICTED: similar to von 
Hippel-Lindau binding protein 1 
isoform 2 VBP1 0.007 7 26.9 NDE NDE -1.8 1.20E-10 
4 gi|73968675 PREDICTED: similar to CCT2 0.001 10 29.6 NDE NDE -1.64 2.60E-08 
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chaperonin containing TCP1, 
subunit 2 isoform 2 
Miscellaneous 
1 gi|66730313 Hypothetical protein LOC499689  --- 0.004 6 23.4 2.2  2.80E-08 NDE NDE 
2 gi|13161222 MHC class II antigen beta chain  MHC II β 0.007 7 62.9 1.87  2.70E-08 NDE NDE 
3 gi|75765278 Chain A, Crystal Structure Of The 
Human Sh3 Binding Glutamic-
Rich Protein Like SH3BGRL 0 8 74.4 1.7 1.80E-07 NDE NDE 
4 gi|73963786 PREDICTED: similar to Protein 
C14orf166  --- 0.002 8 24.6 1.5  1.80E-07 NDE NDE 
5 gi|12841560 Unnamed protein product --- 0.006 5 43.8 NDE NDE -1.54 1.60E-08 
Legends: a Expectation value is an approximation of “the probability that a certain protein candidate is a random hit”.  
b
 The fold change was calculated using DeCyder software as an ‘Average Ratio’ by dividing the spot abundance at 144hrs by that at 
72hrs. ‘-’ represents down regulation and ‘+’ up regulation of protein at 144hrs of culture compared to 72hrs of culture.  
c/d/e represents the proteins identified at multiple spots.  
NDE: proteins that are Not Differentially Expressed at cut-off criteria of at least 1.5 fold up/down regulated with a t-test score ≤0.05. 
‘---’: Not specified 
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Of the 35 proteins, 12 were observed to be differentially regulated in both temperature-
shifted (72hrs at 370C vs 144hrs at 310C) and standard culture (72hrs at 370C vs 144hrs 
at 370C), of which 4 proteins were up regulated and 8 were down regulated at 144hrs of 
culture in comparison to cultures at 72hrs (Table 3.2.5). These proteins represent the 
process-dependent changes in expression of proteins in culture. Calponin 3 (CNN3) was 
1.96 fold down regulated in cells at 144hrs at 310C in temperature-shifted culture and 
3.37 fold down regulated in cells at 144hrs at 370C in comparison to cells at 72hrs at 
370C in standard culture. Comparison of expression of CNN3 at 144hrs at 310C vs. 
144hrs at 370C revealed that this protein was 1.72 fold up regulated at 144hrs in cells 
maintained at 310C. Besides CNN3, the expression of proteins between 72hrs and 
144hrs was similar in both temperature-shifted (72hrs at 370C vs 144hrs at 310C) and 
standard culture (72hrs at 370C vs 144hrs at 370C) indicating that these changes are 
time-dependent changes in culture. For example, TXNL2 was 1.8 fold down regulated 
at 144hrs in both temperature-shifted (72hrs at 370C vs 144hrs at 310C) and standard 
culture (72hrs at 370C vs 144hrs at 370C) compared to cultures maintained at 72hrs.  
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Table 3.2.5. Differential expression of process-dependent proteins at 144hrs between temperature-shifted and standard culture conditions. 
N
u
m
b
e
r
 
Protein Description  
A
b
b
r
e
v
i
a
t
i
o
n
 
Fold Change in 
temperature-shifted 
culture (at 144hrs at 
310C compared to 72hrs 
at 370C) 
Fold Change in 
standard culture (at 
144hrs at 370C 
compared to 72hrs at 
370C) 
Fold Change in 
stationary culture (at 
144hrs at 310C 
compared to 144hrs at 
370C) 
1 Calponin 3, acidic  CNN3 -1.96 -3.37 1.72 
2 Chain A, Structure Of Bovine Beta-Actin-
Profilin Complex  --- -1.59 -1.53 -1.04 
3 PREDICTED: similar to NADH 
dehydrogenase (ubiquinone) Fe-S protein 1, 
75kDa precursor  NDUFS1 2 1.59 1.26 
4 Succinate dehydrogenase flavoprotein subunit  SDHA 1.7 1.87 -1.1 
5 PREDICTED: similar to 
Dihydropyrimidinase related protein-2 DPYSL2 2.58 1.97 1.31 
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6 Eukaryotic translation initiation factor 3, 
subunit I  EIF3I -1.72 -2 1.16 
7 Eukaryotic translation initiation factor 5A EIF5A -1.81 -2.07 1.14 
8 PREDICTED: similar to Activator of 90 kDa 
heat shock protein ATPase homolog 1 
AHSA1 
-1.69 -1.73 1.02 
9 Thioredoxin-like 2  TXNL2 -1.8 -1.8 1 
10 Menkes disease gene product ATP7A 1.79 1.6 1.12 
11 FK506 binding protein 4 FKBP4 -2.5 -2.43 -1.02 
12 PREDICTED: similar to heat shock protein 8 
isoform 3 HSPA8 -1.9 -2.09 1.1 
Legends: ‘---’: Not specified 
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3.2.4.3 Standard culture (72hrs at 370C vs. 144hrs at 370C) 
The protein expression maps (PEMs) for cells at 72hrs at 370C were compared with the 
PEMs for cells maintained for 144hrs at 370C to identify differentially expressed proteins. 
These differentially expressed proteins could be associated with the regulation of various 
cellular phenotypes such as structure, metabolism, growth and apoptosis in CHO culture.  
Of the 53 identified proteins, 30 proteins were differentially regulated in the comparison of 
cells at 72hrs at 370C vs. 144hrs at 370C (Figure 3.2.4.3 and Table 3.2.4), of which 9 
proteins were up regulated and 21 proteins were down regulated in cells at 144hrs at 370C 
in comparison to cells at 72hrs at 370C. Eighteen proteins were specifically differentially 
regulated in standard culture (72hrs at 370C vs. 144hrs at 370C). Four from these 18 
proteins were up regulated and 14 proteins were down regulated in cells at 144hrs at 370C 
compared to cells at 72hrs at 370C. For example, ENO1 a metabolic protein was 1.51 fold 
up regulated at 144hrs at 370C in comparison to cells maintained at 72hrs at 370C in 
standard culture. This protein remained unchanged in the temperature-shifted cultures 
(72hrs at 370C vs. 144hrs at 310C). GRB2, a protein that is involved in signal transduction, 
was 1.72 fold down regulated at 144hrs in cells maintained at 370C compared to cells at 
72hrs at 370C.  
The proteins specifically observed differentially expressed in standard culture (72hrs at 
370C vs. 144hrs at 370C) were mainly associated with the regulation of cell structure and 
metabolism. For example, TUBB2 and CAPZB were reduced by 2.02 fold and 1.5 fold 
respectively in cells at 144hrs at 370C compared to cells at 72hrs at 370C in standard 
culture. ACTB was identified at two different locations in the gel indicating possible post-
translational modification of these proteins. ACTB was down regulated in cells at 144hrs at 
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370C by 1.97 and 1.74 fold at both spots compared to cells at 72hrs at 370C. All of these 
proteins, TUBB2, CAPZB and ACTB, are involved in the regulation of cell shape and 
structure. A number of proteins involved in cellular metabolism proteins were also altered 
in stationary phase of culture at 144hrs of culture at 370C in comparison to cells 
exponentially growing at 72hrs of culture at 370C. For example, ALDH1A1 and PHB were 
reduced by 1.64 and 1.66 fold respectively in cells at 144hrs at 370C in standard culture 
compared to cells at 72hrs at 370C. Proteins involved in the regulation of protein translation 
were also observed differentially expressed. EIF4E was 1.67 fold up regulated whereas 40S 
ribosomal protein SA (p40) was 1.9 fold down regulated in cells at 144hrs at 370C in 
comparison to cells at 72hrs at 370C.  
 
3.2.4.4 Stationary culture (144hrs at 310C vs. 144hrs at 370C) 
The expression of identified proteins observed in stationary phase induced by low 
temperature culture (144hrs at 310C) were compared to the stationary phase in standard 
culture (144hrs at 370C). This comparison enabled us to identify changes in protein 
expression that could be associated with cell death and various stress conditions, i.e. 
nutrient limitation and/or waste accumulation in culture. 
Of the 53 identified proteins, 21 were found to be differentially expressed in the stationary 
phase of culture (144hrs at 310C vs. 144hrs at 370C) (Figure 3.2.4.3 and Table 3.2.6). In 
this comparison, 17 proteins were up regulated and 4 were down regulated at 144hrs of 
culture at 310C compared to 144hrs of culture at 370C. For example, importin-α was 2.09 
fold up regulated in cells in the stationary phase of culture at 144hrs at 370C compared to 
cultures at 144hrs at 310C. Importin-α has been associated with the transport of various 
apoptotic and growth regulating factors, i.e. p53, into the nucleus. CCT2 was 1.74 fold 
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down regulated in cells in stationary phase at 144hrs at 370C compared to cells at 144hrs at 
310C. CCT2 is a member of molecular chaperone family and has been associated with 
protein folding including actin and tubulin proteins. The proteins differentially expressed in 
this comparison were mainly involved in the regulation of cell structure and metabolism. 
All structural proteins identified in this investigation were up regulated in cells at stationary 
phase of culture induced by low temperature in comparison to the cells in stationary phase 
in standard culture. For example, vimentin, CNN3, ACTB, CAPZB and TUBB2 were 1.9, 
1.72, 2.2, 1.88 and 1.76  fold up regulated respectively in cells at stationary phase at 144hrs 
at 310C compared to cells at 144hrs at 370C. A number of metabolic proteins were also 
differentially regulated. ALDH1A1 was 1.76 fold up regulated while ENO1 was 1.51 fold 
down regulated in cells at stationary phase at 144hrs at 310C in comparison to cells at 
stationary phase at 144hrs at 370C. 
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Table 3.2.6. Differential expression of proteins at 144hrs between temperature-shifted and 
standard culture conditions. 
N
u
m
be
r 
Protein Description  
A
bb
re
v
ia
tio
n
 Fold Change at 144hrs 
at  310C (144hrs at 310C 
vs. 144hrs at 370C) 
1 Vimentin  VIM 1.9 
2 Calponin 3, acidic CNN3 1.72 
3 Beta actin ACTB 2.2 
4 Capping protein (actin filament) muscle Z-
line, beta 
CAPZB 
1.88 
5 Tubulin T beta15 TUBB2B 1.76 
6 Aldehyde dehydrogenase family 1, 
subfamily A1 
ALDH1A1 
1.76 
7 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH 1.64 
8 PREDICTED: similar to UDP-N-
acetylhexosamine pyrophosphorylase 
(Antigen X)  
AGX 
-2.90 
9 Acetyl-Coenzyme A dehydrogenase, long-
chain  
ACADL 
1.71 
10 PREDICTED: similar to alpha enolase ENO1 -1.51 
11 PREDICTED: similar to ATP synthase beta 
chain, mitochondrial precursor isoform 1 
ATP5B 
1.6 
12 Annexin A4 ANXA4 1.9 
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13 PREDICTED: similar to eukaryotic 
translation initiation factor 4E isoform 1 
EIF4E 
-2.42 
14 PREDICTED: similar to prohibitin  PHB 2.32 
15 Lectin, galactose binding, soluble 1 LGALS1 1.56 
16 Chain A, Importin Alpha, Mouse Importin-α -2.09 
17 PREDICTED: similar to von Hippel-Lindau 
binding protein 1 isoform 2 
VBP1 
1.51 
18 PREDICTED: similar to chaperonin 
containing TCP1, subunit 2 isoform 2 
CCT2 
1.74 
19 Hypothetical protein LOC499689  --- 1.53 
20 MHC class II antigen beta chain  MHC II- β 2.08 
21 Chain A, Crystal Structure Of The Human 
Sh3 Binding Glutamic-Rich Protein Like 
SH3BGRL 
1.56 
Legends: ‘---’: Not specified 
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3.2.5 Validation of proteomics results by Western blotting 
Two proteins, vimentin and HNRPC, were selected from the list of differentially expressed 
identified proteins for validation by Western blotting. RNA binding motif protein 3 
(RBM3) is well known to be induced following shift to low temperature. RBM3 is a small 
protein and was not identified in our study due to limitation of 2D-gel electrophoresis-
based methods in detecting low molecular weight proteins. RBM3 was included in this 
study as a positive control. α-Tubulin was used as a loading control as it was not identified 
differentially expressed in our study and has been used previously to show equal protein 
loading. Western blot analysis (Figure 3.2.5) reflected a similar pattern of expression to 
those observed using 2D-DIGE (Table 3.2.4).  
Vimentin was 2.05 fold up regulated in cells at 144hrs at 310C compared to cells at 72hrs at 
370C in temperature-shifted culture and not differentially regulated (1.08 fold up) in 
standard culture (72hrs at 370C vs. 144hrs at 370C) from 2D-DIGE analysis. Densitometry 
analysis of Western blot data revealed that vimentin was 1.9 fold up regulated in cells at 
144hrs at 310C compared to cells at 72hrs at 370C in temperature-shifted culture and 1.11 
fold down regulated in cells at 144hrs at 370C compared to cells at 72hrs at 370C in 
standard culture.  
HNRPC was reduced following temperature-shift by 1.52 fold in cultures at 144hrs at 310C 
in comparison to cultures maintained at 72hrs at 370C and by 1.26 fold in cultures at 144hrs 
at 370C compared to cultures maintained standard culture at 72hrs at 370C from 2D-DIGE 
analysis. The densitometry analysis of Western blot data showed that HNRPC was 1.33 
fold down regulated in cells at 144hrs at 310C and 1.07 fold down regulated in cells at 
144hrs at 370C compared to cells at 72hrs at 370C.  
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The slight difference observed in the expression of vimentin and HNRPC using 2D-DIGE 
and Western blotting could be due to the difference in the sensitivity of both techniques, i.e. 
Western blotting is only a semi-quantitative technique in comparison to 2D-DIGE. RBM3 
was only expressed in cultures maintained at low temperature (144hrs at 310C) confirming 
the expected induction of expression of this protein following temperature-shift. 
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Figure 3.2.5. Comparative Western blot analysis for HNRPC, vimentin and RBM3 proteins 
between 72hrs and 144hrs of culture in temperature-shifted and standard culture (A). α-
tubulin was used as a loading control. The graph indicates the fold change, derived from 
normalized intensities of bands from densitometry analysis, of vimentin and HNRPC 
between 72hrs and 144hrs of culture (B). Error bars represent the standard deviation 
calculated from normalized intensities of bands from three biological replicate samples for 
vimentin and HNRPC. 
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3.2.6 Protein target selection for knockdown and siRNA design 
Five protein targets (EIF4A, HNRPC, importin-α, LGALS1 and PFN2) were selected for 
functional validation based on their expression pattern observed in proteomics study and/or 
potential impact on cellular phenotypes, i.e. cell proliferation, apoptosis and cell structure, 
etc, that are observed at low temperature.  
• EIF4A is a RNA helicase enzyme that catalyzes the unwinding of messenger RNAs 
(mRNAs) and facilitates cap-dependent and independent translation. EIF4A was 1.81 
fold up regulated in cells at 144hrs at 310C following temperature-shift in comparison to 
cells at 72hrs at 370C which suggests its potential role in the regulation of protein 
translation at low temperature. 
• HNRPC, a nuclear pre-mRNA binding protein, can regulate pre-mRNA processing and 
can contribute to the regulation of cell proliferation in culture. HNRPC was 1.52 fold 
down regulated in cells at 144hrs at 310C in comparison to cells at 72hrs at 370C and 
could have a role in the regulation of cell growth and protein translation at low 
temperature.  
• Importin-α is a nuclear import receptor that transports proteins associated with various 
biological functions, i.e. apoptosis and cell proliferation, in cells. The expression of 
importin-α was reduced by 1.8 fold in cells at 144hrs at 310C following temperature-
shift compared to cells at 72hrs at 370C. This suggests that importin-α could be 
associated with reduced cell growth and improved viability in culture at low 
temperature.  
• LGALS1, a cell adhesion protein, acts as a negative regulator of growth in fibroblasts. 
LGALS1 was 1.62 fold up regulated at 144hrs of culture at 310C compared to 72hrs of 
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culture at 370C in temperature-shifted cultures which suggests its potential role in the  
regulation of cell growth at low temperature.  
• PFN2 is involved in the regulation of actin polymerization in response to extracellular 
signals, including the low temperature inductions. PFN2 was increased by 1.69 fold in 
cells at 144hrs at 310C following temperature-shift compared to cells at 72hrs at 370C 
and could be associated with the maintenance of cell structure and viability in culture at 
low temperature. 
The full genome sequence of hamster is not yet publicly available. As a result, the siRNAs 
for selected protein targets are not commercially available for CHO-K1 cells. However, 
partial sequence information can be used to design siRNAs to the selected proteins. 
Therefore siRNAs were designed by sequencing the fragments of coding regions amplified 
using PCR primers against orthologus gene sequences.  
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3.2.6.1 Primer design 
Sequences of orthologous genes from other mammalian species were aligned using 
ClustalW (multiple sequence alignment software). These species included human, rat, 
mouse, chicken, chimpanzee, cow, horse, rhesus monkey, pig and rabbit. Conserved 
regions in the sequences were identified and used to design primers for PCR (Table 
3.2.6.1). 
 
Table 3.2.6.1. PCR primers for target proteins identified from proteomic study 
Target Protein Forward Primer Reverse Primer 
EIF4A ggcgtcatcgagagtaactg accggaactccctcatgatc 
HNRPC acgatctgcagcggagatgt ctatgtgcttaagagtcatc 
Importin-α attcagtttgaatctgcttg ctctgcagcctgaaagatat 
LGALS1 ggtctggtcgccagcaacct tctggcagcttgatggtcag 
PFN2 gactgcacaatggacatccg tctgagctactgcaatga 
 
 
3.2.6.2 RT-PCR amplification of fragments coding DNA sequences for target proteins 
Reverse transcription was performed using the reverse primer to generate the cDNAs for 
target genes from extracted RNA. cDNA was then used as a template for PCR 
amplification. PCR products were separated on a 2% (w/v) agarose gel to ensure specific 
amplification of the fragments of interest. As expected bands at approximately 898, 636, 
951, 299 and 1209 bp were observed confirming the amplification of fragments of EIF4A, 
HNRPC, importin-α, LGALS1 and PFN2 respectively (Figure 3.2.6.1).  
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Figure 3.2.6.1. Investigation of amplification of fragments coding DNA for protein targets 
using RT-PCR product on 2% agarose gel. The expected molecular weight for each target 
has been included in green. 
 
The purified cDNA fragments were sent out for sequencing (Eurofins MWG Operon). Of 
the 5 targets, 3 targets, EIF-4A, HNRPC and PFN2, were successfully sequenced (Figure 
3.2.6.2). 
  
  
 182 
Figure 3.2.6.2. The sequence information for the amplified fragments of EIF4A, HNRPC 
and PFN2. 
 
3.2.6.3 Analysis of cDNA sequences 
To confirm the specificity of target amplification, the CHO cDNA sequences were aligned 
using ClustalW with the respective orthologous sequences from other mammalian species 
(Figure 3.2.6.3, 3.2.6.4 & 3.2.6.5). Multiple sequence alignment showed that the sequence 
information generated for CHO cells contained high similarity with respective orthologous 
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sequences tested and was suitable for siRNA design. Two siRNA molecules for each target 
were designed using Silencer Select Algorithm® by Applied Biosystems.    
 
 
Figure 3.2.6.3. Analysis of multiple orthologous sequence alignment for EIF4A.  
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Figure 3.2.6.4. Analysis of multiple orthologous sequence alignment for HNRPC.  
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Figure 3.2.6.5. Analysis of multiple orthologous sequence alignment for PFN2.  
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3.2.7 Effect of silencing protein targets using siRNA knockdown 
siRNAs can be transfected to the cells to investigate the effects of selected protein target on 
desired cellular phenotype by specifically inhibiting the expression of selected target. 
Therefore siRNAs for EIF4A, HNRPC and PFN2 were transfected into the SEAP-secreting 
CHO-K1 cells and were evaluated for their effects on cell growth and productivity. Results 
indicate that the inhibition of these targets can reduce cell growth and improve cell specific 
productivity in culture.   
 
3.2.7.1 Optimization of siRNA transfection conditions in non-producer suspension-
adapted CHO-K1 cells 
Optimization of siRNA transfection conditions and initial screening for the effects of 
knockdown of each target on cell growth and viability was performed in non-producer, 
suspension and low serum adapted CHO-K1 cells. All transfections were performed in 
biological triplicates using spin tubes containing 1x105 cells/mL in 2mL final volume. Two 
independent siRNA molecules for each target were transfected to ensure target-specific 
effects using neoFX, a lipid-based transfection agent. NeoFX treated cultures were 
considered as controls for this investigation as no validated siRNA control was available 
for CHO cells. Un-treated cultures were also monitored to differentiate effects of 
transfection reagent on these cells. The cultures were monitored at various time points over 
144hrs. Figure 3.2.7.1 shows timing of transfection and sampling to measure the impact of 
siRNA transfection on cell growth. Cell counts and viability measurements were performed 
by flow cytometry using Guava ViaCount® Assays (Section 2.7.8.2). This allowed us to 
identify the optimal time point to investigate the effects of target knockdown for further 
studies.  
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Figure 3.2.7.1 A representative figure of transfected culture showing time of transfection 
and sampling points for cell growth measurements. All transfection were performed using 
2mL of 1x105 cells/mL and cells were subsequently maintained at 370C or 310C for 144hrs 
of culture. Samples were collected at every 24hrs after 72hrs of transfection to investigate 
the effect of transfections on cell growth.   
 
3.2.7.1.1 EIF4A 
EIF4A facilitates cap-dependent and independent protein translation and due to this 
inhibition of EIF4A could be expected to reduce growth and/or viability of culture due to 
reduced global protein translation. EIF4A is also involved in blocking cell cycle transition 
and therefore knockdown of EIF4A could be expected to facilate cell-cycle and hence 
improve cell growth.  
EIF4A was 1.81 fold up regulated in cells at 144hrs at 310C following temperature-shift in 
comparison to cells at 72hrs at 370C in the proteomics study and therefore siRNA 
transfection was performed at low temperature (LT, 310C). The inhibition of eIF4A at LT 
was expected to mimic the growth behaviour of cells maintained at standard culture. 
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Transfections were performed using 2mL of 1x105 cells/mL. Following transfections, cells 
were maintained at 310C for 144hrs of culture. NeoFX-treated cultures were used as 
controls in this investigation, however un-treated cultures were also monitored. Impact of 
siRNA transfection on cell growth were measured at every 24hrs time interval after 72hrs 
of transfection over the period of 144hrs of culture (Figure 3.2.7.1). The cell growth was 
reduced by up to 75% in comparison to the neoFX-treated control cultures, whereas the cell 
viability of cultures remained unchanged following siRNA transfection (Figure 
3.2.7.2C&D and Table 3.2.7.1). This indicates that inhibition of EIF4A might have reduced 
the global protein translation in culture. 
 
3.2.7.1.2 HNRPC 
HNRPC, a pre-mRNA processing protein, can facilitate cell proliferation and hence 
inhibition of HNRPC was expected to reduce growth of culture.  
HNRPC was 1.52 fold down regulated at 144hrs of culture at 310C compared to 72hrs of 
culture at 370C in the 2D-DIGE experiment and therefore to see if we could mimic the 
effect of temperature-shift on growth, cells were maintained at 370C after transfection. 
Transfections were performed using 2mL of 1x105 cells/mL and cells were subsequently 
maintained at 370C for 144hrs of culture. NeoFX-treated cultures were used as controls in 
this investigation. Un-treated cultures were also monitored. Cell growth was monitored at 
every 24hrs time interval after 72hrs of transfection over a period of 144hrs  (Figure 
3.2.7.1). Following knockdown of HNRPC, cell growth was reduced (Figure 3.2.7.2A and 
Table 3.2.7.1). The maximum growth inhibition (48%) was observed at 96hrs of culture, 
however cells recovered at the end of culture (at 144hrs). The viability of culture was 
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comparable to neoFX treated control cultures through out the testing period (Figure 
3.2.7.2B and Table 3.2.7.1). Results indicate that down regulation of HNRPC can reduce 
cell growth.  
 
3.2.7.1.3 PFN2 
PFN2 is involved in the regulation of cytoskeleton in response to various stress conditions 
including thermal stresses and therefore inhibition of PFN2 was expected to reduce growth 
and viability of culture due to distortion in the cytoskeleton of cells.  
PFN2 were 1.69 fold up regulated in cells at 144hrs at 310C following temperature-shift 
compared to cells maintained at 72hrs at 370C in the proteomics study following 
temperature-shift and therefore transfection was performed at LT. The inhibition of PFN2 
expression at LT was expected to mimic the growth behaviour of cells maintained at 
standard culture. Transfections were performed using 2mL of 1x105 cells/mL. Following 
transfections, cells were maintained at 310C for 144hrs of culture. NeoFX-treated cultures 
were used as controls in this investigation. Un-treated cultures were also monitored. Impact 
of siRNA transfection on cell growth were measured at every 24hrs time interval after 
72hrs of transfection over the period of 144hrs of culture  (Figure 3.2.7.1). Cell growth was 
reduced up to 74% for siRNA 1 following knockdown of PFN2 (Figure 3.2.7.2C and Table 
3.2.7.1). A pattern of reduced cell growth was also observed for siRNA 2, however it was 
not significant. A drop in the viability was also observed for the siRNA 1 treated culture 
(Figure 3.2.7.2D and Table 3.2.7.1). Results confirmed that down regulation of PFN2 
reduced the growth and viability of culture.  
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Figure 3.2.7.2. Investigation in to the effects of siRNA transfection targeting HNRPC in standard culture (370C) and EIF4A and PFN2 
at low temperature 310C (LT) on growth and viability of low serum-adapted CHO-K1 cells. A & C represent growth and B & D 
represent viability of CHO-K1 cells during 144hrs of culture after siRNA transfection. Control denotes un-treated cultures. NFX 
denotes transfection reagent only treated culture.  
  
 191 
Table 3.2.7.1. Comparative analysis of effects of siRNA transfection for protein targets on growth and viability of low serum adapted 
CHO-K1 cells at standard and low temperature cultures. This data was calculated (in percentage) from Figure 3.2.7.2. by comparing 
neoFX-treated control cultures (NFX) with siRNA treated cultures. Shaded columns represent the optimized conditions selected for 
inhibition of expression of target proteins in SEAP-secreting CHO-K1 cells. 
Cell growth Viability Protein 
target 
Culture 
Condition 
Time 
(Hrs) siRNA 1 
(%) p-value 
siRNA 2 
(%) p-value 
siRNA 1 
(%) p-value 
siRNA 2 
(%) p-value 
72 -44 0.002 -39 0.002 -10 0.002 -4 0.032 
96 -60 0.0002 -54 0.0003 -6 0.02 -2 0.37 
120 -68 0.0007 -66 0.0009 -8 0.02 -5 0.044 
EIF4A Low 
temperature 
culture 
(310C) 144 -75 0.003 -66 0.005 -14 0.01 -3 0.5 
72 -11 0.04 -21 0.004 0 0.96 0 0.63 
96 -36 0.0006 -48 0.0001 -2 0.13 -8 0.004 
120 -20 0.15 -34 0.02 +10 0.04 +4 0.25 
HNRPC Standard 
culture 
(370C) 
144 +5 0.84 +4 0.89 -7 0.52 +6 0.79 
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72 -49 0.002 -11 0.12 -12 0.001 -2 0.44 
96 -69 0.0005 -16 0.02 -19 0.005 -3 0.10 
120 -69 0.001 -11 0.22 -23 0.01 -4 0.12 
PFN2 Low 
temperature 
culture 
(310C) 144 -74 0.003 -15 0.26 -29 0.0017 -3 0.39 
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In general, the cultures at 96hrs after transfection represented the most efficient (or 
comparable to other tested time points) effects on growth and viability of culture and 
therefore was considered as the optimal time point for the investigation of the effects of 
knockdown of all protein targets in SEAP secreting CHO-K1 cells (Table 3.2.7.1). A 
significant difference in growth and vibility of neoFX treated culture compared to untreated 
culture was also observed highlighting the requirement for an appropriate scambled control 
in future siRNA transfection studies.  
 
3.2.7.2 Effect of knockdown of protein targets on SEAP-secreting suspension-adapted 
CHO-K1 cells 
Suspension and low serum-adapted SEAP-secreting CHO-K1 cells were transfected with 
siRNAs against EIF4A, HNRPC and PFN2. After transfection cells were maintained in two 
culture conditions, standard culture for 96hrs at 370C or shifted to 310C for a further 72hrs 
after 24hrs of culture at 370C (Figure 3.2.7.3). Cells were analysed for the effects of 
siRNAs on growth, viability and SEAP productivity after 96hrs of culture (Sections 2.5.7 
and 2.8.2). Human scrambled (non-sense) siRNA was included as a control to ensure that 
the effects observed following transfection are only due to the effect of inhibition of protein 
targets and are not due to RNA delivery in the cells. The use of a scrambled siRNA 
designed for human cells is an imperfect control but in the absence of a hamster genome 
sequence, it was an appropriate choice. NeoFX-treated cultures were also monitored as 
negative controls. The observations that scrambled siRNAs had similar effects on cellular 
phenotypes compared to neoFX-only suggests that human scrambled siRNA could be used 
as negative control in these experiments, however further studies needed to confirm it. 
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Fi
gure 3.2.7.3. A representative figure of transfected culture showing time of transfection, 
temperature-shift and sampling points for cell growth measurements. All transfections were 
performed using 2mL of 1x105 cells/mL and subsequently cells were maintained in 
standard culture for 96 hrs at 370C or shifted to 310C for 72hrs after 24hrs of transfection at 
370C. Samples were collected at 96hrs post-transfection to investigate the effect on growth 
and productivity of cells.   
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3.2.7.2.1 EIF4A 
The siRNA transfections were performed using 2mL final volume containing 1x105 
cells/mL and cells were subsequently maintained in two culture conditions, standard culture 
for 96hrs at 370C or shifted to 310C for a further 72hrs after 24hrs of culture at 370C (Figure 
3.2.7.3). The srambled siRNA-treated cultures were used as a control in this investigation. 
Un-treated and neoFX-treated cultures were also monitored. The impact of siRNA 
transfection were measured after 96hrs of transfection. Cell growth was reduced by up to 
55% following the inhibition of expression of EIF4A whereas the viability of cultures did 
not change significantly for either standard or biphasic cultures (Figure 3.2.7.4 and Table 
3.2.7.2). This is consistant with the effects observed with the non-producer CHO-K1 cells 
(Figure 3.2.7.2 and Table 3.2.7.1). The total productivity was also significantly reduced in 
temperature-shifted and non-shifted cultures (Figure 3.2.7.5 and Table 3.2.7.2). EIF4A is a 
translation initiation factor and knockdown of EIF4A, apart from reducing cell growth, 
could be expected to inhibit specific productivity of cells. A pattern of improved cell 
specific productivity (Qp) was observed, however it was significant only for siRNA1 in 
temperature-shifted culture and for siRNA 2 at standard culture. 
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Figure 3.2.7.4. Investigation of the effects of siRNA knockdown of EIF4A on growth and 
viability of SEAP-secreting CHO-K1 cells in standard and temperature-shifted cultures. 
After transfection (0hrs), the cells were maintained at 370C for 96hrs in standard culture 
and in biphasic culture where cells were shifted to 310C for a further 72hrs after 24hrs of 
transfection. The effects for inhibition of EIF4A were measured after 96hrs of transfection. 
Columns denote viable cells and superimposed red lines show viability of culture. Control 
denotes un-treated cultures. NFX is transfection reagent only and SCR denotes scrambled 
siRNA treated cells. Error bars represent standard deviation calculated using 3 biological 
replicate samples. 
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Figure 3.2.7.5. Investigation of the effects of siRNA knockdown of EIF4A on total and 
specific productivity of SEAP-secreting CHO-K1 cells in standard and temperature-shifted 
cultures. After transfection (0hrs), the cells were maintained at 370C for 96hrs in standard 
culture and in biphasic culture where cells were shifted to 310C for a further 72hrs after 
24hrs of transfection. The effects for inhibition of EIF4A were measured after 96hrs of 
transfection. Columns denote total productivity and superimposed red lines show specific 
productivity. Control denotes un-treated cultures. NFX is transfection reagent only and 
SCR denotes scrambled siRNA treated cells. NP Control represents samples collected from 
non-producer CHO-K1 cells. Error bars represent standard deviation calculated using 3 
biological replicate samples. 
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Table 3.2.7.2. Comparative analysis of the effects of knockdown of EIF4A on the growth, 
viability, and total and specific productivity of SEAP secreting CHO-K1 cells in standard 
and temperature-shifted cultures after 96hrs of transfection. This data was calculated (in 
percentage) from Figures 3.2.7.4 and 3.2.7.5 by comparing human scrambled treated 
control cultures (SCR) with siRNA treated cultures. ‘+’ represents increase and ‘-’ 
represents decrease in effect. Shaded columns represent the significant effects (20% 
decrease or increase in effect with p-value ≤ 0.05).  
 
Standard Culture Temperature-shifted Culture Phenotype siRNA 
Molecule Effect (%) p-value Effect (%) p-value 
1 -47 0.005 -55 0.007 Growth 
2 -53 0.003 -42 0.035 
1 +3 0.013 -9 0.13 Viability 
2 +3 0.13 -7 0.36 
1 -43 0.004 -20 0.02 Total 
Productivity 2 -26 0.038 -23 0.05 
1 +7 0.14 +76 0.03 Specific 
Productivity 2 +58 0.001 +32 0.2 
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3.2.7.2.2 HNRPC 
Cells (1x105 cells/mL) were transfected using 2mL final volume and were maintained in 
standard culture for 96hrs at 370C or shifted to 310C for a further 72hrs after 24hrs of 
culture at 370C (Figure 3.2.7.3). The srambled siRNA-treated cultures were used as a 
control. Un-treated and neoFX-treated cultures were also monitored. The growth and 
productivity of culture were measured after 96hrs of transfection. As expected a pattern of 
reduced cell growth in standard culture was observed following the inhibition of expression 
of HNRPC (Figure 3.2.7.6 and Table 3.2.7.3). It was significant only in the case of siRNA 
2 treated cultures. On the other hand, growth in temperature-shifted culture remained 
unaffected following the inhibition of HNRPC and the reason for this could be that 
temperature-shifted cultures did not grow enough to show the effects of HNRPC 
knockdown. The viability of cultures was also comparable to control cultures (SCR as well 
as NFX) after transfection in both standard and temperature-shifted cultures. HNRPC, 
which was 1.52 fold down regulated following temperature-shift, was also expected to 
improve SEAP productivity of CHO cells. The total production of SEAP was not affected 
significantly in standard culture but was improved in temperature-shifted cultures, 54% for 
siRNA 1 and 83% for siRNA 2 (Figure 3.2.7.7 and Table 3.2.7.3). As expected, a pattern of 
improved specific productivity was observed following knockdown of HNRPC. It was 
improved by 48% for siRNA 1 treated cultures at 370C and by 124% and 97% for siRNA 2 
treated cultures at 370C and in biphasic cultures (Table 3.2.7.3).  
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Figure 3.2.7.6. Investigation of the effects of siRNA knockdown of HNRPC on the growth 
and viability of SEAP-secreting CHO-K1 cells in standard and temperature-shifted 
cultures. After transfection (0hrs), the cells were maintained at 370C for 96hrs in standard 
culture and in biphasic culture where cells were shifted to 310C for a further 72hrs after 
24hrs of transfection. The effects for inhibition of HNRPC were measured after 96hrs of 
transfection. Columns denote viable cells and superimposed red lines show viability of 
culture. Control denotes un-treated cultures. NFX is transfection reagent only and SCR 
denotes scrambled siRNA treated cells. Error bars represent standard deviation calculated 
using 3 biological replicate samples. 
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Figure 3.2.7.7. Investigation of the effects of siRNA knockdown of HNRPC on the total 
and specific productivity of SEAP-secreting CHO-K1 cells in standard and temperature-
shifted cultures. After transfection (0hrs), the cells were maintained at 370C for 96hrs in 
standard culture and in biphasic culture where cells were shifted to 310C for a further 72hrs 
after 24hrs of transfection. The effects for inhibition of HNRPC were measured after 96hrs 
of transfection. Columns denote total productivity and superimposed red lines show 
specific productivity. Control denotes un-treated cultures. NFX is transfection reagent only 
and SCR denotes scrambled siRNA treated cells. NP Control represents samples collected 
from non-producer CHO-K1 cells. Error bars represent standard deviation calculated using 
3 biological replicate samples. 
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Table 3.2.7.3. Comparative analysis of the effects of knockdown of HNRPC on the growth, 
viability, and total and specific productivity of SEAP secreting CHO-K1 cells in standard 
and temperature-shifted cultures after 96hrs of transfection. This data was calculated (in 
percentage) from Figures 3.2.7.6 and 3.2.7.7 by comparing human scrambled treated 
control cultures (SCR) with siRNA treated cultures. ‘+’ represents increase and ‘-’ 
represents decrease in effect. Shaded columns represent the significant effects (20% 
decrease or increase in effect with p-value ≤ 0.05).  
 
Standard Culture Temperature-shifted Culture Phenotype siRNA 
Molecule Effect (%) p-value Effect (%) p-value 
1 -21 0.28 +11 0.5 Growth 
2 -48 0.0048 -11 0.4 
1 -1 0.69 -2 0.34 Viability 
2 -9 0.002 -14 0.009 
1 +15 0.48 +54 0.009 Total 
Productivity 
2 +15 0.18 +83 0.0001 
1 +48 0.0004 +33 0.1 Specific 
Productivity 
2 +124 0.002 +97 0.003 
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3.3.8.2.3 PFN2 
The siRNA transfections were performed using 2mL of 1x105 cells/mL and following 
transfection, cells were maintained in standard culture for 96hrs at 370C or shifted to 310C 
for a further 72hrs after 24hrs of culture at 370C (Figure 3.2.7.3). The srambled siRNA-
treated cultures were used as a control. Un-treated and neoFX-treated cultures were also 
monitored. The growth and productivity of culture were measured after 96hrs of 
transfection. A significant reduction in cell growth in siRNA 1 treated cultures compared to 
control cultures was observed for cells maintained at 370C (Figure 3.2.7.8 and Table 
3.2.7.4). The effects of siRNA 1 on cell growth were more pronounced in the case of 
standard cultures (86%) in comparison to temperature-shifted cultures (54%). The viability 
of culture was also reduced following transfection with siRNA 1. On the other hand, 
transfection with siRNA 2 significantly reduced cell growth by 28% in only the standard 
culture. Although total productivity was reduced by 47% by siRNA 1 in standard culture, 
no effect was observed in cultures incorporating a temperature-shift (Figure 3.2.7.9 and 
Table 3.2.7.4). siRNA 2 improved the total productivity in both temperature-shifted and 
non-shifted cultures. It was improved by 40% in standard culture and by 94% in 
temperature-shifted cultures. The increased level of PFN2 at low temperature as observed 
in the proteomics study could be possibly expected to facilitate secretion of recombinant 
protein product from cells. A pattern of an improvement in Qp was observed following the 
inhibition of PFN2 in standard and temperature-shifted cultures.  
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Figure 3.2.7.8. Investigation of the effects of siRNA knockdown of PFN2 on the growth 
and viability of SEAP-secreting CHO-K1 cells in standard and temperature-shifted 
cultures. After transfection (0hrs), the cells were maintained at 370C for 96hrs in standard 
culture and in biphasic culture where cells were shifted to 310C for a further 72hrs after 
24hrs of transfection. The effects for inhibition of PFN2 were measured after 96hrs of 
transfection. Columns denote viable cells and superimposed red lines show viability of 
culture. Control denotes un-treated cultures. NFX is transfection reagent only and SCR 
denotes scrambled siRNA treated cells. Error bars represent standard deviation calculated 
using 3 biological replicate samples. 
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Figure 3.2.7.9. Investigation of the effects of siRNA knockdown of PFN2 on the total and 
specific productivity of SEAP-secreting CHO-K1 cells in standard and temperature-shifted 
cultures. After transfection (0hrs), the cells were maintained at 370C for 96hrs in standard 
culture and in biphasic culture where cells were shifted to 310C for a further 72hrs after 
24hrs of transfection. The effects for inhibition of PFN2 were measured after 96hrs of 
transfection. Columns denote total productivity and superimposed red lines show specific 
productivity. Control denotes un-treated cultures. NFX is transfection reagent only and 
SCR denotes scrambled siRNA treated cells. NP Control represents samples collected from 
non-producer CHO-K1 cells. Error bars represent standard deviation calculated using 3 
biological replicate samples. 
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Table 3.2.7.4. Comparative analysis of the effects of knockdown of PFN2 on the growth, 
viability and total and specific productivity of SEAP secreting CHO-K1 cells in standard 
and temperature-shifted cultures after 96hrs of transfection. This data was calculated (in 
percentage) from Figures 3.2.7.8 and 3.2.7.9 by comparing human scrambled treated 
control cultures (SCR) with siRNA treated cultures. ‘+’ represents increase and ‘-’ 
represents decrease in effect. Shaded columns represent the significant effects (20% 
decrease or increase in effect at p-value ≤ 0.05). 
 
Standard Culture Temperature-shifted Culture Phenotype siRNA 
Molecule Effect (%) p-value Effect (%) p-value 
1 -86 0.0002 -54 0.009 Growth 
2 -28 0.04 +39 0.08 
1 -50 0.0001 -27 0.0003 Viability 
2 -3 0.13 -6 0.08 
1 -47 0.002 -10 0.4 Total 
Productivity 
2 +40 0.005 +94 5.37E-05 
1 +288 2.77E-05 +92 0.01 Specific 
Productivity 
2 +95 0.0005 +36 0.13 
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3.2.7.3 Validation of siRNA induced inhibition of target protein expression 
Proteins from biological duplicate samples were collected after 96hrs of transfection at 
standard culture and were separated on a 10% SDS gel (section 2.6.10). Western blots were 
developed using appropriate antibodies. All control samples (untreated, neoFX- and 
scrambled-treated controls) showed comparable expression levels in Western blots. The 
expression of PFN2 was however reduced in the scrambled siRNA-treated samples in 
comparison to the other controls, untreated and neoFX and the reason for this is unclear. 
The expression of all protein targets was reduced to undetectable levels after siRNA 
transfection in comparison to their respective control samples (SCR) (Figure 3.2.7.4). 
Therefore the effects observed on cellular phenotypes, i.e. cell growth, viability and 
recombinant protein productivity, are likely due to the specific inhibition of the expression 
of the protein targets.  
 
 
Figure 3.2.7.4. Investigation of inhibition of expression of target proteins due to siRNA 
transfection at standard culture using Western blotting.  A represents expression of eIF4A, 
B represents expression of hnRPC and C represents expression of PFN2 after 96hrs of 
siRNA transfection. Expression of GAPDH was used as a loading control in all cases. 
Control NFX SCR siRNA 1 siRNA 2
EIF4A
GAPDH
HNRPC
GAPDH
PFN2
GAPDH
A
B
C
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3.3 Investigation of low temperature induced differential expression of miRNA using 
miRNA array 
As described in section 1.6, miRNAs are small endogenous single-stranded non-coding 
RNA molecules. Recently miRNAs have been reported to be involved in regulation of 
various cellular phenotypes such as cell growth, apoptosis, metabolism and protein 
secretion, all of which are very important for production of recombinant protein in 
mammalian cells. Therefore suspension-adapted CHO-K1 cells were cultured in a low 
temperature based biphasic culture process and analysed for differential expression of 
miRNAs following temperature-shift using a hybridization-array (bioarray). This allowed 
us to identify 2 potential miRNAs, miR-7 and miR-24, that could regulate cell growth and 
productivity of cells. 
 
3.3.1 miRNA-bioarrays 
A miRNA-bioarray (Ambion) containing 640 probes representing a comprehensive panel of 
human, mouse and rat microRNAs was used in this investigation. The miRNA expression 
profiles of cells maintained at 370C for 72 hrs were compared with profiles of cells shifted 
to low temperature (310C) for further 72hrs to identify temperature-dependent changes. 
Two miRNA, miR-21 and miR-24, were found to be up regulated following temperature-
shift and could be associated with regulation of cell growth and productivity of cells at low 
temperature.   
 
3.3.1.1 Cell culture 
CHO-K1 cells were seeded at 1x105 cells/mL in spinner flasks and cultured at either 370C 
for 144hrs or for 72hrs at 370C followed by a temperature-shift to 310C for a further 72hrs. 
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As can be seen in Figure 3.3.1.1 the cells that were temperature-shifted immediately ceased 
logarithmic growth and did not exceed a peak viable cell density of 1.67 x106 ± 0.15 
cells/mL, whereas the cells cultured at 370C continued in logarithmic growth for a further 
24hrs and achieved average peak viable density of 2.02 x 106 ± 0.11 cells/mL. Cells were 
sampled at 72hrs and 144hrs for RNA extraction reflecting the conditions used for 2D-
DIGE experiment. Total RNA quality was checked using Agilent Bioanalyzer and the 
presence and integrity of small RNA species was confirmed by visualisation on a 15% 
denaturing polyacrylamide gel (Figure 3.4.1.2). 
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Figure 3.3.1.1. Viable cell counts for CHO-K1 batch culture following seeding at 1x105 cells/mL for cultures incorporating a 
temperature-shift (A) and cells cultured at a constant temperature of 37 0C. In each case, samples were taken from 3 independent 
spinner flasks at 72 and 144hrs post seeding (indicated by arrows). 
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Figure 3.3.1.2. A 15% denaturing acrylamide gel analysis of RNA extracted from the 
temperature-shifted samples demonstrating the yield and integrity of the small RNA 
species.  
 
3.3.1.2 miRNA differential expression analysis 
Biological triplicate samples of total RNA isolated at 72hrs (TSd3) and 144hrs (TSd6) were 
extracted from cells that were shifted to 310C at 72hrs and subsequently used for miRNA 
bioarray analysis.  
The miRNA-bioarrays are designed to be used with human samples and due to this 
implication of these human miRNA bioarray to investigate the differential expression of 
miRNAs in CHO cells was an uncertain task. We observed that when human miRNA 
bioarrays were probed with labelled Cricetus griseus RNA, the average percent present call 
was in the region of 27.3% (± 4.8) which compares favourably with human cell line RNA 
1 2 3 4 5 6
37oC 31oC
tRNA
5 S RNA
5.8 S RNA
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which had an average present call of 26.9% (± 5.7). The average fluorescence signal from 
arrays probed with CHO-K1 RNA was 306.4 ± 55.2 Fluorescence Units which was 
comparable to human (296.6 ± 71.5). Unsupervised hierarchial cluster analysis of the 
expression data revealed that CHO-K1 samples clustered as a discrete sub-cluster separate 
to six human cell lines included in the analysis as non-hamster controls (Figure 3.3.1.3). 
Unsupervised hierarchial clustering within the CHO-K1 samples also resulted in separation 
of the exponential samples (72hrs at 370C, TSd3) from those in stationary phase (144hrs at 
310C, TSd6) (Figure 3.3.1.4). Within the sub-clusters, the samples TSd3A & TSd6B were 
outliers. Since cultures grew similarly and had similar viabilities, it is likely that this is an 
artefact of labelling and/or hybridisation based on overall lower median foreground 
readings and lower percent present calls associated with these arrays. This is an important 
quality control metric for the subsequent analysis steps. The samples TSd3A & TSd6B 
were therefore omitted during re-analysis of data. 
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Figure 3.3.1.3. Unsupervised hierarchial clustering analysis of CHO-K1 samples and 6 
human samples. CHO samples clustered together and were distinctly separate from human 
samples based on miRNA expression profiles. CHO samples are denoted by red box. 
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Figure 3.3.1.4. Unsupervised hierarchial clustering analysis of all 6 CHO-K1 samples 
resulted in 2 main clusters of samples which separate the exponential (72hrs at 370C, TSd3) 
samples from the quiescent (144hrs at 310C, TSd6) samples. From the dendrogram at the 
top it is clear that TSd3A and TSd6B samples are outliers. The relative expression of each 
miRNA is represented by colour ranging from low (Blue) to high (Red) expression. The 
range bar of relative expression is given below the cluster. 
 
 
 
  
 215 
Using the statistical methods outlined in Section 2.7.4.2 to analyse all samples, it was found 
that 6 miRNAs were considered statistically different (p≤ 0.05) between the 72hrs at 370C 
(TSd3) and 144hrs at 310C (TSd6) samples (Table 3.3.1.1). However, removal of the outlier 
samples identified by clustering (TSd3A & TSd6B) resulted in a total of 23 miRNAs 
passing the 95% confidence level (Table 3.3.1.2). Overall, 26 different miRNAs were 
identified as differentially expressed in this system. Two miRNAs, miR-21 and 24, that are 
known to regulate cell growth were found to be differentially regulated in response to 
hypothermic conditions at 144hrs at 310C compared to 72hrs at 370C.  
• miR-21 was 2.23 fold increased in cells at 144hrs at 310C compared to cells at 72hrs 
at 370C in temperature-shifted culture. miR-21 is known to regulate growth and 
apoptosis in culture (Chan et al. 2005, Schetter et al. 2008, Chan et al. 2008). For 
example, the inhibition of miR-21 has been reported to increase growth of HeLa 
cells (Cheng et al. 2005).  
• miR-24 was 1.73 fold up regulated in cells at 144hrs at 310C compared to cells at 
72hrs at 370C in temperature-shifted cultures. miR-24 could have cell line specific 
effects as inhibition of miR-24 increased growth of HeLa cells while reduced 
growth of A549 cells (Chan et al. 2005).  
This suggests that these miRNAs could be involved in regulation of cell growth and 
recombinant productivity of culture at low temperature. 
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Table 3.3.1.1. miRNAs that are statistically differentially expressed between samples at 72hrs at 370C (TSd3) and 144hrs at 310C 
(TSd6) when all samples are included in the statistical analysis. Fold change was calculated by dividing average raw fluorescence 
(RF) value at TSd6 by average RF value at TSd3. Negative RF value was considered no-signal-detected. 
 
TSd3 (370C) TSd6 (310C) No.  miRNA ID p- value 
TSd3A  TSd3B  TSd3C  TSd6A  TSd6B  TSd6C  
Fold Change 
1 hsa_miR_27a 0.011 150 244 223.5 471.5 115.5 353 1.52 
2 hsa_miR_126_AS 0.018 2.5 1 1 -2.5 -1 -2.5 -1.5 
3 hsa_miR_30d_MM1 0.027 9 2.5 9.5 -0.5 0 -2.5 -10.5 
4 hsa_miR_516_3p 0.030 -2 -0.5 -3.5 7.5 1.5 7 5.33 
5 hsa_miR_191 0.034 140.5 288 237 295.5 83 245 -1.07 
6 hsa_miR_495 0.037 2.5 2 8 1.5 -0.5 -4 -3.57 
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Table 3.3.1.2. Statistically differentially expressed miRNAs observed using miRNA-
bioarray between samples at 72hrs at 370C (TSd3) and 144hrs at 310C (TSd6) after removal 
of outlier samples from the statistical analysis. Fold change was calculated by dividing 
average raw fluorescence (RF) value at TSd6 by average RF value at TSd3. Negative RF 
value was considered no-signal-detected. 
TSd3 (370C) TSd6 (310C) 
N
o
.
 
miRNA ID p-
value TSd3B TSd3C TSd6A TSd6C 
Fold 
Change 
1 hsa_miR_320 0.001 113.5 103 220.5 179.5 1.85 
2 hsa_miR_10a 0.009 66.5 54 137.5 111 2.06 
3 hsa_miR_126_AS 0.009 1 1 -2.5 -2.5 1 
4 hsa_miR_30c 0.010 111.5 105 202.5 178.5 1.76 
5 hsa_miR_181a 0.013 239 199.5 488 453 2.15 
6 hsa_miR_21 0.015 808 650.5 1844.5 1404.5 2.23 
7 hsa_miR_30d 0.017 143 130 213.5 186.5 1.47 
8 hsa_miR_29a 0.017 716.5 579.5 1317.5 1154 1.91 
9 hsa_miR_125b 0.022 1743 1492 1795.5 1458.5 1.01 
10 hsa_miR_513 0.022 2 2 8.5 5.5 3.5 
11 hsa_miR_107 0.024 150 131 212 174 1.37 
12 hsa_miR_27a 0.025 244 223.5 471.5 353 1.76 
13 hsa_miR_449 0.026 1 1.5 8.5 8 6.6 
14 mmu_miR_298 0.027 16.5 16 13.5 12 -1.28 
15 hsa_miR_24 0.027 705.5 583.5 1254.5 977 1.73 
16 hsa_let_7f 0.035 52 43 129 147 2.90 
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17 hsa_miR_221 0.035 378.5 316 572 502 1.54 
18 hsa_miR_516_3p 0.036 -0.5 -3.5 7.5 7 7.25 
19 mmu_miR_7b_M
M1 
0.036 
-0.5 -0.5 3 3 
3 
20 hsa_miR_197 0.038 3.5 2.5 -1 0 -3 
21 hsa_miR_19b 0.038 292.5 279 443.5 383 1.45 
22 mmu_miR_346 0.049 4.5 4 3.5 3 -1.31 
23 hsa_miR_10b 0.049 131.5 81.5 304 262.5 2.66 
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3.3.1.3 Validation of miRNA-bioarrays results with qRT-PCR  
Total RNA from CHO-K1 cells cultured at 370C for 144hrs was sampled at 72hrs at 370C 
(37d3), and 144hrs at 370C (37d6) (Figure 3.3.1.1B). The RNA from cells incorporating a 
temperature-shift at 72hrs (TSd3 & TSd6) and cells maintained at 370C (37d3 & 37d6) 
were used for qRT-PCR analysis of selected targets from the bioarray analysis. The 
reaction is based on a proprietary RT-primer specific for the 3’ end of a target miRNA 
which is then extended into a micro-cDNA by an ArrayScript enzyme during the RT-
reaction step. The qPCR step is carried out in-situ and uses a 5’ miRNA specific primer and 
a 3’ universal primer targeting the universal 3’ end of the original RT-primer (Figure 
3.3.1.5). Hence this is a highly specific means of amplifying individual mature miRNAs. 
 
 
Figure 3.3.1.5.  An outline of the Ambion qRT-PCR process for the detection and 
quantification of mature miRNAs. This image has been used courtesy of Ambion Inc. 
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Five miRNAs were selected for further analysis and the data is presented in Table 3.3.1.3. 
Of the 5 miRNAs selected, mmu-miR-290 was selected to test the limits of the system as 
this miRNA was found to have a very low expression level on the bioarray. The expression 
of mmu-miR-290 was confirmed as being low by qRT-PCR with an average cycle 
threshold (CT) of 26.2. This is very low expression compared to miR-21 which had an 
average CT of 17.4. This demonstrates that the relative quantities indicated by the bioarray 
were reproducible by qRT-PCR. The 1.51 fold increase seen in mmu-miR-290 at TSd6 was 
not significant (p = 0.07) and may be an artefact of the noisy data associated with low-level 
expression of this miRNA. miR-21 and miR-24 were confirmed as being highly expressed 
in CHO-K1 cells and to be significantly increased (p ≤0.05) at 144hrs compared to 72hrs 
regardless of culture temperature (Table 3.4.1.3). The apparently higher level of miR-24 in 
TSd6 (144hrs at 310C) samples compared to 37d6 (144hrs at 370C)  samples was 
interesting although not statistically significant (p = 0.14). The other miRNAs assayed by 
qRT-PCR were not found to be significantly differentially expressed. 
 
 
 
 
 
 
 
 
  
 221 
Table 3.3.1.3. qRT-PCR data for selected miRNAs identified as differentially expressed in 
miRNA bioarray analysis. The data is presented as fold change increase (+) or decrease (-) 
compared to the 72hrs (d3) samples for the temperature-shifted culture (TS) and the culture 
maintained at 37oC. Statistically significant changes as identified by students t-test 
(P≤0.05), are in bold.  
Temperature-shift Standard Culture miRNA 
TSd3     TSd6 P Value 37d3      37d6 P Value 
let-7f 1 -1.04 0.43 1 -1.01 0.49 
miR-21 1 +1.67 0.04 1 +1.76 0.01 
miR-24 1 +1.54 0.03 1 +1.29 0.0031 
miR-27a 1 +1.06 0.39 1 +1.23 0.16 
mir-290 1 -1.51 0.07 1 -1.03 0.46 
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3.3.2 Analysis of low temperature induced differential expression of miRNAs using 
Taqman Low Density Arrays (TLDA) 
miRNA-TLDAs are PCR based highly advanced arrays that contain primers for >350 
human miRNA targets. PCR is a highly sensitive and reproducible technique and therefore 
miRNA-TLDAs could be more informative and reliable in comparison to miRNA 
bioarrays. The miRNA expression profiles for cells cultured at 370C for 72 hrs were 
compared with cells maintained at 310C for further 24hrs using miRNA-TLDAs as 
preliminary experiment to ensure the applicability of miRNA-TLDAs in CHO cells. This 
investigation has enabled us to identify early-mid differential expression of miRNAs in 
response to low temperature induction. 
 
3.3.2.1 Cell culture  
CHO-K1 cells were seeded at 1×105 cells/mL in spinner flasks and maintained at 37°C for 
96hrs or for 72hrs at 37°C followed by a temperature-shift to 31°C for another 24hrs. The 
average viable cell density of both cultures at 72hrs was 1.47 x106 ± 0.08 cells/mL. The 
cells that were temperature-shifted were immediately growth arrested and reached only 1.6 
x106 ± 0.16 cells/mL after 24hrs of shift to 310C whereas the cells in standard culture 
reached 1.9x106 ± 0.13 cells/mL at 96hrs of culture. Biphasic cultures were sampled at 
72hrs and 96hrs for total RNA extraction from 2 independent experiments. 
 
3.3.2.2 miRNA differential expression analysis 
The quality of total RNA was checked using Agilent Bioanalyzer and the presence and 
integrity of small RNA species including 5S RNA. The total RNA samples were used for 
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cDNA synthesis with the TaqMan® MicroRNA Reverse Transcription Kit (Applied 
Biosystems) according to the manufacturer's instructions. The cDNA samples were then 
used for miRNA TaqMan Low Density Array (TLDA) analysis. miR-let-7c (human) was 
used as an endogenous control in this investigation since the expression of usual 
endogenous controls, RNU6B, RNU44 and RNU48 was very low. This could be due to 
various reasons including the fact that the PCR primers on TLDA and the reverse-
transcription (RT) step using a primer megaplex are designed specifically for human 
miRNAs. Primer megaplex is a pool of RT primers that transcribes all miRNA species in 
the sample in a single RT reaction. Expression of miRNAs in cells grown at 370C for 72hrs 
was compared (using Real-Time StatMiner™ software) with the expression of miRNAs 
after a further 24hrs growth at 310C. A total of 237 miRNA species were detected on 
TLDA cards (CT≤35), of which 17 miRNAs were differentially expressed (DE) in the 
comparison of cells at 96hrs at 310C to the cells at 72hrs at 370C. Of the 17 DE miRNAs, 9 
were up regulated in cells at 96hrs at 310C following temperature-shift in comparison to 
cells maintained at 370C at 72hrs (Table 3.3.2.1). Among them, two miRNAs, miR-126 and 
miR-7, that are known to be involved in regulation of cell growth were observed to be 
differentially regulated in cells at 96hrs at 310C compared to cells at 72hrs at 370C. 
• miR-126 was 3.06 fold up regulated at 96hrs of culture at 310C in comparison to 
72hrs at 370C in temperature-shifted culture. miR-126 has been reported to inhibit 
cell cycle progression and regulate cell growth in breast cancer cells (Zhang et al. 
2008, Guo et al. 2008).  
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• miR-7, was 8.43 fold down regulated in cells at 96hrs at 310C compared to cells at 
370C in biphasic culture. The inhibition of miR-7 has been reported to reduce the 
cell growth of lung carcinoma cell line, A549 (Cheng et al. 2005).  
This indicates that these both miRNAs could serve as potential targets to regulate cell 
growth and recombinant producitivity in culture. 
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Table 3.3.2.1. miRNAs observed differentially expressed using miRNA TaqMan Low 
Density Array. Fold change was calculated by dividing expression at 96hrs at 310C by 
expression at 72hrs at 370C. miR-200c, a non-significant hit, was included in this list as it 
was selected for singleplex qRT-PCR validation to test the sensitivity limits of miRNA-
TLDA. ‘+’ denotes up regulation and ‘-’ down regulation of miRNA following shift. 
No. miRNA ID p-value Fold change 
1 Has-miR-101 4.52E-02 -1.69 
2 Has-miR-126 8.22E-03 3.06 
3 Has-miR-134 4.61E-03 -4.01 
4 Has-miR-199b 9.98E-03 -2.58 
5 Has-miR-219 1.50E-03 5.42 
6 Has-miR-30e-5p 1.46E-02 9.04 
7 hsa-miR-320 2.75E-02 -2.84 
8 hsa-miR-345 4.70E-02 3.05 
9 hsa-miR-374 2.49E-02 2.26 
10 hsa-miR-376a 5.32E-03 -4.58 
11 hsa-miR-449 3.37E-02 -1.68 
12 hsa-miR-489 1.98E-02 2.69 
13 hsa-miR-517 1.24E-03 -4.49 
14 hsa-miR-518d 2.11E-03 3.5 
15 hsa-miR-520d 2.18E-03 -4.23 
16 hsa-miR-578 9.36E-03 2.58 
17 hsa-miR-7 0.02 -8.43 
18 hsa-miR-200c 0.4 1.50 
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3.3.2.3 Validation of miRNA-TLDA results with singleplex qRT-PCR 
The processing of miRNA-TLDAs require all miRNA species present in the samples to be 
reverse-transcribed using a primer megaplex (a pool of primers) which is designed 
specifically for human samples. Moreover, the miRNA profiling using TLDA cards was 
performed only using biological duplicate samples from biphasic culture. Due to these 
reasons, the validation of miRNA-TLDAs data using singleplex qRT-PCR was an 
important aspect of this investigation. 
The singleplex qRT-PCR was performed to validate the miRNA expression data using 
biological triplicate samples taken every 24hrs during 144hrs of biphasic and standard 
cultures. For this, low serum adapted CHO-K1 cells were seeded at 1×105 cells/mL in 
filter-capped spin tubes and maintained at 37°C for 144hrs or for 72hrs at 37°C followed by 
a temperature-shift to 31°C for a further 72hrs. The cells that were temperature-shifted 
achieved maximum viable cell density of 1.37x106 ± 0.18 cells/mL whereas the cells in 
standard culture achieved 1.82x106 cells/mL on 144hrs of culture (Figure 3.3.2.1A). The 
growth of temperature-shifted cultures was reduced following the shift. In comparison to 
temperature-shifted cultures, cells maintained at 370C were actively growing throughout the 
duration of cell culture. The viability of temperature-shifted cultures was slightly better 
than the standard culture through out (Figure 3.3.2.1B).  
Two miRNA targets, miR-7 (significant) and miR-200c (non-significant) were selected for 
validation using singleplex qRT-PCR based on cycle threshold value (CT ≤ 35), expression 
pattern observed using miRNA-TLDA and evidence of a role in regulation of cell growth in 
the literature. miR-7 was selected from the list of differentially expressed miRNAs. It was 
8.43 fold down regulated in cells at 96hrs at 310C compared to 72hrs at 370C in 
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temperature-shifted culture. miR-7 was selected because it has been reported to be 
associated with cell growth in literature (Zhang et al. 2008, Kefas et al. 2008). miRNA 
profiling was done only for biological duplicate samples and miRNA-TLDAs are 
specifically designed for human cells and therefore one non-significant change (miR-200c) 
from the comparison of cells at 72hrs at 370C with cells at 144hrs at 310C was also included 
for singleplex qRT-PCR validation to confirm the expression pattern observed and the 
applicability of human miRNA-TLDA in CHO cells. qRT-PCR analysis revealed that  
• the expression of miR-7 was gradually decreasing as the culture progressed from lag 
phase to log and stationary phase of culture. The decrease in miR-7 expression was 
more pronounced in biphasic cultures at every time point after temperature-shift in 
comparison to the standard culture. This indicates its growth phase specific and 
dose dependent expression in culture. The down regulation of miR-7 observed in 
qRT-PCR is in agreement with the expression pattern observed using miRNA-
TLDA.  
• miR-200c was not significantly differentially expressed in biphasic or constant 
cultures at 370C. This is in keeping with the expression pattern as observed using 
miRNA-TLDA. 
Taken together results indicated that the human TLDA is a reliable way of profiling 
miRNA expression in CHO cells. 
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Figure 3.3.2.1. Comparison of viable cell number (A) and percentage viability (B) of low serum adapted CHO-K1 cells grown in 
either a biphasic temperature-shifted culture (--∆--) or a constant culture at 37°C (--■--). Error bars represent the standard deviation 
calculated from three biological replicate cultures. 
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Figure 3.3.2.2 Validation of miRNA-TLDA expression data. Two miRNA targets were selected for validation using qRT-PCR 
analysis. Samples were taken at every 24hrs from the cells cultered in standard culture at 370C for 144hrs and in biphasic culture, 
where cells were initially cultured at 370C for 72hrs and then shifted to 310C for further a 72hrs. Red bars represent standard cultures 
while green columns represent temperature-shifted cultures. The blue line indicates cut-off limits of 1.5 fold up or down regulation of 
miRNA levels compared to expression at 72hrs. A represent miR-7; B miR-200c. Error bars represent the standard deviation 
calculated from three biological replicate cultures. 
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3.3.2.4 Isolation and cloning of the Cricetulus griseus miRNA cgr-miR-21 
miRNAs are typically more conserved during evolution in comparison to other genes. The 
sequences of miRNAs in CHO cells have not been reported yet. The sequencing of 
miRNAs from CHO cells could help to understand the conservation of miRNAs through 
various specieses during evolution. miR-21, a well known growth regulator, was selected as 
an model miRNA to clone and sequence to compare the conservation of miRNAs across the 
species. Primers were designed for cloning C. griseus miR-21 based on alignment of the 
corresponding genomic regions flanking the pre-miR-21 sequence from Mus musculus, 
Rattus norvigicus and Homo sapiens. This region was amplified from CHO genomic DNA 
and was sequenced. The sequence similarity between the C. griseus miRNA and other 
mammalian sequences confirmed a novel C. griseus miRNA orthologue of a known human 
and mouse miRNA, miR-21 (Figure 3.3.2.4). In keeping with the Sanger registry-naming 
conventions, this miRNA has the prefix cgr- to represent C. griseus. This new miRNA cgr-
miR-21 has been confirmed by the miRBase registry. The sequence has also been lodged 
with EMBL and given the accession no. AM600961. 
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Figure 3.3.2.4. (A) Alignment of CHO-K1 cgr-miR-21 sequence with the sequences of 
mouse (mmu-), rat (rno-), human (hsa-) and bovine (bta-)miR-21. The CHO sequence is 
identical to that of the murine sequence (rno-miR-21) published in the Sanger miRNA 
repository (http://microrna.sanger.ac.uk/sequences/). Red arrow indicates the position of 
mature cgr-miR-21 (B) Predicted stem loop structure of cgr-miR-21 with the mature 
miRNA highlighted in red. (C) Alignment of forward and reverse primers which were used 
for RT-PCR with the sequence of cgr-miR-21. The red arrows indicate direction of PCR 
amplification. 
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3.3.2.5 miRNA Target selection 
miR-7 was observed to be reduced by 8.43 fold in cells at 96hrs at 310C compared to cells 
at 72hrs at 370C in miRNA-TLDAs. The expression of miR-7 reflected a growth phase 
specific pattern when measured by qRT-PCR (Figure 3.3.2.2) suggesting that regulation of 
miR-7 expression in a dose dependent manner could provide a valuable means to regulate 
bioprocess related cellular phenotypes, i.e. growth, viability and productivity in culture. 
miR-24 was observed to be up regulated in cells at 144hrs at 310C compared to cells at 
72hrs at 310C using a miRNA-bioarray. miR-24 has been shown to modulate the growth of 
mammalian cells in culture (Table 3.3.1.2). Therefore, miR-7 and miR-24 were selected for 
further functional studies in CHO cells. 
 
3.3.3 Effects of inhibition or over expression of miRNA targets in CHO cells  
3.3.3.1 Optimization of transfection conditions in non-producer suspension-adapted 
CHO-K1 cells 
Optimization of transfection conditions and initial screening for the effects of both miRNA 
targets on cell growth and viability were performed in non-producer, suspension and low 
serum adapted CHO-K1 cells (Figure 3.3.3.1). All transfections were performed in 
biological triplicates using spin tubes containing 1x105 cells/mL in 2mL final volume. A 
human scrambled anti-mir miRNA was used as a control for inhibition studies and a human 
scrambled pre-mir miRNA was used as a control for over expression studies in all 
transfection experiments. Figure 3.2.7.1 shows timing of transfection and sampling to 
measure the impact of miRNA transfection on cell growth. Cell counts and viability assays 
were performed by flow cytometry using Guava ViaCount® Assays (section 2.82). This 
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enabled us to identify the optimal time-point for investigating the effects of miRNA 
transfection.  
3.3.3.1.1 miR-7 
In the TLDA experiments, the expression of miR-7 was found to be 8.43 fold down 
regulated in cells at 96hrs at 310C compared to cells at 72hrs at 370C in biphasic culture. 
Therefore in an attempt to mimic effects of biphasic culture, we down regulated the 
expression of endogenous miR-7 using specific inhibitors (Anti-mirs, AM) in cells growing 
at 370C and artificially over expressed it using Pre-mirs (PM) at low temperature (310C).  
The miRNA transfections were performed using 2mL of 1x105 cells/mL and cells were 
maintained over 144hrs of culture (Figure 3.2.7.1). A scrambled anti-mir miRNA for 
inhibition studies and a scrambled pre-mir miRNA for over expression studies were used as 
controls. Un-treated and neoFX-treated cultures were also monitored. The impacts of 
miRNA transfection on cell growth were measured at every 24hrs after 72hrs of 
transfection over the period of 144hrs (Figure 3.2.7.1). The cell growth was significantly 
reduced compared to PM control by the over expression of miR-7 at 310C (Figure 3.3.3.1C 
and Table 3.3.3.1). Reduced cell growth compared to AM control was also observed 
following inhibition of miR-7 at 370C, however it was not significant. The viability of both 
standard and low temperature cultures following inhibition or over expression was 
comparable to their respective controls (AM or PM controls) (Figure 3.3.3.1 and Table 
3.3.3.2).  
3.3.3.1.2 miR-24 
The expression of miR-24 was observed to be 1.73 fold up regulated in cells maintained at 
144hrs at 310C compared to cells at 72hrs at 370C and therefore we artificially up regulated 
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its expression in CHO cells at 370C and inhibited at 310C in order to investigate whether 
this would induce temperature-shift-like effects. The miRNA transfections were performed 
using 2mL final volume containing 1x105 cells/mL and cells were maintained over 144hrs 
of culture (Figure 3.2.7.1). A scrambled anti-mir miRNA for inhibition studies and a 
scrambled pre-mir miRNA for over expression studies were used as controls. Un-treated 
and neoFX-treated cultures were also monitored. The impacts of miRNA transfection on 
cell growth were measured at every 24hrs after 72hrs of transfection over the period of 
144hrs (Figure 3.2.7.1). The over expression of miR-24 in the standard culture at 370C 
resulted in reduced cell growth, however it was not significant (Figure 3.3.3.1A and Table 
3.3.3.1). The inhibition of miR-24 at 310C did not have any effect on cell growth. The 
viability of cultures remained unaffected by inhibition or over expression of miR-24 at 
310C or 370C respectively (Figure 3.3.3.1 and Table 3.3.3.2).  
 
(Note: it is recognized that this was an incomplete experiment which did not look at all 
possible combinations of AM and PM miRNAs at temperatures. This was essentially a 
‘range-finding’ exercise leading on to more detailed experiments described below). 
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Figure 3.3.3.1. Inhibition and over expression analysis of miR-7 and miR-24 on the cell growth and viability of low serum adapted 
CHO-K1 cells in standard (370C) and low-temperature (310C) culture (LT). A & C represent growth and B & D represent the viability 
of CHO-K1 cells over 144hrs of culture after miRNA transfection. Control denotes un-treated cultures. NFX denoted transfection 
reagent only, AM-Control represents scrambled Anti-mir and PM-Control represents scrambled Pre-mir. 
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Table 3.3.3.1. Comparative analysis of effects of inhibition and over expression on growth of low serum adapted CHO-K1 cells at 
standard and temperature-shifted cultures. This data was calculated (in percentage) from Figure 3.3.3.1A&C by comparing AM 
Control with AM treated cultures and PM Control with PM treated cultures. Shaded columns represent promising observations 
considered for miRNA transfection in SEAP secreting CHO-K1 cells. 
Inhibition Over expression miRNA 
target 
Culture 
Condition 
Time (Hrs) 
Growth 
(%) 
p-value 
Culture 
Condition 
Time (Hrs) 
Growth 
(%) 
p-value 
72 -7 0.17 72 -28 5.7E-05 
96 -13 0.04 96 -33 0.001 
120 -24 0.1 120 -42 0.0003 
miR-7 Standard Culture 
144 -25 0.67 
Low temperature 
culture 
144 -57 0.004 
72 -11 0.005 72 -10 0.05 
96 -7 0.07 96 -14 0.004 
120 -8 0.13 120 -22 0.13 
miR-24 Low temperature 
culture 
144 -4 0.40 
Standard Culture 
144 -67 0.15 
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Table 3.3.3.2. Comparative analysis of effects of inhibition and over expression on viability of low serum adapted CHO-K1 cells at 
standard and temperature-shifted cultures. This data was calculated (in percentage) from Figure 3.3.3.1B&D by comparing AM 
Control with AM treated cultures and PM Control with PM treated cultures. Shaded columns represent the promising observations 
considered for miRNA transfection in SEAP secreting CHO-K1 cells. 
Inhibition Over expression miRNA 
target 
Culture 
Condition 
Time (Hrs) 
Viability 
(%) 
p-value 
Culture Condition Time (Hrs) 
Viability 
(%) 
p-value 
72 0 0.36 72 -2 0.01 
96 -1 0.09 96 -2 0.08 
120 -13 0.01 120 -1 0.44 
miR-7 Standard Culture 
144 -1 0.88 
Temperature-
shifted culture 
144 -5 0.34 
72 -1 0.23 72 +1 0.14 
96 -2 0.001 96 +1 0.07 
120 -3 0.02 120 +18 0.0002 
miR-24 Temperature-
shifted culture 
144 -3 0.29 
Standard Culture 
144 +2 0.64 
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As for siRNA transfection, 96hrs was chosen as an appropriate timepoint subsequent to 
transfection to assay cell cultures for effects on growth and viability. This time point was 
used in the further miRNA transfection experiments in SEAP secreting CHO-K1 cells. 
 
3.3.3.2 Effect of miRNAs on SEAP-secreting suspension-adapted CHO-K1 cells 
After optimizing transfection conditions in suspension and low-serum adapted CHO-K1 
cells, SEAP secreting CHO-K1 cells were transfected with AMs and PMs miRNAs for 
miR-7 and miR-24 and were maintained in standard culture at 370C for 96hrs and biphasic 
culture at 310C for a further 72hrs after 24hrs of transfection at 370C (Figure 3.2.7.3). The 
inhibition and over expression of these miRNAs at both standard and temperature-shifted 
culture enabled us to investigate the effects of these miRNAs more extensively. Cells were 
analysed for effects of miRNA transfection on cell growth, viability and SEAP productivity 
after 96hrs of transfection (section 2.5.3.7, 2.8.2).  
 
3.3.3.2.1 miR-7 
The miRNA transfections were performed using 2mL of 1x105 cells/mL and cells were 
maintained for 96hrs at 370C in standard culture and for a further 72hrs at 310C after 24hrs 
of culture at 370C in biphasic culture (Figure 3.2.7.3). A scrambled anti-mir miRNA for 
inhibition studies and a scrambled pre-mir miRNA for over expression studies were used as 
controls. Un-treated and neoFX-treated cultures were also monitored. The impact of siRNA 
transfection were measured after 96hrs of transfection. 
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The over expression of miR-7 at standard culture resulted in almost complete growth arrest 
as it reduced cell growth by 88% (Figure 3.3.3.2 and Table 3.3.3.3). However, there was no 
significant effect of over expression on growth in temperature-shifted culture (where 
growth was already arrested). The viability of cultures was maintained following over 
expression of miR-7 in standard and temperature-shifted cultures. Inhibition of miR-7 did 
not result in any significant effect on cell growth or viability in either either culture format. 
The total yield of SEAP was reduced by 74% following over expression of miR-7 reflecting 
the reduced cell growth whereas the Qp was improved by 116% in standard cultures 
(Figure 3.3.3.3 and Table 3.3.3.3). No significant alterations were observed in the total and 
specific productivity compared to the control treatments following the inhibition or over 
expression of miR-7 in temperature-shifted culture.  
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Figure 3.3.3.2.  Effects of inhibition and over expression of miR-7 on growth and viability 
of SEAP secreting CHO-K1 cells at standard and temperature-shifted culture. After 
transfection (0hrs), the cells were maintained at 370C for 96hrs in standard culture and in 
biphasic culture where cells were shifted to 310C for 72hrs after 24hrs of transfection. The 
effects of miR-7 were measured after 96hrs of transfection. Columns denote viable cells 
and superimposed red lines show viability of culture. Control denotes un-treated cultures. 
NFX denoted transfection reagent only, AM-Control represents scrambled Anti-mir and 
PM-Control represents scrambled Pre-mir. Error bars represent standard deviation 
calculated using 3 biological replicate samples. 
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Figure 3.3.3.3. Effects of inhibition and over expression of miR-7 on the total and specific 
productivity of SEAP secreting CHO-K1 cells in standard and temperature-shifted culture. 
After transfection (0hrs), the cells were maintained at 370C for 96hrs in standard culture 
and in biphasic culture where cells were shifted to 310C for 72hrs after 24hrs of 
transfection. The effects of miR-7 were measured after 96hrs of transfection. Columns 
denote total productivity and superimposed red lines show specific productivity. Control 
denotes un-treated cultures. NP Control denotes non-producer CHO-K1 cells. NFX denoted 
transfection reagent only, AM-Control represents scrambled Anti-mir and PM-Control 
represents scrambled Pre-mir. Error bars represent standard deviation calculated using 3 
biological replicate samples. 
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Table 3.3.3.3. Comparative analysis of effects of inhibition and over expression of miR-7 
on growth, viability, total productivity and specific productivity of low serum-adapted 
SEAP secreting CHO-K1 cells in standard and temperature-shifted cultures after 96hrs of 
transfection. These data were calculated (in percentage) from Figure 3.3.3.2 and 3.3.3.3 by 
comparing AM Control with AM treated cultures and PM Control with PM treated cultures. 
‘+’ represent increase and ‘-’ represent decrease in effect on cell growth or viability of 
culture. Shaded columns represent the significant effects (20% decrease or increase in 
effect at p-value ≤ 0.05). 
Inhibition Over expression Phenotype Culture condition 
Effect (%) p-value Effect (%) p-value 
Standard culture -1 0.93 -88 1.5E-05 Growth 
Temperature-shifted 
culture -21 0.17 -17 0.36 
Standard culture +3 0.11 -6 0.02 Viability 
Temperature-shifted 
culture -4 0.003 -4 0.09 
Standard culture +5 0.37 -74 0.0002 Total 
productivity 
Temperature-shifted 
culture -5 0.53 0 0.10 
Standard culture +7 0.56 116 0.002 Specific 
productivity 
Temperature-shifted 
culture +23 0.18 +16 0.3 
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3.3.3.2.2 miR-24 
The miRNA transfections were performed using 2mL of 1x105 cells/mL and cells were 
maintained for 96hrs at 370C in standard culture and for a further 72hrs at 310C after 24hrs 
of culture at 370C in biphasic culture (Figure 3.2.7.3). A scrambled anti-mir miRNA for 
inhibition studies and a scrambled pre-mir miRNA for over expression studies were used as 
controls. Un-treated and neoFX-treated cultures were also monitored. The impact of siRNA 
transfection were measured after 96hrs of transfection. 
Cell growth was reduced by 56% following over expression of miR-24 at 370C, whereas 
the inhibition of miR-24 expression had an insignificant effect (Figure 3.3.3.4 and Table 
3.3.3.4). There was no significant effect of over expression of miR-24 in temperature-
shifted cultures. Cell viability was also unchanged after over expression in standard and 
temperature-shifted cultures. Total yield was reduced due to over expression of miR-24 at 
370C which was a reflection of reduced cell number in culture, whereas no significant 
effect was observed in biphasic cultures. The Qp was observed to be improved by either 
inhibition (25%) or over expression (68%) of miR-24 at standard culture, while it was 
unchanged in temperature-shifted cultures (Figure 3.3.3.5 and Table 3.3.3.4). 
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Figure 3.3.3.4. Effects of inhibition and over expression of miR-24 on growth and viability 
of SEAP secreting CHO-K1 cells in standard and temperature-shifted culture. After 
transfection (0hrs), the cells were maintained at 370C for 96hrs in standard culture and in 
biphasic culture where cells were shifted to 310C for 72hrs after 24hrs of transfection. The 
effects of miR-24 were measured after 96hrs of transfection. Control denotes un-treated 
cultures. NFX denoted transfection reagent only, AM-Control represents scrambled Anti-
mir and PM-Control represents scrambled Pre-mir. Error bars represent standard deviation 
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Figure 3.3.3.5. Effects of inhibition and over expression of miR-24 on the total and specific 
productivity of SEAP secreting CHO-K1 cells in standard and temperature-shifted culture. 
After transfection (0hrs), the cells were maintained at 370C for 96hrs in standard culture 
and in biphasic culture where cells were shifted to 310C for 72hrs after 24hrs of 
transfection. The effects of miR-24 were measured after 96hrs of transfection. Columns 
denote total productivity and superimposed red lines show specific productivity. Control 
denotes un-treated cultures. NP Control denotes non-producer CHO-K1 cells. NFX denoted 
transfection reagent only, AM-Control represents scrambled Anti-mir and PM-Control 
represents scrambled Pre-mir. Error bars represent standard deviation calculated using 3 
biological replicate samples. 
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Table 3.3.3.4. Comparative analysis of effects of inhibition and over expression of miR-24 
on growth, viability, total productivity and specific productivity of low serum-adapted 
SEAP secreting CHO-K1 cells in standard and temperature-shifted cultures after 96hrs of 
transfection. These data were calculated (in percentage) from Figure 3.3.3.4 and 3.3.3.5 by 
comparing AM Control with AM treated cultures and PM Control with PM treated cultures. 
‘+’ represent increase and ‘-’ represent decrease in effect on cell growth or viability of 
culture. Shaded columns represent the significant effects (20% decrease or increase in 
effect at p-value ≤ 0.05). 
Inhibition Over expression Phenotype Culture condition 
Effect 
(%) 
p-value Effect 
(%) 
p-value 
Standard culture -9 0.22 -56 0.0002 Growth 
Temperature-shifted culture -8 0.64 +5 0.82 
Standard culture +2 0.23 -1 0.47 Viability 
Temperature-shifted culture -3 0.10 -8 0.001 
Standard culture +13 0.02 -27 0.02 Total 
productivity 
Temperature-shifted culture -2 0.92 +24 0.22 
Standard culture +25 0.01 +68 9.69E-05 Specific 
productivity 
Temperature-shifted culture +6 0.15 +14 0.37 
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3.3.4 Confirmation of inhibition or over expression of miRNA targets  
To ensure that the effects observed on growth, viability or recombinant productivity of 
CHO-K1 cells following transfection were due to specific inhibition or over expression of 
miR-7 or miR-24, biological triplicate samples for each transfection conditions were 
analysed using singleplex qRT-PCR analysis. Results indicated that the expression of 
miRNA targets was increased following transfection of pre-miR-7 and pre-miR-24 at both 
standard and temperature-shifted culture conditions (Figure 3.3.4).  
The anti-mir molecules bind specifically to thier miRNA target to inhibit its effects in the 
cell. As such the target miRNA is not degraded and during RNA extraction and reverse 
transcription, the bound anti-mer is released resulting in no detectable differences in 
miRNA levels during subsequent qPCR. Therefore, as expected, the inhibition miR-7 and 
miR-24 was not detected in singleplex qRT-PCR.  
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Figure 3.3.4. Investigation of expression of miR-7 and miR-24 following AM and PM 
transfection using singleplex qRT-PCR assays specific to mature miR-7 and miR-24. Data 
represents the relative quantity of miRNAs for biological triplicate samples harvested at 
96hrs after transfection.  A expression of miR-7 and B expression of miR-24. NFX denotes 
transfection reagent only, AM-Control represents scrambled Anti-mir and PM-Control 
represents scrambled Pre-mir. Error bars represent standard deviation calculated using 3 
biological replicate samples. 
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Conclusion 
Data indicate that low temperature cultivation of cells altered expression of miRNAs and 
this contributed to reduced growth and improved viability and recombinant protein 
productivity in culture. miRNA-bioarrays and TLDAs were used to identify these 
temperature-dependent changes in expression of miRNAs in this investigation. Among the 
differentially expressed miRNAs, two known growth regulatory miRNAs, miR-7 and miR-
24, were found to be differentially expressed. miR-7 was down regulated and miR-24 was 
up regulated in biphasic cultures in comparison to standard cultures. Functional studies 
revealed that exogenous over expression of miR-7 and miR-24 can significantly reduce cell 
growth and increase recombinant protein productivity and therefore are potential targets to 
be implemented in cell engineering based approaches to improve efficiency of industrial 
production processes. 
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3.4 Investigation of secreted low molecular weight proteins by CHO-K1 cells in 
culture using SELDI-ToF MS 
As described in section 1.7, secreted proteins can regulate cell growth, viability and 
recombinant protein productivity in culture. The culture environment can modulate post 
translational modifications (PTMs) and hence the quality of the protein product. There is a 
possibility that secreted proteins can also contribute towards the regulation of PTMs in 
protein products. Moreover, knowledge of secreted host cell proteins can help in designing 
efficient product recovery processes from production culture. Therefore conditioned media 
from different phases of the growth cycle of low-serum adapted CHO-K1 cells were 
investigated using SELDI-ToF MS in collaboration with Priyanka Maurya from the 
Proteomics Group at NICB, Dublin City University Dublin, Ireland.   
 
3.4.1 Cell culture 
CHO-K1 cells were grown in low serum medium (0.5%) over 144hrs of culture. Cells were 
seeded at 3x105 cells/mL in T-75cm2 flasks. Four biological replicate flasks were set up at 
each time point. Cell counts were performed and conditioned media samples were collected 
every day. Control flasks containing cell free media were also set up at each time point to 
account for serum proteins that may be consumed by the cells over time in culture. Figure 
3.4.1 shows the growth of the cells over 144hrs of culture and clearly represents the 
different stages of growth (lag, logarithmic and stationary phases). Cells were in lag phase 
at 24hrs, mid-log phase at 72hrs and stationary phase of growth cycle at 120hrs of culture 
(Figure 3.4.1A). The viability of the culture also remained high throughout the testing 
period (Figure 3.4.1B).   
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Figure 3.4.1. Growth profiles of CHO-K1 cells adapted to growth in low serum (0.5%) medium in monolayer culture.  A. Viable cell 
counts. B. Percentage viability percentage. Error bars represents the standard deviation calculated from data obtained from the 
experiment (n=4). 
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3.4.2 Selection of chip surface 
Conditioned media samples were concentrated using 5000 MW cut-off centricons 
(Millipore). Prior to full profiling analysis, optimization studies were performed using 10 
µg and 50 µg of extracted protein from conditioned media samples representing 96hrs of 
culture on four different chromatographic surfaces to see which protein concentration and 
Protein Chip array gave optimal results. The following Protein Chip arrays were selected, 
an IMAC30 (immobilized metal affinity capture) activated with copper ions, CM10 (weak 
cation-exchange) with 20 mM Tris pH 4.5, Q10 (strong anion-exchange) with 50 mM Tris 
pH 8.0 and H50 (reverse-phase hydrophobic surface) with 10% acetonitrile/0.1% 
trifluoroacetic acid. The IMAC30 and Q10 ProteinChip 8-spot arrays provided better 
profiles under these conditions in terms of number and resolution of peaks and therefore 
were considered for the investigations (Table 3.4.2). The conditioned media from biological 
duplicate samples of CHO-K1 cells representing 96hrs of culture with and without media 
change after 48hrs of culture were profiled using IMAC surface to investigate if this alters 
the profiles on the chromatographic surface due to the removal of proteins accumulated in 
culture. Similar profiles for both culture conditions (with and without a change of culture 
medium) were observed in terms of resolution and detected peaks in both the low and high 
molecular weight range (Figure 3.4.2). The numbers of peaks detected for the low 
molecular weight range are greater in comparison to the high molecular weight range.   
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Table 3.4.2. Comparative analysis of the number of the peaks detected using SELDI-ToF 
MS with different chromatographic surfaces. 
 Array type Total no of peaks 
with conc. of 10 µg 
Total no of peaks 
with conc. of 50 µg 
Cation exchange surface  CM10 25 29 
Anion exchange surface Q10 70 75 
Reversed-phase surface  H50 26 34 
Metal affinity chip surface  
IMAC30 
29 50 
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Figure 3.4.2. Investigation of the effects of proteins accumulated in late-exponential phase of culture on the binding of proteins with 
the IMAC surface. This experiment was carried out using biological duplicate samples. A represents the profile at low molecular 
weight range (5-20000Da) and B represents the profile at high molecular weight range (20-100000Da). 
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3.4.3 Analysis of differential expression of proteins/peptides on selected surfaces 
Three biological replicate samples from each time point were profiled on each of the two 
surfaces, IMAC30 and Q10 ProteinChip arrays. Twenty four proteins/peptides were found 
to be differentially expressed over the 144 hrs of culture with a p-value < 0.05. The results 
for these 24 peaks are shown in Table 3.4.3. Figure 3.4.3.1A shows the SELDI-TOF MS 
profiles from two of these differentially expressed peaks at m/z 8118 (8.1 kDa) from the 
IMAC30 chip. Figure 3.4.3.1B clearly shows that the 8.1 kDa protein is increased until 
72hrs of culture and then its expression is decreased over the next 72hrs. The 14.7 kDa 
protein is accumulated at later stages in culture, only appearing during the stationary phase, 
at 120 and 144hrs of growth (Figure 3.4.3.2). Figure 3.4.3.3 and 3.4.3.4 show the SELDI-
TOF MS profile of two differentially expressed peaks from the Q10 array at m/z 7346 (7.3 
kDa) and 11347 (11.3 kDa). The 7.3 kDa protein is increased over time in culture from 
24hrs to 144hrs (Figure 3.4.3.3) while the 11.3 kDa protein is only increasing over time 
96hrs onwards (Figure 3.4.3.4). The majority of the proteins differentially expressed on the 
two chromatographic surfaces used in this study are increased over time in culture, such as 
the 7.3 kDa and the 11.3 kDa proteins detected on the Q10 array.   
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Table 3.4.3. Protein/peptide peaks differentially expressed over time in culture of CHO-K1 
cells on Q10 and IMAC30 ProteinChip arrays. 
 
 
 
Q10  IMAC30 No.  
m/z of peak p-value  m/z of peak p-value 
1 5753.43 0.042 1 5109.49 0.037 
2 5913.81 0.029 2 5261.48 0.045 
3 6191.46 0.032 3 5864.21 0.026 
4 7346.27 0.022 4 6065.27 0.043 
5 7542.91 0.048 5 8118.21 0.032 
6 8492.30 0.027 6 8591.44 0.034 
7 9746.85 0.034 7 14735.28 0.029 
8 9882.51 0.031 8 17975.62 0.022 
9 10883.34 0.044 9 20343.55 0.023 
10 11347.01 0.046 10 20853.77 0.021 
11 12168.91 0.047 11 25798.46 0.037 
12 13593.09 0.038    
13 15215.28 0.024    
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Figure 3.4.3.1. Differentially expressed proteins of CHO-K1 cells observed at 8.1 kDa 
over time in culture using IMAC-Cu2+ array. A represents the profile of three biological 
replicate samples from each time point from 24-144hrs. Profiles from control, cell-free 
flasks at each time point are also shown, i.e. one profile from each time point. The red 
box highlights the location of the differentially expressed peak. B represents the graph 
of the comparison of the average peak intensities over time in culture. 
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Figure 3.4.3.2. Differentially expressed proteins of CHO-K1 cells observed at 14.7 kDa 
protein/peptides over time in culture using IMAC-Cu2+ array. A represents the profile of 
three biological replicate samples from each time point from 24-144hrs. Profiles from 
control, cell-free flasks at each time point are also shown, i.e. one profile from each 
time point. The red box highlights the location of the differentially expressed peak. B 
represents the graph of the comparison of the average peak intensities over time in 
culture. 
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Figure 3.4.3.3. Differentially expressed proteins of CHO-K1 cells observed at 7.3 kDa 
protein/peptides over time in culture using Q10 array. A represents the profile of three 
biological replicate samples from each time point from 24-144hrs. Profiles from control, 
cell-free flasks at each time point are also shown, i.e. one profile from each time point. 
The red box highlights the location of the differentially expressed peak. B represents the 
graph of the comparison of the average peak intensities over time in culture. 
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Figure 3.4.3.4. Differentially expressed proteins of CHO-K1 cells observed at 11.3 kDa 
protein/peptides over time in culture using Q10 array. A represents the profile of three 
biological replicate samples from each time point from 24-144hrs. Profiles from control, 
cell-free flasks at each time point are also shown, i.e. one profile from each time point. 
The red box highlights the location of the differentially expressed peak. B represents the 
graph of the comparison of the average peak intensities over time in culture. 
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3.4.4 Analysis of reproducibility of results 
Three biological replicate samples of conditioned media representing lag, log and 
stationary phases of growth in culture were profiled, along with a technical duplicate of 
each sample, to assess the reproducibility of SELDI-TOF MS for profiling conditioned 
media samples from CHO-K1 cells. One time point was selected from each of the 
growth phases; 24 hrs from lag phase, 72 hrs from logarithmic phase, and 120 hrs from 
the stationary phase of growth. Figure 14A shows the SELDI-TOF MS profiles for each 
of these 6 samples at the three selected time points from different phases of the growth 
cycle. Figure 3.4.4.1 and 3.4.4.2 shows the increased expression of two peaks; one at 
m/z 11347 (11.3 kDa protein) on the Q10 array and a second peak at m/z 14735 (14.7 
kDa protein) on the IMAC30 array. From this experiment, coefficients of variance (CV) 
values were calculated from the intensity readings from five randomly selected peaks 
from each conditioned media sample from each of the ProteinChip array surfaces. The 
CV values ranged from 11.42% to 20.7% for the Q10 array, and from 8.05% to 17.4% 
on the IMAC30 array, demonstrating the reproducibility of the technique. We also 
looked at inter-experimental variability, and found that the average mean CV from the 
intensity readings from 5 randomly selected peaks across all experiments in the study 
was 22.68%.  
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Figure 3.4.4.1. SELDI-TOF MS profiling of 24hrs (from lag phase), 72hrs (from log 
phase) and 120hrs (from stationary phase) conditioned media from CHO-K1 cells for 
the 11.3 kDa species on the Q10 array. A represents the profile of three biological 
replicate samples from each time point along with a technical duplicate (total of 6 
samples per time point) to demonstrate the reproducibility of the method. The red box 
highlights the location of the differentially expressed peak. B represents the graph of the 
comparison of the average peak intensities. 
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Figure 3.4.4.2. SELDI-TOF MS profiling of 24hrs (from lag phase), 72hrs (from log 
phase) and 120hrs (from stationary phase) conditioned media from CHO-K1 cells for 
the 14.7 kDa species on the IMAC30 array. A represents the profile of three biological 
replicate samples from each time point along with a technical duplicate (total of 6 
samples per time point) to demonstrate the reproducibility of the method. The red box 
highlights the location of the differentially expressed peak. B represents the graph of the 
comparison of the average peak intensities. 
B
A
0
0.5
1
1.5
2
2.5
3
3.5
Lag phase Log phase Stationary phase
Samples
Av
er
ag
e 
Pe
ak
 
In
te
n
si
ty
1 0 0 0 0 1 2 5 0 0 1 5 0 0 0 1 7 5 0 0
1 0 0 0 0 1 2 5 0 0 1 5 0 0 0 1 7 5 0 0
0
1 0
2 0
3 0
4 0
1 4 7 5 7 . 7 + H
0
1 0
2 0
3 0
4 0
1 4 7 6 0 . 6 + H
0
1 0
2 0
3 0
4 0
1 4 7 4 4 . 6 + H
0
1 0
2 0
3 0
4 0
1 4 7 4 4 . 6 + H
0
1 0
2 0
3 0
4 0
1 4 7 4 4 . 6 + H
0
1 0
2 0
3 0
4 0
1 4 7 4 4 . 6 + H
0
1 0
2 0
3 0
4 0
1 4 7 4 3 . 8 + H
0
1 0
2 0
3 0
4 0
1 4 7 4 4 . 6 + H
0
1 0
2 0
3 0
4 0
1 4 7 2 3 . 9 + H
0
1 0
2 0
3 0
4 0
1 4 7 4 4 . 6 + H
0
1 0
2 0
3 0
4 0
1 4 7 4 9 . 1 + H
0
1 0
2 0
3 0
4 0
1 4 7 2 4 . 7 + H
0
1 0
2 0
3 0
4 0
1 4 7 2 4 . 4 + H
0
1 0
2 0
3 0
4 0
1 4 7 2 4 . 9 + H
0
1 0
2 0
3 0
4 0
1 4 7 1 7 . 7 + H
0
1 0
2 0
3 0
4 0
1 4 7 9 1 . 4 + H
0
1 0
2 0
3 0
4 0
1 4 7 1 9 . 8 + H
0
1 0
2 0
3 0
4 0
1 4 7 1 3 . 2 + H
Stationary phase
Log phase
Lag phase
  
 264 
Section 4.0  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Discussion 
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Mammalian cells, specially Chinese Hamster Ovary (CHO) cells, are being extensively 
used for the production of recombinant proteins for therapeutic use. The prevalence of 
mammalian cells is largely attributable to their ability to impart appropriate protein 
folding and post-translational modification (glycosylation, phosphorylation, etc.) in the 
recombinant protein product, such modifications are required for the biological activity 
and quality of many products (Wurm 2004, Bollati-Fogolin et al. 2005, Schriebl et al. 
2006). Currently, about 70% of all mammalian-cell-derived protein pharmaceuticals 
licensed in the USA were produced in CHO cells (Birch and Racher 2006). 
Approximatly $70 billion of sales revenue has been estimated to be generated using 
CHO cell factories in the biopharmaceutical market by the end of 2010 (Walsh 2006). 
These products include recombinant human growth hormone (rhGH) which is used to 
treat growth hormone deficiencies and erythropoietin (rEPO) which promotes the 
formation of red blood cells in the bone marrow. 
The demand for protein therapeutics is increasing and this necessitates improving 
productivity from CHO cells. The methods currently applied to improve productivity 
include optimization of culture conditions (temperature, pH, aeration rate, etc.), 
improved reactor designs, medium formulation and cell engineering. Low temperature 
cultivation of mammalian cells has been observed to arrest cell growth while 
maintaining cell viability and this inhibition has been positively correlated with 
increased productivity and therefore has been used in industrial settings (Al-Fageeh et 
al. 2006, Al-Fageeh and Smales 2006, Kaufmann et al. 1999). However, the 
mechanisms regulating these phenotypes remain poorly understood. Therefore, low 
temperature-induced differential expression of proteins and miRNAs were investigated 
in CHO cells in this study to improve our understanding of the low temperature 
response in mammalian cells and help to improve recombinant protein productivity. The 
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secretome of CHO cells over distinct phases of culture, i.e lag, log and stationary phase, 
was also analysed to identify differently expressed secreted proteins that may affect 
growth and productivity of CHO cells.    
 
4.1 Establishment of a recombinant protein-secreting CHO-K1 cell lines  
The majority of industrial recombinant protein (rP) production processes are performed 
in suspension culture. Removal of serum from culture medium minimizes the risk of 
contamination from microbial species (viruses or mycoplasma etc), batch-to-batch 
variation and cost of down stream processing. Therefore a recombinant protein product 
expression CHO-K1 cells were established that were able to grow in reduced serum 
supplemented medium.  
4.1.1 Cell Adaptation 
Adherent CHO-K1 cells growing in 10% serum supplemented medium were adapted to 
grow in suspension by culturing them in spinner flasks. The growth behaviour of the 
cells gradually improved with time as cells at P-42 had shorter lag phase and achieved 
higher maximum cell densities in comparison to the cells at early stage of adaptation (P-
1) (Figure 3.1.1). The cultures were also able to maintain high viability (≥94%) through 
out the adaptation which is in keeping with previous studies (Sinacore et al. 1996, 
Sinacore et al. 2000, Astley and Al-Rubeai 2008).  
These suspension-adapted CHO-K1 cells were further adapted to grow in low serum 
(0.5%) or serum-free culture conditions (Figure 3.1.2). The cells took only 4 days to 
adapt to each reduced serum level from 5 to 1% in culture medium, may be because 
even 1% serum in the medium could be providing a sufficient nourishment and 
protection for the growth of CHO cells. When serum was reduced to 0.5%, the cells 
started to take more time to meet set criteria of adaptation (≥ 1x 106 cells/mL within 4 
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days of culture) in new culture environment. For example, cells took 10 days in 0.5 % 
FCS and 34 days in SFM (ExCell). To summarise, CHO-K1 cells were successfully 
adapted to grow in adherent as well as suspension culture in 0.5% FCS supplemented 
ATCC medium and ExCell serum-free medium.  
4.1.2 Establishment of SEAP secreting CHO-K1 cells 
Suspension-adapted CHO-K1 cells, exponentially growing in 0.5% FCS supplemented 
ATCC culture medium, were grown in adherent culture and transfected with a plasmid 
pcDNA-SEAP2 containing a gene of interest, secreted alkaline phosphatase (SEAP) 
(SEAP) (Figure 3.3.2.3). SEAP, a glycosylated protein, is a well known reporter protein 
used to investigate the recombinant protein production by cells (Carvalhal et al. 2003, 
Fussenegger et al. 1998, Kaufmann et al. 2001). The use of low serum adapted CHO-
K1 cells minimized the risk of loosing the SEAP gene due to genetic re-arrangements 
that may occur during the process of cell adaptation (Brill et al. 1979, Sobecky et al. 
1992, Prozorov 2001), whereas use of adherent culture facilitated clone isolation 
through limiting dilution. Only cells that have incorporated the neomycin resistant gene, 
with or without the SEAP, would survive in presence of G418 in the culture and 
therefore use of G418 allowed us to select transfectant cells (Figure 3.1.2.3). The 
transfectants were tested for SEAP productivity by measuring the enzymatic activity of 
SEAP in culture media. Only 1 clone (Clone 19) and 2 subclones from clone 19 were 
isolated as SEAP-producing clones. The comparison of productivity among these clones 
revealed that 12s was the highest producer clone followed by 3s and clone-19 
respectively. Clones 3s and 12s were found to be stable in SEAP productivity over 
testing period (27days). However, longer testing-periods including cell-freezing and 
thawing cycles would be advantageous to further confirm the stability in expression of 
SEAP in both clones and suitability as model cell lines. Therefore, both subclones were 
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adapted to grow in suspension (Figure 3.1.2.9) and since 12s was the highest producer, 
it was selected for further studies. 
 
4.2 Analysis of low temperature induced differential expression of proteins in 
CHO-K1 cells 
The incorporation of a temperature reduction step is commonly employed during 
production cell culture in the biopharmaceutical industry. This temperature-shift is used 
as a means of simultaneously inducing growth arrest and extending long term culture 
viability thus increasing recombinant protein productivity and yield (Al-Fageeh et al. 
2006, Kaufmann et al. 1999, Marchant et al. 2008, Yee et al. 2008). The mechanism 
allowing improved productivity are poorly understood and therefore a greater 
understanding of these mechanisms would enables us to manipulate cellular machinery 
to further increase yield.  
Proteomics is the large-scale study of structures and functions of the proteins (section 
1.9.1). Two dimentional gel electrophoresis has been used to investigate the molecular 
mechanism of various cellular processes, such as growth, apoptosis or secretion in 
mammalian expression systems (Baik et al. 2006, Underhill and Smales 2007, Dinnis et 
al. 2006). While 2D- gel electrophoresis is very good for looking at a large number of 
changes in protein expression, it has limitation in investigating very acidic, basic, 
hydrophobic, small and large proteins as well as low or overly abundant proteins. 
Moreover, only one sample can be separated on a single gel using 2D-gel 
electrophoresis and therefore this technique suffers from low sensitivity and 
reproducibility (Bunai and Yamane 2005). A modified 2D-gel electrophoresis, 2D-
DIGE, enables separation of 2-3 fluorescently labelled protein samples on a singe gel 
and this minimizes gel-to-gel variation and improves reproducibility and sensitivity. 
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Although 2D-DIGE has been extensively used to investigate the changes in protein 
expression associated with various diseases such as cancer (Kondo 2008, Maurya et al. 
2007), its use in bioprocess-related research is still limited. Here, we used 2D-DIGE and 
MALDI-ToF mass spectrometry to investigate the temperature-dependent differential 
expression of proteins to understand the mechanisms regulating the effects of low 
temperature in CHO-K1 cells.  
 
4.2.1 Cell Culture 
CHO-K1 cells were cultured in a biphasic process where cells were maintained for 
72hrs at 370C and were then shifted to reduced temperature (310C) for a further 72hrs. 
Cells were also maintained in standard culture (370C) paralally. Following the 
temperature-shift, cell growth was immediately arrested compared to cells maintained in 
standard cultures (Figure 3.2.1A). Cells in temperature-shifted culture were observed to 
maintain a steady viable cell density throughout the culture whereas the cells at 370C 
began entering the death phase by 120hrs of culture. While the viabilities of both 
cultures were comparable throughout the 144hrs of culture, it was slightly reduced 
towards the end of the experiment for the cells maintained at 370C (Figure 3.2.1B). It is 
possible that the high percentage of serum (10%) in the culture medium protected both 
cultures from apoptotic cell death (Zanghi et al. 1999), therefore maintaining the high 
viabilities recorded. The CHO cells cultured in 10% serum supplemented culture 
medium were used in this early stage investigation as it was carried out before adapting 
cells to grow in reduced serum supplemented medium. 
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4.2.2 Protein identification  
Following 2D-DIGE analysis to compare the differences in global protein expression at 
72hrs and 144hrs of culture, 201 differentially expressed (DE) spots were observed in 
the temperature-shifted cells whereas 404 differentially expressed spots were observed 
for the cells maintained at 370C. A total of 247 spots comprising of 127 up and 120 
down regulated at 144hrs were picked for identification using MALDI-ToF MS, of 
which, 53 proteins were successfully identified (Table 3.2.4). A number of spots 
resulted in high quality spectra but were not successfully identified. This could be due 
to various reasons including that the number of protein sequences for CHO cells are still 
very low in the protein database, i.e. Swiss-Prot+TrEMBL database contains only ~600 
CHO proteins. The CHO proteins being investigated could have post-translational 
modifications and may differ in their peptide mass fingerprints (PMFs) compared to 
orthologous proteins from other mammalian species. Additionally the amino acids in 
the CHO proteins may also be different to orthologous sequences resulting in differing 
PMF.  
 
4.2.3 Analysis of differential expression of proteins 
The identified differentially expressed proteins were mainly analyzed in three groups, 
72hrs at 370C vs. 144hrs at 310C (temperature-shifted culture), 72hrs at 370C vs. 144hrs 
at 370C (standard culture) and 144hrs at 310C vs. 144hrs at 370C (stationary culture). 
These comparisons enabled us to identify temperature-dependent and independent 
changes in protein expression.  
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4.2.3.1 Temperature-shifted culture (72hrs at 370C vs. 144hrs at 310C) 
A total of 53 differentially expressed proteins were identified in this investigation, of 
which 35 proteins were in the temperature-shifted culture (72hrs at 370C vs. 144hrs at 
310C) (Figure 3.2.4.3). Of these 35 proteins, 22 were up and 13 were down regulated in 
temperature-shifted cells. A number of proteins have previously been identified as 
differentially expressed following temperature-shift in CHO cells, including up 
regulation of vimentin and GAPDH (Baik et al. 2006, Yee et al. 2008). These proteins 
were up regulated in our study also (Table 4.2.1). RNA binding motif protein 3 
(RBM3), a well known up regulated cold inducible protein in a variety of cell lines 
including CHO cells (Yee et al. 2008, Danno et al. 2000), was observed to be up 
regulated following temperature-shift using Western blotting in our study, although it 
was not identified to be differentially regulated using 2D-DIGE possibly due to its low 
molecular weight (~17kDa) (Table 4.2.1). β-actin, prohibitin and triosephosphate 
isomerise were observed to be differentially regulated in previous studies in response to 
low temperature culture (Baik et al. 2006) but they were found to be unchanged in our 
investigation possibly due to a different temperature (330C instead of 310C) or clonal 
heterogeneity. Apart from this, the proteins identified as differentially expressed in this 
study have not been previously reported to be associated with low temperature response 
in CHO cells and may help to improve the understanding of low temperature response 
in mammalian cells.   
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Table 4.2.1. Comparison of differentially expressed proteins identified in this study with previous studies on the effect of low temperature. 
Previous Study  Protein This Study 
Protein/Transcript Author Effect 
Function 
Baik et al, 2006 Up regulated Vimentin Up regulated Vimentin 
Yee et al, 2008 Up regulated 
Cell size, proliferation, cell growth rate 
and apoptosis. 
GAPDH Up regulated GAPDH Baik et al, 2006 Up regulated Apoptosis, nuclear tRNA export, DNA 
replication, DNA repair and transcription 
ACTB No Change β-actin (identified 
at multiple spots) 
Baik et al, 2006 Up regulated at 2 spots and 
down regulated at 1 spot 
Cell size, shape and proliferation, 
transcription and apoptosis 
PHB No Change Prohibitin Baik et al, 2006 Up regulated Proliferation, differentiation and apoptosis 
Baik et al, 2006 No change TPI1 No Change Triosephosphate 
isomerise Yee et al, 2008 Down regulated 
Stress conditions and cell death 
RBM3 Up regulated RNA binding motif 
protein 3 
Yee et al, 2008 Up regulated Transcription, translation, proliferation, 
differentiation and apoptosis 
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Comparing proteins differentially expressed in temperature-shifted cultures with those in 
standard cultures revealed that 23 proteins to be specifically altered in response to low 
temperature (Table 3.2.4), whereas 12 proteins were differentially regulated in both 
temperature-shifted and standard culture representing the temperature-independent changes 
in culture. 
 
4.2.3.1.1 Analysis of temperature-specific differential expression of proteins 
Of the 23 temperature-dependent differentially expressed proteins, 18 were up regulated 
and 5 were down regulated at 144hrs at 310C. These temperature-specific differentially 
expressed proteins were associated with the regulation of a variety of cellular functions, 
including protein translation, cell growth, apoptosis, structure and metabolism. Analysis of 
these proteins may identify targets critical for the regulation of low-temperature induced 
cellular phenotypes and to improved recombinant protein productivity.    
 
4.2.3.1.1.1 Protein Translation 
It has been observed that protein synthesis rates are reduced at low temperature due to a 
general inhibition of cap-dependent protein synthesis (Roobol et al. 2009, Phadtare et al. 
1999). However some proteins, e.g. RBM3, are translated under cold stress via an IRES-
mediated cap-independent mechanism (Al-Fageeh et al. 2006, Al-Fageeh and Smales 2006, 
Chappell et al. 2001). This type of protein translation initiation requires both eukaryotic 
initiation factors (EIF2, EIF3, EIF4A, EIF4B and EIF4F) and message-specific cellular 
IRES trans-acting factors (ITAFs) such as upstream of N-ras (Unr) and polypyrimidine 
tract binding protein (PTB) (Pilipenko et al. 2000). A number of proteins that are involved 
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in regulation of both cap-dependent and independent protein translation, such as EIF4A and 
HNRPC, were observed to be differentially regulated following temperature-shift in this 
investigation (Table 3.2.4).  
EIF4A is an RNA helicase enzyme that plays an important part in translation of mRNAs 
and was found to be increased by 1.81 fold following temperature-shift. EIF4A exhibits 
RNA-dependent ATPase activity and ATP-stimulated RNA binding activity and unwinds 
local secondary structures in the 5′ UTR of mRNAs to facilitate cap-dependent translation. 
EIF4A is also one of the critical translational initiation factors that is required in IRES 
mediated cap-independent translation, however the molecular mechanism is unknown (Lin 
et al. 2009, Pilipenko et al. 2000, Pause et al. 1994). Thus, the over expression of EIF4A 
following temperature-shift may facilitate translation for proteins required by cells to cope 
with hypothermic conditions.  
HNRPC is a nuclear pre-mRNA binding protein and was observed to be 1.52 fold down 
regulated following temperature-shift. HNRPC can interact with the IRESs to regulate 
expression of proteins involved in various cellular phenotypes such as cell growth (c-myc) 
and stress management (Upstream of N-Ras, Unr). HNRPC has been shown to interact with 
IRESs in the 5’UTR of Unr and facilitates cell proliferation through IRESs, including the 
PITSLRE IRES, which is activated at mitosis (Schepens et al. 2007) and known to be 
essential for eukaryotic cell cycle control (Tinton et al. 2005). This is important because 
during mitosis, similar to low temperature culture inductions, protein synthesis is rapidly 
and severely repressed possibly due to the inhibition of global cap-dependent translation 
(Fan and Penman 1970).  
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The fact that EIF4A and HNRPC are both differentially expressed in this experiment 
following temperature-shift clearly indicates the importance of IRES-based regulation of 
the translational machinery under hypothermic conditions. This also establishes EIF4A and 
HNRPC as potential protein targets that need to be investigated for their roles in the 
regulation of low-temperature induced phenotypes in CHO cells. EIF4A and HNRPC are 
our novel finding as they have not been previously reported to be associated with 
recombinant protein production in CHO cells. 
 
4.2.3.1.1.2 Cell growth 
The most obvious effect following reduction of culture temperature is the immediate 
decrease in growth. A number of growth-related proteins were identified as being 
differentially expressed in a temperature-specific manner, including EIF4A, HNRPC, 
RRN3 and LGALS1 (Table 3.2.4 and 3.2.6).  
EIF4A is also involved in the regulation of cell growth being up regulated in G2 arrested 
CHO cells (Sasaki et al. 2000). The reduced expression of EIF4A has been observed to 
inhibit translation resulting in inhibition of cell cycle and growth (Daga and Jimenez 1999). 
Therefore, increased expression of EIF4A in this study as a cause or consequence of cell 
cycle arrest due to temperature-shift remains unclear.  
HNRPC may also have a role in regulating cell growth as well as translation. HNRPC can 
enhance the translation of c-myc mRNA and thus increase proliferation in human 
embryonic kidney cells (HEK293/T) (Kim et al. 2003). Silencing of HNRP C1/C2 protein 
expression by siRNA has also been shown to result in the inhibition of cell proliferation 
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(Schepens et al. 2007). These results are in keeping with our finding that HNRPC is down 
regulated following the reduction of the culture temperature.  
RRN3 (RRN3 RNA polymerase I transcription factor) level was found to be 1.53 fold 
down regulated at the end of the temperature-shifted culture compared to exponentially 
growing cells. RRN3, also known as TIF-IA, is an essential polymerase-associated protein 
required for transcription. However it is unclear whether RRN3 is required for initiation or 
elongation by RNA polymerase I (Pol I). Growth arrest can result in reduced RRN3 is 
reduced in stationary phase cells following drug-treatments or nutrient deprivation or in an 
inactive dephosphorylated forms (Zhao et al. 2003). The growth-dependent control of Pol I 
transcription through RRN3 suggests that this factor is targeted by signal transduction 
pathways which are important for cell proliferation. Therefore, down regulation of RRN3 
following temperature-shift is consistent with its activity in stationary cells.  
LGALS1 (lectin, galactoside-binding, soluble, 1 or galectin 1) was 1.62 fold up regulated 
on temperature-shift. LGALS1 has an affinity for β-galactoside sugars which upon binding 
to the appropriate glycoligands elicits a multitude of biological activities. LGALS1 has 
been shown to have effects on cell adhesion (Mahanthappa et al. 1994), regulation of cell 
proliferation (Wells and Mallucci 1991, Allione et al. 1998) and apoptosis (Perillo et al. 
1995). LGALS1 acts as a negative cell growth regulator in fibroblasts (Wells and Mallucci 
1991, Allione et al. 1998) and reduces proliferation of mouse thymocytes (Vespa et al. 
1999). LGALS1 blocks the mitogenic MAP kinase cascade that is normally activated by 
binding of growth factor ligand to the appropriate receptor tyrosine kinase (Vespa et al. 
1999). LGALS1 induces apoptosis of activated human T cells (Perillo et al. 1995) and 
human T leukaemia cell lines (Allione et al. 1998). Conversely, LGALS1 can act in a dose-
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dependent manner, at low concentrations, significantly promoting cell proliferation without 
inducing cell death in the mouse leydig tumour cells (MA-10) (Biron et al. 2006). 
Moreover, LGALS1 has been reported to be down regulated in high producer CHO cells in 
comparison to low producers, indicating its potential involvement in the regulation of 
recombinant protein productivity in CHO cells (Meleady et al. 2008). LGALS1 was up 
regulated in the temperature-shifted cells in our investigation and therefore correlates with 
the reduced cell growth. 
 
4.2.3.1.1.3 Apoptosis 
Another common feature of cells that are cultured at reduced temperatures is delayed 
apoptosis compared to cells cultured at 370C (Al-Fageeh and Smales 2006, Moore et al. 
1997). It has been proposed that the reduction in apoptosis is a result of reduced cellular 
metabolism at low temperatures (Moore et al. 1997). However, others have reported the 
induction of anti-apoptotic proteins (e.g. BCL-2) following culture at reduced temperature 
(Zhang et al. 2001). BCL-2 (a low molecular weight protein, which are often under 
represented on 2D-gels) was not identified as differentially expressed in this study but a 
few apoptosis-associated proteins were identified including importin-α (Table 3.2.4 and 
3.2.6).  
Importin-α, a nuclear import receptor, was 1.8 fold down regulated in temperature-shifted 
cultures. It facilitates trafficking of the growth promoting Ras effector, RASSF5, into the 
nucleus (Kumari et al. 2007). Over expression of importin-α results in significant increases 
in p21(waf1/cip1) transcript levels and apoptosis, implicating it in the nuclear import of p53 
(Kim et al. 2000).  
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4.2.3.1.1.4 Structure 
A number of cytoskeletal proteins including vimentin, profilin and LASP1 were 
differentially expressed following temperature-shift (Table 3.2.4). Vimentin and profilin 
were also observed to be differentially expressed by Baik et. al. (Baik et al. 2006) and 
support their potential involvement in low temperature response in CHO cells.  
Vimentin, a major cytoskeletal proteins, was 2.05 fold up regulated in temperature-shifted 
cells and is consistant with recent observations in CHO cells (Baik et al. 2006, Yee et al. 
2008, Underhill and Smales 2007). Its role in the regulation of cell growth and recombinant 
protein productivity is complex as increased levels of vimentin have also been shown in the 
heat-resistant phenotypes of CHO cells (Lee et al. 1992), whereas reduced expression has 
been observed in high producer CHO cells (Meleady et al. 2008). The investigation of 
expression of vimentin in low, medium and high producer clones could possibly improve 
our understanding of role of vimentin in regulation of growth and productivity in CHO 
cells.  
Profilin (PFN2) is a small ubiquitous actin monomer sequestering protein and it is found to 
be 1.69 fold up regulated in temperature-shifted culture. PFN2 is important for spatial and 
temporal growth control of actin microfilaments, an essential process in the regulation of 
shape, structure and integrity of cells. PFN2 has been shown to be critical for normal actin 
polymerization in response to thermal stress (Yeh and Haarer 1996a) and therefore 
increased level of profilin 2 following low temperature induction may have roles in the 
regulation of cytoskeleton of cells in response to hypothermic conditions.  
The LIM and SH3 domain protein, LASP1, was observed to be 2.06 fold up regulated 
following temperature-shift. This protein functions as an actin-binding protein and possibly 
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in cytoskeletal organization, however the exact cellular function is not known yet. LASP1 
has been observed to be down regulated in high producer CHO cells (Meleady et al. 2008) 
suggesting that the up regulation of LASP1 in response to low temperature could be 
associated with regulation of cytoskeleton at hypothermic conditions. Similar to vimentin, 
investigation of LASP1 level in a range of producer clones could improve our 
understanding of its role in regulation of growth and productivity.  
 
4.2.3.1.1.5 Metabolism 
Cellular metabolism is generally reduced in low culture temperature (Moore et al. 1997) 
but this does not apply to every enzyme and pathway. GAPDH, a multi-functional 
glycolytic enzyme, was almost 2 fold up regulated following temperature-shifted cells, 
similar to other published data (Table 4.2.1) (Baik et al. 2006). GAPDH has also been 
observed to be abundant in high producer NS0 cells (Dinnis et al. 2006) indicating that 
increased expression could be associated with increased productivity. 
Another enzyme alpha glucosidase 2 (alpha neutral subunit) (GANAB) is a component of 
the glycan-processing enzyme, glucosidase II and is involved in carbohydrate metabolism. 
GANAB was 2.19 fold up regulated in temperature-shifted cells. It trims two α-1, 3-linked 
Glc residues from the glycoprotein oligosaccharide Glc2Man9GlcNAc2 to give 
Glc1Man9GlcNAc2 and Man9GlcNAc2 in the endoplasmic reticulum (Totani et al. 2006). 
Monoglucosylated glycans generated by this process play a key role in glycoprotein quality 
control in the ER, as they are primary ligands for the lectin chaperones calnexin (CNX) and 
calreticulin (CRT) that are involved in ensuring glycoprotein quality prior to secretion 
(Totani et al. 2006). The increased levels of GANAB may contribute to the improved 
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product quality observed following low culture temperature. Further work including 
knockdown of GANAB expression followed by glycoprotein quality analysis could clear 
the role of GANAB in cell growth and quantitative and qualitative productivity.  
 
The presented data indicate that the expressions of a number of proteins were specifically 
altered in response to low temperature. These proteins were involved in the regulation of 
variety of functions, such as translational machinery (EIF4A and HNRPC), cell growth 
(EIF4A, HNRPC, RRN3 and LGALS1), apoptosis (Importin-α), cell structure (vimentin, 
LASP1 and profilin 2) and cellular metabolism (GAPDH and GANAB). Investigation of 
these proteins could enable us to improve the growth behaviour of cells and recombinant 
protein production in culture.  
 
4.2.3.1.2 Analysis of temperature-independent differential expression of proteins 
Of 53 identified proteins, 12 proteins were commonly differentially expressed in both the 
temperature-shifted and standard culture (Table 3.2.5). These 12 proteins (4 up and 8 down 
regulated at 144hrs at 370C) represented the process-dependent changes in expression of 
proteins in culture. The majority of proteins were similarly regulated between temperature-
shifted and standard cultures indicating time-dependent changes in culture. For example, 
levels of AHSA1, TXNL2, FKBP4 and 1HLUA were similar in both culture conditions and 
therefore could be involved in the regulation of house keeping proteins in cells. Only 
calponin 3 (CNN3) was up regulated in temperature-shifted culture. CNN3 is ubiquitously 
distributed in intermediate microfilaments (Fujii et al. 2000). Besides interating with actin, 
CNN3 can interact with gelsolin, one of the abundant cytoskeleton proteins required to 
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sever actin filaments coming from damaged compartments. Calponin by reducing the actin-
binding activity of gelsolin during actin filament formation could regulate the cellular 
morphology (Ferjani et al. 2006). The increased level of CNN3 might strengthen the 
cytoskeleton due to increased gelsolin activity and this could contribute to the improved 
viability of cells maintained at low temperature. 
 
4.2.3.1.3 Analysis of possible low temperature-induced post-translational 
modifications of proteins 
Two proteins, ALDH and DPYSL2, were identified at two different pIs on gels from the 
temperature-shifted culture suggesting potential low temperature-induced post-
transcriptional or translational modifications (PTMs). Identification of these modifications 
could improve our understanding of the signalling pathways and other associated proteins 
in response to low temperature.  
ALDH is a NAD(P)+-dependent enzyme that can protect against hyperoxia-induced cell 
death through reduction of ROS, activation of ERK/MAPK and PI3K-Akt cell survival 
signalling pathways (Xu et al. 2006). Analysis of the ALDH spots revealed 1.63 and 1.98 
fold up regulation in temperature-shifted culture.  
DPYSL2 promotes microtubule formation by binding to tubulin heterodimers (Fukata et al. 
2002). Different variants, possibly phosphorylated, of DPYSL2 have been reported 
previously (Franzen et al. 2003). In this study, at one spot, DPYSL2 was 2.58 fold up 
regulated following temperature-shift, whereas it was 1.97 fold up regulated in standard 
culture. However, at second spot, DPYSL2 was 2.51 fold down regulated only in 
temperature-shifted cultures.  
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The functional association of ALDH and DPYSL2 with low temperature response is 
unknown. In-silico phosphoproteome analysis predicted that both ALDH and DPYSL2 
contain phosphorylation sites and hence the multiple spots may indicate that they are 
phosphorylated. A previous study also observed two proteins (80 and 180 kDa) as being 
phosphorylated at tyrosine residues in CHO cells cultured at low temperature (Kaufmann et 
al. 1999) suggesting that active cell signalling occurs in response to temperature-shift.  
 
4.2.3.2 Standard culture (72hrs at 370C vs. 144hrs at 370C) 
The identification of differential protein expression between cells in exponential phase at 
72hrs of culture at 370C and cells in stationary phase of growth at 144hrs of culture at 370C 
may reveal proteins involved in regulating cellular phenotypes, such as cell growth and 
apoptosis. A total of 30 differentially expressed proteins were identified comparing 
exponential and stationary phase of standard culture in this investigation (Figure 3.2.4.3 
and Table 3.2.4). Of these, 18 proteins were specifically differentially regulated between 
exponential and stationary phase of standard culture.   
The cells at 144hrs in standard culture were in the early death phase as reflected by the 
slight reduction in viability (Figure 3.2.1B). This is likely due to a variety of reasons 
including nutrient limitation, oxygen depletion and waste accumulation. As such, metabolic 
enzymes PYP and ATP5B, involved in energy generation, were 1.58 and 2.28 fold down 
regulated respectively in the cells at 144hrs in comparison to exponentially growing cells at 
72hrs (Table 3.2.4).  
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A number of apoptosis and growth-related proteins were found to be differentially 
regulated in cells at stationary phase at 144hrs in comparison to cells growing exponentially 
at 72hrs of culture (Table 3.3.4).  
 
4.2.3.2.1 Apoptosis-related metabolic proteins 
Cells generate energy mainly from carbohydrate metabolism and usually store it 
temporarily in the form of ATP using it to drive activities, such as DNA synthesis and cell 
growth. Defects in energy generation therefore may lead to the cell death in culture. A 
number of apoptosis-related metabolic proteins, including prohibitin (PHB), Aldehyde 
dehydrogenase family 1, subfamily A1 (ALDH1A1) and alpha-enolase (ENO1), were 
observed to be differentially regulated in standard culture.     
PHB is an evolutionarily conserved and ubiquitously expressed membrane protein. PHB 
was observed to be 1.66 fold down regulated in the cells in stationary phase at 144hrs in 
comparison to the cells exponentially growing at 72hrs. Prohibitins can be localized to 
different cellular compartments, the plasma membrane, the nucleus and mitochondria. A 
diverse array of cellular functions have been attributed to prohibitin, however the 
mechanism by which it regulates such a diverse range of functions remains poorly 
understood. PHB was observed to block DNA synthesis in normal fibroblasts and HeLa 
cells thereby arresting cell cycle progression into the S-phase with antisense inhibition of 
PHB recovering the cell growth (Nuell et al. 1991). Similarly, over expression of PHB 
inhibits cell proliferation by arresting cells in G0/G1 phase and has also been shown to 
increase survival of T47D cells (Wang et al. 2002). Besides anti-proliferative effects, PHB 
has been implicated in transcriptional regulation (Fusaro et al. 2003), cellular signalling 
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(Rajalingam et al. 2005), mitochondrial biogenesis (Nijtmans et al. 2000) and apoptosis 
(Fusaro et al. 2002). PHB is capable of physically interacting with p53 in vivo and in vitro 
promoting p53-mediated transcriptional activity by enhancing its recruitment to promoters 
(Fusaro et al. 2003). Although the localization of PHB which can affect the cellular 
function was not investigated in the present study, the down regulation of the expression of 
PHB suggests that it may protect cells from stationary/apoptotic conditions in culture.  
ALDH1A1 is a cytosolic enzyme belonging to the aldehyde dehydrogenase family of 
proteins which are involved in the conversion of wide variety of aldehydes (retinaldehyde, 
acetaldehyde, etc.) to their corresponding acids (retinoic acid, acetic acid, etc.) by NAD(P)+ 
dependent reactions (Yoshida et al. 1998). It was 1.64 fold down regulated in cells at 
144hrs compared to cells at 72hrs in standard culture and could be contributing to 
stationary phase or apoptosis in culture. Down regulation of ALDH1A1 results in increased 
generation of toxic reactive-oxygen-species (ROS) that include highly reactive superoxide 
molecules and hydrogen peroxides which could have proliferative as well as apoptotic 
effects on cells (Gyamfi et al. 2006). ALDH1A1 has been observed to be down regulated in 
lens epithelial cells from human, mouse and rat that have increased susceptibility towards 
apoptosis (Choudhary et al. 2005). Down regulation of ALDH1A1 in this investigation is 
therefore in agreement with the published literature and suggests its negative correlation 
with cell death in culture. Up regulation of ALDH1A1 levels in culture could help to 
maintain high viability for longer periods of time.  
ENO1 is an essential cytosolic enzyme for glycolysis and gluconeogenesis. ENO1 was 
observed to be 1.51 fold up regulated in cells at 144hrs compared to 72hrs in standard 
culture. ENO1 catalyses the conversion of 2-phosphoglycerate (2-PG) into 
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phosphoenolpyruvate (PEP). The over expression of ENO1 has been shown to inhibit cell 
growth and induce apoptosis in neuroblastoma cells (Ejeskar et al. 2005). Recently ENO1 
has been reported to be over expressed in high producer CHO cells implicating the 
possibility that it could be involved in the regulation of recombinant protein productivity in 
cells (Meleady et al. 2008). ENO1 was observed to be unchanged in temperature-shifted 
cultures which are known to improve productivity and this complicates the elucidation of 
its role in improving recombinant productivity of CHO cells. Therefore increased level of 
ENO1 in cells in stationary phase (144hrs) in comparison to cells exponentially growing 
(72hrs) in standard culture suggests that ENO1 may have potential role in regulation of 
apoptosis in culture, although no evaluation of the rate of apoptosis in the culture for any of 
these apoptosis-related proteins has been made. Further, it would be necessary to look at the 
rate of apoptosis in the stationary and exponentially growing cells.   
 
4.2.3.2 Growth and apoptosis-related structural proteins 
The cytoskeleton acts as the mechanical supporting framework to maintain the shape of 
cells. It is generally accepted that cells under going apoptosis show a dramatic change in 
their cytoskeleton. The alteration of structural proteins may dysregulate mechanical 
coupling between cytoskeletal microtubules and actin microfilaments, and this could play a 
key role in control of proliferation as well as apoptosis (Rodolfo and Piacentini 2002). A 
number of structural proteins including ACTB and CAPZB were observed to be down 
regulated in cells at stationary phase indicating their potential role in regulation of cell 
death in culture.   
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ACTB, was identified at two different pIs and molecular weights on the gel containing 
samples from standard culture indicating that different variants of ACTB may exists in 
CHO cells. However ACTB was down regulated by 1.97 and 1.72 fold at both positions in 
cells at 144hrs in comparison to cells at 72hrs in standard culture. ACTB is involved in 
many biological functions in the cells including regulation of cell shape and growth. 
Increased expression of ACTB has been shown to provide resistance against apoptosis in 
HL-60 myeloid leukemia cells by supporting morphological changes associated with the 
development of cell death (Veselska et al. 2003). ACTB has been observed to be abundant 
in NS0 cells with increased productivity of Mab (Dinnis et al. 2006) indicating that 
cytoskeleton proteins also important for efficient protein production by cells. The down 
regulation of ACTB at 144hrs in comparison to 72hrs of culture possibly indicate that 
ACTB should be up regulated to maintain growth, viability and productivity in culture. 
CAPZB is an actin-binding protein and was 1.5 fold down regulated in cells at 144hrs in 
comparison to cells at 72hrs in standard culture. CAPZB binds to one end of actin 
filaments, regulates actin polymerization including the number and length of actin 
filaments, and strengthens the actin cytoskeleton in the cytoplasm (Pappas et al. 2008, Xu 
et al. 1999). Therefore, reduced expression of CAPZB, as well as ACTB, is likely to be 
associated with dysregulation of cytoskeleton and possibly increased apoptosis in stationary 
phase of standard culture. 
 
4.2.3.3 Growth-promoting protein 
GRB2, involve in the regulation of cell growth, was observed to be 1.72 fold down 
regulated in cells at 144hrs compared to cells at 72hrs in standard culture. GRB2 contains 
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SH2 and SH3 domains and is involved in the signal transduction pathways involving 
epidermal growth factor receptor to regulate cell proliferation in culture (Yu et al. 2008a & 
b). Increased GRB2 expression in colorectal carcinoma correlates to increased tumour 
growth (Yu et al. 2008a). The down regulation of GRB2 at the stationary phase of culture 
reflects the reduced growth.  
Therefore, data presented here indicates that altered levels of PHB, ALDH1A1, ENO1, 
ACTB and CAPZB could be associated with development of stationary phase of culture 
whereas GRB2 contributes to the reduced growth of cells. This suggests that these proteins 
may possibly be implemented in to the production culture to regulate growth and 
productivity of culture.  
 
4.2.3.3 Stationary culture (144hrs at 310C vs. 144hrs at 370C) 
Identification of differentially expressed proteins between stationary phases at temperature-
shifted and standard cultures could further help us to identify proteins that may be involved 
in the regulation of cell death and various other stress conditions such as nutrient or oxygen 
depletion. A total of 21 proteins were observed to be differentially expressed, of which, 17 
proteins were up regulated and 4 were down regulated (Table 3.2.6). A number of proteins 
that were involved in the regulation of growth and/or apoptosis were observed to be 
differentially expressed. These include vimentin, importin-α, ENO1, CNN3, ACTB, 
CAPBZ and ALDH1A1 etc. As discussed in sections 4.2.3.1 and 4.2.3.2, investigation of 
these proteins could enable us to regulate growth and hence recombinant protein 
productivity of mammalian cultures. 
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4.2.4 Selection of protein target selection to investigate their effects on cell growth and 
productivity using siRNA knockdown technique  
Based on the expression pattern observed using 2D-DIGE and information in published 
literature, 5 protein targets were selected for knockdown of their expression in CHO-K1 
cells in suspension. The targets are described in Table 4.2.4. As discussed in section 4.2.3, 
these protein targets were specifically differentially regulated in temperature-shifted culture 
and were in agreement with the published literature in respect of various cellular 
phenotypes such as cell growth and apoptosis, that are typically observed in low 
temperature culture. Briefly,  
• EIF4A, a critical factor for cap-independent translation pathways, was up regulated in 
temperature-shifted cultures. EIF4A has also been shown to block cell cycle 
progression. Therefore the up regulation of EIF4A could be associated with the reduced 
cell growth due to its role in cell cycle transition and/or improved recombinant protein 
production due to role in the regulation of cap-independent translation pathways at low 
temperature. 
• HNRPC was down regulated following temperature-shift. HNRPC can induce 
translation of c-myc which is known to regulate cell growth in culture. HNRPC is also 
involved in regulation of cap-independent translation. Down regulation of HNRPC 
following temperature-shift could potentially be contributing towards reduced cell 
growth and increased recombinant protein productivity at low temperature.  
• Importin-α was down regulated in temperature-shifted cells. Importin-α is involved in 
transporting cell proliferation and apoptosis related factors into the nucleus, so down 
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regulation of importin-α at low temperature could be associated with the regulation of 
cell growth and resistance to apoptosis in culture. 
• LGALS1 was up regulated following temperature-shift. LGALS1 is known to inhibit 
cell growth in culture. Due to this, it may have potential involvement in reducing the 
cell growth at low temperature.  
• PFN2 was over expressed in cells at low temperature. PFN2 has been shown to regulate 
normal actin polymerization in response to thermal stresses. This suggests that PFN2 
may be involved in regulation of cell structure in response to hypothermic conditions 
and hence could regulate growth and apoptosis in culture. 
Therefore, it was hoped that inhibiting the expression of these protein targets could be 
expected to give a greater insight into the regulation of growth in culture and to improve 
recombinant protein productivity in culture.  
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Table 4.2.4 Differential expression of selected protein targets observed using 2D-DIGE in 
temperature-shifted and standard culture at 144hrs of culture in comparison to cultures 
maintained at 72hrs. NDE denotes proteins that are Not Differentially Expressed at the set 
criteria (±1.5 fold up/down regulated with t-test score ≤0.05) in the comparison of cells at 
72hrs with cells at 144hrs of culture.  
Target Temperature-
shifted Culture 
Standard 
Culture 
Cellular Function 
EIF4A 1.81 NDE IRES-mediated cap-independent protein 
translation, cell cycle arrest 
HNRPC -1.52 NDE Cell proliferation and IRES mediated cap-
independent protein translation 
Importin-α -1.8 NDE trafficking of the growth promoting and 
apoptotic factors to nucleus  
LGALS1 1.62 NDE cell adhesion and negative regulation of 
the cell cycle/proliferation 
PFN2 1.69 NDE normal actin polymerisation in response to 
thermal stress 
 
 
The CHO genome has still not been fully elucidated and as a result of this, siRNAs for 
selected protein targets are currently not commercially available for CHO-K1 cells. 
Sufficient sequence information was obtained by amplifying part of the coding sequences 
using PCR primers designed against conserved regions based on orthologous sequence 
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alignment enabling design of siRNAs against 3 protein targets using the Silencer Select™ 
Algorithm® by Applied Biosystems. Two siRNAs were generated for each target to ensure 
at least effective siRNA was identified by the siRNA design algorithym. 
4.2.5 Effect of silencing protein targets  
Small interfering RNA molecules (siRNA) were used to investigate the effects of knocking 
down selected protein targets on growth and recombinant protein productivity in CHO 
cells. siRNAs can inhibit the expression of target proteins by directing the degradation of 
their mRNA transcript. However there is evidence that siRNAs can exert off-target effects 
by inhibiting the expression of other genes non-specifically following transfection (Jackson 
et al. 2003). The transfection reagent used (neoFX) or siRNA delivery can also cause 
temporary changes in the cells, for example, by affecting growth or viability. Therefore, 
each set of siRNA experiments at both culture conditions (temperature-shifted and non-
shifted) included as many appropriate controls (neoFX only and scrambled siRNA controls) 
as possible. There is no definitive scrambled siRNA control available for CHO cells as its 
genome is not fully sequenced. Therefore scrambled siRNAs based on human sequence 
information were used in this investigation. NeoFX-only and scrambled siRNA-treated 
cultures resulted in nearly similar effects on cellular phenotypes suggesting that human 
scrambled siRNA control could be used as a negative control, however, this is a suitable 
control remains unclear. NeoFX only and scrambled siRNA controls used for transfection 
in this study were same for temperature-shifted and standard culture. The effects of target 
knockdown on the cellular phenotypes were calculated by comparing the observed effects 
for target-siRNA-treated cultures with scrambled siRNA-treated cultures. Both of these 
controls ensured that the effects observed in CHO cells after transfection were not an 
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artefact of the RNA delivery process. In each experiment, the protein target was inhibited 
using 2 independent siRNA molecules so that the target could be silenced at least by any of 
these siRNA.  
Although 2D-DIGE experiment was performed using suspension-adapted CHO-K1 cells 
growing in 10% FCS supplemented medium, siRNA knockdown experiments were 
performed using suspension and low serum-adapted SEAP-secreting CHO-K1 cells (Figure 
3.2.7.3). The reason for this is that low serum culture condition is more closer to industrial 
requirements compared to serum supplemented conditions. Secondly, the effects of low 
temperature on cells were observed to be more intense for HNRPC and RBM3 using 
Western blotting in low serum-adapted cells compared high serum-adapted in this 
laboratory suggesting the suitability of low serum-adapted cells to investigate the effect of 
target knockdown. The cells were maintained in standard culture (370C) for 96hrs and in 
temperature-shifted culture where cells were maintained at 310C for 72hrs after 24hrs of 
transfection at 370C (Figure 3.2.7.3). The effects of the target knockdown on cell growth 
and recombinant protein productivity were evaluated after 96hrs of siRNA transfection. 
Western blot analysis of samples from cells transfected at standard culture confirmed the 
successful knockdown of all 3 protein targets (Figure 3.2.7.10), however knockdown 
efficiency for temperature-shifted cultures need to be validated. After 96hrs at 370C, the 
expression of all target proteins was observed to be reduced to undetectable levels in the 
transfected cultures in comparison to controls (neoFX-only and scrambled-treated), which 
is unusual. This could possibly be due to the partial sequence information used for 
designing siRNAs for all target proteins were generated in this laboratory using genomic 
DNA from the same CHO cells in which knockdown experiments were performed. This 
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would have improved the efficiency of siRNA designing algorithm. Moreover, the Silencer 
Select™ Algorithm® itself has been developed to achieve ~99% knockdown which might 
have further improved the efficiency of siRNA designing. Crucially, Western blot analysis 
of samples from siRNA-transfected cells maintained in biphasic culture would further 
confirm the efficiency of target knockdown following transfection. Therefore, the effects 
observed on cellular phenotypes are most likely to be due to knockdown of specific protein 
targets. However, it is also possible that these siRNAs may be causing off-target effects in 
the cells. Moreover, it will be necessary to confirm the extent of target knockdown and its 
effects on cellular phenotypes at different time-points in temperature-shifted and standard 
culture conditions.  
 
4.2.5.1 EIF4A 
EIF4A was observed to be 1.81 fold up regulated following temperature-shift in proteomics 
study. EIF4A has previously been shown to be up regulated in G2-arrested CHO cells 
(Sasaki et al. 2000) suggesting that its inhibition should improve cell growth. In contrast, 
cell growth was reduced following siRNA-mediated inhibition of EIF4A in temperature-
shifted and non-shifted cultures in both non-producer and SEAP-secreting CHO-K1 cells 
without any significant impact on viability (Figure 3.2.7.2 & 3.2.7.4 and Table 3.3.7.2). 
The expression of EIF4A was reduced to non-detectable levels following its knockdown 
(Figure 3.2.7.10). Thus, inhibition of EIF4A could have compromised global cap-
dependent and independent protein translation pathways extensively (Pilipenko et al. 2000, 
Pause et al. 1994). Indeed, the knockdown of EIF4A in biphasic cultures would need to be 
confirm by Western blotting. This might be expected to reduce the translation of house 
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keeping proteins, as reflected in Figure 3.2.7.10 where expression of GAPDH was observed 
to be slightly reduced in siRNA-treated cultures compared to control cultures, resulting in 
reduced cell growth. Similar results have been observed by other groups previously for the 
translation factor EIF5A where its inhibition was observed to reduce the growth of CHO 
without affecting viability for a period of time depending on the level of EIF5A inhibition 
(Park et al. 1994). The inhibition of other translation factors has also been observed to 
impair proliferation of mammalian cells (Kang and Hershey 1994, Jasiulionis et al. 2007, 
Lei et al. 2002, Cnop et al. 2007). Therefore, the titration of siRNAs used to inhibit the 
EIF4A to see if effects on growth could be modulated and would further improve our 
understanding of the role of EIF4A in regulation of low temperature response in CHO cells. 
Given the 6-fold difference in cell numbers, there would also be off-target effects of 
siRNAs in temperature-shifted cultures. 
The reduced cell numbers accounted for reduced total SEAP yield. In general, a pattern of 
improved cell specific productivity (Qp) was observed, however it was statistically 
significant only for siRNA 1 in temperature-shifted culture and siRNA 2 in standard culture 
(Figure 3.2.7.5 and Table 3.2.7.2). The expression of EIF4A was observed to be reduced to 
undetectable levels using Western blot analysis for both siRNAs (siRNA 1 & 2) following 
transfection at 370C (Figure 3.2.7.10). However, Western blot analysis of samples from 
siRNA-transfected cells maintained in biphasic culture would be advantageous to confirm 
the effects of EIF4A knockdown on Qp. Therefore, discrepancies for the effect of inhibition 
of EIF4A on Qp between both siRNA could possibly a reflection of off-target effects by 
any of these siRNA. Taken together, this supports the hypothesis that EIF4A needs to be up 
regulated to improve productivity of culture as it was up regulated in cells following 
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temperature-shift. However, reduced cell growth and improved cell specific productivity 
due to inhibition of EIF4A establishes it as a potential candidate to be employed to regulate 
growth and productivity in culture. For instance, the inhibition of EIF4A, once a production 
culture has achieved a desired biomass concentration (~60-70% confluency), could arrest 
growth and improve the cell specific productivity given that it improves viability over 
144hrs (Figure 3.2.7.2). This may increase the yield of culture compared to the standard 
cultures after ~5-7th day of inhibiting EIF4A expression due to increased Qp (7-58%, 
depending on the siRNA used (Table 3.2.7.2)) and culture longetivity, while the standard 
culture would enter into the decline phase.   
 
4.2.5.2 HNRPC 
HNRPC is a nuclear pre-mRNA binding protein. It was 1.52 fold down regulated following 
temperature-shift in proteomics study. Cell growth of non-producer CHO-K1 cells was 
significantly reduced following inhibition of HNRPC in standard culture (Figure 3.2.7.2 
and Table 3.2.7.1). HNRPC can enhance cell proliferation by inducing IRES-mediated 
translation of c-myc mRNA (Kim et al. 2003). Silencing of HNRP C1/C2 protein 
expression by siRNA has also been shown to inhibit cell proliferation due to defects in 
G2/M transition phase of cell cycle (Schepens et al. 2007). These findings are in keeping 
with our results and suggest that reduced levels of HNRPC could be one of the factors 
responsible for reduced cell growth at low temperature. Reduced cell growth in SEAP-
secreting CHO-K1 cells following knockdown of HNRPC was also observed; however this 
was not evident in the temperature-shifted culture (Figure 3.2.7.6 and Table 3.2.7.3). This 
could possibly be due to that the cells in temperature-shifted cultures had only 24hrs to 
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grow (at 370C) before shift to low temperature (310C) and therefore cultures may not have 
enough growth to show any effect of HNRPC inhibition. The viability of culture was 
comparable to controls throughout the testing period in all cases.  
The total productivity of SEAP was also not affected significantly in standard culture but 
was improved in temperature-shifted cultures following inhibition of HNRPC (Figure 
3.2.7.7 and Table 3.2.7.3). Improved Qp was observed in both standard and temperature-
shifted cultures presumably due to reduced levels of HNRPC which was reflected in an 
improvement in the total productivity value. The improvement in Qp was not significant for 
siRNA 1 for temperature-shifted cultures but when siRNA 1-treated cultures were 
compared with neoFX-only-treated controls cultures (instead of scrambled-treated), this 
improvement turned into a significant change (33% with p-value 0.048). This suggests that 
the use of neoFX-only-treated controls cultures could help to reveal the effects of 
knockdown experiments in the absence of designated scrambled control for CHO cells. It 
should be noted that while there was complete knockdown of the HNRPC at 370C as 
determined by Western Blotting, the extent of knockdown in temperature-shifted cultures 
has not been evaluated. Further given the almost 10-fold reduction in cell number in 
temperature-shifted controls compared to the standard culture, it is highly possible that 
there are non-specific effects occurring at 310C.  HNRPC can regulate the cap-independent 
translation by inducing IRES-mediated expression of the number of specific proteins 
including ‘upstream of N-Ras’ (Unr) which is also involved in translation of specific 
proteins using cap-independent translation pathways during mitosis (Schepens et al. 2007). 
This is important because during mitosis, similar to low temperature exposure, protein 
synthesis is rapidly and severely repressed possibly due to the inhibition of global cap-
  
 297 
dependent translation (Fan and Penman 1970). The cap-independent translation is thought 
be increased at these hypothermic conditions. Since the inhibition of HNRPC has been 
reported to abrogate the cap-independent translation during mitosis (Schepens et al. 2007), 
the role of reduced HNRPC as observed in this investigation to improve recombinant 
protein production remains unclear. The improvement in the Qp due to inhibition of 
HNRPC was more pronounced in standard cultures in comparison to biphasic cultures and 
this suggests that the effects of HNRPC on Qp could be temperature-independent. 
However, it should be considered that the extent of knockdown was not confirmed using 
Western blotting in temperature-shifted cultures in this study and therefore, differential 
effects of HNRPC on Qp could be due to differences in extent of its knockdown between 
temperature-shifted and standard cultures. Over expression of HNRPC in CHO cells and 
the investigation of HNRPC-associated proteins may help to clarify the role of HNRPC in 
the regulation of cell growth and recombinant protein productivity at low temperature. The 
inhibition of growth and the increase in Qp after knockdown of HNRPC in CHO cells at 
370C establishes it as an attractive target for cell engineering-based approaches to regulate 
cell growth and recombinant protein production in culture providing the previously 
mentioned issues (such as optimised knockdown conditions) can be overcome. Based on 
these findings, the temporal inhibition of HNRPC, once the culture has reached the 
desirable cell density, would induce growth arrest as well as improving Qp of the culture 
contributing to improved overall recombinant protein productivity. This could increase the 
yield of culture compared to the standard cultures after 1-5 day of inhibiting HNRPC 
expression due to increased Qp (48-124%) and culture longetivity and as standard culture 
would be in the decline phase.   
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4.2.5.3 PFN2 
PFN2 (Profilin 2), a small ubiquitous actin monomer sequestering cytoskeletal protein, was 
observed to be 1.69 fold up regulated following temperature-shift in proteomics study. 
PFN2 is typically required for normal actin polymerisation in response to thermal stress 
(Yeh and Haarer 1996b). The inhibition of PFN2 was expected to reduce viability and 
growth since dysregulation of cytoskeleton has been associated with increased cell death in 
culture (Rodolfo and Piacentini 2002, Kulms et al. 2002) and this was shown to be the case 
for siRNA 1 (more striking in standard cultures than temperature-shifted cultures) but not 
for siRNA 2 (Figure 3.2.7.8 and Table 3.2.7.4). siRNA 1 was more effective in reducing the 
viable cell counts in both culture conditions with opposing effects of siRNA 2. The 
expression of PFN2 was observed using Western blotting to be completely knockdown 
after 96hrs of transfection at 370C (Figure 3.2.7.10) but the extent of PFN2 knockdown at 
310C was not evaluated. Moreover, there appears to be some process effects as the PFN2 in 
scrambled-treated controls is also quit strongly reduced compared to neoFX-treated control 
and is different from the observations with EIF4A and HNRPC (Figure 3.2.7.10). Opposing 
effects for both siRNAs were observed for total productivity in standard culture (siRNA 1 
reduced while siRNA 2 increased) (Table 3.2.7.4). In the temperature-shifted cultures, the 
effects of siRNA 1 was insignificant but for siRNA 2, the effect was significant. However, 
compared to the satandard culture controls, siRNA 2 improved total productivity.  
The effects of siRNA 1 and 2 on viability and total and specific productivity of culture were 
also varying extensively among themselves. This suggests that the titration of siRNAs 
concentration for inhibiting PFN2 levels or use of other independent siRNAs (i.e. 3rd 
siRNA) could help to further clarify its specific effects in CHO cells at low temperature. 
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Investigation of PFN2 knockdown in temperature-shifted cultures using Western blotting 
would help to understand the reason for phenotypic differences observed between 2 
siRNAs. However, cell specific productivity was observed to be improved for both 
temperature-shifted and non-shifted cultures. Therefore, the role of PFN2 in the regulation 
of growth and recombinant protein productivity at low temperature remains unclear. The 
Western blot analysis of the samples from siRNA-transfected cells maintained in biphasic 
culture could help to understand the effects of PFN2 inhibition of these cellular phenotypes. 
Moreover, investigation of actin level following siRNA transfection using Western blotting 
or other quantitative technique would further confirm the role of PFN2 in regulation of 
actin cytoskeleton as well as efficiency of PFN2 knockdown in cells. 
As an engineering target, the most effective approach would be to switch-off expression of 
endogenous PFN2 using an inducible shRNA system, once the required cell density (~60-
70% confluency) has been reached. This would have dual effects of inhibiting further cell 
growth and increasing specific productivity during the production phase of a batch or fed-
batch culture. This may increase the yield of culture compared to the standard cultures 
within further 24hrs of inhibiting PFN2 expression due to increased Qp (95-288%). 
However the main drawback would be the detrimental effects on viability and significant 
variation between batches in biphasic cultures. Alternatively PFN2 could be over expressed 
in early stage of culture where it might increase growth early in the process and then 
switch-off its expression to improve Qp.  
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4.3 Analysis of low temperature induced differential expression of miRNAs in CHO-
K1 cells  
An understanding of the molecular events regulating cell growth, protein production and 
death in CHO suspension culture is a crucial initial step in developing ways to increase the 
longevity and productivity of recombinant CHO cell lines. A number of transcriptional and 
proteomic profiling studies have been recently published describing the genes and 
pathways involved in CHO growth, death and temperature response (Marchant et al. 2008, 
Baik et al. 2006, Wong et al. 2006, Swiderek and Al-Rubeai 2008). However there are 
apparent discrepancies between microarray and proteomic data in the literature, for 
example PDI, phosphoglycerate kinase and heat shock cognate 71 kDa protein were up 
regulated upon reduction of culture temperature, although the transcripts encoding these 
proteins were not significantly altered (Baik et al. 2006). It is possible that the increases in 
these proteins may be through the change in expression of one or more miRNAs or other 
levels of translational controls. miRNAs are small (~22nt) non-coding RNAs (ncRNAs) 
that regulate gene expression at the level of translation and each miRNA apparently can 
regulate multiple genes (Lim et al. 2003, Miska 2005). Moreover miRNAs have been found 
to regulate cell proliferation (O'Donnell et al. 2005), apoptosis (Cheng et al. 2005, 
Cimmino et al. 2005), cell stress (Hua et al. 2006), metabolism (Gauthier and Wollheim 
2006) and secretion (Poy et al. 2007), all of which are important characteristics to consider 
for production cell lines in bioreactors. miRNAs have been suggested recently to impact on 
global protein translation by interacting with RBM3 (Dresios et al. 2005). 
One of the challenges in profiling gene expression in CHO cells is the lack of sequence 
data. Although both rat and mouse cDNA arrays have been employed to profile CHO 
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systems (Baik et al. 2006) with some success, mouse has been identified as likely to be the 
most appropriate for CHO study based on mitochondrial genome comparisons (Wlaschin et 
al. 2005). In comparison with mRNA and proteins, sequence conservation at miRNA level 
has been observed to be much higher between species (Berezikov et al. 2005). Therefore 
miRNA profiling technologies that are developed for human and/or mouse to date may be a 
useful route to gain a greater understanding of regulation of the gene/protein expression in 
CHO cells. In this work, samples from CHO-K1 cells growing exponentially at 370C were 
compared with the cells growth arrested at 310C in a biphasic culture process using 
miRNA-bioarrays and highly sensitive and reproducible miRNA Taqman Low Density 
Array (TLDA) approaches to identify low temperature-induced differential expression of 
miRNAs. This has enabled us to identify miRNAs that have been found to regulate growth 
and productivity in CHO culture and have potential to be implemented in industrial 
production process to improve product yield.  
 
4.3.1 Analysis of low temperature induced differential expression of miRNAs using 
miRNA-bioarrays. 
In a preliminary experiment, temperature-shifted cells at 144hrs at 310C were compared to 
the exponentially growing cells at 72hrs at 370C using miRNA-bioarrays. miRNA-
bioarrays are microarrays comprised of primers for a comprehensive selection of human, 
mouse and rat miRNAs. Unsupervised hierarchical clustering analysis of CHO samples 
with 6 human cells lines indicated that CHO cells are unique in profile of miRNAs that 
they express (Figure 3.3.1.3). In this investigation, a total of 26 miRNAs were identified as 
being significantly differently expressed between 72hrs at 370C (TSd3) and 144hrs at 310C 
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(TSd6) samples (Table 3.3.1.1 and 3.3.1.2). These include two well known growth 
regulatory miRNAs, miR-21 and miR-24.  
• miR-21 was 2.23 fold up regulated in cells at 144hrs at 310C compared to cells at 
72hrs at 370C in biphasic culture. miR-21 has been observed to be elevated in 
various cancers, such as breast, ovarian and lung cancer, as well as glioblastomas 
(Chan et al. 2005, Schetter et al. 2008, Chan et al. 2008). The effect of miR-21 can 
be cell line specific; inhibition of miR-21 induced growth in the HeLa cells and 
reduced growth in HCC cells but had no effect on A549 cells (Connolly et al. 
2008). Although, the role of miR-21 in regulation of growth in CHO cells is not 
clear, the increased expression of miR-21 following temperature-shift could be 
expected to facilitate reduced cell growth at low temperature. 
• miR-24 was 1.73 fold up regulated at 144hrs at 310C compared to 72hrs at 370C in 
temperature-shifted cultures. The inhibition of miR-24 induced the growth of HeLa 
cells while reducing growth of A549 cells (Chan et al. 2005). miR-24 suppresses 
p16INK4a translation in cultured human cells (Lal et al. 2008). p16INK4a inhibits the 
cyclin-dependent kinases CDK4 and CDK6, thereby keeping cells arrested (Shapiro 
et al. 2000). miR-24 can also exert its regulatory effects on cell proliferation by 
activin-associated activities (Wang et al. 2008). Activin is a member of TGF-β 
superfamily and has been observed to inhibit growth of hematopoietic progenitor 
cells (HPCs). The ectopic expression of miR-24 has been shown to attenuate the 
anti-proliferative effect of activin resulting into increased proliferation of HPCs 
(Wang et al. 2008).  
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This suggests that these miRNAs could be involved in regulation of cell growth and 
recombinant productivity of culture at low temperature. 
Of these 26, 4 miRNAs were chosen for qRT-PCR validation using temperature-shifted and 
non-shifted samples and this enabled us to identify temperature-dependent changes. miR-21 
and miR-24 were observed to be significantly up regulated at 144hrs in a temperature-
independent manner in qRT-PCR analysis (Table 3.3.1.3). Of the two miRNAs that were 
not found to be significantly changed by qRT-PCR, miR27a displayed a 1.76 fold increase 
in cells at 144hrs at 310C compared to cells at 72hrs at 370C using the bioarrays which was 
not reflected by the qRT-PCR. Therefore it may be that 2 fold or higher may be a more 
appropriate cut-off when selecting targets from array profiling. Let-7f was expressed at 
intensities less than 150 units and this has been used by other researchers as a cut-off for 
analysis (Gu and Iyer 2006). Let-7f was used as an endogenous control in qRT-PCR 
quantification in this investigation. This analysis suggests that miRNA-bioarray could be 
used to identify potential bioprocess-related miRNA targets, however it is important to 
confirm with another alternative technique. 
 
4.3.2 Analysis of low temperature induced differential expression of miRNAs using 
Taqman Low Density Arrays (TLDA). 
In the first miRNA profiling study, we analysed the cells maintained for 72hrs at 370C  with 
the cells shifted for a further 72hrs at 310C using miRNA bioarrays. To gain a greater 
insight into the role of miRNAs in regulation of cellular phenotypes, i.e. growth and 
viability, at low temperature, we also investigated cells that were temperature-shifted to 
310C for only 24hrs after growing at 370C for 72hrs (96hrs) in comparison to the cells 
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continuously maintained at 370C for 72hrs (72hrs) using PCR-based Taqman Low Density 
miRNA Arrays (miRNA-TLDA). miRNA-TLDAs are more sensitive and reproducible in 
comparison to miRNA bioarrays. Duplicate samples were used for each condition. The aim 
of this investigation was to identify early-mid stage alterations in the expression of 
miRNAs in response to cold-shock. Seventeen miRNAs were differentially regulated in 
cells at 96hrs at 310C compared to cells at 72hrs at 370C in biphasic culture, of which 9 
were down and 8 were up regulated. From the list of differentially expressed miRNAs, 
miR-7 (8.43 fold down regulated) and miR-126 (3.08 fold up regulated) have been recently 
reported to play a role in the regulation of cell growth (Zhang et al. 2008, Kefas et al. 
2008).  
• Inhibition of miR-7 has been reported to reduce the cell growth of lung carcinoma cell 
line, A549 (Cheng et al. 2005). miR-7 has been reported to exert differing effects on 
apoptosis. Increased apoptosis in culture were observed in A549 cells following 
inhibition of miR-7 (Cheng et al. 2005), whereas over expression of miR-7 also 
increased apoptosis glioma lines (U87MG and T98G) (Kefas et al. 2008). Therefore the 
reduced expression of miR-7 following temperature-shift could be facilitating reduced 
cell growth or apoptosis in culture. 
• miR-126 has been reported to be down regulated in breast cancer cells, MDA-MB 231 
and MCF-7 and inhibits cell cycle progression from G1/G0 to S (Zhang et al. 2008, 
Guo 2008). Over expression of mir-126 decreased the expression of insulin receptor 
substrate 1 (IRS-1) at the translation level and drastically suppressed cell growth in 
HEK293 and MCF-7 (Zhang et al. 2008). Therefore up regulation of miR-126 
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following temperature-shift could be associated with the reduced cell growth at low 
temperature. 
Therefore miR-7 and miR-126 could be playing a critical role in regulation of growth and 
productivity at low temperature. 
In the miRNA-TLDA protocol, a pool of primers is used to reverse transcribe all species of 
miRNAs in the sample whereas singleplex qRT-PCR uses primers specific only for 1 
miRNA target. The confirmation of a non-significant change in expression observed using 
miRNA-TLDA with singleplex qRT-PCR could help to establish the sensitivity as well as 
applicability of miRNA-TLDA in CHO cells. Two miRNAs, miR-7 and miR-200c, were 
analysed for their expression using singleplex qRT-PCR over 144hrs of culture in both 
temperature-shifted and non-shifted culture. miR-200c was selected as an example of 
miRNA that was identified as being differentially expressed (+1.5 fold) on miRNA-TLDA 
but with a p-value ≥0.05 (non-significant). The differential expression of miR-200c was 
also found to be non-significant using singleplex qRT-PCR, confirming the data from 
miRNA-TLDA. Differential expression of miR-7 observed using qRT-PCR confirmed the 
change observed using miRNA-TLDA. The expression of miR-7 was gradually reduced in 
stationary phase of culture in comparison to lag and log phase of cultures maintained at 
370C but this inhibition was more pronounced in temperature-shifted cells (Figure 3.3.3.2). 
Therefore miR-7 might be expected to exert its effect on cells in a dose-dependent manner. 
This data demonstrate that miRNA-TLDA can be used to identify CHO miRNAs that could 
be involved in regulation of particular phenotypes, however it is important that results are 
further confirmed using alternative techniques. 
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4.3.3 Isolation and cloning of Cricetus griseus miRNAs 
At the time of writing (31 October 2008), there were no Cricetus griseus miRNA sequences 
listed in the miRNA registry (http://microrna.sanger.ac.uk/) apart from the miRNA 
sequence which we submitted. The sequence for miR-21 has been generated successfully in 
this investigation. The sequence of miR-21 from C. griseus was observed to be similar to 
the orthologous miRNA sequences from human and mouse (Figure 3.3.1.5). This was in 
agreement with the fact that miRNAs are more conserved during evolution in comparison 
to other genes. This also ensured the applicability of miRNA probes from orthologous 
species to investigate the expression of miRNA in CHO cells. The sequence for miR-21 has 
been submitted in Sanger database. In keeping with the Sanger registry-naming 
conventions, this miRNA has the prefix cgr- to represent C. griseus. This new miRNA cgr-
miR-21 has been confirmed by the miRBase registry. The sequence has also been lodged 
with EMBL and given the accession no. AM600961.  
 
4.3.4 Selection of miRNA targets for functional validation 
miR-24 and miR-7 expression levels were consistently altered in both the miRNA-array 
study as well as in singleplex qRT-PCR analysis in both temperature-shifted and standard 
culture. These were selected for further studies to investigate their role in the regulation of 
cell growth and recombinant protein productivity in CHO cells by exogenous inhibition or 
over expression.  
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4.3.5 Effects of inhibition or over expression of miRNA targets 
Chemically modified RNA molecules can be transfected into the cells to inhibit or enhance 
miRNA levels. This enables us to investigate the effects of artificial inhibition or over 
expression of selected miRNA targets on cellular phenotypes. The cells were maintained in 
standard culture at 370C for 96hrs and in temperature-shifted culture where cells were 
maintained at 310C for 72hrs after 24hrs of transfection (Figure 3.2.7.3). The impact of 
miRNA transfections were measured after 96hrs of culture. Each set of experiments 
included, as much as possible, appropriate controls for miRNA transfection. Since no 
validated non-specific control for miRNA inhibition and over expression in CHO cells is 
available, scrambled anti-mir (AM, for inhibition) and pre-mir (PM, for over expression) 
controls, which are designed to be nonsense miRNAs in human cells, were used in this 
investigation. In addition, neoFX (lipid based transfection reagent) only treated cultures 
were also closely monitored to ensure that the effects observed were due to specific 
inhibition or over expression of miRNAs and not an artefact of the delivery. qRT-PCR 
analysis was used to confirm the efficiency of miRNA knockdown or over expression in 
CHO cells.  
4.3.5.1 miR-7 
The expression of miR-7 was observed to be 8.43 fold down regulated in temperature-
shifted cells at 96hrs at 310C compared to cells maintained at 72hrs at 370C using miRNA-
TLDAs (Table 3.3.2.1). Growth of CHO-K1 cells was significantly inhibited following 
over expression of miR-7 in standard culture (Figure 3.3.3.2 and Table 3.3.3.3). miR-7 
levels were found to be gradually reduced in stationary phase of culture in comparison to 
cells maintained in lag and log phase of culture at 370C in qRT-PCR (Figure 3.3.2.2). This 
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reduction was more pronounced in temperature-shifted cells compared to the cells 
maintained at 370C. Growth phase specific expression of miR-7 suggests that it could 
regulate cell growth in dose-dependent manner. Compared to the PM- or neoFX-controls, 
over expression of miR-7 reduced cell growth significantly across the time frame without 
affecting viability at standard culture, reflecting the expression profile observed using qRT-
PCR during the validation of miR-7 (Figure 3.3.2.2A) suggesting some other mechanisms 
controling miR-7 following temperature-shifts. miR-7 has been previously reported to 
reduce growth of the lung carcinoma cell line, A549 due to increased apoptosis (Cheng et 
al. 2005). In contrast, we did not observe any affect on growth and viability of CHO cells 
following inhibition of miR-7 expression in any culture conditions, i.e. standard or 
temperature-shifted cultures. It could be that either the effect of miR-7 on growth might be 
cell line-dependent or reduction in expression of miR-7 is a consequence of low 
temperature induction and not a cause for low-temperature-induced cellular phenotypes.  
miR-7 has been shown to regulate the expression of the transcription factor Yan by a 
reciprocal negative feedback loop. The 3'-UTR of human EGFR contains binding sites for 
miR-7 and recently has been demonstrated as being potently and directly regulated the miR-
7 (Kefas et al. 2008). Apart from EGFR, miR-7 can inhibit the Akt pathway that is critical 
for cell growth. A marked down regulation of miR-7 has been observed in glioblastoma 
(Kefas et al. 2008). miR-7 negatively regulates the expression of lymphoid-specific 
helicase (LSH) that is essential for correct DNA methylation patterning (Ilnytskyy et al. 
2008). Aberrant methylation of DNA has been associated with cancer. The loss-of-function 
mutations in the LSH gene result in dramatic hypomethylation of the murine genome and 
reactivation of transposable elements possibly leading to cancer (Huang et al. 2004). Over 
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expression of LSH, contrarily leads to re-establishment of methylation pattern and is 
viewed as a genome stabilizing event (Myant and Stancheva 2008).  
The total productivity of SEAP was reduced following over expression of miR-7 at 370C, 
which was expected as growth was completely arrested and volumetric yield is dependent 
on the number of producer cells (Figure 3.3.3.3 and Table 3.3.3.3). Conversely, the specific 
productivity (Qp) was improved by 2 fold at 370C due to over expression of miR-7. miR-7 
has been found to be highly expressed in pancreatic islets and the neurosecretory cells of  
the annelid Platynereis dumerilii and of the zebrafish (Bravo-Egana et al. 2008, Tessmar-
Raible et al. 2007). Pancreatic islets and neurosecretory cells are specialized in secretion of 
specific proteins and therefore miR-7 has been proposed as an endocrine miRNA. 
Published data is in agreement with our observations that over expression of miR-7 can 
improve protein production. The Qp was un-affected in biphasic culture following over 
expression of miR-7. This indicates that over expression of miR-7 utilizes a temperature-
independent route to improve Qp. The nearly complete growth-arrest and improved Qp of 
CHO cells due to over expression of miR-7 can offer potential for its implementation in cell 
engineering based approaches to improve recombinant protein production providing the 
total yield can be improved over standard culture conditions. The over expression of miR-7 
using a inducible expression system, once the culture reached a desirable biomass (~60-
70% confluency) should arrest growth and be able to maintain viability for a longer period 
of time while simultaneously improving Qp in the culture. This could be expected to 
increase the yield of culture compared to the standard cultures within further 24hrs of 
temporal expression due to increased Qp (116%) following miR-7 over expression 
assuming that over expression of miR-7 exerts its effects immediately.   
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4.3.5.2 miR-24 
mir-24 was observed to be 1.73 fold up regulated in cells at 144hrs at 310C compared to 
cells at 72hrs at 370C in temperature-shifted culture using miRNA-bioarrays. A marked 
reduction in cell growth was observed following over expression of miR-24 at 370C (Figure 
3.3.3.4 and Table 3.3.3.4) but no significant effect was observed on the temperature-shifted 
cultures. Inhibition of miR-24 has been shown to induce growth in HeLa cells, whereas it 
down regulates growth of A549 cells (Chan et al. 2005). Our data demonstrate that over 
expression of miR-24 inhibits growth of CHO cells supporting miR-24 to be cell line 
specific in exerting its effects. The lack of effects in biphasic culture could be due to the 
short period of time (24 hrs) at 370C to grow before being shifted to low temperature 
(310C). Inhibition of miR-24 had no effects on either culture. Taken together, miR-24 might 
affect cell growth only when it is expressed above a certain level but does not have any 
effect on CHO cell growth below this concentration or it could have curtailed effects at low 
temperature. The viability of cultures were unaffected by inhibition of miR-24 which is in 
agreement with published literature (Chan et al. 2005). Over expression also did not affect 
the culture viability.  
The total yield of SEAP in standard culture was reduced following over expression of miR-
24 compared to the over expression control (PM-Control) but was not significantly 
different from untreated cultures (neoFX-Controls), whereas it was unchanged in 
temperature-shifted culture (Figure 3.3.3.5 and Table 3.3.3.4). The Qp was improved 
significantly due to both over expression and inhibition of miR-24 in standard culture, 
whereas no significant effect was observed in temperature-shifted cultures. There is no 
published information available to date on the role of miR-24 in recombinant protein 
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production. This is the first demonstration of miR-24 improving cell specific protein 
productivity in recombinant cell lines. It is proposed that over expression of miR-24 in 
production culture, once the desired cell density (~60-70% confluency) has been reached, 
could attenuate cell growth, increase culture longevity and improve Qp hence contributing 
to improved yield of recombinant protein providing that the effects of miR-24 over 
expression is not hampered by temperature-shift. This could increase the yield of culture 
compared to the standard cultures after 3rd day of temporal expression due to increased Qp 
(68%) following miR-24 over expression and because the standard culture would enter into 
the decline phase by next 2-3 days of culture assuming that over expression of miR-24 
exerts its effects immediately.   
 
miRNAs are endogenous, small, usually single-stranded and non-coding RNAs (ncRNAs) 
that can play important regulatory roles in animals and plants by targeting mRNAs for 
cleavage or translational repression (Bartel 2004). Recently a number of miRNAs that are 
involved in regulation of various cellular phenotypes such as cell proliferation (Gammell 
2007, Brennecke et al. 2003), apoptosis (Xu et al. 2007) and metabolism (Gauthier and 
Wollheim 2006) have been reported. All these phenotypes are very important for the 
bioprocess industry.  
Low temperature based biphasic culture strategy is commonly employed in pharmaceutical 
industry to reduce cell growth and hold culture viability for a longer period of time and this 
contributes to improved recombinant protein production in culture. We have investigated 
the changes in miRNA expression in response to temperature-shift to 310C in suspension-
adapted CHO-K1 cells in this study and identified 2 miRNAs, miR-7 and miR-24, that 
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were observed to regulate cell growth and recombinant protein productivity in CHO cells. 
The over expression of miR-7 and miR-24 was found to significantly arrest growth and 
improved specific productivity of CHO-K1 cells. Although effects of miR-7 were more 
pronounced in comparison to miR-24, both miRNA targets have potential to be used in 
cell-engineering based approaches to improve recombinant protein production in 
mammalian cells, providing the total productivity can be improved over standard culture 
conditions. 
Employing temperature-shift in culture is a costly, cell line specific and inconsistent 
process. Low temperature improves cell specific productivity for only a short period of time 
as the cells have tendency to adapt to grow in hypothermic culture conditions. This has 
limited the implication of low temperature cultivation of producer cells in the 
pharmaceutical industry. A number of chemical compounds have also been tried to improve 
recombinant protein production of mammalian cells. For example, sodium butyrate (NaBu) 
can reduce growth and improve productivity of recombinant proteins in CHO cells. 
However, increased apoptosis due to NaBu treatment limit the beneficial effects of 
improved productivity. Implementation of either miR-7, miR-24 or both and their temporal 
expression would potentially eliminate the need for performing such costly treatment, i.e. 
temperature-shift or NaBu treatments, to improve production. Engineering of miR-7 or 
miR-24 might also be used in conjunction with temperature-shift or NaBu treatment to 
achieve synergistic effects on yield.  
A more in-depth investigation of the molecular mechanism by which these miRNAs exert 
their effects on cell growth and recombinant protein productivity could also help to 
improve the efficiency of production process. Differential expression profiling of proteins 
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in cells stably expressing miR-7, miR-24 or both using proteomics tools, i.e. 2D-DIGE or 
SILAC coupled with mass-spectrometry, could enable the identification of proteins or 
biological pathways that are being regulated specifically by these miRNAs. These 
differentially expressed proteins (following over expression of miR-7 and miR-24) could 
enable us to identify downstream targets for miR-7 and miR-24 and to identify other 
potential targets which may be more critical in regulation of growth and productivity in 
culture. This information could then be applied to improve efficiency of the production 
process. The expression of miR-7 and miR-24 could also be investigated for their potential 
involvement in regulation of metabolism, i.e. nutrient consumption or waste production in 
culture etc, or post-translational modification in recombinant protein product expressed by 
the cells. This will further clear the role for miR-7 and miR-24 in regulation of low 
temperature response in mammalian cells.  
Apart from biopharmaceutical research, this knowledge could be used in other biomedical 
research areas such as efficient storage of organs and in cancer research. Organs, such as 
heart and kidney etc, are typically stored for a short period of time at low temperature. The 
improved understanding of low temperature response in mammalian cells could lead to 
identify targets that might help to store organs for longer period of time while maintaining 
stability and bioactivity of organs. The over expression of miR-7 and miR-24 were 
observed to reduce cell growth. Reduction of cancerous cell growth is one of the major 
goals of the cancer research and therefore both miRNAs could be screened for their effects 
in various type of cancer, for example, breast cancer and lung cancer etc. This knowledge 
would be critical to regulate growth of mammalian cells and offers more potential to be 
implemented in cancer research.          
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4.4 Investigation of secreted proteins by CHO-K1 cells in culture 
Protein profiles generated for both total intracellular and extracellular samples from 
bioreactors will hopefully allow the identification of markers that may be exploited to 
improve bioprocess cultures, with the ultimate aim to improve productivity of protein 
therapeutics. Most of the studies to date have concentrated on profiling cell lysates from 
high producer CHO cells and other producer cell lines such as NS0 to gain an 
understanding of the biology of these cells to improve productivity (Marchant et al. 2008, 
Baik et al. 2006, Smales et al. 2004, Swiderek and Al-Rubeai 2008, Seth et al. 2007, 
Krampe et al. 2008, Meleady 2007), however few, if any, studies have explored the 
proteome of extracellularly secreted proteins from mammalian cell lines. In this 
investigation, the conditioned medium from low serum adapted adherent CHO-K1 cells 
was profiled using different chromatographic surfaces, i.e. anionic and cationic, coupled 
with SELDI-ToF MS to monitor protein/peptide expression over time in culture.  
4.4.1. Cell culture 
Low serum-adapted CHO-K1 cells (0.5% FBS) were used in this investigation. SELDI-ToF 
MS is a highly sensitive technique and therefore the presence of serum proteins in 
conditioned medium could potentially mask the proteins secreted from cells. The cells 
represented well demarcated distinct phases of the growth cycle over 144hrs of culture 
(Figure 3.4.1). The use of cell-free conditioned medium as a control in this investigation 
enabled us to separate CHO-induced changes in expression of proteins from the changes 
originating from culture medium.   
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4.4.2 Analysis of differentially regulated secreted low molecular weight proteins 
using SELDI-ToF MS 
The analysis of SELDI-ToF MS profiles from the conditioned media from CHO-K1 cells 
using IMAC30 and Q10 chip surfaces indicated that 24 low molecular weight 
proteins/peptides were differentially expressed in the different phases of the growth cycle 
over 144hrs of culture. These proteins/peptides appear to have a number of distinct profiles 
over the course of the culture. A peak at m/z 8118 (8.1kDa) was observed at the early stage 
of culture (24hrs) since no peak at 8.1kDa was observed for cell-free medium. The 8.1kDa 
protein/peptide was increasing until 72hrs of culture and then decreased over the next 72hrs 
(Figure 3.4.3.1). This is a very similar situation to the production of lactate in CHO cells, 
where cells initially secrete lactate into the medium and later start to consume it as a carbon 
and energy source (Tsao et al. 2005). The 8.1kDa protein/peptide could possibly be an 
exogenous growth factor or a cytokine produced by the cell and secreted into the media, 
and its expression increased as the biomass increased over time. During early stages of 
growth, there are possibly many proteins that could be secreted into the media such as 
exogenous growth factors and cytokines, and knowledge of these may be useful in 
designing and improving serum-free and protein-free media formulations. This 8.1 kDa 
protein/peptide is then possibly consumed by the cell at/after 96hrs of culture as the 
biomass levels increase, and then decreased over 120 and 144hrs of culture as the viable 
cell numbers begin to plateau and decline. Recently truncated transferrin fragment has been 
reported in the conditioned medium from melanoma cells and is possibly due to the 
degradation of transferrin protein by proteolytic enzymes secreted by the cells in to the 
culture medium (Vandewalle et al. 1989, Dowling et al. 2007, Gronborg et al. 2006). 
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Therefore the decrease in the expression of the 8.1kDa protein/peptide could also be due to 
the protein being degraded as a result of proteolysis. A number of other studies have also 
reported increased proteolytic activity todate in the production culture. For example, an 
MMP pro-enzyme has been found to be released from CHO cells during the production 
phase of recombinant factor VIII, and as a result of auto-proteolysis, a number of smaller, 
less specific MMPs were also detected (Sandberg et al. 2006). In another study, pro-MMP9 
(gelatinase B) was identified from conditioned media of CHO-K1 cells grown in serum-free 
conditions (Elliott et al. 2003). These studies demonstrate that knowledge of proteolytic 
enzymes secreted by CHO cells is important for optimal bioprocess conditions. In 
manufacturing recombinant proteins, the use of serum-free media for cell cultivation is 
preferred in order to meet quality and regulatory requirements but this could increase the 
exposure of the expressed product to proteolytic attacks that can result in product 
heterogeneity, denaturation and loss of protein function. This further necessitates 
investigations targeting the identification of proteins/peptides secreted by cells into the 
production culture so that the quality and productivity of cells can be improved.  
The majority of the proteins differentially expressed on the two chromatographic surfaces 
used in this study are increased over time in culture and are therefore most likely associated 
with increasing numbers of cells within the cultures; examples of these are the m/z 14735 
peak (14.7kDa) at IMAC30 chip surface and the m/z 7346 peak (7.3 kDa) and the m/z 
11347 peak (11.3 kDa) detected on the Q10 chip (Figure 3.4.3.1, 3.4.3.2 & 3.4.3.3). These 
proteins are accumulating in the media over time and are potential contaminants that need 
to be purified from recombinant protein. The accumulation of these contaminants could be 
increasing the osmolality of culture medium which can induce apoptosis in culture and 
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result in decreased cell growth (Zhu et al. 2005). Additionally the accumulation of 
proteins/peptides over time can alter the composition of host cell proteins (HCP) in culture. 
This could potentially affect the efficiency of the purification process of recombinant 
protein product since the change in HCP composition could reduce the affinity of HCP to 
the chromatographic surface that are typically used for purification. The product quality 
assessment assays may also be affected with the change of HCP composition since the 
antibody used in these assays could have compromised specificity for such changes in HCP 
composition (Denizli and Piskin 1995, Ouyang et al. 2007).  Therefore knowledge of these 
potential contaminant proteins could be useful for designing strategies for monitoring and 
removing host cell proteins from the recombinant product and to improve the quality of 
product.  
The 14.7 kDa protein/peptide is first detected at day 120hrs of culture and then increased on 
144hrs of culture (Figure 3.4.3.2), even though the total cell number is similar for 96, 120 
and 144hrs of cultures but viability is beginning to decline from 96hrs onwards (Figure 
3.4.1). The 11.3kDa protein/peptide also appeared in the culture on Q10 chip surface after 
96hrs of culture and was increased over time. These proteins/peptides could be host cell 
proteins that are perhaps linked to apoptosis and are therefore released by the cells as the 
viability begins to drop and waste products begin to accumulate in the media. The 7.3kDa 
protein/peptide was increased over time in culture from 24hrs to 144hrs of culture as the 
biomass increases and therefore it can be expected that 7.3kDa protein could be associated 
with cell number. This knowledge may be useful in monitoring cell-engineering strategies 
using anti-apoptotic mechanisms to increase viability over time, especially for suspension 
cultures which are subjected to harsher conditions compared to cells grown in monolayer. 
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4.4.3 Reproducibility of Results 
Recently SELDI-TOF MS-based serum profiling has been subject to criticism, with results 
published by some groups not being reproduced by others (Diamandis 2004, Baggerly et al. 
2004, Liotta et al. 2005). However, the same level of criticism may not apply to cell 
culture-based analyses since multiple biological replicate samples from the same cell line 
are easily obtainable. Therefore reproducibility of SELDI-TOF MS for profiling of 
conditioned media from CHO-K1 cells was also estimated for the samples representing lag, 
log and stationary phases of culture. The coefficients of variance (CV) values for intra-
experiment was ≤17.4% and for five randomly selected peaks inter-experiments for 
IMAC30 and Q10 arrays were ≤22.7% and therefore confirmed the reproducibility and 
applicability of the technique in similar type of systems with SELDI. This study suggest 
that SELDI-TOF MS profiling of conditioned media from cell culture processes may be a 
useful method to monitor the secretion of low molecular weight host cell proteins into the 
media. 
 
Future work will identify these 24 proteins/peptides using various enrichment techniques 
followed by mass spectrometry, and also to apply the technique to more bioprocess-
relevant conditions such as serum-free suspension culture. Identification of protein markers 
by SELDI-ToF MS remains challenging due to the fact that it is difficult to elute 
proteins/peptides of interest from ProteinChip arrays for direct mass spectrometry 
identification, as compared to 2D gel-based methods. Identification can involve 
fractionation and enrichment of proteins/peptides of interest using spin columns with the 
  
 319 
same chemistry as the ProteinChip array surfaces, followed by separation on 1D gels and 
identification by mass spectrometry (Butler 2005, Paradis et al. 2005).  
However, despite these challenges, the use of SELDI-ToF MS to monitor culture progress 
for process optimization is attractive because of the small sample size and the rapid assay 
time, compared to other possible monitoring methods. Therefore we are interested to profile 
the conditioned media from a low temperature based biphasic culture using SELDI-ToF 
MS to identify secreted proteins that may have impact on the cellular phenotypes observed 
at low temperature. The proteomic patterns (or protein ‘fingerprints’) may also be very 
useful for distinguishing or predicting a ‘good’ or ‘bad’ culture with high sensitivity and 
specificity, and this approach is being used in discovering protein profiles that distinguish 
disease and disease-free states (Ciordia et al. 2006). The comparison of proteomic profiles 
of good or bad cultures or time points could enable to identify proteins/peptides that are 
driving the development of those phenotypes. This could also have potential to identify 
biomarkers for apoptosis in culture. The proteomic profiles could also enable us to identify 
the best time point for product harvesting. 
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Conclusions 
The increasing demand for therapeutically important protein products is leading to improve 
the recombinant protein productivity of mammalian cells. Low culture temperature has 
been shown to reduce the growth rate, metabolism and shear sensitivity and increase culture 
longevity and productivity in CHO cells but the mechanisms are still poorly understood.  
Understanding cellular response to low temperature at the molecular level could help in 
designing more efficient production processes. In this study, we have investigated 
alterations in the expression of proteins and miRNAs associated with the low temperature 
response or different phases of culture in CHO-K1 cells to identify potential proteins and 
miRNAs. Based on the findings described in this thesis, the following conclusions can be 
made. 
 
• Adherent CHO-K1 cells were maintained continuously in suspension culture and were 
adapted to grow in suspension. These suspension-adapted CHO-K1 cells were further 
adapted to grow in low serum-supplemented or serum-free culture medium. In this 
investigation, we have successfully established CHO-K1 cells in low serum-
supplemented and serum-free culture medium (ExCell, Sigma) and SEAP-secreting 
CHO-K1 cells in low serum-supplemented culture medium.  
 
• Suspension-adapted CHO-K1 cells cultured in a temperature-shifted biphasic culture 
(grown at 370C for 72hrs and shifted to 310C for a further 72hrs) and standard culture 
(370C for 144hrs) were analyzed using 2D-DIGE to identify temperature-dependent and 
independent differential expression of proteins. Twenty-three proteins were specifically 
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differentially regulated in the temperature-shifted cultures (72hrs at 370C vs. 144hrs at 
310C) and were involved in the regulation of variety of cellular functions such as cell 
growth (HNRPC), cap-independent translation (EIF4A) and the cytoskeleton (PFN2) of 
cells. Two proteins, DPYSL2 and ALDH, were identified at more than one location on 
the temperature-shifted 2D-gel indicating a possible low temperature-induced post-
translational modification of these proteins. 
 
• A total of 21 proteins (17 up regulated and 4 down regulated) were specifically 
differentially regulated in standard culture at 144hrs at 370C compared to 72hrs at 370C. 
The majority of the identified differentially expressed proteins in this group were 
involved in the regulation of cell growth (GRB2), structure (ACTB) and apoptosis 
(ENO1) in culture.  
 
• Twelve proteins were commonly differentially regulated in both temperature-shifted and 
standard culture indicating the process-dependent changes in expression, except CNN3. 
  
• EIF4A was up regulated in temperature-shifted cultures. EIF4A is a critical factor for 
both cap-dependent and independent translation pathways. Inhibition of EIF4A with 
siRNAs reduced growth of CHO-K1 cells and total SEAP productivity but increased cell 
specific productivity (Qp) for one of the two siRNAs. By inhibiting EIF4A at the desired 
biomass, it may be possible to increase total productivity of production culture.   
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• HNRPC, down regulated in temperature-shifted biphasic culture, is involved in IRES-
mediated cap-independent protein translation and can regulate cell proliferation. 
Following knockdown of HNRPC at 370C, growth was reduced and Qp and the total 
productivity was improved. The improvement in Qp in temperature-shifted culture was 
more pronounced in comparison to standard culture suggesting that HNRPC may 
improve recombinant protein productivity in a temperature-independent manner. As with 
EIF4A, HNRPC may be an excellent protein target to inhibit at the desired biomass. 
However the effect of the siRNA knockdown at the reduced temperature have yet to be 
established. 
 
• PFN2, up regulated in temperature-shifted culture, is a cytoskeletal protein and required 
for normal actin polymerisation in response to thermal stress. One of the two siRNA 
inhibited PFN2 resulting in reduced cell growth, viability and total productivity. Qp was 
improved due to the inhibition of PFN2 in both temperature-shifted and standard culture 
and as with EIF4A and HNRPC, PFN2 may be a suitable target to inhibit at the desired 
biomass.    
 
• Differential expression profiles of miRNAs for temperature-shifted cultures sampled after 
24hrs or 72hrs compared to 72hrs at 370C revealed up regulation of miR-24 and down 
regulation of miR-7 which was confirmed using qRT-PCR. qRT-PCR analysis further 
showed that expression of miR-7 was gradually reduced from lag and log phase to 
stationary phase. This inhibition was more pronounced in temperature-shifted cells. This 
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indicates that miR-7 could be involved in the regulation of cell growth and productivity in 
a dose-dependent manner. 
 
• Over expression of miR-7 in standard culture resulted in nearly complete growth arrest 
(88%) in SEAP-secreting CHO-K1 cells. The Qp was improved by 116% following over 
expression of miR-7 at 370C but was unchanged in temperature-shifted cultures. This 
suggested that miR-7 may improve recombinant productivity of cells in temperature-
dependent manner. Thus, miR-7 may be an excellent target to regulate the growth and 
improve recombinant protein production in culture once the appropriate biomass is 
achieved in standard cultures. The cell growth arrest, improved culture longevity and Qp 
could result in a significant improvement in the total yield of recombinant protein 
product. 
 
• Over expression of miR-24 reduced growth by 56% in standard culture without affecting 
the viability of culture. It also improved Qp at standard but not in temperature-shifted 
cultures and may be a useful target to over express in standard culture once desired 
biomass is achieved.  
 
• The conditioned medium representing different phases of growth cycle (i.e. lag, log and 
stationary phase) from low serum-adapted CHO-K1 cells was profiled using IMAC30 
and Q10 chromatographic surfaces with SELDI-ToF MS. A total of 24 proteins/peptides 
were observed to be differentially expressed in this investigation. These proteins showed 
differing patterns of expression over culture period. For example, 8.1 kDa protein/peptide 
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was initially secreted into the conditioned media and later was either consumed by the 
cells or degraded by proteolysis. The 11.3 kDa and 14.7 kDa proteins/peptides were 
observed in the stationary phase of culture which possibly could be due to either the 
accumulation of cellular waste arising from cell death or increased biomass in culture. 
The 7.3 kDa protein/peptide was increased over time and could be associated with cell 
number. Identification of these proteins could enable us to identify proteins/peptides that 
may be critical for regulating growth and apoptosis in culture.    
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Future Plans 
 
• SEAP-secreting CHO-K1 cells were adapted to grow in low serum supplemented culture 
medium but will need to be adapted to grow in serum-free culture conditions as serum-
free culture is more relevant to the industrial production process.  
 
• Western blot analysis was performed only for cells siRNA-transfected at standard culture. 
It would be necessary to investigate the expression of protein targets in temperature-
shifted cultures following siRNA transfection to further confirm the efficiency of 
knockdown at reduced temperature using Western blotting.  
 
• The inhibition of expression of EIF4A reduced growth and total productivity of SEAP-
secreting CHO-K1 cells. A pattern of improvement in the cell specific productivity (Qp) 
was also observed, however it was not significant in all cases. Therefore over expression 
of EIF4A in CHO cells could reveal its role in improving recombinant protein production 
at low temperature. 
 
• The inhibition of HNRPC was found to improve the Qp of SEAP-secreting CHO-K1 cells 
in a temperature-independent manner. The development of CHO cells stably expressing 
reduced levels of HNRPC would be ideal to further investigate the role of HNRPC 
towards improved productivity at low temperature.  
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• siRNA 2 for PFN2 exerted opposite effects on growth in temperature-shifted culture 
compared to standard culture. The use of higher concentrations of siRNA 2 or other 
independent siRNA molecules (i.e. 3rd siRNA) for PFN2 should further clarify its impact 
on cell growth at low temperature.  
 
• DPYSL2 and ALDH proteins were identified at more than 1 location on the temperature-
shifted 2D-gels suggesting the possible low temperature-induced post-translational 
modification (PTMs) of these proteins. Analysis of these proteins with LC-MS/MS and 
immunoprecipitation studies could potentially identify PTMs and associated proteins 
involved in the cell signalling pathways induced by low temperature.  
 
• A number of miRNAs (miR-7, miR-21 and miR-24) associated with regulation of cell 
growth were observed to be differentially expressed following temperature-shift. 
However the genomic sequences of these miRNAs for CHO cells have not been reported 
previously. We have published the sequence CHO miRNA, cgr-miR-21. This is the first 
known miRNA from CHO cells to date. Future work includes cloning and sequencing 
miR-7 and miR-24.  
 
• The over expression of miR-7 and miR-24 reduced growth and recombinant protein 
productivity of CHO cells. This proves that controlling the expression of miRNAs holds 
the prospect of modulating several cellular pathways and functions simultaneously and 
temporal expression of these miRNAs could improve efficiency of recombinant protein 
production once suitable biomass has been achieved. Further 2d-DIGE in miR-7 and/or 
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miR-24 over expressing clones could identify protein targets and biological pathways 
modulated by these miRNAs, leading to greater understanding of the regulation of cell 
growth and productivity in culture. In addition, it would be interesting to investigate the 
effects of the over expression or inhibition of these miRNAs in other mammalian cells 
lines including NS0 to see if they have cell-line dependent effects. This might open the 
possibility of implementing these miRNAs in other expression systems (i.e. NS0) or 
medico-biological fields such as tissue storage etc.   
 
• Twenty-four secreted proteins/peptides were observed to be differentially regulated in the 
conditioned media of CHO-K1 cells in different phases of growth cycle (i.e. lag, log and 
stationary phase). Of these proteins, the level of 8.1 kDa protein/peptide was initially 
increased and latter reduced in culture either due to consumption by cells or by 
proteolysis. Identification of this protein could lead to understand the role of 8.1kDa 
protein/peptide in regulation of cell growth or increased proteolytic activity in culture. 
The expression of 7.3 kDa protein/peptide was increased over time and could be 
associated with cell number. This protein/peptide may be used as a highly sensitive 
indicator of cell growth in culture. Apart from these proteins/peptides, a numbers of 
proteins were observed to accumulate in medium in the late-stage of culture, possibly due 
to either cellular waste accumulation arising from cell death or increased biomass in 
culture over time. Identification of these proteins could enable us to identify apoptosis-
related or stress-related proteins.  
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• Differential profiling of secreted proteins for culture incorporating temperature-shift 
using SELDI-ToF MS followed by identification of differentially expressed 
protein/peptides using LC-MS/MS could enable us to identify temperature-dependent 
secreted proteins that may have role in regulation of growth and recombinant protein 
productivity in culture. This information would be useful to design better strategy to 
improve efficiency of production process.    
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